Varagon Capital 10-K 25 Mar 24 2023 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2023	Mar. 25, 2024
Cover [Abstract]
Document Type	10-K
Amendment Flag	false
Document Period End Date	Dec. 31, 2023
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	FY
Entity Registrant Name	VARAGON CAPITAL CORPORATION
Entity Central Index Key	0001784700
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Common Stock, Shares Outstanding		41,511,677
Entity Public Float	$ 0
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Shell Company	false
Entity File Number	814-01538
Entity Incorporation, State or Country Code	MD
Entity Tax Identification Number	30-1206578
Entity Address, Address Line One	151 West 42nd Street
Entity Address, Address Line Two	53rd Floor
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10036
City Area Code	212
Local Phone Number	235-2600
Document Annual Report	true
Document Transition Report	false
ICFR Auditor Attestation Flag	false
Document Financial Statement Error Correction [Flag]	false
Documents Incorporated by Reference [Text Block]	Portions of the registrant’s Proxy Statement for its 2024 Annual Meeting of Shareholders to be filed not later than 120 days after the end of the fiscal year are incorporated by reference into Part III of the Annual Report on Form 10-K for the fiscal year ended December 31, 2023.
Auditor Name	Ernst & Young LLP
Auditor Firm ID	42
Auditor Location	Dallas, Texas

CONSOLIDATED STATEMENTS OF ASSE

CONSOLIDATED STATEMENTS OF ASSETS AND LIABILITIES - USD ($) $ in Thousands		Dec. 31, 2023	Dec. 31, 2022
Investments, at fair value
Fair Value		$ 686,037	$ 666,136
Total investments, at fair value (amortized cost of $698,613 and $678,695, respectively)		686,037	666,136
Cash		19,976	20,416
Interest receivable		11,263	9,271
Deferred financing costs		2,649	3,572
Prepaid expenses		416	694
Other assets		21	83
Total assets		720,362	700,172
LIABILITIES
Revolving credit facility payable (Note 6)		241,670	270,500
Notes payable (net of debt issuance costs of $362, and $0, respectively) (Note 6)		49,638	0
Fronting amount payable (Note 7)		0	8,000
Shareholder distributions payable		14,950	9,978
Derivative contracts payable, at fair value		91	0
Interest and credit facility fees payable		5,002	4,367
Base management fees payable (Note 7)		1,286	1,264
Income incentive fees payable (Note 7)		2,207	473
Administrator expenses payable		287	295
Directors' fees and expenses payable (Note 9)		82	84
Due to affiliates		859	783
Accounts payable and accrued expenses		1,140	751
Total liabilities		317,212	296,495
Commitments and contingencies (Note 8)
Net Assets
Common stock, $0.01 par value; 500,000,000 shares authorized; 41,505,531 shares issued and outstanding at December 31, 2023, and 500,000,000 shares authorized; 41,490,642 shares issued and outstanding at December 31, 2022		415	415
Paid-in capital in excess of par value		414,985	414,868
Total accumulated earnings (loss)		(12,250)	(11,606)
Total net assets	[1],[2]	$ 403,150	$ 403,677
NET ASSETS PER SHARE	[1],[2]	$ 9.71	$ 9.73	[3]
Non-controlled, Non-affiliated Investments
Investments, at fair value
Fair Value		$ 501,552	$ 487,769
Controlled, Investments
Investments, at fair value
Fair Value		$ 184,485	$ 178,367
[1] (1) The per share data for 2023 was derived by using the weighted average shares outstanding. The per share data for 2022 was derived by using the weighted average shares outstanding from June 2, 2022 (commencement of investment operations) through December 31, 2022. (2) Per share data for the year ended December 31, 2022 based upon the weighted average shares outstanding from March 29, 2022 (first issuance of common stock) through December 31, 2022 were as follows: Net investment income of $ 0.71 per share, net unrealized loss of $ 0.30 per share, net increase in net assets resulting from operations of $ 0.41 per share, distributions of net investment income of $ 0.68 per share, and net asset value per share at the end of the period of $ 9.73 per share. (3) Net asset value at the beginning of the period from June 2, 2022 (commencement of investment operations) through December 31, 2022 is adjusted to reverse the initial share issuance of 100 shares of common stock in connection with the Company's seed audit, as well as $ 81,049 of accrued expenses. Net asset value after the Company's seed audit was $( 810.39 ) per share.

CONSOLIDATED STATEMENTS OF AS_2

CONSOLIDATED STATEMENTS OF ASSETS AND LIABILITIES (Parenthetical) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Amortized Cost	$ 698,613	$ 678,695
Debt issuance costs	$ 362	$ 0
Common Stock, Par or Stated Value Per Share	$ 0.01	$ 0.01
Common Stock, Shares Authorized	500,000,000	500,000,000
Common stock, Shares issued	41,505,531	41,490,642
Common Stock, Shares, Outstanding	41,505,531	41,490,642
Non-controlled, Non-affiliated Investments
Amortized Cost	$ 510,142	$ 496,688
Controlled, Investments
Amortized Cost	$ 188,471	$ 182,007

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2023		Dec. 31, 2022
Investment income:
Total investment income		$ 82,549		$ 38,229
Expenses:
Base management fees (Note 7)		5,081		2,818
Income incentive fees (Note 7)		6,035		1,329
Professional fees		2,295		1,254
Administrator expenses		1,188		728
Interest expenses (Note 6)		21,187		8,191
Credit facility fees (Note 6)		2,676		1,146
Directors fees and expenses (Note 9)		339		349
Organizational expenses		378		187
Insurance expenses		385		240
Other general and administrative expenses		344		124
Total expenses before taxes		39,908		16,366
Net investment income before taxes		42,641		21,863
Excise tax expense		2		62
Net investment income (loss)		42,639		21,801
Net realized gain (loss) on investments		(289)		0
Net Change In Unrealized Appreciation Depreciation On Investments [Abstract]
Net change in unrealized appreciation (depreciation) on investments		(17)		(12,559)
Net change in unrealized appreciation (depreciation) on derivatives		(91)		0
Net change in unrealized appreciation (depreciation)		(108)		(12,559)
Net realized and unrealized gains (losses)		(397)		(12,559)
Net increase (decrease) in net assets resulting from operations		$ 42,242		$ 9,242
Per Common Share Information:
Weighted average shares outstanding, Basic	[3]	41,499,392	[1],[2]	39,848,927
Weighted average shares outstanding, Diluted		41,499,392	[1],[2]	39,848,927
Net investment income per share basic	[4]	$ 1.03		$ 0.55
Net investment income per share diluted	[4]	1.03		0.55
Earnings per share basic	[3],[4]	1.02		0.23
Earnings per share diluted	[3],[4]	$ 1.02		$ 0.23
Non-controlled, Non-affiliated Investments
Investment income:
Interest income		$ 55,932		$ 25,020
Fee income		684		332
Total investment income		56,616		25,352
Expenses:
Net realized gain (loss) on investments		(289)		0
Net Change In Unrealized Appreciation Depreciation On Investments [Abstract]
Net change in unrealized appreciation (depreciation) on investments		329		(8,919)
Controlled, Investments
Investment income:
Interest income		25,933		12,877
Total investment income		25,933		12,877
Net Change In Unrealized Appreciation Depreciation On Investments [Abstract]
Net change in unrealized appreciation (depreciation) on investments		$ (346)		$ (3,640)
[1] (10) Weighted average common shares outstanding for the year ended December 31, 2022 was 30,531,755 , calculated from March 29, 2022 (first issuance of shares of common stock) through December 31, 2022. (9) Calculated for the period from June 2, 2022 (the commencement of investment operations) through December 31, 2022. (1) Per share data for the year ended December 31, 2022 was derived by using the weighted average shares outstanding from the June 2, 2022 (commencement of investment operations) through December 31, 2022 and does not include the 100 shares issued in connection with the Company's seed audit on March 29, 2022 that were subsequently redeemed on June 2, 2022 in connection with the Merger. Per share data was derived by using the weighted average shares outstanding from the June 2, 2022 (commencement of investment operations) through December 31, 2022 and does not include the 100 shares issued in connection with the Company's seed audit on March 29, 2022 that were subsequently redeemed on June 2, 2022 in connection with the merger of Varagon Fund I, L.P. with and into the Company, with the Company as the surviving entity in the merger.

CONSOLIDATED STATEMENTS OF OP_2

CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical)	Mar. 29, 2022 shares
Redeemable shares issued	100

CONSOLIDATED STATEMENTS OF CHAN

CONSOLIDATED STATEMENTS OF CHANGES IN NET ASSETS - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2023		Dec. 31, 2022
Beginning balance, shares	[1],[2]	41,490,642
Begining balance,value		$ 403,677		$ 0
Net investment income (loss)		42,639		21,801
Net realized gains/(losses) on investments		(289)		0
Net change in unrealized appreciation (depreciation) on investments		(17)		(12,559)
Net change in unrealized appreciation (depreciation) on derivatives		(91)		0
Issuance of common stock				415,305
Issuance of common shares pursuant to distribution reinvestment plan		147		40
Distributions to shareholders		42,916		20,910
Total increase (decrease) value		$ (527)		$ 403,677
Ending balance, shares	[1],[2]	41,505,531		41,490,642
Ending balance,value		$ 403,150		$ 403,677
Common Stock
Beginning balance, shares		41,490,642		0
Begining balance,value	[3]	$ 415		$ 0
Issuance of common stock	[3]			$ 415
Issuance of common stock, shares				41,486,827
Issuance of common shares pursuant to distribution reinvestment plan, shares		14,889		3,915
Redemption of common stock, shares				(100)
Total increase (decrease), shares		14,889		41,490,642
Total increase (decrease) value	[3]			$ 415
Ending balance, shares		41,505,531		41,490,642
Ending balance,value	[3]	$ 415		$ 415
Paid in Capital in Excess of Par
Begining balance,value	[3]	414,868		0
Issuance of common stock	[3]			414,890
Issuance of common shares pursuant to distribution reinvestment plan	[3]	147		40
Tax reclassification of net assets		(30)	[3]	(62)
Total increase (decrease) value	[3]	117		414,868
Ending balance,value	[3]	414,985		414,868
Accumulated earnings (losses)
Begining balance,value		(11,606)	[3]	0
Net investment income (loss)		42,639		21,801
Net realized gains/(losses) on investments		(289)
Net change in unrealized appreciation (depreciation) on investments		(17)		(12,559)
Net change in unrealized appreciation (depreciation) on derivatives		(91)
Distributions to shareholders		(42,916)		(20,910)
Tax reclassification of net assets		30		62
Total increase (decrease) value	[3]	(644)		(11,606)
Ending balance,value	[3]	$ (12,250)		$ (11,606)
[1] (1) The per share data for 2023 was derived by using the weighted average shares outstanding. The per share data for 2022 was derived by using the weighted average shares outstanding from June 2, 2022 (commencement of investment operations) through December 31, 2022. (2) Per share data for the year ended December 31, 2022 based upon the weighted average shares outstanding from March 29, 2022 (first issuance of common stock) through December 31, 2022 were as follows: Net investment income of $ 0.71 per share, net unrealized loss of $ 0.30 per share, net increase in net assets resulting from operations of $ 0.41 per share, distributions of net investment income of $ 0.68 per share, and net asset value per share at the end of the period of $ 9.73 per share. (1) Par Amount and Paid in Capital in Excess of Par were both less than $ 1,000 for the periods shown above.

CONSOLIDATED STATEMENTS OF CH_2

CONSOLIDATED STATEMENTS OF CHANGES IN NET ASSETS (Parenthetical) $ in Thousands	12 Months Ended
	Dec. 31, 2023 USD ($)
Statement of Stockholders' Equity [Abstract]
Adjustments to additional paid in capital, dividends in excess of retained earnings.	$ 1,000

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities:
Net increase (decrease) in net assets resulting from operations		$ 42,242	$ 9,242
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:
Purchases of investments	[1]	(89,894)	(587,666)
Payment-in-kind and other adjustments to cost		574	(265)
Repayments of investments		70,951	52,772
Net realized (gain) loss		289	0
Net change in unrealized (appreciation) depreciation on investments		17	12,559
Net change in unrealized (appreciation) depreciation on derivatives		91	0
Net amortization (accretion) on investments		(1,838)	(1,401)
Amortization of deferred financing costs		2,120	471
Changes in operating assets:
Interest receivable		(1,992)	(9,271)
Prepaid expenses		278	(694)
Other assets		62	(83)
Changes in operating liabilities:
Interest and credit facility fees payable		635	4,367
Base management fees payable		22	1,264
Income incentive fees payable		1,734	473
Administrator expenses payable		(8)	295
Directors' fees and expenses payable (Note 9)		(2)	84
Due to affiliates		76	783
Accounts payable and accrued expenses		389	751
Net cash provided by (used in) operating activities		25,746	(516,319)
Cash flows from financing activities:
Proceeds from issuance of common stock	[1]	0	273,170
Redemption of common stock	[2]	0	0
Borrowings on debts		124,614	290,500
Repayments of debts		(111,444)	(12,000)
Financing costs paid		(1,559)	(4,043)
Dividends paid in cash		(37,797)	(10,892)
Net cash provided by (used in) financing activities		(26,186)	536,735
Net increase (decrease) in cash		(440)	20,416
Cash, beginning of period		20,416	0
Cash, end of period		19,976	20,416
Supplemental cash information:
Cash paid during the period for interest		21,108	4,499
Cash paid during the period for taxes		64	0
Supplemental non cash information:
Non-cash purchase of investments		0	142,135
Distributions reinvested		$ 147	$ 40
[1] (1) Not inclusive of non-cash purchase of investment during the year ended December 31, 2022. (2) Proceeds from the redemption of common stock for the year ended December 31, 2022 were less than $ 1,000 .

CONSOLIDATED STATEMENTS OF CA_2

CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) $ in Thousands	12 Months Ended
	Dec. 31, 2022 USD ($)
Minimum
Proceeds from redemption of common stock	$ 1,000

CONSOLIDATED SCHEDULE OF INVEST

CONSOLIDATED SCHEDULE OF INVESTMENTS - USD ($)		12 Months Ended
		Dec. 31, 2023		Dec. 31, 2022
Schedule of Investments [Line Items]
Amortized Cost		$ 698,613,000		$ 678,695,000
Fair Value		686,037,000		666,136,000
Notional Amount		50,000,000
Derivative contracts payable, at fair value		91,000		$ 0
Interest Rate Swap
Schedule of Investments [Line Items]
Notional Amount		50,000,000
Derivative contracts payable, at fair value		(91,000)
Upfront Payments / Receipts		0
Unrealized Appreciation / (Depreciation)		$ (91,000)
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Industry Health Care Providers & Services, Senior Secured First Lien Loans, Company SGA Dental Partners Opco, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+ 6.00%, Interest Rate 10.77%, Maturity 12/30/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[2],[3],[4],[5]			6%
Interest Rate *	[1],[2],[3],[4],[5],[6]			10.77%
Maturity	[1],[2],[3],[4],[5]			Dec. 30, 2026
Principal	[1],[2],[3],[4],[5]			$ 118
Amortized Cost	[1],[2],[3],[4],[5],[7]			114,000
Fair Value	[1],[2],[3],[4],[5]			$ 109,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services, Company ADPD Holdings, LLC, Type of Investment Revolver, Reference Rate and Spread SOFR+6.00%, Interest Rate 11.68%, Maturity 08/16/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[9],[10],[11],[12]	6%
Interest Rate *	[8],[9],[10],[11],[12],[13]	11.68%
Maturity	[8],[9],[10],[11],[12]	Aug. 16, 2028
Principal	[8],[9],[10],[11],[12]	$ 2
Amortized Cost	[8],[9],[10],[11],[12],[14]	2,000
Fair Value	[8],[9],[10],[11],[12]	$ 1,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services, Company Any Hour LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.75%, Interest Rate 11.23%, Maturity 07/21/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5.75%
Interest Rate *	[8],[10],[12],[13],[15]	11.23%
Maturity	[8],[10],[12],[15]	Jul. 21, 2027
Principal	[8],[10],[12],[15]	$ 7,396
Amortized Cost	[8],[10],[12],[14],[15]	7,285,000
Fair Value	[8],[10],[12],[15]	$ 7,304,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services, Company North Haven Stallone Buyer, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.50%, Interest Rate 11.14%, Maturity 05/24/27 Three
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12],[16]	5.50%
Interest Rate *	[8],[9],[10],[11],[12],[13]	11.14%
Maturity	[8],[9],[10],[11],[12]	May 24, 2027
Principal	[8],[9],[10],[11],[12]	$ 0
Amortized Cost	[8],[9],[10],[11],[12],[14]	0
Fair Value	[8],[9],[10],[11],[12]	$ 0
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services, Company North Haven Stallone Buyer, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.50%, Interest Rate 11.14%, Maturity 05/24/27 Two
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	5.50%
Interest Rate *	[8],[10],[11],[12],[13]	11.14%
Maturity	[8],[10],[11],[12]	May 24, 2027
Principal	[8],[10],[11],[12]	$ 1
Amortized Cost	[8],[10],[11],[12],[14]	1,000
Fair Value	[8],[10],[11],[12]	$ 1,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services, Company North Haven Stallone Buyer, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.50%, Interest Rate 11.33%, Maturity 05/24/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	5.50%
Interest Rate *	[8],[10],[11],[12],[13]	11.33%
Maturity	[8],[10],[11],[12]	May 24, 2027
Principal	[8],[10],[11],[12]	$ 1
Amortized Cost	[8],[10],[11],[12],[14]	1,000
Fair Value	[8],[10],[11],[12]	$ 1,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services, Company North Haven Stallone Buyer, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.50%, Interest Rate 11.41%, Maturity 05/24/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	5.50%
Interest Rate *	[8],[10],[11],[12],[13]	11.41%
Maturity	[8],[10],[11],[12]	May 24, 2027
Principal	[8],[10],[11],[12]	$ 3
Amortized Cost	[8],[10],[11],[12],[14]	3,000
Fair Value	[8],[10],[11],[12]	$ 3,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Equipment & Supplies, Company Zavation Medical Products, LLC, Type of Investment Term Loan, Reference Rate and Spread LIBOR+4.50%, Interest Rate 9.23%, Maturity 06/30/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			4.50%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.23%
Maturity	[1],[3],[4],[5],[17]			Jun. 30, 2027
Principal	[1],[3],[4],[5],[17]			$ 4,962
Amortized Cost	[1],[3],[4],[5],[7],[17]			4,918,000
Fair Value	[1],[3],[4],[5],[17]			$ 4,776,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company SGA Dental Partners Opco, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+ 6.00%, Interest Rate 10.82%, Maturity 12/30/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[2],[3],[4],[5]			6%
Interest Rate *	[1],[2],[3],[4],[5],[6]			10.82%
Maturity	[1],[2],[3],[4],[5]			Dec. 30, 2026
Principal	[1],[2],[3],[4],[5]			$ 506
Amortized Cost	[1],[2],[3],[4],[5],[7]			489,000
Fair Value	[1],[2],[3],[4],[5]			$ 470,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Professional Services, Company The Chartis Group, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread LIBOR+5.00%, Interest Rate 9.76%, Maturity 05/01/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5]			5%
Interest Rate *	[1],[3],[4],[5],[6]			9.76%
Maturity	[1],[3],[4],[5]			May 01, 2025
Principal	[1],[3],[4],[5]			$ 826
Amortized Cost	[1],[3],[4],[5],[7]			816,000
Fair Value	[1],[3],[4],[5]			$ 805,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Software, Company TimeClock Plus, LLC, Type of Investment Term Loan, Reference Rate and Spread LIBOR+5.25%, Interest Rate 9.98%, Maturity 08/28/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.25%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.98%
Maturity	[1],[3],[4],[5],[17]			Aug. 28, 2026
Principal	[1],[3],[4],[5],[17]			$ 6,530
Amortized Cost	[1],[3],[4],[5],[7],[17]			6,516,000
Fair Value	[1],[3],[4],[5],[17]			6,400,000
Investment, Identifier [Axis]: Controlled Investments, Industry Investment Funds and Vehicles
Schedule of Investments [Line Items]
Amortized Cost	[1],[4],[5],[7],[18]			182,007,000
Fair Value	[1],[4],[5],[18]			$ 178,367,000
Percentage of Net Assets ^	[1],[4],[5],[18],[19]			44.19%
Investment, Identifier [Axis]: Controlled Investments, Industry Investment Funds and Vehicles, Company Senior Direct Lending Program, LLC, Type of Investment Limited Partnership Units, Reference Rate and Spread LIBOR + 8.00%, Interest Rate 12.77%, Maturity 12/31/36
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[2],[4],[5],[18],[20],[21]			8%
Interest Rate *	[1],[2],[4],[5],[6],[18],[20],[21]			12.77%
Maturity	[1],[2],[4],[5],[18],[20],[21]			Dec. 31, 2036
Amortized Cost	[1],[2],[4],[5],[7],[18],[20],[21]			$ 182,007,000
Fair Value	[1],[2],[4],[5],[18],[20],[21]			178,367,000
Investment, Identifier [Axis]: Controlled Investments, Industry Investment Funds and Vehicles, Company Senior Direct Lending Program, LLC, Type of Investment Limited Partnership Units, Reference Rate and Spread SOFR + 8.00%, Interest Rate 14.25%, Maturity 12/31/36
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[9],[12],[22],[23]	8%
Interest Rate *	[8],[9],[12],[13],[22],[23],[24]	14.25%
Maturity	[8],[9],[12],[22],[23],[24]	Dec. 31, 2036
Principal	[8],[9],[12],[22],[23],[24]	$ 189,701
Amortized Cost	[8],[9],[12],[14],[22],[23],[24]	188,471,000
Fair Value	[8],[9],[12],[22],[23],[24]	$ 184,485,000
Investment, Identifier [Axis]: Interest Rate Swap, Maturity Date December 21, 2026 Derivatives
Schedule of Investments [Line Items]
Company Receives	[25]	8.10%
Investment, Variable Interest Rate, Type [Extensible Enumeration]		USD-SOFR-Compound Plus Four Point Two Zero Two Percentage [Member]
Securities Borrowed, Counterparty Name [Extensible Enumeration]		CIBC Bank USA [Member]
Maturity Date	[25]	Dec. 21, 2026
Notional Amount	[25]	$ 25,000,000
Derivative contracts payable, at fair value	[25]	(20,000)
Upfront Payments / Receipts	[25]	0
Unrealized Appreciation / (Depreciation)	[25]	$ (20,000)
Investment, Identifier [Axis]: Interest Rate Swap, Maturity Date December 21, 2028 Derivatives
Schedule of Investments [Line Items]
Company Receives	[25]	8.20%
Investment, Variable Interest Rate, Type [Extensible Enumeration]		USD-SOFR-Compound Plus Four Point Five Five Zero Percentage [Member]
Securities Borrowed, Counterparty Name [Extensible Enumeration]		CIBC Bank USA [Member]
Maturity Date	[25]	Dec. 21, 2028
Notional Amount	[25]	$ 25,000,000
Derivative contracts payable, at fair value	[25]	(71,000)
Upfront Payments / Receipts	[25]	0
Unrealized Appreciation / (Depreciation)	[25]	$ (71,000)
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Equity Chemicals, Company Techmer BB Aggregator, LP, Type of Investment Limited Partnership Units
Schedule of Investments [Line Items]
Units/shares	[8],[11],[12],[26]	333
Amortized Cost	[8],[11],[12],[14],[26]	$ 333,000
Fair Value	[8],[11],[12],[26]	250,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Equity, Industry Auto Components
Schedule of Investments [Line Items]
Amortized Cost		500,000	[8],[12],[14]	500,000	[1],[4],[5],[7]
Fair Value		$ 607,000	[8],[12]	$ 500,000	[1],[4],[5]
Percentage of Net Assets ^		0.15%	[8],[12],[27]	0.12%	[1],[4],[5],[19]
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Equity, Industry Auto Components, Company M&D Parent Holdings, LLC, Type of Investment Class B Units
Schedule of Investments [Line Items]
Units/shares	[8],[11],[12],[26]	5,000
Principal	[5]			$ 500,000
Amortized Cost		$ 500,000	[8],[11],[12],[14],[26]	500,000	[1],[4],[5],[7],[28]
Fair Value		607,000	[8],[11],[12],[26]	500,000	[1],[4],[5],[28]
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Equity, Industry Chemicals
Schedule of Investments [Line Items]
Amortized Cost		1,138,000	[8],[12],[14]	1,138,000	[1],[4],[5],[7]
Fair Value		$ 1,055,000	[8],[12]	$ 1,138,000	[1],[4],[5]
Percentage of Net Assets ^		0.26%	[8],[12],[27]	0.28%	[1],[4],[5],[19]
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Equity, Industry Chemicals, Company MDI Aggregator LP, Type of Investment Common Units
Schedule of Investments [Line Items]
Units/shares	[8],[11],[12],[16],[26]	8,046
Principal	[5],[29]			$ 8,046
Amortized Cost		$ 805,000	[8],[11],[12],[14],[16],[26]	805,000	[1],[4],[5],[7],[28],[29]
Fair Value		805,000	[8],[11],[12],[16],[26]	805,000	[1],[4],[5],[28],[29]
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Equity, Industry Chemicals, Company Techmer BB Aggregator, LP, Type of Investment Limited Partnership Units
Schedule of Investments [Line Items]
Principal	[5]			333
Amortized Cost	[1],[4],[5],[7],[28]			333,000
Fair Value	[1],[4],[5],[28]			333,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Equity, Industry Commercial Services & Supplies
Schedule of Investments [Line Items]
Amortized Cost		300,000	[8],[12],[14]	300,000	[1],[4],[5],[7]
Fair Value		$ 318,000	[8],[12]	$ 300,000	[1],[4],[5]
Percentage of Net Assets ^		0.08%	[8],[12],[27]	0.07%	[1],[4],[5],[19]
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Equity, Industry Commercial Services & Supplies, Company RFI Group Holdings, L.P, Type of Investment Class A Units
Schedule of Investments [Line Items]
Units/shares	[8],[11],[12],[26]	3,000
Principal	[5]			$ 3,000
Amortized Cost		$ 300,000	[8],[11],[12],[14],[26]	300,000	[1],[4],[5],[7],[28]
Fair Value		318,000	[8],[11],[12],[26]	300,000	[1],[4],[5],[28]
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Equity, Industry Containers & Packaging
Schedule of Investments [Line Items]
Amortized Cost		550,000	[8],[12],[14]	500,000	[1],[4],[5],[7]
Fair Value		$ 476,000	[8],[12]	$ 500,000	[1],[4],[5]
Percentage of Net Assets ^		0.12%	[8],[12],[27]	0.12%	[1],[4],[5],[19]
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Equity, Industry Containers & Packaging, Company Oliver Investors, LP Type of Investment Class A Units
Schedule of Investments [Line Items]
Units/shares	[8],[11],[12],[26]	5,500
Principal	[5]			$ 5,500
Amortized Cost		$ 550,000	[8],[11],[12],[14],[26]	500,000	[1],[4],[5],[7],[28]
Fair Value		476,000	[8],[11],[12],[26]	500,000	[1],[4],[5],[28]
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Equity, Industry Diversified Consumer Services
Schedule of Investments [Line Items]
Amortized Cost		500,000	[8],[12],[14]	500,000	[1],[4],[5],[7]
Fair Value		$ 307,000	[8],[12]	$ 500,000	[1],[4],[5]
Percentage of Net Assets ^		0.08%	[8],[12],[27]	0.12%	[1],[4],[5],[19]
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Equity, Industry Diversified Consumer Services, Company FS NU Investors, LP, Type of Investment Class A Units
Schedule of Investments [Line Items]
Units/shares	[8],[11],[12],[26]	5,000
Principal	[5]			$ 5,000
Amortized Cost		$ 500,000	[8],[11],[12],[14],[26]	500,000	[1],[4],[5],[7],[28]
Fair Value		307,000	[8],[11],[12],[26]	500,000	[1],[4],[5],[28]
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Equity, Industry Health Care Technology
Schedule of Investments [Line Items]
Amortized Cost		500,000	[8],[12],[14]	500,000	[1],[4],[5],[7]
Fair Value		$ 485,000	[8],[12]	$ 500,000	[1],[4],[5]
Percentage of Net Assets ^		0.12%	[8],[12],[27]	0.12%	[1],[4],[5],[19]
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Equity, Industry Health Care Technology, Company BRG Group Holdings, LLC, Type of Investment Class A Units
Schedule of Investments [Line Items]
Units/shares	[8],[11],[12],[26]	500,000
Principal	[5]			$ 500,000
Amortized Cost		$ 500,000	[8],[11],[12],[14],[26]	500,000	[1],[4],[5],[7],[28]
Fair Value		485,000	[8],[11],[12],[26]	500,000	[1],[4],[5],[28]
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Equity, Industry Personal Products
Schedule of Investments [Line Items]
Amortized Cost		501,000	[8],[12],[14]	500,000	[1],[4],[5],[7]
Fair Value		$ 393,000	[8],[12]	$ 500,000	[1],[4],[5]
Percentage of Net Assets ^		0.10%	[8],[12],[27]	0.12%	[1],[4],[5],[19]
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Equity, Industry Personal Products, Company KLC Fund 1-C1 LP, Type of Investment Limited Partnership Units
Schedule of Investments [Line Items]
Units/shares	[8],[11],[12],[26]	500,000
Principal	[5],[29]			$ 500,000
Amortized Cost		$ 501,000	[8],[11],[12],[14],[26]	500,000	[1],[4],[5],[7],[28],[29]
Fair Value		393,000	[8],[11],[12],[26]	500,000	[1],[4],[5],[28],[29]
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Aerospace & Defense
Schedule of Investments [Line Items]
Amortized Cost		28,706,000	[8],[12],[14]	27,894,000	[1],[4],[5],[7]
Fair Value		$ 28,341,000	[8],[12]	$ 27,316,000	[1],[4],[5]
Percentage of Net Assets ^		7.03%	[8],[12],[27]	6.77%	[1],[5],[18],[19]
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Aerospace & Defense, Company AIM Acquisition, LLC, Type of Investment Term Loan, Reference Rate and Spread LIBOR+5.25%, Interest Rate 10.46%, Maturity 12/02/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.25%
Interest Rate *	[1],[3],[4],[5],[6],[17]			10.46%
Maturity	[1],[3],[4],[5],[17]			Dec. 02, 2025
Principal	[1],[3],[4],[5],[17]			$ 11,000
Amortized Cost	[1],[3],[4],[5],[7],[17]			10,746,000
Fair Value	[1],[3],[4],[5],[17]			$ 10,560,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Aerospace & Defense, Company AIM Acquisition, LLC,Type of Investment Term Loan, Reference Rate and Spread SOFR+5.00%, Interest Rate 10.49%, Maturity 12/02/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5%
Interest Rate *	[8],[10],[12],[13],[15]	10.49%
Maturity	[8],[10],[12],[15]	Dec. 02, 2025
Principal	[8],[10],[12],[15]	$ 11,000
Amortized Cost	[8],[10],[12],[14],[15]	10,819,000
Fair Value	[8],[10],[12],[15]	$ 10,780,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Aerospace & Defense, Company Air Comm Corporation LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.00%, Interest Rate 10.45%, Maturity 07/01/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5%
Interest Rate *	[8],[10],[12],[13],[15]	10.45%
Maturity	[8],[10],[12],[15]	Jul. 01, 2027
Principal	[8],[10],[12],[15]	$ 3,543
Amortized Cost	[8],[10],[12],[14],[15]	3,523,000
Fair Value	[8],[10],[12],[15]	$ 3,410,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Aerospace & Defense, Company Air Comm Corporation LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.00%, Interest Rate 10.45%, Maturity 07/01/27 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5%
Interest Rate *	[8],[10],[12],[13],[15]	10.45%
Maturity	[8],[10],[12],[15]	Jul. 01, 2027
Principal	[8],[10],[12],[15]	$ 1,133
Amortized Cost	[8],[10],[12],[14],[15]	1,127,000
Fair Value	[8],[10],[12],[15]	$ 1,091,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Aerospace & Defense, Company Air Comm Corporation LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR+5.00%, Interest Rate 10.45%, Maturity 07/01/27 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5%
Interest Rate *	[8],[10],[12],[13],[15]	10.45%
Maturity	[8],[10],[12],[15]	Jul. 01, 2027
Principal	[8],[10],[12],[15]	$ 1,657
Amortized Cost	[8],[10],[12],[14],[15]	1,648,000
Fair Value	[8],[10],[12],[15]	$ 1,595,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Aerospace & Defense, Company Air Comm Corporation, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread LIBOR+5.50%, Interest Rate 10.23%, Maturity 07/01/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.50%
Interest Rate *	[1],[3],[4],[5],[6],[17]			10.23%
Maturity	[1],[3],[4],[5],[17]			Jul. 01, 2027
Principal	[1],[3],[4],[5],[17]			$ 3,579
Amortized Cost	[1],[3],[4],[5],[7],[17]			3,554,000
Fair Value	[1],[3],[4],[5],[17]			$ 3,480,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Aerospace & Defense, Company Air Comm Corporation, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread LIBOR+5.50%, Interest Rate 10.23%, Maturity 07/01/27 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.50%
Interest Rate *	[1],[3],[4],[5],[6],[17]			10.23%
Maturity	[1],[3],[4],[5],[17]			Jul. 01, 2027
Principal	[1],[3],[4],[5],[17]			$ 1,145
Amortized Cost	[1],[3],[4],[5],[7],[17]			1,137,000
Fair Value	[1],[3],[4],[5],[17]			$ 1,113,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Aerospace & Defense, Company Air Comm Corporation, LLC, Type of Investment Term Loan, Reference Rate and Spread LIBOR+5.50%, Interest Rate 10.23%, Maturity 07/01/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.50%
Interest Rate *	[1],[3],[4],[5],[6],[17]			10.23%
Maturity	[1],[3],[4],[5],[17]			Jul. 01, 2027
Principal	[1],[3],[4],[5],[17]			$ 1,674
Amortized Cost	[1],[3],[4],[5],[7],[17]			1,663,000
Fair Value	[1],[3],[4],[5],[17]			$ 1,628,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Aerospace & Defense, Company Precinmac (US) Holdings Inc., Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR + 6.00%, Interest Rate 11.46%, Maturity 08/31/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	6%
Interest Rate *	[8],[10],[12],[13],[15]	11.46%
Maturity	[8],[10],[12],[15]	Aug. 31, 2027
Principal	[8],[10],[12],[15]	$ 7,254
Amortized Cost	[8],[10],[12],[14],[15]	7,183,000
Fair Value	[8],[10],[12],[15]	$ 7,109,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Aerospace & Defense, Company Precinmac (US) Holdings Inc., Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+6.00%, Interest Rate 10.42%, Maturity 08/31/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			6%
Interest Rate *	[1],[3],[4],[5],[6],[17]			10.42%
Maturity	[1],[3],[4],[5],[17]			Aug. 31, 2027
Principal	[1],[3],[4],[5],[17]			$ 7,328
Amortized Cost	[1],[3],[4],[5],[7],[17]			7,245,000
Fair Value	[1],[3],[4],[5],[17]			$ 7,071,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Aerospace & Defense, Company Precinmac (US) Holdings Inc., Type of Investment Term Loan, Reference Rate and Spread SOFR + 6.00%, Interest Rate 10.42%, Maturity 08/31/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			6%
Interest Rate *	[1],[3],[4],[5],[6],[17]			10.42%
Maturity	[1],[3],[4],[5],[17]			Aug. 31, 2027
Principal	[1],[3],[4],[5],[17]			$ 3,589
Amortized Cost	[1],[3],[4],[5],[7],[17]			3,549,000
Fair Value	[1],[3],[4],[5],[17]			3,464,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Aerospace & Defense, Company Precinmac (US) Holdings Inc., Type of Investment Term Loan, Reference Rate and Spread SOFR + 6.00%, Interest Rate 11.54%, Maturity 08/31/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	6%
Interest Rate *	[8],[10],[12],[13],[15]	11.54%
Maturity	[8],[10],[12],[15]	Aug. 31, 2027
Principal	[8],[10],[12],[15]	$ 3,553
Amortized Cost	[8],[10],[12],[14],[15]	3,518,000
Fair Value	[8],[10],[12],[15]	$ 3,482,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Aerospace & Defense, Company Trident Maritime Systems, Inc.,Type of Investment Term Loan, Reference Rate and Spread SOFR + 5.50%, Interest Rate 11.00%, Maturity 02/26/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	5.50%
Interest Rate *	[8],[10],[11],[12],[13]	11%
Maturity	[8],[10],[11],[12]	Feb. 26, 2027
Principal	[8],[10],[11],[12]	$ 908
Amortized Cost	[8],[10],[11],[12],[14]	888,000
Fair Value	[8],[10],[11],[12]	874,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Auto Components
Schedule of Investments [Line Items]
Amortized Cost		38,894,000	[8],[12],[14]	42,734,000	[1],[4],[5],[7]
Fair Value		$ 37,078,000	[8],[12]	$ 41,629,000	[1],[4],[5]
Percentage of Net Assets ^		9.19%	[8],[12],[27]	10.31%	[1],[4],[5],[19]
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Auto Components, Company AAMP Global Holdings Inc., Type of Investment Term Loan, Reference Rate and Spread SOFR+5.75%, Interest Rate 10.95%, Maturity 11/05/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5.75%
Interest Rate *	[8],[10],[12],[13],[15]	10.95%
Maturity	[8],[10],[12],[15]	Nov. 05, 2025
Principal	[8],[10],[12],[15]	$ 14,738
Amortized Cost	[8],[10],[12],[14],[15]	14,633,000
Fair Value	[8],[10],[12],[15]	$ 14,516,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Auto Components, Company AAMP Global Holdings, Inc., Type of Investment Term Loan, Reference Rate and Spread LIBOR+5.75%, Interest Rate 10.48%, Maturity 11/05/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.75%
Interest Rate *	[1],[3],[4],[5],[6],[17]			10.48%
Maturity	[1],[3],[4],[5],[17]			Nov. 05, 2025
Principal	[1],[3],[4],[5],[17]			$ 14,888
Amortized Cost	[1],[3],[4],[5],[7],[17]			14,732,000
Fair Value	[1],[3],[4],[5],[17]			$ 14,404,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Auto Components, Company Arrowhead Holdco Company, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+2.50% (2.75% PIK), Interest Rate 10.05%, Maturity 08/31/28 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	2.50%
Interest Rate *	[8],[10],[11],[12],[13]	10.05%
Interest Rate * PIK	[8],[10],[11],[12],[13]	2.75%
Maturity	[8],[10],[11],[12]	Aug. 31, 2028
Principal	[8],[10],[11],[12]	$ 19
Amortized Cost	[8],[10],[11],[12],[14]	19,000
Fair Value	[8],[10],[11],[12]	$ 16,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Auto Components, Company Arrowhead Holdco Company, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+2.50%, Interest Rate 10.05% (2.75% PIK) Maturity 08/31/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	2.50%
Interest Rate *	[8],[10],[11],[12],[13]	10.05%
Interest Rate * PIK	[8],[10],[11],[12],[13]	2.75%
Maturity	[8],[10],[11],[12]	Aug. 31, 2028
Principal	[8],[10],[11],[12]	$ 2,205
Amortized Cost	[8],[10],[11],[12],[14]	2,179,000
Fair Value	[8],[10],[11],[12]	$ 1,846,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Auto Components, Company Arrowhead Holdco Company, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+2.50%, Interest Rate 10.05% (2.75% PIK), Maturity 08/31/28 Two
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	2.50%
Interest Rate *	[8],[10],[11],[12],[13]	10.05%
Interest Rate * PIK	[8],[10],[11],[12],[13]	2.75%
Maturity	[8],[10],[11],[12]	Aug. 31, 2028
Principal	[8],[10],[11],[12]	$ 2,532
Amortized Cost	[8],[10],[11],[12],[14]	2,502,000
Fair Value	[8],[10],[11],[12]	$ 2,120,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Auto Components, Company Arrowhead Holdco Company, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+4.50%, Interest Rate 8.61%, Maturity 08/31/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			4.50%
Interest Rate *	[1],[3],[4],[5],[6],[17]			8.61%
Maturity	[1],[3],[4],[5],[17]			Aug. 31, 2028
Principal	[1],[3],[4],[5],[17]			$ 2,227
Amortized Cost	[1],[3],[4],[5],[7],[17]			2,197,000
Fair Value	[1],[3],[4],[5],[17]			$ 2,127,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Auto Components, Company Arrowhead Holdco Company, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+4.50%, Interest Rate 8.61%, Maturity 08/31/28 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[2],[3],[4],[5]			4.50%
Interest Rate *	[1],[2],[3],[4],[5],[6]			8.61%
Maturity	[1],[2],[3],[4],[5]			Aug. 31, 2028
Principal	[1],[2],[3],[4],[5]			$ 19
Amortized Cost	[1],[2],[3],[4],[5],[7]			19,000
Fair Value	[1],[2],[3],[4],[5]			$ 17,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Auto Components, Company Arrowhead Holdco Company, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+4.50%, Interest Rate 8.61%, Maturity 08/31/28 Two
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			4.50%
Interest Rate *	[1],[3],[4],[5],[6],[17]			8.61%
Maturity	[1],[3],[4],[5],[17]			Aug. 31, 2028
Principal	[1],[3],[4],[5],[17]			$ 2,558
Amortized Cost	[1],[3],[4],[5],[7],[17]			2,523,000
Fair Value	[1],[3],[4],[5],[17]			$ 2,443,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Auto Components, Company Arrowhead Holdco Company, Type of Investment Term Loan, Reference Rate and Spread SOFR+2.50%, Interest Rate 10.05% (2.75% PIK), Maturity 08/31/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	2.50%
Interest Rate *	[8],[10],[11],[12],[13]	10.05%
Interest Rate * PIK	[8],[10],[11],[12],[13]	2.75%
Maturity	[8],[10],[11],[12]	Aug. 31, 2028
Principal	[8],[10],[11],[12]	$ 205
Amortized Cost	[8],[10],[11],[12],[14]	203,000
Fair Value	[8],[10],[11],[12]	$ 172,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Auto Components, Company Arrowhead Holdco Company, Type of Investment Term Loan, Reference Rate and Spread SOFR+4.50%, Interest Rate 8.61%, Maturity 08/31/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			4.50%
Interest Rate *	[1],[3],[4],[5],[6],[17]			8.61%
Maturity	[1],[3],[4],[5],[17]			Aug. 31, 2028
Principal	[1],[3],[4],[5],[17]			$ 207
Amortized Cost	[1],[3],[4],[5],[7],[17]			204,000
Fair Value	[1],[3],[4],[5],[17]			$ 198,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Auto Components, Company Arrowhead Holdco Company, Type of Investment Term Loan, Reference Rate and Spread SOFR+4.50%, Interest Rate 9.05%, Maturity 08/31/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			4.50%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.05%
Maturity	[1],[3],[4],[5],[17]			Aug. 31, 2028
Principal	[1],[3],[4],[5],[17]			$ 1,070
Amortized Cost	[1],[3],[4],[5],[7],[17]			1,055,000
Fair Value	[1],[3],[4],[5],[17]			$ 1,022,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Auto Components, Company M&D Midco Inc, Type of Investment Delayed Draw Term Loan, Interest Rate 0.00%, Maturity 08/31/28
Schedule of Investments [Line Items]
Interest Rate *	[1],[2],[3],[4],[5],[6]			0%
Maturity	[1],[2],[3],[4],[5]			Aug. 31, 2028
Principal	[1],[2],[3],[4],[5]			$ 0
Amortized Cost	[1],[2],[3],[4],[5],[7]			0
Fair Value	[1],[2],[3],[4],[5]			$ (1,000)
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Auto Components, Company M&D Midco, Inc, Type of Investment Revolver, Interest Rate 0.00%, Maturity 08/31/28
Schedule of Investments [Line Items]
Interest Rate *	[1],[2],[3],[4],[5],[6]			0%
Maturity	[1],[2],[3],[4],[5]			Aug. 31, 2028
Principal	[1],[2],[3],[4],[5]			$ 0
Amortized Cost	[1],[2],[3],[4],[5],[7]			0
Fair Value	[1],[2],[3],[4],[5]			$ 0
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Auto Components, Company M&D Midco, Inc, Type of Investment Term Loan, Reference Rate and Spread SOFR+5.75%, Interest Rate 10.70%, Maturity 08/31/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.75%
Interest Rate *	[1],[3],[4],[5],[6],[17]			10.70%
Maturity	[1],[3],[4],[5],[17]			Aug. 31, 2028
Principal	[1],[3],[4],[5],[17]			$ 65
Amortized Cost	[1],[3],[4],[5],[7],[17]			64,000
Fair Value	[1],[3],[4],[5],[17]			$ 64,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Auto Components, Company M&D Midco, Inc., Type of Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.50%, Interest Rate 11.04%, Maturity 08/31/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[9],[10],[11],[12]	5.50%
Interest Rate *	[8],[9],[10],[11],[12],[13]	11.04%
Maturity	[8],[9],[10],[11],[12]	Aug. 31, 2028
Principal	[8],[9],[10],[11],[12]	$ 9
Amortized Cost	[8],[9],[10],[11],[12],[14]	9,000
Fair Value	[8],[9],[10],[11],[12]	$ 9,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Auto Components, Company M&D Midco, Inc., Type of Investment Revolver, Reference Rate and Spread PRIME+4.50%, Interest Rate 13.00%, Maturity 08/31/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[9],[10],[11],[12]	4.50%
Interest Rate *	[8],[9],[10],[11],[12],[13]	13%
Maturity	[8],[9],[10],[11],[12]	Aug. 31, 2028
Principal	[8],[9],[10],[11],[12]	$ 1
Amortized Cost	[8],[9],[10],[11],[12],[14]	1,000
Fair Value	[8],[9],[10],[11],[12]	$ 1,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Auto Components, Company M&D Midco, Inc., Type of Investment Term Loan, Reference Rate and Spread SOFR+5.50%, Interest Rate 11.04%, Maturity 08/31/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	5.50%
Interest Rate *	[8],[10],[11],[12],[13]	11.04%
Maturity	[8],[10],[11],[12]	Aug. 31, 2028
Principal	[8],[10],[11],[12]	$ 65
Amortized Cost	[8],[10],[11],[12],[14]	64,000
Fair Value	[8],[10],[11],[12]	$ 65,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Auto Components, Company M&D Midco, Inc.,Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.50%, Interest Rate 11.01%, Maturity 08/31/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[9],[10],[11],[12]	5.50%
Interest Rate *	[8],[9],[10],[11],[12],[13]	11.01%
Maturity	[8],[9],[10],[11],[12]	Aug. 31, 2028
Principal	[8],[9],[10],[11],[12]	$ 3
Amortized Cost	[8],[9],[10],[11],[12],[14]	3,000
Fair Value	[8],[9],[10],[11],[12]	$ 3,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Auto Components, Company Race Winning Brands, Inc., Type of Investment Term Loan, Reference Rate and Spread LIBOR+ 5.25, Interest Rate 9.63%, Maturity 11/16/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.25%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.63%
Maturity	[1],[3],[4],[5],[17]			Nov. 16, 2027
Principal	[1],[3],[4],[5],[17]			$ 14,925
Amortized Cost	[1],[3],[4],[5],[7],[17]			14,791,000
Fair Value	[1],[3],[4],[5],[17]			$ 14,402,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Auto Components, Company Race Winning Brands, Inc., Type of Investment Term Loan, Reference Rate and Spread SOFR + 5.25%, Interest Rate 10.71%, Maturity 11/16/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5.25%
Interest Rate *	[8],[10],[12],[13],[15]	10.71%
Maturity	[8],[10],[12],[15]	Nov. 16, 2027
Principal	[8],[10],[12],[15]	$ 3,585
Amortized Cost	[8],[10],[12],[14],[15]	3,558,000
Fair Value	[8],[10],[12],[15]	$ 3,316,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Auto Components, Company Race Winning Brands, Inc., Type of Investment Term Loan, Reference Rate and Spread SOFR + 5.25%, Interest Rate 10.71%, Maturity 11/16/27 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5.25%
Interest Rate *	[8],[10],[12],[13],[15]	10.71%
Maturity	[8],[10],[12],[15]	Nov. 16, 2027
Principal	[8],[10],[12],[15]	$ 3,164
Amortized Cost	[8],[10],[12],[14],[15]	3,141,000
Fair Value	[8],[10],[12],[15]	$ 2,927,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Auto Components, Company Race Winning Brands, Inc., Type of Investment Term Loan, Reference Rate and Spread SOFR + 5.25%, Interest Rate 10.71%, Maturity 11/16/27 Three
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5.25%
Interest Rate *	[8],[10],[12],[13],[15]	10.71%
Maturity	[8],[10],[12],[15]	Nov. 16, 2027
Principal	[8],[10],[12],[15]	$ 1,646
Amortized Cost	[8],[10],[12],[14],[15]	1,634,000
Fair Value	[8],[10],[12],[15]	$ 1,523,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Auto Components, Company Race Winning Brands, Inc., Type of Investment Term Loan, Reference Rate and Spread SOFR + 5.25%, Interest Rate 10.71%, Maturity 11/16/27 Two
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5.25%
Interest Rate *	[8],[10],[12],[13],[15]	10.71%
Maturity	[8],[10],[12],[15]	Nov. 16, 2027
Principal	[8],[10],[12],[15]	$ 1,500
Amortized Cost	[8],[10],[12],[14],[15]	1,489,000
Fair Value	[8],[10],[12],[15]	$ 1,387,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Auto Components, Company Race Winning Brands, Inc., Type of Investment Term Loan, Reference Rate and Spread SOFR+ 5.25%, Interest Rate 10.71%, Maturity 11/16/27 Four
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5.25%
Interest Rate *	[8],[10],[12],[13],[15]	10.71%
Maturity	[8],[10],[12],[15]	Nov. 16, 2027
Principal	[8],[10],[12],[15]	$ 1,027
Amortized Cost	[8],[10],[12],[14],[15]	1,019,000
Fair Value	[8],[10],[12],[15]	$ 950,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Auto Components, Company USSC Acquisition Corp, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+6.75%, Interest Rate 11.41%, Maturity 09/30/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[2],[3],[4],[5]			6.75%
Interest Rate *	[1],[2],[3],[4],[5],[6]			11.41%
Maturity	[1],[2],[3],[4],[5]			Sep. 30, 2027
Principal	[1],[2],[3],[4],[5]			$ 83
Amortized Cost	[1],[2],[3],[4],[5],[7]			82,000
Fair Value	[1],[2],[3],[4],[5]			$ 69,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Auto Components, Company USSC Acquisition Corp, Type of Investment Term Loan, Reference Rate and Spread SOFR+6.75%, Interest Rate 11.48%, Maturity 09/30/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			6.75%
Interest Rate *	[1],[3],[4],[5],[6],[17]			11.48%
Maturity	[1],[3],[4],[5],[17]			Sep. 30, 2027
Principal	[1],[3],[4],[5],[17]			$ 7,115
Amortized Cost	[1],[3],[4],[5],[7],[17]			7,067,000
Fair Value	[1],[3],[4],[5],[17]			6,884,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Auto Components, Company USSC Acquisition Corp., Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR + 6.25%, Interest Rate 11.75%, Maturity 09/28/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	6.25%
Interest Rate *	[8],[10],[11],[12],[13]	11.75%
Maturity	[8],[10],[11],[12]	Sep. 28, 2027
Principal	[8],[10],[11],[12]	$ 53
Amortized Cost	[8],[10],[11],[12],[14]	53,000
Fair Value	[8],[10],[11],[12]	$ 52,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Auto Components, Company USSC Acquisition Corp., Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR + 6.25%, Interest Rate 11.77%, Maturity 09/28/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	6.25%
Interest Rate *	[8],[10],[11],[12],[13]	11.77%
Maturity	[8],[10],[11],[12]	Sep. 28, 2027
Principal	[8],[10],[11],[12]	$ 82
Amortized Cost	[8],[10],[11],[12],[14]	82,000
Fair Value	[8],[10],[11],[12]	$ 81,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Auto Components, Company USSC Acquisition Corp., Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR + 6.25%, Interest Rate 11.78%, Maturity 09/28/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	6.25%
Interest Rate *	[8],[10],[11],[12],[13]	11.78%
Maturity	[8],[10],[11],[12]	Sep. 28, 2027
Principal	[8],[10],[11],[12]	$ 184
Amortized Cost	[8],[10],[11],[12],[14]	183,000
Fair Value	[8],[10],[11],[12]	$ 181,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Auto Components, Company USSC Acquisition Corp., Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR + 6.25%, Interest Rate 11.79%, Maturity 09/28/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	6.25%
Interest Rate *	[8],[10],[11],[12],[13]	11.79%
Maturity	[8],[10],[11],[12]	Sep. 28, 2027
Principal	[8],[10],[11],[12]	$ 72
Amortized Cost	[8],[10],[11],[12],[14]	72,000
Fair Value	[8],[10],[11],[12]	$ 71,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Auto Components, Company USSC Acquisition Corp., Type of Investment Term Loan, Reference Rate and Spread SOFR + 6.25%, Interest Rate 11.75%, Maturity 09/28/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	6.25%
Interest Rate *	[8],[10],[12],[13],[15]	11.75%
Maturity	[8],[10],[12],[15]	Sep. 28, 2027
Principal	[8],[10],[12],[15]	$ 7,043
Amortized Cost	[8],[10],[12],[14],[15]	7,004,000
Fair Value	[8],[10],[12],[15]	6,955,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Capital Markets
Schedule of Investments [Line Items]
Amortized Cost		52,000	[8],[12],[14]	36,000	[1],[4],[5],[7]
Fair Value		$ 52,000	[8],[12]	$ 36,000	[1],[4],[5]
Percentage of Net Assets ^		0.01%	[8],[12],[27]	0.01%	[1],[4],[5],[19]
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Capital Markets, Company Adviser Investments, LLC, Type of Investment Delayed Draw Term Loan, Interest Rate 0.00%, Maturity 08/31/28
Schedule of Investments [Line Items]
Interest Rate *	[1],[2],[3],[4],[5],[6]			0%
Maturity	[1],[2],[3],[4],[5]			Aug. 31, 2028
Principal	[1],[2],[3],[4],[5]			$ 0
Amortized Cost	[1],[2],[3],[4],[5],[7]			1,000
Fair Value	[1],[2],[3],[4],[5]			$ (1,000)
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Capital Markets, Company Adviser Investments, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+4.75%, Interest Rate 10.10%, Maturity 08/31/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[9],[10],[11],[12]	4.75%
Interest Rate *	[8],[9],[10],[11],[12],[13]	10.10%
Maturity	[8],[9],[10],[11],[12]	Aug. 31, 2028
Principal	[8],[9],[10],[11],[12]	$ 2
Amortized Cost	[8],[9],[10],[11],[12],[14]	2,000
Fair Value	[8],[9],[10],[11],[12]	$ 2,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Capital Markets, Company Adviser Investments, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+4.75%, Interest Rate 10.15%, Maturity 08/31/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[9],[10],[11],[12]	4.75%
Interest Rate *	[8],[9],[10],[11],[12],[13]	10.15%
Maturity	[8],[9],[10],[11],[12]	Aug. 31, 2028
Principal	[8],[9],[10],[11],[12]	$ 13
Amortized Cost	[8],[9],[10],[11],[12],[14]	13,000
Fair Value	[8],[9],[10],[11],[12]	$ 13,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Capital Markets, Company Adviser Investments, LLC, Type of Investment Revolver, Interest Rate 0.00%, Maturity 08/31/28
Schedule of Investments [Line Items]
Interest Rate *	[1],[2],[3],[4],[5],[6]			0%
Maturity	[1],[2],[3],[4],[5]			Aug. 31, 2028
Principal	[1],[2],[3],[4],[5]			$ 0
Amortized Cost	[1],[2],[3],[4],[5],[7]			0
Fair Value	[1],[2],[3],[4],[5]			$ 0
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Capital Markets, Company Adviser Investments, LLC, Type of Investment Revolver, Maturity 08/31/28
Schedule of Investments [Line Items]
Maturity	[8],[9],[10],[11],[12]	Aug. 31, 2028
Principal	[8],[9],[10],[11],[12]	$ 0
Amortized Cost	[8],[9],[10],[11],[12],[14]	0
Fair Value	[8],[9],[10],[11],[12]	$ 0
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Capital Markets, Company Adviser Investments, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR+4.50%, Interest Rate 8.90%, Maturity 08/31/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			4.50%
Interest Rate *	[1],[3],[4],[5],[6],[17]			8.90%
Maturity	[1],[3],[4],[5],[17]			Aug. 31, 2028
Principal	[1],[3],[4],[5],[17]			$ 38
Amortized Cost	[1],[3],[4],[5],[7],[17]			37,000
Fair Value	[1],[3],[4],[5],[17]			37,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Capital Markets, Company Adviser Investments, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR+4.75%, Interest Rate 10.14%, Maturity 08/31/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	4.75%
Interest Rate *	[8],[10],[11],[12],[13]	10.14%
Maturity	[8],[10],[11],[12]	Aug. 31, 2028
Principal	[8],[10],[11],[12]	$ 38
Amortized Cost	[8],[10],[11],[12],[14]	37,000
Fair Value	[8],[10],[11],[12]	37,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Chemicals
Schedule of Investments [Line Items]
Amortized Cost		6,991,000	[8],[12],[14]	5,950,000	[1],[4],[5],[7]
Fair Value		$ 6,832,000	[8],[12]	$ 5,854,000	[1],[4],[5]
Percentage of Net Assets ^		1.69%	[8],[12],[27]	1.45%	[1],[4],[5],[19]
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Chemicals, Company Boulder Scientific Company, LLC, Type of Investment Delayed Draw Term Loan, Interest Rate 0.00%, Maturity 12/28/25
Schedule of Investments [Line Items]
Interest Rate *	[1],[2],[3],[4],[5],[6]			0%
Maturity		Dec. 28, 2025	[8],[9],[10],[11],[12]	Dec. 28, 2025	[1],[2],[3],[4],[5]
Principal		$ 0	[8],[9],[10],[11],[12]	$ 0	[1],[2],[3],[4],[5]
Amortized Cost		(1,000)	[8],[9],[10],[11],[12],[14]	1,000	[1],[2],[3],[4],[5],[7]
Fair Value		$ (19,000)	[8],[9],[10],[11],[12]	$ (23,000)	[1],[2],[3],[4],[5]
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Chemicals, Company Boulder Scientific Company, LLC, Type of Investment Term Loan, Reference Rate and Spread LIBOR+4.25%, Interest Rate 7.99%, Maturity 12/28/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			4.25%
Interest Rate *	[1],[3],[4],[5],[6],[17]			7.99%
Maturity	[1],[3],[4],[5],[17]			Dec. 28, 2025
Principal	[1],[3],[4],[5],[17]			$ 5,863
Amortized Cost	[1],[3],[4],[5],[7],[17]			5,805,000
Fair Value	[1],[3],[4],[5],[17]			$ 5,731,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Chemicals, Company Boulder Scientific Company, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR+4.50%, Interest Rate 10.01%, Maturity 12/28/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	4.50%
Interest Rate *	[8],[10],[11],[12],[13]	10.01%
Maturity	[8],[10],[11],[12]	Dec. 28, 2025
Principal	[8],[10],[11],[12]	$ 414
Amortized Cost	[8],[10],[11],[12],[14]	411,000
Fair Value	[8],[10],[11],[12]	$ 401,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Chemicals, Company Boulder Scientific Company, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR+4.50%, Interest Rate 10.04%, Maturity 12/28/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	4.50%
Interest Rate *	[8],[11],[12],[13]	10.04%
Maturity	[8],[10],[11],[12]	Dec. 28, 2025
Principal	[8],[10],[11],[12]	$ 5,798
Amortized Cost	[8],[11],[12],[14]	5,760,000
Fair Value	[8],[10],[11],[12]	$ 5,624,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Chemicals, Company MDI Buyer, Inc., Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.75%, Interest Rate 10.30%, Maturity 07/25/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5]			5.75%
Interest Rate *	[1],[3],[4],[5],[6]			10.30%
Maturity	[1],[3],[4],[5]			Jul. 25, 2028
Principal	[1],[3],[4],[5]			$ 24
Amortized Cost	[1],[3],[4],[5],[7]			23,000
Fair Value	[1],[3],[4],[5]			$ 23,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Chemicals, Company MDI Buyer, Inc., Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+6.00%, Interest Rate 11.63%, Maturity 07/25/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	6%
Interest Rate *	[8],[10],[11],[12],[13]	11.63%
Maturity	[8],[10],[11],[12]	Jul. 25, 2028
Principal	[8],[10],[11],[12]	$ 24
Amortized Cost	[8],[10],[11],[12],[14]	23,000
Fair Value	[8],[10],[11],[12]	$ 23,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Chemicals, Company MDI Buyer, Inc., Type of Investment Revolver, Reference Rate and Spread SOFR+5.75%, Interest Rate 10.20%, Maturity 07/25/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[2],[3],[4],[5]			5.75%
Interest Rate *	[1],[2],[3],[4],[5],[6]			10.20%
Maturity	[1],[2],[3],[4],[5]			Jul. 25, 2028
Principal	[1],[2],[3],[4],[5]			$ 1
Amortized Cost	[1],[2],[3],[4],[5],[7]			1,000
Fair Value	[1],[2],[3],[4],[5]			$ 1,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Chemicals, Company MDI Buyer, Inc., Type of Investment Revolver, Reference Rate and Spread SOFR+5.75%, Interest Rate 10.30%, Maturity 07/25/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[2],[3],[4],[5]			5.75%
Interest Rate *	[1],[2],[3],[4],[5],[6]			10.30%
Maturity	[1],[2],[3],[4],[5]			Jul. 25, 2028
Principal	[1],[2],[3],[4],[5]			$ 2
Amortized Cost	[1],[2],[3],[4],[5],[7]			2,000
Fair Value	[1],[2],[3],[4],[5]			$ 2,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Chemicals, Company MDI Buyer, Inc., Type of Investment Revolver, Reference Rate and Spread SOFR+6.00%, Interest Rate 11.62%, Maturity 07/25/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[9],[10],[11],[12]	6%
Interest Rate *	[8],[9],[10],[11],[12],[13]	11.62%
Maturity	[8],[9],[10],[11],[12]	Jul. 25, 2028
Principal	[8],[9],[10],[11],[12]	$ 2
Amortized Cost	[8],[9],[10],[11],[12],[14]	2,000
Fair Value	[8],[9],[10],[11],[12]	$ 2,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Chemicals, Company MDI Buyer, Inc., Type of Investment Revolver, Reference Rate and Spread SOFR+6.00%, Interest Rate 11.63%, Maturity 07/25/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[9],[10],[11],[12]	6%
Interest Rate *	[8],[9],[10],[11],[12],[13]	11.63%
Maturity	[8],[9],[10],[11],[12]	Jul. 25, 2028
Principal	[8],[9],[10],[11],[12]	$ 2
Amortized Cost	[8],[9],[10],[11],[12],[14]	2,000
Fair Value	[8],[9],[10],[11],[12]	$ 2,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Chemicals, Company MDI Buyer, Inc., Type of Investment Term Loan, Reference Rate and Spread SOFR+5.75%, Interest Rate 10.54%, Maturity 07/25/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.75%
Interest Rate *	[1],[3],[4],[5],[6],[17]			10.54%
Maturity	[1],[3],[4],[5],[17]			Jul. 25, 2028
Principal	[1],[3],[4],[5],[17]			$ 66
Amortized Cost	[1],[3],[4],[5],[7],[17]			65,000
Fair Value	[1],[3],[4],[5],[17]			$ 65,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Chemicals, Company MDI Buyer, Inc., Type of Investment Term Loan, Reference Rate and Spread SOFR+6.00%, Interest Rate 11.60%, Maturity 07/25/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	6%
Interest Rate *	[8],[10],[12],[13],[15]	11.60%
Maturity	[8],[10],[12],[15]	Jul. 25, 2028
Principal	[8],[10],[12],[15]	$ 65
Amortized Cost	[8],[10],[12],[14],[15]	64,000
Fair Value	[8],[10],[12],[15]	$ 64,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Chemicals, Company SI Holdings, Inc., Type of Investment Term Loan, Reference Rate and Spread SOFR+6.00%, Interest Rate 11.45%, Maturity 12/31/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	6%
Interest Rate *	[8],[10],[12],[13],[15]	11.45%
Maturity	[8],[10],[12],[15]	Dec. 31, 2027
Principal	[8],[10],[12],[15]	$ 682
Amortized Cost	[8],[10],[12],[14],[15]	665,000
Fair Value	[8],[10],[12],[15]	$ 671,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Chemicals, Company Techmer BB Bidco, LLC, Type of Investment Delayed Draw Term Loan, Interest Rate 0.00%, Maturity 09/01/28
Schedule of Investments [Line Items]
Interest Rate *	[1],[2],[3],[4],[5],[6]			0%
Maturity	[1],[2],[3],[4],[5]			Sep. 01, 2028
Principal	[1],[2],[3],[4],[5]			$ 0
Amortized Cost	[1],[2],[3],[4],[5],[7]			0
Fair Value	[1],[2],[3],[4],[5]			$ (1,000)
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Chemicals, Company Techmer BB Bidco, LLC, Type of Investment Delayed Draw Term Loan, Maturity 09/01/28
Schedule of Investments [Line Items]
Maturity	[8],[9],[10],[11],[12]	Sep. 01, 2028
Principal	[8],[9],[10],[11],[12]	$ 0
Amortized Cost	[8],[9],[10],[11],[12],[14]	0
Fair Value	[8],[9],[10],[11],[12]	$ (1,000)
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Chemicals, Company Techmer BB Bidco, LLC, Type of Investment Revolver, Reference Rate and Spread PRIME + 4.25%, Interest Rate 12.75%, Maturity 09/01/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	4.25%
Interest Rate *	[8],[10],[11],[12],[13]	12.75%
Maturity	[8],[10],[11],[12]	Sep. 01, 2028
Principal	[8],[10],[11],[12]	$ 1
Amortized Cost	[8],[10],[11],[12],[14]	1,000
Fair Value	[8],[10],[11],[12]	$ 1,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Chemicals, Company Techmer BB Bidco, LLC, Type of Investment Revolver, Reference Rate and Spread SOFR + 5.25%, Interest Rate 10.53%, Maturity 09/01/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12],[16]	5.25%
Interest Rate *	[8],[10],[11],[12],[13],[16]	10.53%
Maturity	[8],[10],[11],[12],[16]	Sep. 01, 2028
Principal	[8],[10],[11],[12],[16]	$ 0
Amortized Cost	[8],[10],[11],[12],[14],[16]	0
Fair Value	[8],[10],[11],[12],[16]	$ 0
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Chemicals, Company Techmer BB Bidco, LLC, Type of Investment Revolver, Reference Rate and Spread SOFR + 5.25%, Interest Rate 10.53%, Maturity 09/01/28 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	5.25%
Interest Rate *	[8],[10],[11],[12],[13]	10.53%
Maturity	[8],[10],[11],[12]	Sep. 01, 2028
Principal	[8],[10],[11],[12]	$ 1
Amortized Cost	[8],[10],[11],[12],[14]	1,000
Fair Value	[8],[10],[11],[12]	$ 1,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Chemicals, Company Techmer BB Bidco, LLC, Type of Investment Revolver, Reference Rate and Spread SOFR + 5.25%, Interest Rate 10.53%, Maturity 09/01/28 Two
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12],[16]	5.25%
Interest Rate *	[8],[10],[11],[12],[13],[16]	10.53%
Maturity	[8],[10],[11],[12],[16]	Sep. 01, 2028
Principal	[8],[10],[11],[12],[16]	$ 0
Amortized Cost	[8],[10],[11],[12],[14],[16]	0
Fair Value	[8],[10],[11],[12],[16]	$ 0
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Chemicals, Company Techmer BB Bidco, LLC, Type of Investment Revolver, Reference Rate and Spread SOFR + 5.25%, Interest Rate 10.72%, Maturity 09/01/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	5.25%
Interest Rate *	[8],[10],[11],[12],[13]	10.72%
Maturity	[8],[10],[11],[12]	Sep. 01, 2028
Principal	[8],[10],[11],[12]	$ 2
Amortized Cost	[8],[10],[11],[12],[14]	2,000
Fair Value	[8],[10],[11],[12]	$ 2,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Chemicals, Company Techmer BB Bidco, LLC, Type of Investment Revolver, Reference Rate and Spread SOFR + 5.25%, Interest Rate 10.72%, Maturity 09/01/28 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	5.25%
Interest Rate *	[8],[10],[11],[12],[13]	10.72%
Maturity	[8],[10],[11],[12]	Sep. 01, 2028
Principal	[8],[10],[11],[12]	$ 1
Amortized Cost	[8],[10],[11],[12],[14]	1,000
Fair Value	[8],[10],[11],[12]	$ 1,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Chemicals, Company Techmer BB Bidco, LLC, Type of Investment Revolver, Reference Rate and Spread SOFR + 5.25%, Interest Rate 10.74%, Maturity 09/01/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	5.25%
Interest Rate *	[8],[9],[10],[11],[12],[13]	10.74%
Maturity	[8],[10],[11],[12]	Sep. 01, 2028
Principal	[8],[10],[11],[12]	$ 1
Amortized Cost	[8],[10],[11],[12],[14]	1,000
Fair Value	[8],[10],[11],[12]	$ 1,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Chemicals, Company Techmer BB Bidco, LLC, Type of Investment Revolver, Reference Rate and Spread SOFR + 5.25%, Interest Rate 10.74%, Maturity 09/01/28 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	5.25%
Interest Rate *	[8],[10],[11],[12],[13]	10.74%
Maturity	[8],[10],[11],[12]	Sep. 01, 2028
Principal	[8],[10],[11],[12]	$ 1
Amortized Cost	[8],[10],[11],[12],[14]	1,000
Fair Value	[8],[10],[11],[12]	$ 1,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Chemicals, Company Techmer BB Bidco, LLC, Type of Investment Revolver, Reference Rate and Spread SOFR + 5.25%, Interest Rate 10.82%, Maturity 09/01/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	5.25%
Interest Rate *	[8],[10],[11],[12],[13]	10.82%
Maturity	[8],[10],[11],[12]	Sep. 01, 2028
Principal	[8],[10],[11],[12]	$ 1
Amortized Cost	[8],[10],[11],[12],[14]	1,000
Fair Value	[8],[10],[11],[12]	$ 1,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Chemicals, Company Techmer BB Bidco, LLC, Type of Investment Revolver, Reference Rate and Spread SOFR + 5.25%, Interest Rate 10.85%, Maturity 09/01/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	5.25%
Interest Rate *	[8],[10],[11],[12],[13]	10.85%
Maturity	[8],[10],[11],[12]	Sep. 01, 2028
Principal	[8],[10],[11],[12]	$ 1
Amortized Cost	[8],[10],[11],[12],[14]	1,000
Fair Value	[8],[10],[11],[12]	$ 1,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Chemicals, Company Techmer BB Bidco, LLC, Type of Investment Revolver, Reference Rate and Spread SOFR+5.25% Interest Rate 9.75%, Maturity 09/01/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[2],[3],[4],[5]			5.25%
Interest Rate *	[1],[2],[3],[4],[5],[6]			9.75%
Maturity	[1],[2],[3],[4],[5]			Sep. 01, 2028
Principal	[1],[2],[3],[4],[5]			$ 1
Amortized Cost	[1],[2],[3],[4],[5],[7]			0
Fair Value	[1],[2],[3],[4],[5]			$ 1,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Chemicals, Company Techmer BB Bidco, LLC, Type of Investment Revolver, Reference Rate and Spread SOFR+5.25%, Interest Rate 9.53%, Maturity 09/01/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[2],[3],[4],[5]			5.25%
Interest Rate *	[1],[2],[3],[4],[5],[6]			9.53%
Maturity	[1],[2],[3],[4],[5]			Sep. 01, 2028
Principal	[1],[2],[3],[4],[5]			$ 2
Amortized Cost	[1],[2],[3],[4],[5],[7]			2,000
Fair Value	[1],[2],[3],[4],[5]			$ 2,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Chemicals, Company Techmer BB Bidco, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR + 5.25%, Interest Rate 10.73%, Maturity 09/01/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12],[16]	5.25%
Interest Rate *	[8],[10],[11],[12],[13],[16]	10.73%
Maturity	[8],[10],[11],[12],[16]	Sep. 01, 2028
Principal	[8],[10],[11],[12],[16]	$ 0
Amortized Cost	[8],[10],[11],[12],[14],[16]	0
Fair Value	[8],[10],[11],[12],[16]	$ 0
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Chemicals, Company Techmer BB Bidco, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR + 5.25%, Interest Rate 10.73%, Maturity 09/01/28 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	5.25%
Interest Rate *	[8],[10],[11],[12],[13]	10.73%
Maturity	[8],[10],[11],[12]	Sep. 01, 2028
Principal	[8],[10],[11],[12]	$ 1
Amortized Cost	[8],[10],[11],[12],[14]	1,000
Fair Value	[8],[10],[11],[12]	$ 1,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Chemicals, Company Techmer BB Bidco, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR + 5.25%, Interest Rate 10.73%, Maturity 09/01/28 Two
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	5.25%
Interest Rate *	[8],[10],[11],[12],[13]	10.73%
Maturity	[8],[10],[11],[12]	Sep. 01, 2028
Principal	[8],[10],[11],[12]	$ 1
Amortized Cost	[8],[10],[11],[12],[14]	1,000
Fair Value	[8],[10],[11],[12]	$ 1,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Chemicals, Company Techmer BB Bidco, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR + 5.25%, Interest Rate 10.77%, Maturity 09/01/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	5.25%
Interest Rate *	[8],[10],[11],[12],[13]	10.77%
Maturity	[8],[10],[11],[12]	Sep. 01, 2028
Principal	[8],[10],[11],[12]	$ 1
Amortized Cost	[8],[10],[11],[12],[14]	1,000
Fair Value	[8],[10],[11],[12]	$ 1,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Chemicals, Company Techmer BB Bidco, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR + 5.25%, Interest Rate 10.79%, Maturity 09/01/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12],[16]	5.25%
Interest Rate *	[8],[10],[11],[12],[13],[16]	10.79%
Maturity	[8],[10],[11],[12],[16]	Sep. 01, 2028
Principal	[8],[10],[11],[12],[16]	$ 0
Amortized Cost	[8],[10],[11],[12],[14],[16]	0
Fair Value	[8],[10],[11],[12],[16]	$ 0
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Chemicals, Company Techmer BB Bidco, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR + 5.25%, Interest Rate 10.79%, Maturity 09/01/28 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	5.25%
Interest Rate *	[8],[10],[11],[12],[13]	10.79%
Maturity	[8],[10],[11],[12]	Sep. 01, 2028
Principal	[8],[10],[11],[12]	$ 1
Amortized Cost	[8],[10],[11],[12],[14]	1,000
Fair Value	[8],[10],[11],[12]	$ 1,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Chemicals, Company Techmer BB Bidco, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR + 5.25%, Interest Rate 10.80%, Maturity 09/01/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12],[16]	5.25%
Interest Rate *	[8],[10],[11],[12],[13],[16]	10.80%
Maturity	[8],[10],[11],[12],[16]	Sep. 01, 2028
Principal	[8],[10],[11],[12],[16]	$ 0
Amortized Cost	[8],[10],[11],[12],[14],[16]	0
Fair Value	[8],[10],[11],[12],[16]	$ 0
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Chemicals, Company Techmer BB Bidco, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR + 5.25%, Interest Rate 10.83%, Maturity 09/01/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	5.25%
Interest Rate *	[8],[10],[11],[12],[13]	10.83%
Maturity	[8],[10],[11],[12]	Sep. 01, 2028
Principal	[8],[10],[11],[12]	$ 53
Amortized Cost	[8],[10],[11],[12],[14]	52,000
Fair Value	[8],[10],[11],[12]	52,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Chemicals, Company Techmer BB Bidco, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR+5.25%, Interest Rate 9.47%, Maturity 09/01/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.25%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.47%
Maturity	[1],[3],[4],[5],[17]			Sep. 01, 2028
Principal	[1],[3],[4],[5],[17]			$ 0
Amortized Cost	[1],[3],[4],[5],[7],[17]			0
Fair Value	[1],[3],[4],[5],[17]			$ 0
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Chemicals, Company Techmer BB Bidco, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR+5.25%, Interest Rate 9.75%, Maturity 09/01/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.25%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.75%
Maturity	[1],[3],[4],[5],[17]			Sep. 01, 2028
Principal	[1],[3],[4],[5],[17]			$ 54
Amortized Cost	[1],[3],[4],[5],[7],[17]			53,000
Fair Value	[1],[3],[4],[5],[17]			53,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Commercial Services & Supplies
Schedule of Investments [Line Items]
Amortized Cost		26,623,000	[8],[12],[14]	23,620,000	[5],[7]
Fair Value		$ 25,481,000	[8],[12]	$ 23,133,000	[5]
Percentage of Net Assets ^		6.32%	[8],[12],[27]	5.73%	[5],[19]
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Commercial Services & Supplies, Company Advanced Web Technologies Holding Company, Type of Investment Delayed Draw Term Loan, Interest Rate 0.00%, Maturity 12/17/26
Schedule of Investments [Line Items]
Interest Rate *	[1],[2],[3],[4],[5],[6]			0%
Maturity	[1],[2],[3],[4],[5]			Dec. 17, 2026
Principal	[1],[2],[3],[4],[5]			$ 0
Amortized Cost	[1],[2],[3],[4],[5],[7]			(2,000)
Fair Value	[1],[2],[3],[4],[5]			$ (1,000)
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Commercial Services & Supplies, Company Advanced Web Technologies Holding Company, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+6.50%, Interest Rate 12.01%, Maturity 12/17/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	6.50%
Interest Rate *	[8],[10],[11],[12],[13]	12.01%
Maturity	[8],[10],[11],[12]	Dec. 17, 2026
Principal	[8],[10],[11],[12]	$ 76
Amortized Cost	[8],[10],[11],[12],[14]	75,000
Fair Value	[8],[10],[11],[12]	$ 76,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Commercial Services & Supplies, Company Advanced Web Technologies Holding Company, Type of Investment Term Loan, Reference Rate and Spread LIBOR+6.50%, Interest Rate 10.85%, Maturity 12/17/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			6.50%
Interest Rate *	[1],[3],[4],[5],[6],[17]			10.85%
Maturity	[1],[3],[4],[5],[17]			Dec. 17, 2026
Principal	[1],[3],[4],[5],[17]			$ 24
Amortized Cost	[1],[3],[4],[5],[7],[17]			23,000
Fair Value	[1],[3],[4],[5],[17]			$ 23,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Commercial Services & Supplies, Company Advanced Web Technologies Holding Company, Type of Investment Term Loan, Reference Rate and Spread SOFR+6.50%, Interest Rate 12.01%, Maturity 12/17/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	6.50%
Interest Rate *	[8],[10],[11],[12],[13]	12.01%
Maturity	[8],[10],[11],[12]	Dec. 17, 2026
Principal	[8],[10],[11],[12]	$ 23
Amortized Cost	[8],[10],[11],[12],[14]	23,000
Fair Value	[8],[10],[11],[12]	$ 23,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Commercial Services & Supplies, Company Advanced Web Technologies Holding Company, Type of Investment Term Loan, Reference Rate and Spread SOFR+6.75%, Interest Rate 12.26%, Maturity 12/17/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	6.75%
Interest Rate *	[8],[10],[11],[12],[13]	12.26%
Maturity	[8],[10],[11],[12]	Dec. 17, 2026
Principal	[8],[10],[11],[12]	$ 304
Amortized Cost	[8],[10],[11],[12],[14]	296,000
Fair Value	[8],[10],[11],[12]	$ 304,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Commercial Services & Supplies, Company Castleworks Home Services Company, Type of Investment Revolver, Reference Rate and Spread SOFR+5.50%, Interest Rate 12.92% (2.00% PIK), Maturity 06/29/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[9],[10],[11],[12]	5.50%
Interest Rate *	[8],[9],[10],[11],[12],[13]	12.96%
Interest Rate * PIK	[8],[9],[10],[11],[24]	2%
Maturity	[8],[9],[10],[11],[12]	Jun. 29, 2028
Principal	[8],[9],[10],[11],[12]	$ 403
Amortized Cost	[8],[9],[10],[11],[12],[14]	397,000
Fair Value	[8],[9],[10],[11],[12]	$ 332,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Commercial Services & Supplies, Company Castleworks Home Services Company, Type of Investment Revolver, Reference Rate and Spread SOFR+5.50%, Interest Rate 12.95% (2.00% PIK), Maturity 06/29/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[9],[10],[11],[12]	5.50%
Interest Rate *	[8],[9],[10],[11],[12],[13]	12.95%
Interest Rate * PIK	[8],[9],[10],[11],[12]	2%
Maturity	[8],[9],[10],[11],[12]	Jun. 29, 2028
Principal	[8],[9],[10],[11],[12]	$ 136
Amortized Cost	[8],[9],[10],[11],[12],[14]	134,000
Fair Value	[8],[9],[10],[11],[12]	$ 112,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Commercial Services & Supplies, Company Castleworks Home Services Company, Type of Investment Revolver, Reference Rate and Spread SOFR+5.50%, Interest Rate 12.96% (2.00% PIK), Maturity 06/29/28 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[9],[10],[11],[12]	5.50%
Interest Rate *	[8],[9],[10],[11],[12],[13]	12.96%
Interest Rate * PIK	[8],[9],[10],[11],[12]	2%
Maturity	[8],[9],[10],[11],[12]	Jun. 29, 2028
Principal	[8],[9],[10],[11],[12]	$ 136
Amortized Cost	[8],[9],[10],[11],[12],[14]	134,000
Fair Value	[8],[9],[10],[11],[12]	$ 112,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Commercial Services & Supplies, Company Castleworks Home Services Company, Type of Investment Revolver, Reference Rate and Spread SOFR+5.50%, Interest Rate 9.92%, Maturity 06/29/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[2],[3],[4],[5]			5.50%
Interest Rate *	[1],[2],[3],[4],[5],[6]			9.92%
Maturity	[1],[2],[3],[4],[5]			Jun. 29, 2028
Principal	[1],[2],[3],[4],[5]			$ 399
Amortized Cost	[1],[2],[3],[4],[5],[7]			387,000
Fair Value	[1],[2],[3],[4],[5]			$ 379,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Commercial Services & Supplies, Company Castleworks Home Services Company, Type of Investment Term Loan, Reference Rate and Spread SOFR+5.50%, Interest Rate 12.96% (2.00% PIK), Maturity 06/29/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	5.50%
Interest Rate *	[8],[10],[11],[12],[13]	12.96%
Interest Rate * PIK	[8],[9],[10],[11],[24]	2%
Maturity	[8],[10],[11],[12]	Jun. 29, 2028
Principal	[8],[10],[11],[12]	$ 5,653
Amortized Cost	[8],[10],[11],[12],[14]	5,564,000
Fair Value	[8],[10],[11],[12]	$ 4,663,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Commercial Services & Supplies, Company Castleworks Home Services Company, Type of Investment Term Loan, Reference Rate and Spread SOFR+5.50%, Interest Rate 9.92%, Maturity 06/29/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.50%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.92%
Maturity	[1],[3],[4],[5],[17]			Jun. 29, 2028
Principal	[1],[3],[4],[5],[17]			$ 5,652
Amortized Cost	[1],[3],[4],[5],[7],[17]			5,549,000
Fair Value	[1],[3],[4],[5],[17]			$ 5,483,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Commercial Services & Supplies, Company LAV Gear Holdings, Inc., Type of Investment Term Loan, Reference Rate and Spread SOFR+6.25%, Interest Rate 11.78%, Maturity 10/31/24
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	6.25%
Interest Rate *	[8],[10],[12],[13],[15]	11.78%
Maturity	[8],[10],[12],[15]	Oct. 31, 2024
Principal	[8],[10],[12],[15]	$ 2,481
Amortized Cost	[8],[10],[12],[14],[15]	2,445,000
Fair Value	[8],[10],[12],[15]	$ 2,481,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Commercial Services & Supplies, Company LAV Gear Holdings, Inc., Type of Investment Term Loan, Reference Rate and Spread SOFR+6.25%, Interest Rate 11.79%, Maturity 10/31/24
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	6.25%
Interest Rate *	[8],[10],[11],[12],[13]	11.79%
Maturity	[8],[10],[11],[12]	Oct. 31, 2024
Principal	[8],[10],[11],[12]	$ 10
Amortized Cost	[8],[10],[11],[12],[14]	10,000
Fair Value	[8],[10],[11],[12]	$ 10,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Commercial Services & Supplies, Company Liquid Environmental Solutions Corporation, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+4.75%, Interest Rate 10.24%, Maturity 05/31/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	4.75%
Interest Rate *	[8],[10],[12],[13],[15]	10.24%
Maturity	[8],[10],[12],[15]	May 31, 2026
Principal	[8],[10],[12],[15]	$ 5,070
Amortized Cost	[8],[10],[12],[14],[15]	5,022,000
Fair Value	[8],[10],[12],[15]	$ 4,918,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Commercial Services & Supplies, Company Liquid Environmental Solutions Corporation, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+4.75%, Interest Rate 8.97%, Maturity 05/31/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			4.75%
Interest Rate *	[1],[3],[4],[5],[6],[17]			8.97%
Maturity	[1],[3],[4],[5],[17]			May 31, 2026
Principal	[1],[3],[4],[5],[17]			$ 2,822
Amortized Cost	[1],[3],[4],[5],[7],[17]			2,785,000
Fair Value	[1],[3],[4],[5],[17]			$ 2,730,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Commercial Services & Supplies, Company Liquid Environmental Solutions Corporation, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+4.75%, Interest Rate 9.15%, Maturity 05/31/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			4.75%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.15%
Maturity	[1],[3],[4],[5],[17]			May 31, 2026
Principal	[1],[3],[4],[5],[17]			$ 2,300
Amortized Cost	[1],[3],[4],[5],[7],[17]			2,270,000
Fair Value	[1],[3],[4],[5],[17]			$ 2,225,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Commercial Services & Supplies, Company Liquid Environmental Solutions Corporation, Type of Investment Term Loan, Reference Rate and Spread SOFR+4.75%, Interest Rate 10.24%, Maturity 05/31/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	4.75%
Interest Rate *	[8],[10],[12],[13],[15]	10.24%
Maturity	[8],[10],[12],[15]	May 31, 2026
Principal	[8],[10],[12],[15]	$ 839
Amortized Cost	[8],[10],[12],[14],[15]	831,000
Fair Value	[8],[10],[12],[15]	$ 814,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Commercial Services & Supplies, Company Liquid Environmental Solutions Corporation, Type of Investment Term Loan, Reference Rate and Spread SOFR+4.75%, Interest Rate 9.17%, Maturity 05/31/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			4.75%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.17%
Maturity	[1],[3],[4],[5],[17]			May 31, 2026
Principal	[1],[3],[4],[5],[17]			$ 848
Amortized Cost	[1],[3],[4],[5],[7],[17]			837,000
Fair Value	[1],[3],[4],[5],[17]			$ 820,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Commercial Services & Supplies, Company RFI Buyer, Inc., Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR + 4.75%, Interest Rate 10.23%, Maturity 08/05/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	4.75%
Interest Rate *	[8],[10],[11],[12],[13]	10.23%
Maturity	[8],[10],[11],[12]	Aug. 05, 2028
Principal	[8],[10],[11],[12]	$ 15
Amortized Cost	[8],[10],[11],[12],[14]	15,000
Fair Value	[8],[10],[11],[12]	$ 15,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Commercial Services & Supplies, Company RFI Buyer, Inc., Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR + 4.75%, Interest Rate 10.23%, Maturity 08/05/28 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	4.75%
Interest Rate *	[8],[10],[11],[12],[13]	10.23%
Maturity	[8],[10],[11],[12]	Aug. 05, 2028
Principal	[8],[10],[11],[12]	$ 4
Amortized Cost	[8],[10],[11],[12],[14]	4,000
Fair Value	[8],[10],[11],[12]	$ 4,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Commercial Services & Supplies, Company RFI Buyer, Inc., Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR + 4.75%, Interest Rate 10.24%, Maturity 08/05/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	4.75%
Interest Rate *	[8],[10],[11],[12],[13]	10.24%
Maturity	[8],[10],[11],[12]	Aug. 05, 2028
Principal	[8],[10],[11],[12]	$ 6
Amortized Cost	[8],[10],[11],[12],[14]	6,000
Fair Value	[8],[10],[11],[12]	$ 6,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Commercial Services & Supplies, Company RFI Buyer, Inc., Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR + 4.75%, Interest Rate 10.25%, Maturity 08/05/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	4.75%
Interest Rate *	[8],[10],[11],[12],[13]	10.25%
Maturity	[8],[10],[11],[12]	Aug. 05, 2028
Principal	[8],[10],[11],[12]	$ 4
Amortized Cost	[8],[10],[11],[12],[14]	4,000
Fair Value	[8],[10],[11],[12]	$ 4,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Commercial Services & Supplies, Company RFI Buyer, Inc., Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR + 4.75, Interest Rate 9.25 %, Maturity 08/05/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[2],[3],[4],[5]			4.75%
Interest Rate *	[1],[2],[3],[4],[5],[6]			9.25%
Maturity	[1],[2],[3],[4],[5]			Aug. 05, 2028
Principal	[1],[2],[3],[4],[5]			$ 15
Amortized Cost	[1],[2],[3],[4],[5],[7]			15,000
Fair Value	[1],[2],[3],[4],[5]			$ 15,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Commercial Services & Supplies, Company RFI Buyer, Inc., Type of Investment Revolver, Interest Rate 0.00%, Maturity 08/05/28
Schedule of Investments [Line Items]
Interest Rate *	[1],[2],[3],[4],[5],[6]			0%
Maturity	[1],[2],[3],[4],[5]			Aug. 05, 2028
Principal	[1],[2],[3],[4],[5]			$ 0
Amortized Cost	[1],[2],[3],[4],[5],[7]			0
Fair Value	[1],[2],[3],[4],[5]			$ 0
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Commercial Services & Supplies, Company RFI Buyer, Inc., Type of Investment Revolver, Maturity 08/05/28
Schedule of Investments [Line Items]
Maturity	[9],[10],[11]	Aug. 05, 2028
Principal	[8],[9],[10],[11],[12]	$ 0
Amortized Cost	[8],[9],[10],[11],[12],[14]	0
Fair Value	[8],[9],[10],[11],[12]	$ 0
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Commercial Services & Supplies, Company RFI Buyer, Inc., Type of Investment Term Loan, Reference Rate and Spread SOFR + 4.75%, Interest Rate 10.23%, Maturity 08/05/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	4.75%
Interest Rate *	[8],[10],[11],[12],[13]	10.23%
Maturity	[8],[10],[11],[12]	Aug. 05, 2028
Principal	[8],[10],[11],[12]	$ 58
Amortized Cost	[8],[10],[11],[12],[14]	57,000
Fair Value	[8],[10],[11],[12]	$ 58,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Commercial Services & Supplies, Company RFI Buyer, Inc., Type of Investment Term Loan, Reference Rate and Spread SOFR + 4.75%, Interest Rate 9.03%, Maturity 08/05/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			4.75%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.03%
Maturity	[1],[3],[4],[5],[17]			Aug. 05, 2028
Principal	[1],[3],[4],[5],[17]			$ 59
Amortized Cost	[1],[3],[4],[5],[7],[17]			58,000
Fair Value	[1],[3],[4],[5],[17]			$ 58,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Commercial Services & Supplies, Company VRC Companies, LLC, Type of Investment Term Loan, Reference Rate and Spread LIBOR+5.50%, Interest Rate 10.65%, Maturity 06/29/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.50%
Interest Rate *	[1],[3],[4],[5],[6],[17]			10.65%
Maturity	[1],[3],[4],[5],[17]			Jun. 29, 2027
Principal	[1],[3],[4],[5],[17]			$ 11,845
Amortized Cost	[1],[3],[4],[5],[7],[17]			11,698,000
Fair Value	[1],[3],[4],[5],[17]			11,401,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Commercial Services & Supplies, Company VRC Companies,LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR + 5.50%, Interest Rate 11.14%, Maturity 06/29/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5.50%
Interest Rate *	[8],[10],[12],[13],[15]	11.14%
Maturity	[8],[10],[12],[15]	Jun. 29, 2027
Principal	[8],[10],[12],[15]	$ 11,725
Amortized Cost	[8],[10],[12],[14],[15]	11,606,000
Fair Value	[8],[10],[12],[15]	11,549,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Construction & Engineering
Schedule of Investments [Line Items]
Amortized Cost	[8],[12],[14]	662,000
Fair Value	[8],[12]	$ 676,000
Percentage of Net Assets ^	[8],[12],[27]	0.17%
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Construction & Engineering, Company Royal Holdco Corporation, Type of Investment Term Loan, Reference Rate and Spread SOFR + 5.75%, Interest Rate 11.21%, Maturity 12/30/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5.75%
Interest Rate *	[8],[10],[12],[13],[15]	11.21%
Maturity	[8],[10],[12],[15]	Dec. 30, 2026
Principal	[8],[10],[12],[15]	$ 679
Amortized Cost	[8],[10],[12],[14],[15]	662,000
Fair Value	[8],[10],[12],[15]	676,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Containers & Packaging
Schedule of Investments [Line Items]
Amortized Cost		18,458,000	[8],[12],[14]	14,816,000	[1],[4],[5],[7]
Fair Value		$ 17,624,000	[8],[12]	$ 14,619,000	[1],[4],[5]
Percentage of Net Assets ^		4.37%	[8],[12],[27]	3.62%	[1],[4],[5],[19]
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Containers & Packaging, Company Comar Holding Company, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread LIBOR+5.75%, Interest Rate 10.48%, Maturity 06/18/24
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.75%
Interest Rate *	[1],[3],[4],[5],[6],[17]			10.48%
Maturity	[1],[3],[4],[5],[17]			Jun. 18, 2024
Principal	[1],[3],[4],[5],[17]			$ 1,819
Amortized Cost	[1],[3],[4],[5],[7],[17]			1,813,000
Fair Value	[1],[3],[4],[5],[17]			$ 1,783,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Containers & Packaging, Company Comar Holding Company, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread LIBOR+5.75%, Interest Rate 10.48%, Maturity 06/18/24 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.75%
Interest Rate *	[1],[3],[4],[5],[6],[17]			10.48%
Maturity	[1],[3],[4],[5],[17]			Jun. 18, 2024
Principal	[1],[3],[4],[5],[17]			$ 3,017
Amortized Cost	[1],[3],[4],[5],[7],[17]			3,007,000
Fair Value	[1],[3],[4],[5],[17]			$ 2,957,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Containers & Packaging, Company Comar Holding Company, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+2.00%, Interest Rate 12.13% (4.75% PIK), Maturity 06/18/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	2%
Interest Rate *	[8],[10],[12],[13],[15]	12.13%
Interest Rate * PIK	[8],[10],[12],[13],[15]	4.75%
Maturity	[8],[10],[12],[15]	Jun. 18, 2026
Principal	[8],[10],[12],[15]	$ 578
Amortized Cost	[8],[10],[12],[14],[15]	561,000
Fair Value	[8],[10],[12],[15]	$ 530,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Containers & Packaging, Company Comar Holding Company, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+2.00%, Interest Rate 12.13% (4.75% PIK), Maturity 06/18/26 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	2%
Interest Rate *	[8],[10],[12],[13],[15]	12.13%
Interest Rate * PIK	[8],[10],[12],[13],[15]	4.75%
Maturity	[8],[10],[12],[15]	Jun. 18, 2026
Principal	[8],[10],[12],[15]	$ 1,830
Amortized Cost	[8],[10],[12],[14],[15]	1,778,000
Fair Value	[8],[10],[12],[15]	$ 1,679,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Containers & Packaging, Company Comar Holding Company, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+2.00%, Interest Rate 12.13% (4.75% PIK), Maturity 06/18/26 Two
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	2%
Interest Rate *	[8],[10],[12],[13],[15]	12.13%
Interest Rate * PIK	[8],[10],[12],[13],[15]	4.75%
Maturity	[8],[10],[12],[15]	Jun. 18, 2026
Principal	[8],[10],[12],[15]	$ 3,035
Amortized Cost	[8],[10],[12],[14],[15]	3,031,000
Fair Value	[8],[10],[12],[15]	$ 2,784,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Containers & Packaging, Company Comar Holding Company, LLC, Type of Investment Term Loan, Reference Rate and Spread LIBOR+5.75%, Interest Rate 10.48%, Maturity 06/18/24
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.75%
Interest Rate *	[1],[3],[4],[5],[6],[17]			10.48%
Maturity	[1],[3],[4],[5],[17]			Jun. 18, 2024
Principal	[1],[3],[4],[5],[17]			$ 206
Amortized Cost	[1],[3],[4],[5],[7],[17]			205,000
Fair Value	[1],[3],[4],[5],[17]			$ 202,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Containers & Packaging, Company Comar Holding Company, LLC, Type of Investment Term Loan, Reference Rate and Spread LIBOR+5.75%, Interest Rate 10.48%, Maturity 06/18/24 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.75%
Interest Rate *	[1],[3],[4],[5],[6],[17]			10.48%
Maturity	[1],[3],[4],[5],[17]			Jun. 18, 2024
Principal	[1],[3],[4],[5],[17]			$ 5,872
Amortized Cost	[1],[3],[4],[5],[7],[17]			5,851,000
Fair Value	[1],[3],[4],[5],[17]			$ 5,755,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Containers & Packaging, Company Comar Holding Company, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR+2.00%, Interest Rate 12.13% (4.75% PIK), Maturity 06/18/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	2%
Interest Rate *	[8],[10],[12],[13],[15]	12.13%
Interest Rate * PIK	[8],[10],[12],[13],[15]	4.75%
Maturity	[8],[10],[12],[15]	Jun. 18, 2026
Principal	[8],[10],[12],[15]	$ 2,925
Amortized Cost	[8],[10],[12],[14],[15]	2,812,000
Fair Value	[8],[10],[12],[15]	$ 2,684,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Containers & Packaging, Company Comar Holding Company, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR+2.00%, Interest Rate 12.13% (4.75% PIK), Maturity 06/18/26 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	2%
Interest Rate *	[8],[10],[12],[13],[15]	12.13%
Interest Rate * PIK	[8],[10],[12],[13],[15]	4.75%
Maturity	[8],[10],[12],[15]	Jun. 18, 2026
Principal	[8],[10],[12],[15]	$ 207
Amortized Cost	[8],[10],[12],[14],[15]	207,000
Fair Value	[8],[10],[12],[15]	$ 190,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Containers & Packaging, Company Comar Holding Company, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR+2.00%, Interest Rate 12.13% (4.75% PIK), Maturity 06/18/26 Two
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	2%
Interest Rate *	[8],[10],[12],[13],[15]	12.13%
Interest Rate * PIK	[8],[10],[12],[13],[15]	4.75%
Maturity	[8],[10],[12],[15]	Jun. 18, 2026
Principal	[8],[10],[12],[15]	$ 5,905
Amortized Cost	[8],[10],[12],[14],[15]	5,678,000
Fair Value	[8],[10],[12],[15]	$ 5,418,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Containers & Packaging, Company Oliver Packaging, LLC, Type of Investment Revolver, Interest Rate 0.00%, Maturity 07/06/28
Schedule of Investments [Line Items]
Interest Rate *	[1],[2],[3],[4],[5],[6]			0%
Maturity	[1],[2],[3],[4],[5]			Jul. 06, 2028
Principal	[1],[2],[3],[4],[5]			$ 0
Amortized Cost	[1],[2],[3],[4],[5],[7]			(9,000)
Fair Value	[1],[2],[3],[4],[5]			$ (12,000)
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Containers & Packaging, Company Oliver Packaging, LLC, Type of Investment Revolver, Reference Rate and Spread SOFR + 5.00%, Interest Rate 10.45%, Maturity 07/06/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[9],[10],[11],[12]	5%
Interest Rate *	[8],[9],[10],[11],[12],[13]	10.54%
Maturity	[8],[9],[10],[11],[12]	Jul. 06, 2028
Principal	[8],[9],[10],[11],[12]	$ 410
Amortized Cost	[8],[9],[10],[11],[12],[14]	402,000
Fair Value	[8],[9],[10],[11],[12]	$ 395,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Containers & Packaging, Company Oliver Packaging, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR + 5.00%, Interest Rate 10.50%, Maturity 07/06/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5%
Interest Rate *	[8],[10],[12],[13],[15]	10.50%
Maturity	[8],[10],[12],[15]	Jul. 06, 2028
Principal	[8],[10],[12],[15]	$ 3,974
Amortized Cost	[8],[10],[12],[14],[15]	3,919,000
Fair Value	[8],[10],[12],[15]	$ 3,874,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Containers & Packaging, Company Oliver Packaging, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR + 5.00%, Interest Rate 9.73%, Maturity 07/06/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.73%
Maturity	[1],[3],[4],[5],[17]			Jul. 06, 2028
Principal	[1],[3],[4],[5],[17]			$ 4,014
Amortized Cost	[1],[3],[4],[5],[7],[17]			3,949,000
Fair Value	[1],[3],[4],[5],[17]			3,934,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Containers & Packaging, Company Online Labels Group, LLC, Type of Investment Delayed Draw Term Loan, Maturity 12/19/29
Schedule of Investments [Line Items]
Maturity	[8],[9],[10],[11],[12]	Dec. 19, 2029
Principal	[8],[10],[11],[12]	$ 0
Amortized Cost	[8],[9],[10],[11],[12],[14]	0
Fair Value	[8],[9],[10],[11],[12]	$ 0
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Containers & Packaging, Company Online Labels Group, LLC, Type of Investment Delayed Draw Term Loan, Maturity 12/19/29 One
Schedule of Investments [Line Items]
Maturity	[8],[9],[10],[11],[12]	Dec. 19, 2029
Principal	[8],[10],[11],[12]	$ 0
Amortized Cost	[8],[9],[10],[11],[12],[14]	0
Fair Value	[8],[9],[10],[11],[12]	$ 0
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Containers & Packaging, Company Online Labels Group, LLC, Type of Investment Revolver, Maturity 12/19/29
Schedule of Investments [Line Items]
Maturity	[8],[9],[10],[11],[12]	Dec. 19, 2029
Principal	[8],[9],[10],[11],[12]	$ 0
Amortized Cost	[8],[9],[10],[11],[12],[14]	0
Fair Value	[8],[9],[10],[11],[12]	$ 0
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Containers & Packaging, Company Online Labels Group, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR + 5.25%, Interest Rate 10.61%, Maturity 12/19/29
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	5.25%
Interest Rate *	[8],[10],[11],[12],[13]	10.61%
Maturity	[8],[10],[11],[12]	Dec. 19, 2029
Principal	[8],[10],[11],[12]	$ 72
Amortized Cost	[8],[10],[11],[12],[14]	70,000
Fair Value	[8],[10],[11],[12]	70,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Distributors
Schedule of Investments [Line Items]
Amortized Cost		26,990,000	[8],[12],[14]	21,834,000	[1],[4],[5],[7]
Fair Value		$ 25,892,000	[8],[12]	$ 20,742,000	[1],[4],[5]
Percentage of Net Assets ^		6.42%	[8],[12],[27]	5.14%	[1],[4],[5],[19]
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Distributors, Company POY Holdings, LLC, Type of Investment Delayed Draw Term Loan, Maturity 11/16/27
Schedule of Investments [Line Items]
Maturity	[8],[9],[10],[11],[12]	Nov. 16, 2027
Principal	[8],[9],[10],[11],[12]	$ 0
Amortized Cost	[8],[9],[10],[11],[12],[14]	(9,000)
Fair Value	[8],[9],[10],[11],[12]	$ (6,000)
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Distributors, Company POY Holdings, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR+5.50%, Interest Rate 11.00%, Maturity 11/16/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	5.50%
Interest Rate *	[8],[10],[11],[12],[13]	11%
Maturity	[8],[10],[11],[12]	Nov. 16, 2027
Principal	[8],[10],[11],[12]	$ 5,086
Amortized Cost	[8],[10],[11],[12],[14]	4,986,000
Fair Value	[8],[10],[11],[12]	$ 5,061,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Distributors, Company Polk Acquisition Corp., Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR + 5.25%, Interest Rate 9.57% (1.00% PIK), Maturity 12/20/24
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.25%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.57%
Interest Rate * PIK	[1],[3],[4],[5],[6],[17]			1%
Maturity	[1],[3],[4],[5],[17]			Dec. 20, 2024
Principal	[1],[3],[4],[5],[17]			$ 389
Amortized Cost	[1],[3],[4],[5],[7],[17]			386,000
Fair Value	[1],[3],[4],[5],[17]			$ 371,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Distributors, Company Polk Acquisition Corp., Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.25%, Interest Rate 12.96% (2.25% PIK), Maturity 12/20/24
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5.25%
Interest Rate *	[8],[10],[12],[13],[15]	12.96%
Interest Rate * PIK	[8],[10],[12],[13],[15]	2.25%
Maturity	[8],[10],[12],[15]	Dec. 20, 2024
Principal	[8],[10],[12],[15]	$ 6
Amortized Cost	[8],[10],[12],[14],[15]	6,000
Fair Value	[8],[10],[12],[15]	$ 6,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Distributors, Company Polk Acquisition Corp., Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.25%, Interest Rate 12.96% (2.25% PIK), Maturity 12/20/24 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5.25%
Interest Rate *	[8],[10],[12],[13],[15]	12.96%
Interest Rate * PIK	[8],[10],[12],[13],[15]	2.25%
Maturity	[8],[10],[12],[15]	Dec. 20, 2024
Principal	[8],[10],[12],[15]	$ 19
Amortized Cost	[8],[10],[12],[14],[15]	19,000
Fair Value	[8],[10],[12],[15]	$ 19,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Distributors, Company Polk Acquisition Corp., Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.25%, Interest Rate 12.96% (2.25% PIK), Maturity 12/20/24 Two
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5.25%
Interest Rate *	[8],[10],[12],[13],[15]	12.96%
Interest Rate * PIK	[8],[10],[12],[13],[15]	2.25%
Maturity	[8],[10],[12],[15]	Dec. 20, 2024
Principal	[8],[10],[12],[15]	$ 372
Amortized Cost	[8],[10],[12],[14],[15]	371,000
Fair Value	[8],[10],[12],[15]	$ 371,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Distributors, Company Polk Acquisition Corp., Type of Investment Term Loan, Reference Rate and Spread SOFR + 5.25%, Interest Rate 12.96% (2.25% PIK), Maturity 12/20/24
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5.25%
Interest Rate *	[8],[10],[12],[13],[15]	12.96%
Interest Rate * PIK	[8],[10],[12],[13],[15]	2.25%
Maturity	[8],[10],[12],[15]	Dec. 20, 2024
Principal	[8],[10],[12],[15]	$ 10,137
Amortized Cost	[8],[10],[12],[14],[15]	10,097,000
Fair Value	[8],[10],[12],[15]	$ 10,086,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Distributors, Company Polk Acquisition Corp., Type of Investment Term Loan, Reference Rate and Spread SOFR + 5.25%, Interest Rate 12.96% (2.25% PIK), Maturity 12/20/24 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5.25%
Interest Rate *	[8],[10],[12],[13],[15]	12.96%
Interest Rate * PIK	[8],[10],[12],[13],[15]	2.25%
Maturity	[8],[10],[12],[15]	Dec. 20, 2024
Principal	[8],[10],[12],[15]	$ 160
Amortized Cost	[8],[10],[12],[14],[15]	159,000
Fair Value	[8],[10],[12],[15]	$ 159,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Distributors, Company Polk Acquisition Corp., Type of Investment Term Loan, Reference Rate and Spread SOFR + 5.25%, Interest Rate 12.96% (2.25% PIK), Maturity 12/20/24 Two
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5.25%
Interest Rate *	[8],[10],[12],[13],[15]	12.96%
Interest Rate * PIK	[8],[10],[12],[13],[15]	2.25%
Maturity	[8],[10],[12],[15]	Dec. 20, 2024
Principal	[8],[10],[12],[15]	$ 527
Amortized Cost	[8],[10],[12],[14],[15]	525,000
Fair Value	[8],[10],[12],[15]	$ 525,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Distributors, Company Polk Acquisition Corp., Type of Investment Term Loan, Reference Rate and Spread SOFR + 5.25%, Interest Rate 9.57% (1.00% PIK), Maturity 12/20/24
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.25%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.57%
Interest Rate * PIK	[1],[3],[4],[5],[6],[17]			1%
Maturity	[1],[3],[4],[5],[17]			Dec. 20, 2024
Principal	[1],[3],[4],[5],[17]			$ 10,589
Amortized Cost	[1],[3],[4],[5],[7],[17]			10,507,000
Fair Value	[1],[3],[4],[5],[17]			$ 10,113,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Distributors, Company United Scope LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR + 5.00%, Interest Rate 10.50%, Maturity 12/01/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	5%
Interest Rate *	[8],[10],[11],[12],[13]	10.50%
Maturity	[8],[10],[11],[12]	Dec. 01, 2025
Principal	[8],[10],[11],[12]	$ 10,866
Amortized Cost	[8],[10],[11],[12],[14]	10,836,000
Fair Value	[8],[10],[11],[12]	9,671,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Distributors, Company United Scope LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR+5.00%, Interest Rate 9.23%, Maturity 12/01/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.23%
Maturity	[1],[3],[4],[5],[17]			Dec. 01, 2025
Principal	[1],[3],[4],[5],[17]			$ 11,000
Amortized Cost	[1],[3],[4],[5],[7],[17]			10,941,000
Fair Value	[1],[3],[4],[5],[17]			$ 10,258,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Service, Company Express Wash Acquisition Company, LLC, Ltd, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+6.50%, Interest Rate 10.31%, Maturity 07/14/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5]			6.50%
Interest Rate *	[1],[3],[4],[5],[6]			10.31%
Maturity	[1],[3],[4],[5]			Jul. 14, 2028
Principal	[1],[3],[4],[5]			$ 262
Amortized Cost	[1],[3],[4],[5],[7]			257,000
Fair Value	[1],[3],[4],[5]			$ 256,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Service, Company Express Wash Acquisition Company, LLC, Ltd, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+6.50%, Interest Rate 10.32%, Maturity 07/14/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5]			6.50%
Interest Rate *	[1],[3],[4],[5],[6]			10.32%
Maturity	[1],[3],[4],[5]			Jul. 14, 2028
Principal	[1],[3],[4],[5]			$ 292
Amortized Cost	[1],[3],[4],[5],[7]			287,000
Fair Value	[1],[3],[4],[5]			$ 286,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Service, Company Express Wash Acquisition Company, LLC, Ltd, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+6.50%, Interest Rate 10.43%, Maturity 07/14/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5]			6.50%
Interest Rate *	[1],[3],[4],[5],[6]			10.43%
Maturity	[1],[3],[4],[5]			Jul. 14, 2028
Principal	[1],[3],[4],[5]			$ 174
Amortized Cost	[1],[3],[4],[5],[7]			171,000
Fair Value	[1],[3],[4],[5]			$ 170,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Service, Company Express Wash Acquisition Company, LLC, Ltd, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+6.50%, Interest Rate 10.55%, Maturity 07/14/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5]			6.50%
Interest Rate *	[1],[3],[4],[5],[6]			10.55%
Maturity	[1],[3],[4],[5]			Jul. 14, 2028
Principal	[1],[3],[4],[5]			$ 413
Amortized Cost	[1],[3],[4],[5],[7]			405,000
Fair Value	[1],[3],[4],[5]			$ 405,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Service, Company Express Wash Acquisition Company, LLC, Ltd, Type of Investment Revolver, Reference Rate and Spread SOFR+6.50%, Interest Rate 10.32%, Maturity 07/14/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[2],[3],[4],[5]			6.50%
Interest Rate *	[1],[2],[3],[4],[5],[6]			10.32%
Maturity	[1],[2],[3],[4],[5]			Jul. 14, 2028
Principal	[1],[2],[3],[4],[5]			$ 64
Amortized Cost	[1],[2],[3],[4],[5],[7]			62,000
Fair Value	[1],[2],[3],[4],[5]			$ 62,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Service, Company Express Wash Acquisition Company, LLC, Ltd, Type of Investment Revolver, Reference Rate and Spread SOFR+6.50%, Interest Rate 10.83%, Maturity 07/14/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[2],[3],[4],[5]			6.50%
Interest Rate *	[1],[2],[3],[4],[5],[6]			10.83%
Maturity	[1],[2],[3],[4],[5]			Jul. 14, 2028
Principal	[1],[2],[3],[4],[5]			$ 77
Amortized Cost	[1],[2],[3],[4],[5],[7]			74,000
Fair Value	[1],[2],[3],[4],[5]			$ 74,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Service, Company Express Wash Acquisition Company, LLC, Ltd, Type of Investment Term Loan, Reference Rate and Spread SOFR+6.50%, Interest Rate 10.32%, Maturity 07/14/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			6.50%
Interest Rate *	[1],[3],[4],[5],[6],[17]			10.32%
Maturity	[1],[3],[4],[5],[17]			Jul. 14, 2028
Principal	[1],[3],[4],[5],[17]			$ 6,087
Amortized Cost	[1],[3],[4],[5],[7],[17]			5,977,000
Fair Value	[1],[3],[4],[5],[17]			5,966,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services
Schedule of Investments [Line Items]
Amortized Cost		36,719,000	[8],[12],[14]	30,304,000	[1],[4],[5],[7]
Fair Value		$ 36,574,000	[8],[12]	$ 29,900,000	[1],[4],[5]
Percentage of Net Assets ^		9.07%	[8],[12],[27]	7.41%	[1],[4],[5],[19]
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services, Company ADPD Holdings, LLC, Type of Investment Delayed Draw Term Loan, Maturity 08/16/28
Schedule of Investments [Line Items]
Maturity	[8],[9],[10],[11],[12]	Aug. 16, 2028
Principal	[8],[9],[10],[11],[12]	$ 0
Amortized Cost	[8],[9],[10],[11],[12],[14]	0
Fair Value	[8],[9],[10],[11],[12]	$ (1,000)
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services, Company ADPD Holdings, LLC, Type of Investment Delayed Draw Term Loan, Maturity 08/16/28 One
Schedule of Investments [Line Items]
Maturity	[8],[9],[10],[12]	Aug. 16, 2028
Principal	[8],[9],[10],[11],[12]	$ 0
Amortized Cost	[8],[9],[10],[11],[12],[14]	0
Fair Value	[8],[9],[10],[11],[12]	$ (2,000)
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services, Company ADPD Holdings, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR+6.00%, Interest Rate 11.68%, Maturity 08/16/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	6%
Interest Rate *	[8],[10],[11],[12],[13]	11.68%
Maturity	[8],[10],[11],[12]	Aug. 16, 2028
Principal	[8],[10],[11],[12]	$ 66
Amortized Cost	[8],[10],[11],[12],[14]	65,000
Fair Value	[8],[10],[11],[12]	$ 58,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services, Company ADPD Holdings, LLC., Type of Investment Delayed Draw Term Loan, Interest Rate 0.00%, Maturity 08/16/28
Schedule of Investments [Line Items]
Interest Rate *	[1],[2],[3],[4],[5],[6]			0%
Maturity	[1],[2],[3],[4],[5]			Aug. 16, 2028
Principal	[1],[2],[3],[4],[5]			$ 0
Amortized Cost	[1],[2],[3],[4],[5],[7]			0
Fair Value	[1],[2],[3],[4],[5]			$ 0
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services, Company ADPD Holdings, LLC., Type of Investment Delayed Draw Term Loan, Interest Rate 0.00%, Maturity 08/16/28 One
Schedule of Investments [Line Items]
Interest Rate *	[1],[2],[3],[4],[5],[6]			0%
Maturity	[1],[2],[3],[4],[5]			Aug. 16, 2028
Principal	[1],[2],[3],[4],[5]			$ 0
Amortized Cost	[1],[2],[3],[4],[5],[7]			0
Fair Value	[1],[2],[3],[4],[5]			$ 0
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services, Company ADPD Holdings, LLC., Type of Investment Delayed Draw Term Loan, Interest Rate 0.00%, Maturity 08/16/28 Two
Schedule of Investments [Line Items]
Interest Rate *	[1],[2],[3],[4],[5],[6]			0%
Maturity	[1],[2],[3],[4],[5]			Aug. 16, 2028
Principal	[1],[2],[3],[4],[5]			$ 0
Amortized Cost	[1],[2],[3],[4],[5],[7]			0
Fair Value	[1],[2],[3],[4],[5]			$ 0
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services, Company ADPD Holdings, LLC., Type of Investment Revolver, Reference Rate and Spread SOFR+6.00%, Interest Rate 10.38%, Maturity 08/16/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[2],[3],[4],[5]			6%
Interest Rate *	[1],[2],[3],[4],[5],[6]			10.38%
Maturity	[1],[2],[3],[4],[5]			Aug. 16, 2028
Principal	[1],[2],[3],[4],[5]			$ 2
Amortized Cost	[1],[2],[3],[4],[5],[7]			2,000
Fair Value	[1],[2],[3],[4],[5]			$ 2,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services, Company ADPD Holdings, LLC., Type of Investment Term Loan, Reference Rate and Spread SOFR+6.00%, Interest Rate 10.38%, Maturity 08/16/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5]			6%
Interest Rate *	[1],[3],[4],[5],[6]			10.38%
Maturity	[1],[3],[4],[5]			Aug. 16, 2028
Principal	[1],[3],[4],[5]			$ 9
Amortized Cost	[1],[3],[4],[5],[7]			9,000
Fair Value	[1],[3],[4],[5]			$ 8,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services, Company ADPD Holdings, LLC., Type of Investment Term Loan, Reference Rate and Spread SOFR+6.00%, Interest Rate 10.38%, Maturity 08/16/28 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			6%
Interest Rate *	[1],[3],[4],[5],[6],[17]			10.38%
Maturity	[1],[3],[4],[5],[17]			Aug. 16, 2028
Principal	[1],[3],[4],[5],[17]			$ 56
Amortized Cost	[1],[3],[4],[5],[7],[17]			55,000
Fair Value	[1],[3],[4],[5],[17]			$ 55,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services, Company Any Hour, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.75%, Interest Rate 10.17%, Maturity 07/21/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5]			5.75%
Interest Rate *	[1],[3],[4],[5],[6]			10.17%
Maturity	[1],[3],[4],[5]			Jul. 21, 2027
Principal	[1],[3],[4],[5]			$ 4,046
Amortized Cost	[1],[3],[4],[5],[7]			3,972,000
Fair Value	[1],[3],[4],[5]			$ 3,925,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services, Company Any Hour, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.75%, Interest Rate 10.18%, Maturity 07/21/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5]			5.75%
Interest Rate *	[1],[3],[4],[5],[6]			10.18%
Maturity	[1],[3],[4],[5]			Jul. 21, 2027
Principal	[1],[3],[4],[5]			$ 2,750
Amortized Cost	[1],[3],[4],[5],[7]			2,700,000
Fair Value	[1],[3],[4],[5]			$ 2,668,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services, Company Any Hour, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.75%, Interest Rate 10.19%, Maturity 07/21/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5]			5.75%
Interest Rate *	[1],[3],[4],[5],[6]			10.19%
Maturity	[1],[3],[4],[5]			Jul. 21, 2027
Principal	[1],[3],[4],[5]			$ 675
Amortized Cost	[1],[3],[4],[5],[7]			663,000
Fair Value	[1],[3],[4],[5]			$ 655,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services, Company Express Wash Acquisition Company, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+6.50%, Interest Rate 12.16%, Maturity 07/14/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	6.50%
Interest Rate *	[8],[10],[12],[13],[15]	12.16%
Maturity	[8],[10],[12],[15]	Jul. 14, 2028
Principal	[8],[10],[12],[15]	$ 1,129
Amortized Cost	[8],[10],[12],[14],[15]	1,111,000
Fair Value	[8],[10],[12],[15]	$ 1,087,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services, Company Express Wash Acquisition Company, LLC, Type of Investment Revolver, Reference Rate and Spread SOFR+6.50%, Interest Rate 12.16%, Maturity 07/14/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[9],[10],[11],[12]	6.50%
Interest Rate *	[8],[9],[10],[12],[13]	12.16%
Maturity	[8],[9],[10],[12]	Jul. 14, 2028
Principal	[8],[9],[10],[12]	$ 141
Amortized Cost	[8],[9],[10],[12],[14]	137,000
Fair Value	[8],[9],[10],[12]	$ 131,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services, Company Express Wash Acquisition Company, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR+6.50%, Interest Rate 12.16%, Maturity 07/14/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	6.50%
Interest Rate *	[8],[10],[12],[13],[15]	12.16%
Maturity	[8],[10],[12],[15]	Jul. 14, 2028
Principal	[8],[10],[12],[15]	$ 5,272
Amortized Cost	[8],[10],[12],[14],[15]	5,195,000
Fair Value	[8],[10],[12],[15]	$ 5,075,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services, Company HLSG Intermediate, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+6.50%, Interest Rate 11.97%, Maturity 03/31/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[9],[10],[11],[12]	6.50%
Interest Rate *	[8],[10],[11],[12],[13]	11.97%
Maturity	[8],[10],[11],[12]	Mar. 31, 2028
Principal	[8],[10],[11],[12]	$ 887
Amortized Cost	[8],[10],[11],[12],[14]	844,000
Fair Value	[8],[10],[11],[12]	$ 872,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services, Company HLSG Intermediate, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+6.50%, Interest Rate 11.97%, Maturity 03/31/28 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[9],[10],[11],[12]	6.50%
Interest Rate *	[8],[10],[11],[12],[13]	11.97%
Maturity	[8],[10],[11],[12]	Mar. 31, 2028
Principal	[8],[10],[11],[12]	$ 413
Amortized Cost	[8],[10],[11],[12],[14]	393,000
Fair Value	[8],[10],[11],[12]	$ 406,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services, Company HLSG Intermediate, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR+6.50%, Interest Rate 12.11%, Maturity 03/31/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	6.50%
Interest Rate *	[8],[10],[11],[12],[13]	12.11%
Maturity	[8],[10],[11],[12]	Mar. 31, 2028
Principal	[8],[10],[11],[12]	$ 5,898
Amortized Cost	[8],[10],[11],[12],[14]	5,771,000
Fair Value	[8],[10],[11],[12]	$ 5,854,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services, Company North Haven Stallone Buyer, LLC, Type of Investment Delayed Draw Term Loan, Interest Rate 0.00%, Maturity 05/24/27
Schedule of Investments [Line Items]
Interest Rate *	[1],[2],[3],[4],[5],[6]			0%
Maturity	[1],[2],[3],[4],[5]			May 24, 2027
Principal	[1],[2],[3],[4],[5]			$ 0
Amortized Cost	[1],[2],[3],[4],[5],[7]			0
Fair Value	[1],[2],[3],[4],[5]			$ 0
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services, Company North Haven Stallone Buyer, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread LIBOR+5.00%, Interest Rate 10.21%, Maturity 05/24/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5%
Interest Rate *	[1],[3],[4],[5],[6],[17]			10.21%
Maturity	[1],[3],[4],[5],[17]			May 24, 2027
Principal	[1],[3],[4],[5],[17]			$ 865
Amortized Cost	[1],[3],[4],[5],[7],[17]			858,000
Fair Value	[1],[3],[4],[5],[17]			$ 833,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services, Company North Haven Stallone Buyer, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread LIBOR+5.00%, Interest Rate 8.29%, Maturity 05/24/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5%
Interest Rate *	[1],[3],[4],[5],[6],[17]			8.29%
Maturity	[1],[3],[4],[5],[17]			May 24, 2027
Principal	[1],[3],[4],[5],[17]			$ 485
Amortized Cost	[1],[3],[4],[5],[7],[17]			481,000
Fair Value	[1],[3],[4],[5],[17]			$ 467,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services, Company North Haven Stallone Buyer, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread LIBOR+5.00%, Interest Rate 8.51%, Maturity 05/24/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5%
Interest Rate *	[1],[3],[4],[5],[6],[17]			8.51%
Maturity	[1],[3],[4],[5],[17]			May 24, 2027
Principal	[1],[3],[4],[5],[17]			$ 1,562
Amortized Cost	[1],[3],[4],[5],[7],[17]			1,548,000
Fair Value	[1],[3],[4],[5],[17]			$ 1,503,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services, Company North Haven Stallone Buyer, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR +5.25%, Interest Rate 10.89%, Maturity 05/24/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5.25%
Interest Rate *	[8],[10],[12],[13],[15]	10.89%
Maturity	[8],[10],[12],[15]	May 24, 2027
Principal	[8],[10],[12],[15]	$ 872
Amortized Cost	[8],[10],[12],[14],[15]	866,000
Fair Value	[8],[10],[12],[15]	$ 862,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services, Company North Haven Stallone Buyer, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR +5.25%, Interest Rate 10.90%, Maturity 05/24/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5.25%
Interest Rate *	[8],[10],[12],[13],[15]	10.90%
Maturity	[8],[10],[12],[15]	May 24, 2027
Principal	[8],[10],[12],[15]	$ 1,400
Amortized Cost	[8],[10],[12],[14],[15]	1,389,000
Fair Value	[8],[10],[12],[15]	$ 1,382,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services, Company North Haven Stallone Buyer, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.00%, Interest Rate 10.12%, Maturity 05/24/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5%
Interest Rate *	[1],[3],[4],[5],[6],[17]			10.12%
Maturity	[1],[3],[4],[5],[17]			May 24, 2027
Principal	[1],[3],[4],[5],[17]			$ 881
Amortized Cost	[1],[3],[4],[5],[7],[17]			874,000
Fair Value	[1],[3],[4],[5],[17]			$ 848,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services, Company North Haven Stallone Buyer, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.00%, Interest Rate 10.17%, Maturity 05/24/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5%
Interest Rate *	[1],[3],[4],[5],[6],[17]			10.17%
Maturity	[1],[3],[4],[5],[17]			May 24, 2027
Principal	[1],[3],[4],[5],[17]			$ 1,414
Amortized Cost	[1],[3],[4],[5],[7],[17]			1,401,000
Fair Value	[1],[3],[4],[5],[17]			$ 1,361,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services, Company North Haven Stallone Buyer, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.25%, Interest Rate 10.89%, Maturity 05/24/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5.25%
Interest Rate *	[8],[10],[12],[13],[15]	10.89%
Maturity	[8],[10],[12],[15]	May 24, 2027
Principal	[8],[10],[12],[15]	$ 1,546
Amortized Cost	[8],[10],[12],[14],[15]	1,535,000
Fair Value	[8],[10],[12],[15]	$ 1,527,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services, Company North Haven Stallone Buyer, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.25%, Interest Rate 10.89%, Maturity 05/24/27 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5.25%
Interest Rate *	[8],[10],[12],[13],[15]	10.89%
Maturity	[8],[10],[12],[15]	May 24, 2027
Principal	[8],[10],[12],[15]	$ 857
Amortized Cost	[8],[10],[12],[14],[15]	850,000
Fair Value	[8],[10],[12],[15]	$ 846,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services, Company North Haven Stallone Buyer, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.25%, Interest Rate 10.90%, Maturity 05/24/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5.25%
Interest Rate *	[8],[10],[12],[13],[15]	10.90%
Maturity	[8],[10],[12],[15]	May 24, 2027
Principal	[8],[10],[12],[15]	$ 480
Amortized Cost	[8],[10],[12],[14],[15]	477,000
Fair Value	[8],[10],[12],[15]	$ 474,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services, Company North Haven Stallone Buyer, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.50%, Interest Rate 11.14%, Maturity 05/24/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12],[16]	5.50%
Interest Rate *	[8],[10],[11],[12],[13]	11.14%
Maturity	[8],[10],[11],[12]	May 24, 2027
Principal	[8],[10],[11],[12]	$ 0
Amortized Cost	[8],[10],[11],[12],[14]	0
Fair Value	[8],[10],[11],[12]	$ 0
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services, Company North Haven Stallone Buyer, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.50%, Interest Rate 11.14%, Maturity 05/24/27 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	5.50%
Interest Rate *	[8],[10],[11],[12],[13]	11.14%
Maturity	[8],[10],[11],[12]	May 24, 2027
Principal	[8],[10],[11],[12]	$ 1
Amortized Cost	[8],[10],[11],[12],[14]	1,000
Fair Value	[8],[10],[11],[12]	$ 1,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services, Company North Haven Stallone Buyer, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.50%, Interest Rate 11.17%, Maturity 05/24/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	5.50%
Interest Rate *	[8],[10],[11],[12],[13]	11.17%
Maturity	[8],[10],[11],[12]	May 24, 2027
Principal	[8],[10],[11],[12]	$ 1
Amortized Cost	[8],[10],[11],[12],[14]	1,000
Fair Value	[8],[10],[11],[12]	$ 1,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services, Company North Haven Stallone Buyer, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.50%, Interest Rate 11.38%, Maturity 05/24/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12],[16]	5.50%
Interest Rate *	[8],[9],[10],[11],[12],[13]	11.38%
Maturity	[8],[9],[10],[11],[12]	May 24, 2027
Principal	[8],[9],[10],[11],[12]	$ 0
Amortized Cost	[8],[9],[10],[11],[12],[14]	0
Fair Value	[8],[9],[10],[11],[12]	$ 0
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services, Company North Haven Stallone Buyer, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.50%, Interest Rate 11.42%, Maturity 05/24/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	5.50%
Interest Rate *	[8],[10],[11],[12],[13]	11.42%
Maturity	[8],[10],[11],[12]	May 24, 2027
Principal	[8],[10],[11],[12]	$ 1
Amortized Cost	[8],[10],[11],[12],[14]	1,000
Fair Value	[8],[10],[11],[12]	$ 1,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services, Company North Haven Stallone Buyer, LLC, Type of Investment Revolver, Reference Rate and Spread PRIME+4.50%, Interest Rate 13.00%, Maturity 05/24/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[9],[10],[11],[12]	4.50%
Interest Rate *	[8],[9],[10],[11],[12],[13]	13%
Maturity	[8],[9],[10],[11],[12]	May 24, 2027
Principal	[8],[9],[10],[11],[12]	$ 25
Amortized Cost	[8],[9],[10],[11],[12],[14]	23,000
Fair Value	[8],[9],[10],[11],[12]	$ 24,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services, Company North Haven Stallone Buyer, LLC, Type of Investment Revolver, Reference Rate and Spread SOFR+5.50%, Interest Rate 11.12%, Maturity 05/24/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[9],[10],[11],[12]	5.50%
Interest Rate *	[8],[9],[10],[11],[12],[13]	11.12%
Maturity	[8],[9],[10],[11],[12]	May 24, 2027
Principal	[8],[9],[10],[11],[12]	$ 32
Amortized Cost	[8],[9],[10],[11],[12],[14]	30,000
Fair Value	[8],[9],[10],[11],[12]	$ 31,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services, Company North Haven Stallone Buyer, LLC, Type of Investment Revolver, Reference Rate and Spread SOFR+5.50%, Interest Rate 11.13%, Maturity 05/24/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[9],[10],[11],[12]	5.50%
Interest Rate *	[8],[9],[10],[11],[12],[13]	11.13%
Maturity	[8],[9],[10],[11],[12]	May 24, 2027
Principal	[8],[9],[10],[11],[12]	$ 42
Amortized Cost	[8],[9],[10],[11],[12],[14]	39,000
Fair Value	[8],[9],[10],[11],[12]	$ 42,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services, Company North Haven Stallone Buyer, LLC, Type of Investment Revolver, Reference Rate and Spread SOFR+5.50%, Interest Rate 11.14%, Maturity 05/24/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[9],[10],[11],[12]	5.50%
Interest Rate *	[8],[9],[10],[11],[12],[13]	11.14%
Maturity	[8],[9],[10],[11],[12]	May 24, 2027
Principal	[8],[9],[10],[11],[12]	$ 71
Amortized Cost	[8],[9],[10],[11],[12],[14]	66,000
Fair Value	[8],[9],[10],[11],[12]	$ 70,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services, Company North Haven Stallone Buyer, LLC, Type of Investment Revolver, Reference Rate and Spread SOFR+5.50%, Interest Rate 11.14%, Maturity 05/24/27 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[9],[10],[11],[12]	5.50%
Interest Rate *	[8],[9],[10],[11],[12],[13]	11.14%
Maturity	[8],[9],[10],[11],[12]	May 24, 2027
Principal	[8],[9],[10],[11],[12]	$ 42
Amortized Cost	[8],[9],[10],[11],[12],[14]	39,000
Fair Value	[8],[9],[10],[11],[12]	$ 42,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services, Company North Haven Stallone Buyer, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR+5.00%, Interest Rate 10.05%, Maturity 05/24/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5%
Interest Rate *	[1],[3],[4],[5],[6],[17]			10.05%
Maturity	[1],[3],[4],[5],[17]			May 24, 2027
Principal	[1],[3],[4],[5],[17]			$ 1,117
Amortized Cost	[1],[3],[4],[5],[7],[17]			1,107,000
Fair Value	[1],[3],[4],[5],[17]			$ 1,075,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services, Company North Haven Stallone Buyer, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR+5.25%, Interest Rate 10.89%, Maturity 05/24/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5.25%
Interest Rate *	[8],[10],[12],[13],[15]	10.89%
Maturity	[8],[10],[12],[15]	May 24, 2027
Principal	[8],[10],[12],[15]	$ 1,106
Amortized Cost	[8],[10],[12],[14],[15]	1,098,000
Fair Value	[8],[10],[12],[15]	$ 1,092,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services, Company North Haven Stallone Buyer, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR+5.50%, Interest Rate 11.15%, Maturity 05/24/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	5.50%
Interest Rate *	[8],[10],[11],[12],[13]	11.15%
Maturity	[8],[10],[11],[12]	May 24, 2027
Principal	[8],[10],[11],[12]	$ 180
Amortized Cost	[8],[10],[11],[12],[14]	175,000
Fair Value	[8],[10],[11],[12]	$ 179,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services, Company North Haven USHC Acquisition, Inc, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+6.50%, Interest Rate 10.66%, Maturity 10/30/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			6.50%
Interest Rate *	[1],[3],[4],[5],[6],[17]			10.66%
Maturity	[1],[3],[4],[5],[17]			Oct. 30, 2025
Principal	[1],[3],[4],[5],[17]			$ 5,845
Amortized Cost	[1],[3],[4],[5],[7],[17]			5,815,000
Fair Value	[1],[3],[4],[5],[17]			$ 5,743,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services, Company North Haven USHC Acquisition, Inc, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+6.50%, Interest Rate 11.18%, Maturity 10/30/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			6.50%
Interest Rate *	[1],[3],[4],[5],[6],[17]			11.18%
Maturity	[1],[3],[4],[5],[17]			Oct. 30, 2025
Principal	[1],[3],[4],[5],[17]			$ 3,601
Amortized Cost	[1],[3],[4],[5],[7],[17]			3,586,000
Fair Value	[1],[3],[4],[5],[17]			3,538,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services, Company North Haven USHC Acquisition, Inc, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+6.50%, Interest Rate 11.95%, Maturity 10/30/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	6.50%
Interest Rate *	[8],[10],[12],[13],[15]	11.95%
Maturity	[8],[10],[12],[15]	Oct. 30, 2025
Principal	[8],[10],[12],[15]	$ 702
Amortized Cost	[8],[10],[12],[14],[15]	702,000
Fair Value	[8],[10],[12],[15]	$ 691,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services, Company North Haven USHC Acquisition, Inc, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+6.50%, Interest Rate 11.95%, Maturity 10/30/25 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	6.50%
Interest Rate *	[8],[10],[12],[13],[15]	11.95%
Maturity	[8],[10],[12],[15]	Oct. 30, 2025
Principal	[8],[10],[12],[15]	$ 2,863
Amortized Cost	[8],[10],[12],[14],[15]	2,853,000
Fair Value	[8],[10],[12],[15]	$ 2,820,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Consumer Services, Company North Haven USHC Acquisition, Inc, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+6.50%, Interest Rate 11.98%, Maturity 10/30/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	6.50%
Interest Rate *	[8],[10],[12],[13],[15]	11.98%
Maturity	[8],[10],[12],[15]	Oct. 30, 2025
Principal	[8],[10],[12],[15]	$ 5,786
Amortized Cost	[8],[10],[12],[14],[15]	5,766,000
Fair Value	[8],[10],[12],[15]	5,699,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Telecommunication Services
Schedule of Investments [Line Items]
Amortized Cost	[8],[12],[14]	307,000
Fair Value	[8],[12]	$ 315,000
Percentage of Net Assets ^	[8],[12],[27]	0.08%
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Diversified Telecommunication Services, Company MBS Holdings, Inc., Type of Investment Term Loan, Reference Rate and Spread SOFR+6.25%, Interest Rate 11.71%, Maturity 04/16/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	6.25%
Interest Rate *	[8],[10],[11],[12],[13]	11.71%
Maturity	[8],[10],[11],[12]	Apr. 16, 2027
Principal	[8],[10],[11],[12]	$ 315
Amortized Cost	[8],[10],[11],[12],[14]	307,000
Fair Value	[8],[10],[11],[12]	315,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Electronic Equipment, Instruments & Components
Schedule of Investments [Line Items]
Amortized Cost		13,579,000	[8],[12],[14]	19,659,000	[1],[4],[5],[7]
Fair Value		$ 13,510,000	[8],[12]	$ 19,414,000	[1],[4],[5]
Percentage of Net Assets ^		3.35%	[8],[12],[27]	4.81%	[1],[4],[5],[19]
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Electronic Equipment, Instruments & Components, Company BC Group Holdings, Inc., Type of Investment Term Loan, Reference Rate and Spread LIBOR+5.00%, Interest Rate 10.15%, Maturity 12/21/24
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5%
Interest Rate *	[1],[3],[4],[5],[6],[17]			10.15%
Maturity	[1],[3],[4],[5],[17]			Dec. 21, 2024
Principal	[1],[3],[4],[5],[17]			$ 7,425
Amortized Cost	[1],[3],[4],[5],[7],[17]			7,421,000
Fair Value	[1],[3],[4],[5],[17]			$ 7,350,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Electronic Equipment, Instruments & Components, Company BC Group Holdings, Inc., Type of Investment Term Loan, Reference Rate and Spread LIBOR+5.00%, Interest Rate 9.73%, Maturity 12/21/24
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.73%
Maturity	[1],[3],[4],[5],[17]			Dec. 21, 2024
Principal	[1],[3],[4],[5],[17]			$ 19
Amortized Cost	[1],[3],[4],[5],[7],[17]			19,000
Fair Value	[1],[3],[4],[5],[17]			$ 19,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Electronic Equipment, Instruments & Components, Company BC Group Holdings, Inc., Type of Investment Term Loan, Reference Rate and Spread SOFR+5.00%, Interest Rate 10.45%, Maturity 12/23/24
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	5%
Interest Rate *	[8],[10],[11],[12],[13]	10.45%
Maturity	[8],[10],[11],[12]	Dec. 23, 2024
Principal	[8],[10],[11],[12]	$ 801
Amortized Cost	[8],[10],[11],[12],[14]	801,000
Fair Value	[8],[10],[11],[12]	$ 795,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Electronic Equipment, Instruments & Components, Company BC Group Holdings, Inc., Type of Investment Term Loan, Reference Rate and Spread SOFR+5.00%, Interest Rate 10.45%, Maturity 12/23/24 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5%
Interest Rate *	[8],[10],[12],[13],[15]	10.45%
Maturity	[8],[10],[12],[15]	Dec. 23, 2024
Principal	[8],[10],[12],[15]	$ 6,565
Amortized Cost	[8],[10],[12],[14],[15]	6,564,000
Fair Value	[8],[10],[12],[15]	$ 6,516,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Electronic Equipment, Instruments & Components, Company Mobile Communications America, Inc, Type of Investment Term Loan, Reference Rate and Spread SOFR+5.00%, Interest Rate 9.73%, Maturity 03/04/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.73%
Maturity	[1],[3],[4],[5],[17]			Mar. 04, 2025
Principal	[1],[3],[4],[5],[17]			$ 10
Amortized Cost	[1],[3],[4],[5],[7],[17]			10,000
Fair Value	[1],[3],[4],[5],[17]			$ 10,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Electronic Equipment, Instruments & Components, Company Mobile Communications America, Inc, Type of Investment Term Loan, Reference Rate and Spread SOFR+5.38%, Interest Rate 10.11%, Maturity 03/04/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.38%
Interest Rate *	[1],[3],[4],[5],[6],[17]			10.11%
Maturity	[1],[3],[4],[5],[17]			Mar. 04, 2025
Principal	[1],[3],[4],[5],[17]			$ 5,954
Amortized Cost	[1],[3],[4],[5],[7],[17]			5,930,000
Fair Value	[1],[3],[4],[5],[17]			$ 5,850,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Electronic Equipment, Instruments & Components, Company Wildcat Buyerco, Inc., Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.75%, Interest Rate 10.48%, Maturity 02/27/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.75%
Interest Rate *	[1],[3],[4],[5],[6],[17]			10.48%
Maturity	[1],[3],[4],[5],[17]			Feb. 27, 2026
Principal	[1],[3],[4],[5],[17]			$ 1,919
Amortized Cost	[1],[3],[4],[5],[7],[17]			1,919,000
Fair Value	[1],[3],[4],[5],[17]			$ 1,890,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Electronic Equipment, Instruments & Components, Company Wildcat Buyerco, Inc., Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.75%, Interest Rate 10.48%, Maturity 02/27/26 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5]			5.75%
Interest Rate *	[1],[3],[4],[5],[6]			10.48%
Maturity	[1],[3],[4],[5]			Feb. 27, 2026
Principal	[1],[3],[4],[5]			$ 191
Amortized Cost	[1],[3],[4],[5],[7]			190,000
Fair Value	[1],[3],[4],[5]			$ 189,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Electronic Equipment, Instruments & Components, Company Wildcat Buyerco, Inc., Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.75%, Interest Rate 11.10%, Maturity 02/26/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	5.75%
Interest Rate *	[8],[10],[11],[12],[13]	11.10%
Maturity	[8],[10],[11],[12]	Feb. 26, 2027
Principal	[8],[10],[11],[12]	$ 190
Amortized Cost	[8],[10],[11],[12],[14]	189,000
Fair Value	[8],[10],[11],[12]	$ 189,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Electronic Equipment, Instruments & Components, Company Wildcat Buyerco, Inc., Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.75%, Interest Rate 11.10%, Maturity 02/26/27 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5.75%
Interest Rate *	[8],[10],[12],[13],[15]	11.10%
Maturity	[8],[10],[12],[15]	Feb. 26, 2027
Principal	[8],[10],[12],[15]	$ 1,899
Amortized Cost	[8],[10],[12],[14],[15]	1,899,000
Fair Value	[8],[10],[12],[15]	$ 1,894,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Electronic Equipment, Instruments & Components, Company Wildcat Buyerco, Inc., Type of Investment Term Loan, Reference Rate and Spread SOFR+5.75%, Interest Rate 10.48%, Maturity 02/27/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.75%
Interest Rate *	[1],[3],[4],[5],[6],[17]			10.48%
Maturity	[1],[3],[4],[5],[17]			Feb. 27, 2026
Principal	[1],[3],[4],[5],[17]			$ 542
Amortized Cost	[1],[3],[4],[5],[7],[17]			542,000
Fair Value	[1],[3],[4],[5],[17]			$ 533,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Electronic Equipment, Instruments & Components, Company Wildcat Buyerco, Inc., Type of Investment Term Loan, Reference Rate and Spread SOFR+5.75%, Interest Rate 10.48%, Maturity 02/27/26 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.75%
Interest Rate *	[1],[3],[4],[5],[6],[17]			10.48%
Maturity	[1],[3],[4],[5],[17]			Feb. 27, 2026
Principal	[1],[3],[4],[5],[17]			$ 3,628
Amortized Cost	[1],[3],[4],[5],[7],[17]			3,628,000
Fair Value	[1],[3],[4],[5],[17]			3,573,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Electronic Equipment, Instruments & Components, Company Wildcat Buyerco, Inc., Type of Investment Term Loan, Reference Rate and Spread SOFR+5.75%, Interest Rate 11.10%, Maturity 02/26/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5.75%
Interest Rate *	[8],[10],[12],[13],[15]	11.10%
Maturity	[8],[10],[12],[15]	Feb. 26, 2027
Principal	[8],[10],[12],[15]	$ 536
Amortized Cost	[8],[10],[12],[14],[15]	536,000
Fair Value	[8],[10],[12],[15]	$ 535,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Electronic Equipment, Instruments & Components, Company Wildcat Buyerco, Inc., Type of Investment Term Loan, Reference Rate and Spread SOFR+5.75%, Interest Rate 11.10%, Maturity 02/26/27 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5.75%
Interest Rate *	[8],[10],[12],[13],[15]	11.10%
Maturity	[8],[10],[12],[15]	Feb. 26, 2027
Principal	[8],[10],[12],[15]	$ 3,590
Amortized Cost	[8],[10],[12],[14],[15]	3,590,000
Fair Value	[8],[10],[12],[15]	3,581,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Energy Equipment & Services
Schedule of Investments [Line Items]
Amortized Cost		8,320,000	[8],[12],[14]	7,655,000	[1],[4],[5],[7]
Fair Value		$ 8,392,000	[8],[12]	$ 7,477,000	[1],[4],[5]
Percentage of Net Assets ^		2.08%	[8],[12],[27]	1.85%	[1],[4],[5],[19]
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Energy Equipment & Services, Company Energy Labs Holdings Corp, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.25%, Interest Rate 10.73%, Maturity 04/07/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	5.25%
Interest Rate *	[8],[10],[11],[12],[13]	10.73%
Maturity	[8],[10],[11],[12]	Apr. 07, 2028
Principal	[8],[10],[11],[12]	$ 730
Amortized Cost	[8],[10],[11],[12],[14]	727,000
Fair Value	[8],[10],[11],[12]	$ 729,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Energy Equipment & Services, Company Energy Labs Holdings Corp, Type of Investment Term Loan, Reference Rate and Spread SOFR+5.25%, Interest Rate 10.71%, Maturity 04/07/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5.25%
Interest Rate *	[8],[10],[12],[13],[15]	10.71%
Maturity	[8],[10],[12],[15]	Apr. 07, 2028
Principal	[8],[10],[12],[15]	$ 7,682
Amortized Cost	[8],[10],[12],[14],[15]	7,593,000
Fair Value	[8],[10],[12],[15]	7,663,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Energy Equipment & Services, Company Energy Labs Holdings Corp., Type of Investment Delayed Draw Term Loan, Interest Rate 0.00%, Maturity 04/07/28
Schedule of Investments [Line Items]
Interest Rate *	[1],[2],[3],[4],[5],[6]			0%
Maturity	[1],[2],[3],[4],[5]			Apr. 07, 2028
Principal	[1],[2],[3],[4],[5]			$ 0
Amortized Cost	[1],[2],[3],[4],[5],[7]			0
Fair Value	[1],[2],[3],[4],[5]			$ (31,000)
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Energy Equipment & Services, Company Energy Labs Holdings Corp., Type of Investment Term Loan, Reference Rate and Spread SOFR+5.25%, Interest Rate 9.57%, Maturity 04/07/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.25%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.57%
Maturity	[1],[3],[4],[5],[17]			Apr. 07, 2028
Principal	[1],[3],[4],[5],[17]			$ 7,760
Amortized Cost	[1],[3],[4],[5],[7],[17]			7,655,000
Fair Value	[1],[3],[4],[5],[17]			7,508,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Food & Staples Retailing
Schedule of Investments [Line Items]
Amortized Cost		2,862,000	[8],[12],[14]	4,144,000	[1],[4],[5],[7]
Fair Value		$ 2,869,000	[8],[12]	$ 4,077,000	[1],[4],[5]
Percentage of Net Assets ^		0.71%	[8],[12],[27]	1.01%	[1],[4],[5],[19]
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Food & Staples Retailing, Company KeyImpact Holdings, Inc, Type of Investment Term Loan, Reference Rate and Spread LIBOR+4.75%, Interest Rate 9.03%, Maturity 06/21/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			4.75%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.03%
Maturity	[1],[3],[4],[5],[17]			Jun. 21, 2026
Principal	[1],[3],[4],[5],[17]			$ 4,171
Amortized Cost	[1],[3],[4],[5],[7],[17]			4,144,000
Fair Value	[1],[3],[4],[5],[17]			4,077,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Food & Staples Retailing, Company KeyImpact Holdings, Inc., Type of Investment Term Loan, Reference Rate and Spread SOFR+4.75%, Interest Rate 10.23%, Maturity 06/21/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	4.75%
Interest Rate *	[8],[10],[12],[13],[15]	10.23%
Maturity	[8],[10],[12],[15]	Jun. 21, 2026
Principal	[8],[10],[12],[15]	$ 2,876
Amortized Cost	[8],[10],[12],[14],[15]	2,862,000
Fair Value	[8],[10],[12],[15]	2,869,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Food Products
Schedule of Investments [Line Items]
Amortized Cost		17,389,000	[8],[12],[14]	13,978,000	[1],[4],[5],[7]
Fair Value		$ 16,899,000	[8],[12]	$ 13,208,000	[1],[4],[5]
Percentage of Net Assets ^		4.19%	[8],[12],[27]	3.27%	[1],[4],[5],[19]
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Food Products, Company Del Real, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR+6.75%, Interest Rate 13.25%, Maturity 03/28/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	6.75%
Interest Rate *	[8],[10],[12],[13],[15]	13.25%
Interest Rate * PIK	[8],[10],[12],[13],[15]	1%
Maturity	[8],[10],[12],[15]	Mar. 28, 2028
Principal	[8],[10],[12],[15]	$ 3,507
Amortized Cost	[8],[10],[12],[14],[15]	3,461,000
Fair Value	[8],[10],[12],[15]	$ 3,507,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Food Products, Company JTM Foods LLC, Type of Investment Revolver, Reference Rate and Spread PRIME+4.25%, Interest Rate 12.75%, Maturity 05/14/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[9],[10],[11],[12]	4.25%
Interest Rate *	[8],[9],[10],[11],[12],[13]	12.75%
Maturity	[8],[9],[10],[11],[12]	May 14, 2027
Principal	[8],[9],[10],[11],[12]	$ 2
Amortized Cost	[8],[9],[10],[11],[12],[14]	2,000
Fair Value	[8],[9],[10],[11],[12]	$ 2,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Food Products, Company JTM Foods LLC, Type of Investment Revolver, Reference Rate and Spread SOFR+5.25%, Interest Rate 10.77%, Maturity 05/14/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[9],[10],[11],[12]	5.25%
Interest Rate *	[8],[9],[10],[11],[12],[13]	10.77%
Maturity	[8],[9],[10],[11],[12]	May 14, 2027
Principal	[8],[9],[10],[11],[12]	$ 4
Amortized Cost	[8],[9],[10],[11],[12],[14]	4,000
Fair Value	[8],[9],[10],[11],[12]	$ 4,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Food Products, Company JTM Foods LLC, Type of Investment Revolver, Reference Rate and Spread SOFR+5.25%, Interest Rate 10.78%, Maturity 05/14/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[9],[10],[11],[12]	5.25%
Interest Rate *	[8],[9],[10],[11],[12],[13]	10.78%
Maturity	[8],[9],[10],[11],[12]	May 14, 2027
Principal	[8],[9],[10],[11],[12]	$ 5
Amortized Cost	[8],[9],[10],[11],[12],[14]	5,000
Fair Value	[8],[9],[10],[11],[12]	$ 5,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Food Products, Company JTM Foods LLC, Type of Investment Revolver, Reference Rate and Spread SOFR+5.25%, Interest Rate 10.78%, Maturity 05/14/27 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[9],[10],[11],[12]	5.25%
Interest Rate *	[8],[9],[10],[11],[12],[13]	10.78%
Maturity	[8],[9],[10],[11],[12]	May 14, 2027
Principal	[8],[9],[10],[11],[12]	$ 4
Amortized Cost	[8],[9],[10],[11],[12],[14]	4,000
Fair Value	[8],[9],[10],[11],[12]	$ 4,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Food Products, Company JTM Foods LLC, Type of Investment Revolver, Reference Rate and Spread SOFR+5.25%, Interest Rate 10.78%, Maturity 05/14/27 Two
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[9],[10],[11],[12]	5.25%
Interest Rate *	[8],[9],[10],[11],[12],[13]	10.78%
Maturity	[8],[9],[10],[11],[12]	May 14, 2027
Principal	[8],[9],[10],[11],[12]	$ 2
Amortized Cost	[8],[9],[10],[11],[12],[14]	2,000
Fair Value	[8],[9],[10],[11],[12]	$ 2,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Food Products, Company JTM Foods LLC, Type of Investment Revolver, Reference Rate and Spread SOFR+5.25%, Interest Rate 10.79%, Maturity 05/14/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[9],[10],[11],[12]	5.25%
Interest Rate *	[8],[9],[10],[11],[12],[13]	10.79%
Maturity	[8],[9],[10],[11],[12]	May 14, 2027
Principal	[8],[9],[10],[11],[12]	$ 6
Amortized Cost	[8],[9],[10],[11],[12],[14]	6,000
Fair Value	[8],[9],[10],[11],[12]	$ 6,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Food Products, Company JTM Foods LLC, Type of Investment Revolver, Reference Rate and Spread SOFR+5.25%, Interest Rate 10.81%, Maturity 05/14/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[9],[10],[11],[12]	5.25%
Interest Rate *	[8],[9],[10],[11],[12],[13]	10.81%
Maturity	[8],[9],[10],[11],[12]	May 14, 2027
Principal	[8],[9],[10],[11],[12]	$ 2
Amortized Cost	[8],[9],[10],[11],[12],[14]	2,000
Fair Value	[8],[9],[10],[11],[12]	$ 2,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Food Products, Company JTM Foods LLC, Type of Investment Revolver, Reference Rate and Spread SOFR+5.25%, Interest Rate 10.81%, Maturity 05/14/27 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[9],[10],[11],[12]	5.25%
Interest Rate *	[8],[9],[10],[11],[12],[13]	10.81%
Maturity	[8],[9],[10],[11],[12]	May 14, 2027
Principal	[8],[9],[10],[11],[12]	$ 2
Amortized Cost	[8],[9],[10],[11],[12],[14]	2,000
Fair Value	[8],[9],[10],[11],[12]	$ 2,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Food Products, Company JTM Foods LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR+5.25%, Interest Rate 10.75%, Maturity 05/14/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	5.25%
Interest Rate *	[8],[10],[11],[12],[13]	10.75%
Maturity	[8],[10],[11],[12]	May 14, 2027
Principal	[8],[10],[11],[12]	$ 70
Amortized Cost	[8],[10],[11],[12],[14]	68,000
Fair Value	[8],[10],[11],[12]	$ 68,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Food Products, Company JTM Foods, LLC, Type of Investment Revolver, Reference Rate and Spread LIBOR+5.25%, Interest Rate 9.08%, Maturity 05/14/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[2],[3],[4],[5]			5.25%
Interest Rate *	[1],[2],[3],[4],[5],[6]			9.08%
Maturity	[1],[2],[3],[4],[5]			May 14, 2027
Principal	[1],[2],[3],[4],[5]			$ 2
Amortized Cost	[1],[2],[3],[4],[5],[7]			1,000
Fair Value	[1],[2],[3],[4],[5]			$ 1,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Food Products, Company JTM Foods, LLC, Type of Investment Term Loan, Reference Rate and Spread LIBOR+5.25%, Interest Rate 9.98%, Maturity 05/14/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.25%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.98%
Maturity	[1],[3],[4],[5],[17]			May 14, 2027
Principal	[1],[3],[4],[5],[17]			$ 71
Amortized Cost	[1],[3],[4],[5],[7],[17]			69,000
Fair Value	[1],[3],[4],[5],[17]			$ 68,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Food Products, Company KNPC Holdco, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR+5.50%, Interest Rate 11.00%, Maturity 10/22/29
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5.50%
Interest Rate *	[8],[10],[12],[13],[15]	11%
Maturity	[8],[10],[12],[15]	Oct. 22, 2029
Principal	[8],[10],[12],[15]	$ 8,082
Amortized Cost	[8],[10],[12],[14],[15]	7,989,000
Fair Value	[8],[10],[12],[15]	$ 7,900,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Food Products, Company KNPC Holdco, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR+5.75%, Interest Rate 10.17%, Maturity 10/20/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.75%
Interest Rate *	[1],[3],[4],[5],[6],[17]			10.17%
Maturity	[1],[3],[4],[5],[17]			Oct. 20, 2028
Principal	[1],[3],[4],[5],[17]			$ 8,164
Amortized Cost	[1],[3],[4],[5],[7],[17]			8,053,000
Fair Value	[1],[3],[4],[5],[17]			$ 7,878,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Food Products, Company VG Target Holdings, LLC, Type of Investment Term Loan, Reference Rate and Spread LIBOR+5.50%, Interest Rate 10.46% (0.50PIK), Maturity 08/02/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.50%
Interest Rate *	[1],[3],[4],[5],[6],[17]			10.46%
Interest Rate * PIK	[1],[3],[4],[5],[6],[17]			0.50%
Maturity	[1],[3],[4],[5],[17]			Aug. 02, 2027
Principal	[1],[3],[4],[5],[17]			$ 5,961
Amortized Cost	[1],[3],[4],[5],[7],[17]			5,855,000
Fair Value	[1],[3],[4],[5],[17]			5,261,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Food Products, Company VG Target Holdings, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR + 5.50%, Interest Rate 11.14% Maturity 08/02/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	5.50%
Interest Rate *	[8],[10],[11],[12],[13]	11.14%
Maturity	[8],[10],[11],[12]	Aug. 02, 2027
Principal	[8],[10],[11],[12]	$ 5,930
Amortized Cost	[8],[10],[11],[12],[14]	5,844,000
Fair Value	[8],[10],[11],[12]	5,397,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Equipment & Supplies
Schedule of Investments [Line Items]
Amortized Cost		17,053,000	[8],[12],[14]	17,171,000	[1],[4],[5],[7]
Fair Value		$ 16,965,000	[8],[12]	$ 17,003,000	[1],[4],[5]
Percentage of Net Assets ^		4.21%	[8],[12],[27]	4.21%	[1],[4],[5],[19]
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Equipment & Supplies, Company ACP Oak Buyer, Inc., Type of Investment Term Loan, Reference Rate and Spread LIBOR+5.00%, Interest Rate 9.73%, Maturity 08/29/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.73%
Maturity	[1],[3],[4],[5],[17]			Aug. 29, 2025
Principal	[1],[3],[4],[5],[17]			$ 5,954
Amortized Cost	[1],[3],[4],[5],[7],[17]			5,868,000
Fair Value	[1],[3],[4],[5],[17]			$ 5,805,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Equipment & Supplies, Company ACP Oak Buyer, Inc., Type of Investment Term Loan, Reference Rate and Spread SOFR+5.25%, Interest Rate 10.71%, Maturity 08/29/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5.25%
Interest Rate *	[8],[10],[12],[13],[15]	10.71%
Maturity	[8],[10],[12],[15]	Aug. 29, 2025
Principal	[8],[10],[12],[15]	$ 5,892
Amortized Cost	[8],[10],[12],[14],[15]	5,837,000
Fair Value	[8],[10],[12],[15]	$ 5,819,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Equipment & Supplies, Company BioCare Medical, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR+7.00%, Interest Rate 11.42%, Maturity 12/09/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			7%
Interest Rate *	[1],[3],[4],[5],[6],[17]			11.42%
Maturity	[1],[3],[4],[5],[17]			Dec. 09, 2027
Principal	[1],[3],[4],[5],[17]			$ 1,500
Amortized Cost	[1],[3],[4],[5],[7],[17]			1,456,000
Fair Value	[1],[3],[4],[5],[17]			$ 1,500,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Equipment & Supplies, Company BioCare Medical, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR+7.00%, Interest Rate 12.47%, Maturity 12/09/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	7%
Interest Rate *	[8],[10],[12],[13],[15]	12.47%
Maturity	[8],[10],[12],[15]	Dec. 09, 2027
Principal	[8],[10],[12],[15]	$ 1,485
Amortized Cost	[8],[10],[12],[14],[15]	1,448,000
Fair Value	[8],[10],[12],[15]	$ 1,485,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Equipment & Supplies, Company EPTAM Plastics, Ltd, Type of Investment Term Loan, Reference Rate and Spread SOFR+5.75%, Interest Rate 9.75%, Maturity 12/06/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.75%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.75%
Maturity	[1],[3],[4],[5],[17]			Dec. 06, 2025
Principal	[1],[3],[4],[5],[17]			$ 10
Amortized Cost	[1],[3],[4],[5],[7],[17]			10,000
Fair Value	[1],[3],[4],[5],[17]			$ 10,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Equipment & Supplies, Company EPTAM Plastics, Ltd., Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.25%, Interest Rate 9.67%, Maturity 12/06/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.25%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.67%
Maturity	[1],[3],[4],[5],[17]			Dec. 06, 2025
Principal	[1],[3],[4],[5],[17]			$ 1,311
Amortized Cost	[1],[3],[4],[5],[7],[17]			1,300,000
Fair Value	[1],[3],[4],[5],[17]			$ 1,298,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Equipment & Supplies, Company EPTAM Plastics, Ltd., Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.50%, Interest Rate 10.96%, Maturity 12/06/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5.50%
Interest Rate *	[8],[10],[12],[13],[15]	10.96%
Maturity	[8],[10],[12],[15]	Dec. 06, 2025
Principal	[8],[10],[12],[15]	$ 1,298
Amortized Cost	[8],[10],[12],[14],[15]	1,290,000
Fair Value	[8],[10],[12],[15]	$ 1,278,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Equipment & Supplies, Company EPTAM Plastics, Ltd., Type of Investment Term Loan, Reference Rate and Spread SOFR+5.25%, Interest Rate 9.67%, Maturity 12/06/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.25%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.67%
Maturity	[1],[3],[4],[5],[17]			Dec. 06, 2025
Principal	[1],[3],[4],[5],[17]			$ 3,042
Amortized Cost	[1],[3],[4],[5],[7],[17]			3,017,000
Fair Value	[1],[3],[4],[5],[17]			$ 3,012,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Equipment & Supplies, Company EPTAM Plastics, Ltd., Type of Investment Term Loan, Reference Rate and Spread SOFR+5.25%, Interest Rate 9.67%, Maturity 12/06/25 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.25%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.67%
Maturity	[1],[3],[4],[5],[17]			Dec. 06, 2025
Principal	[1],[3],[4],[5],[17]			$ 355
Amortized Cost	[1],[3],[4],[5],[7],[17]			352,000
Fair Value	[1],[3],[4],[5],[17]			$ 352,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Equipment & Supplies, Company EPTAM Plastics, Ltd., Type of Investment Term Loan, Reference Rate and Spread SOFR+5.25%, Interest Rate 9.67%, Maturity 12/06/25 Two
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.25%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.67%
Maturity	[1],[3],[4],[5],[17]			Dec. 06, 2025
Principal	[1],[3],[4],[5],[17]			$ 253
Amortized Cost	[1],[3],[4],[5],[7],[17]			250,000
Fair Value	[1],[3],[4],[5],[17]			250,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Equipment & Supplies, Company EPTAM Plastics, Ltd., Type of Investment Term Loan, Reference Rate and Spread SOFR+5.50%, Interest Rate 10.96%, Maturity 12/06/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5.50%
Interest Rate *	[8],[10],[12],[13],[15]	10.96%
Maturity	[8],[10],[12],[15]	Dec. 06, 2025
Principal	[8],[10],[12],[15]	$ 3,011
Amortized Cost	[8],[10],[12],[14],[15]	2,993,000
Fair Value	[8],[10],[12],[15]	$ 2,966,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Equipment & Supplies, Company EPTAM Plastics, Ltd., Type of Investment Term Loan, Reference Rate and Spread SOFR+5.50%, Interest Rate 10.96%, Maturity 12/06/25 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5.50%
Interest Rate *	[8],[10],[12],[13],[15]	10.96%
Maturity	[8],[10],[12],[15]	Dec. 06, 2025
Principal	[8],[10],[12],[15]	$ 352
Amortized Cost	[8],[10],[12],[14],[15]	350,000
Fair Value	[8],[10],[12],[15]	$ 346,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Equipment & Supplies, Company EPTAM Plastics, Ltd., Type of Investment Term Loan, Reference Rate and Spread SOFR+5.50%, Interest Rate 10.96%, Maturity 12/06/25 Two
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5.50%
Interest Rate *	[8],[10],[12],[13],[15]	10.96%
Maturity	[8],[10],[12],[15]	Dec. 06, 2025
Principal	[8],[10],[12],[15]	$ 251
Amortized Cost	[8],[10],[12],[14],[15]	249,000
Fair Value	[8],[10],[12],[15]	$ 247,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Equipment & Supplies, Company EPTAM Plastics, Ltd., Type of Investment Term Loan, Reference Rate and Spread SOFR+6.00%, Interest Rate 11.53%, Maturity 12/06/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	6%
Interest Rate *	[8],[10],[11],[12],[13]	11.53%
Maturity	[8],[10],[11],[12]	Dec. 06, 2025
Principal	[8],[10],[11],[12]	$ 10
Amortized Cost	[8],[10],[11],[12],[14]	10,000
Fair Value	[8],[10],[11],[12]	$ 10,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Equipment & Supplies, Company Zavation Medical Products, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR + 6.00%, Interest Rate 11.45%, Maturity 06/30/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	6%
Interest Rate *	[8],[10],[11],[12],[13]	11.45%
Maturity	[8],[10],[11],[12]	Jun. 30, 2028
Principal	[8],[10],[11],[12]	$ 4,912
Amortized Cost	[8],[10],[11],[12],[14]	4,876,000
Fair Value	[8],[10],[11],[12]	4,814,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services
Schedule of Investments [Line Items]
Amortized Cost		113,201,000	[8],[12],[14]	103,707,000	[1],[4],[5],[7]
Fair Value		$ 112,463,000	[8],[12]	$ 102,362,000	[1],[4],[5]
Percentage of Net Assets ^		27.89%	[8],[12],[27]	25.36%	[1],[4],[5],[19]
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company Advantage HCS LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR+6.25%, Interest Rate 11.62%, Maturity 11/08/29
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	6.25%
Interest Rate *	[8],[10],[12],[13],[15]	11.62%
Maturity	[8],[10],[12],[15]	Nov. 08, 2029
Principal	[8],[10],[12],[15]	$ 12,500
Amortized Cost	[8],[10],[12],[14],[15]	12,131,000
Fair Value	[8],[10],[12],[15]	$ 12,125,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company Center for Autism and Related Disorders, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+10.00%, Interest Rate 14.79%PIK, Maturity 10/11/23
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[2],[3],[4],[5]			10%
Interest Rate * PIK	[1],[2],[3],[4],[5],[6]			14.79%
Maturity	[1],[2],[3],[4],[5]			Oct. 11, 2023
Principal	[1],[2],[3],[4],[5]			$ 126
Amortized Cost	[1],[2],[3],[4],[5],[7]			126,000
Fair Value	[1],[2],[3],[4],[5]			$ 126,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company Center for Autism and Related Disorders, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+10.00%, Interest Rate 14.81%PIK, Maturity 10/11/23
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[2],[3],[4],[5]			10%
Interest Rate * PIK	[1],[2],[3],[4],[5],[6]			14.81%
Maturity	[1],[2],[3],[4],[5]			Oct. 11, 2023
Principal	[1],[2],[3],[4],[5]			$ 279
Amortized Cost	[1],[2],[3],[4],[5],[7]			279,000
Fair Value	[1],[2],[3],[4],[5]			$ 279,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company Center for Autism and Related Disorders, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+10.00%, Interest Rate 14.81%PIK, Maturity 10/11/23 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5]			10%
Interest Rate * PIK	[1],[3],[4],[5],[6]			14.81%
Maturity	[1],[3],[4],[5]			Oct. 11, 2023
Principal	[1],[3],[4],[5]			$ 349
Amortized Cost	[1],[3],[4],[5],[7]			349,000
Fair Value	[1],[3],[4],[5]			$ 349,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company Center for Autism and Related Disorders, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+10.00%, Interest Rate 14.84%PIK, Maturity 10/11/23
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5]			10%
Interest Rate * PIK	[1],[3],[4],[5],[6]			14.84%
Maturity	[1],[3],[4],[5]			Oct. 11, 2023
Principal	[1],[3],[4],[5]			$ 1,519
Amortized Cost	[1],[3],[4],[5],[7]			1,519,000
Fair Value	[1],[3],[4],[5]			$ 1,519,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company Eye Health America, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.00%, Interest Rate 9.79%, Maturity 07/26/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[2],[3],[4],[5]			5%
Interest Rate *	[1],[2],[3],[4],[5],[6]			9.79%
Maturity	[1],[2],[3],[4],[5]			Jul. 26, 2028
Principal	[1],[2],[3],[4],[5]			$ 1,552
Amortized Cost	[1],[2],[3],[4],[5],[7]			1,516,000
Fair Value	[1],[2],[3],[4],[5]			$ 1,478,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company Eye Health America, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.25%, Interest Rate 10.60%, Maturity 07/26/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[9],[10],[11],[12]	5.25%
Interest Rate *	[8],[9],[10],[11],[12],[13]	10.60%
Maturity	[8],[9],[10],[11],[12]	Jul. 26, 2028
Principal	[8],[9],[10],[11],[12]	$ 1,590
Amortized Cost	[8],[9],[10],[11],[12],[14]	1,560,000
Fair Value	[8],[9],[10],[11],[12]	$ 1,577,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company Eye Health America, LLC, Type of Investment Revolver, Reference Rate and Spread SOFR+5.00%, Interest Rate 8.96%, Maturity 07/26/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[2],[3],[4],[5]			5%
Interest Rate *	[1],[2],[3],[4],[5],[6]			8.96%
Maturity	[1],[2],[3],[4],[5]			Jul. 26, 2028
Principal	[1],[2],[3],[4],[5]			$ 60
Amortized Cost	[1],[2],[3],[4],[5],[7]			56,000
Fair Value	[1],[2],[3],[4],[5]			$ 53,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company Eye Health America, LLC, Type of Investment Revolver, Reference Rate and Spread SOFR+5.00%, Interest Rate 9.79%, Maturity 07/26/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[2],[3],[4],[5]			5%
Interest Rate *	[1],[2],[3],[4],[5],[6]			9.79%
Maturity	[1],[2],[3],[4],[5]			Jul. 26, 2028
Principal	[1],[2],[3],[4],[5]			$ 84
Amortized Cost	[1],[2],[3],[4],[5],[7]			78,000
Fair Value	[1],[2],[3],[4],[5]			$ 74,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company Eye Health America, LLC, Type of Investment Revolver, Reference Rate and Spread SOFR+5.25%, Interest Rate 10.60%, Maturity 07/26/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[9],[10],[11],[12]	5.25%
Interest Rate *	[8],[9],[10],[11],[12],[13]	10.60%
Maturity	[8],[9],[10],[11],[12]	Jul. 26, 2028
Principal	[8],[9],[10],[11],[12]	$ 240
Amortized Cost	[8],[9],[10],[11],[12],[14]	232,000
Fair Value	[8],[9],[10],[11],[12]	$ 237,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company Eye Health America, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR+5.00%, Interest Rate 9.79%, Maturity 07/26/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.79%
Maturity	[1],[3],[4],[5],[17]			Jul. 26, 2028
Principal	[1],[3],[4],[5],[17]			$ 4,190
Amortized Cost	[1],[3],[4],[5],[7],[17]			4,121,000
Fair Value	[1],[3],[4],[5],[17]			$ 4,074,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company Eye Health America, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR+5.25%, Interest Rate 10.60%, Maturity 07/26/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5.25%
Interest Rate *	[8],[10],[12],[13],[15]	10.60%
Maturity	[8],[10],[12],[15]	Jul. 26, 2028
Principal	[8],[10],[12],[15]	$ 4,148
Amortized Cost	[8],[10],[12],[14],[15]	4,090,000
Fair Value	[8],[10],[12],[15]	$ 4,127,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company Fingerpaint Marketing, Inc, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread LIBOR+5.75%, Interest Rate 10.48%, Maturity 12/30/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.75%
Interest Rate *	[1],[3],[4],[5],[6],[17]			10.48%
Maturity	[1],[3],[4],[5],[17]			Dec. 30, 2026
Principal	[1],[3],[4],[5],[17]			$ 2,651
Amortized Cost	[1],[3],[4],[5],[7],[17]			2,604,000
Fair Value	[1],[3],[4],[5],[17]			$ 2,545,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company Fingerpaint Marketing, Inc, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread LIBOR+5.75%, Interest Rate 10.48%, Maturity 12/30/26 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5]			5.75%
Interest Rate *	[1],[3],[4],[5],[6]			10.48%
Maturity	[1],[3],[4],[5]			Dec. 30, 2026
Principal	[1],[3],[4],[5]			$ 618
Amortized Cost	[1],[3],[4],[5],[7]			617,000
Fair Value	[1],[3],[4],[5]			$ 593,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company Fingerpaint Marketing, Inc, Type of Investment Term Loan, Reference Rate and Spread LIBOR+5.75%, Interest Rate 10.48%, Maturity 12/30/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.75%
Interest Rate *	[1],[3],[4],[5],[6],[17]			10.48%
Maturity	[1],[3],[4],[5],[17]			Dec. 30, 2026
Principal	[1],[3],[4],[5],[17]			$ 633
Amortized Cost	[1],[3],[4],[5],[7],[17]			622,000
Fair Value	[1],[3],[4],[5],[17]			$ 607,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company Fingerpaint Marketing, Inc, Type of Investment Term Loan, Reference Rate and Spread SOFR+6.25%, Interest Rate 11.70%, Maturity 12/30/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	6.25%
Interest Rate *	[8],[10],[12],[13],[15]	11.70%
Maturity	[8],[10],[12],[15]	Dec. 30, 2026
Principal	[8],[10],[12],[15]	$ 626
Amortized Cost	[8],[10],[12],[14],[15]	617,000
Fair Value	[8],[10],[12],[15]	$ 609,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company Fingerpaint Marketing, Inc., Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+6.25%, Interest Rate 11.70%, Maturity 12/30/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	6.25%
Interest Rate *	[8],[10],[11],[12],[13]	11.70%
Maturity	[8],[10],[11],[12]	Dec. 30, 2026
Principal	[8],[10],[11],[12]	$ 612
Amortized Cost	[8],[10],[11],[12],[14]	611,000
Fair Value	[8],[10],[11],[12]	$ 595,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company Fingerpaint Marketing, Inc., Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+6.25%, Interest Rate 11.70%, Maturity 12/30/26 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	6.25%
Interest Rate *	[8],[10],[12],[13],[15]	11.70%
Maturity	[8],[10],[12],[15]	Dec. 30, 2026
Principal	[8],[10],[12],[15]	$ 2,624
Amortized Cost	[8],[10],[12],[14],[15]	2,587,000
Fair Value	[8],[10],[12],[15]	$ 2,552,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company Fingerpaint Marketing, Inc., Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+6.75%, Interest Rate 12.20%, Maturity 12/30/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	6.75%
Interest Rate *	[8],[10],[11],[12],[13]	12.20%
Maturity	[8],[10],[11],[12]	Dec. 30, 2026
Principal	[8],[10],[11],[12]	$ 3
Amortized Cost	[8],[10],[11],[12],[14]	3,000
Fair Value	[8],[10],[11],[12]	$ 3,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company Fingerpaint Marketing, Inc., Type of Investment Revolver, Reference Rate and Spread PRIME+5.25%, Interest Rate 13.75%, Maturity 12/30/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[9],[10],[11],[12]	5.25%
Interest Rate *	[8],[9],[10],[11],[12],[13]	13.75%
Maturity	[8],[9],[10],[11],[12]	Dec. 30, 2026
Principal	[8],[9],[10],[11],[12]	$ 38
Amortized Cost	[8],[9],[10],[11],[12],[14]	37,000
Fair Value	[8],[9],[10],[11],[12]	$ 37,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company Fingerpaint Marketing, Inc., Type of Investment Term Loan, Reference Rate and Spread SOFR+6.75%, Interest Rate 12.20%, Maturity 12/30/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	6.75%
Interest Rate *	[8],[10],[11],[12],[13]	12.20%
Maturity	[8],[10],[11],[12]	Dec. 30, 2026
Principal	[8],[10],[11],[12]	$ 4
Amortized Cost	[8],[10],[11],[12],[14]	4,000
Fair Value	[8],[10],[11],[12]	$ 4,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company Heartland Veterinary Partners, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.06%, Interest Rate 10.51%, Maturity 12/10/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[12],[15]	5.06%
Interest Rate *	[8],[12],[13],[15]	10.51%
Maturity	[8],[12],[15]	Dec. 10, 2026
Principal	[8],[12],[15]	$ 1,312
Amortized Cost	[8],[12],[14],[15]	1,304,000
Fair Value	[8],[12],[15]	$ 1,298,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company Heartland Veterinary Partners, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.06%, Interest Rate 9.48%, Maturity 12/10/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[4],[5],[17]			5.06%
Interest Rate *	[1],[4],[5],[6],[17]			9.48%
Maturity	[1],[4],[5],[17]			Dec. 10, 2026
Principal	[1],[4],[5],[17]			$ 1,327
Amortized Cost	[1],[4],[5],[7],[17]			1,316,000
Fair Value	[1],[4],[5],[17]			$ 1,288,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company Heartland Veterinary Partners, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR 5.06%, Interest Rate 9.48%, Maturity 12/10/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[4],[5],[17]			5.06%
Interest Rate *	[1],[4],[5],[6],[17]			9.48%
Maturity	[1],[4],[5],[17]			Dec. 10, 2026
Principal	[1],[4],[5],[17]			$ 9,575
Amortized Cost	[1],[4],[5],[7],[17]			9,495,000
Fair Value	[1],[4],[5],[17]			$ 9,288,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company Heartland Veterinary Partners, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR+5.06%, Interest Rate 10.51%, Maturity 12/10/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[12],[15]	5.06%
Interest Rate *	[8],[12],[13],[15]	10.51%
Maturity	[8],[12],[15]	Dec. 10, 2026
Principal	[8],[12],[15]	$ 9,461
Amortized Cost	[8],[12],[14],[15]	9,406,000
Fair Value	[8],[12],[15]	$ 9,366,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company IMA Group Management Company, LLC, Type of Investment Term Loan, Reference Rate and Spread LIBOR+5.00%, Interest Rate 9.73%, Maturity 05/30/24
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.73%
Maturity	[1],[3],[4],[5],[17]			May 30, 2024
Principal	[1],[3],[4],[5],[17]			$ 1,583
Amortized Cost	[1],[3],[4],[5],[7],[17]			1,569,000
Fair Value	[1],[3],[4],[5],[17]			$ 1,563,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company IMA Group Management Company, LLC, Type of Investment Term Loan, Reference Rate and Spread LIBOR+5.00%, Interest Rate 9.73%, Maturity 05/30/24 Four
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.73%
Maturity	[1],[3],[4],[5],[17]			May 30, 2024
Principal	[1],[3],[4],[5],[17]			$ 828
Amortized Cost	[1],[3],[4],[5],[7],[17]			821,000
Fair Value	[1],[3],[4],[5],[17]			$ 818,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company IMA Group Management Company, LLC, Type of Investment Term Loan, Reference Rate and Spread LIBOR+5.00%, Interest Rate 9.73%, Maturity 05/30/24 Three
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.73%
Maturity	[1],[3],[4],[5],[17]			May 30, 2024
Principal	[1],[3],[4],[5],[17]			$ 5,752
Amortized Cost	[1],[3],[4],[5],[7],[17]			5,701,000
Fair Value	[1],[3],[4],[5],[17]			$ 5,680,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company IMA Group Management Company, LLC, Type of Investment Term Loan, Reference Rate and Spread LIBOR+5.00%, Interest Rate 9.73%, Maturity 05/30/24 Two
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.73%
Maturity	[1],[3],[4],[5],[17]			May 30, 2024
Principal	[1],[3],[4],[5],[17]			$ 891
Amortized Cost	[1],[3],[4],[5],[7],[17]			883,000
Fair Value	[1],[3],[4],[5],[17]			$ 880,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company MWD Management, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.00%, Interest Rate 10.45%, Maturity 06/15/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5%
Interest Rate *	[8],[10],[12],[13],[15]	10.45%
Maturity	[8],[10],[12],[15]	Jun. 15, 2027
Principal	[8],[10],[12],[15]	$ 1,980
Amortized Cost	[8],[10],[12],[14],[15]	1,966,000
Fair Value	[8],[10],[12],[15]	$ 1,950,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company MWD Management, LLC, Type of Investment Revolver, Reference Rate and Spread SOFR+5.00%, Interest Rate 10.45%, Maturity 06/15/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[9],[10],[11],[12]	5%
Interest Rate *	[8],[9],[10],[11],[12],[13]	10.45%
Maturity	[8],[9],[10],[11],[12]	Jun. 15, 2027
Principal	[8],[9],[10],[11],[12]	$ 233
Amortized Cost	[8],[9],[10],[11],[12],[14]	226,000
Fair Value	[8],[9],[10],[11],[12]	$ 226,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company MWD Management, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR+5.00%, Interest Rate 10.45%, Maturity 06/15/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5%
Interest Rate *	[8],[10],[12],[13],[15]	10.45%
Maturity	[8],[10],[12],[15]	Jun. 15, 2027
Principal	[8],[10],[12],[15]	$ 2,469
Amortized Cost	[8],[10],[12],[14],[15]	2,433,000
Fair Value	[8],[10],[12],[15]	$ 2,432,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company NJEye, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+4.75%, Interest Rate 10.39%, Maturity 03/14/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	4.75%
Interest Rate *	[8],[10],[12],[13],[15]	10.39%
Maturity	[8],[10],[12],[15]	Mar. 14, 2025
Principal	[8],[10],[12],[15]	$ 1,508
Amortized Cost	[8],[10],[12],[14],[15]	1,508,000
Fair Value	[8],[10],[12],[15]	$ 1,504,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company NJEye, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+4.75%, Interest Rate 10.40%, Maturity 03/14/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	4.75%
Interest Rate *	[8],[10],[12],[13],[15]	10.40%
Maturity	[8],[10],[12],[15]	Mar. 14, 2025
Principal	[8],[10],[12],[15]	$ 216
Amortized Cost	[8],[10],[12],[14],[15]	216,000
Fair Value	[8],[10],[12],[15]	$ 216,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company NJEye, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+4.75%, Interest Rate 10.42%, Maturity 03/14/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	4.75%
Interest Rate *	[8],[10],[12],[13],[15]	10.42%
Maturity	[8],[10],[12],[15]	Mar. 14, 2025
Principal	[8],[10],[12],[15]	$ 241
Amortized Cost	[8],[10],[12],[14],[15]	241,000
Fair Value	[8],[10],[12],[15]	$ 240,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company NJEye, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+4.75%, Interest Rate 10.46%, Maturity 03/14/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	4.75%
Interest Rate *	[8],[10],[12],[13],[15]	10.46%
Maturity	[8],[10],[12],[15]	Mar. 14, 2025
Principal	[8],[10],[12],[15]	$ 929
Amortized Cost	[8],[10],[12],[14],[15]	929,000
Fair Value	[8],[10],[12],[15]	$ 927,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company NJEye, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+4.75%, Interest Rate 7.63%, Maturity 09/14/24
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			4.75%
Interest Rate *	[1],[3],[4],[5],[6],[17]			7.63%
Maturity	[1],[3],[4],[5],[17]			Sep. 14, 2024
Principal	[1],[3],[4],[5],[17]			$ 1,771
Amortized Cost	[1],[3],[4],[5],[7],[17]			1,771,000
Fair Value	[1],[3],[4],[5],[17]			$ 1,748,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company NJEye, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+4.75%, Interest Rate 7.75%, Maturity 09/14/24
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			4.75%
Interest Rate *	[1],[3],[4],[5],[6],[17]			7.75%
Maturity	[1],[3],[4],[5],[17]			Sep. 14, 2024
Principal	[1],[3],[4],[5],[17]			$ 216
Amortized Cost	[1],[3],[4],[5],[7],[17]			216,000
Fair Value	[1],[3],[4],[5],[17]			$ 213,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company NJEye, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+4.75%, Interest Rate 9.02%, Maturity 09/14/24
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			4.75%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.02%
Maturity	[1],[3],[4],[5],[17]			Sep. 14, 2024
Principal	[1],[3],[4],[5],[17]			$ 929
Amortized Cost	[1],[3],[4],[5],[7],[17]			929,000
Fair Value	[1],[3],[4],[5],[17]			$ 918,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company NJEye, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR+4.75%, Interest Rate 10.39%, Maturity 03/14/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	4.75%
Interest Rate *	[8],[10],[12],[13],[15]	10.39%
Maturity	[8],[10],[12],[15]	Mar. 14, 2025
Principal	[8],[10],[12],[15]	$ 7,029
Amortized Cost	[8],[10],[12],[14],[15]	7,029,000
Fair Value	[8],[10],[12],[15]	$ 7,012,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company NJEye, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR+4.75%, Interest Rate 7.63%, Maturity 09/14/24
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			4.75%
Interest Rate *	[1],[3],[4],[5],[6],[17]			7.63%
Maturity	[1],[3],[4],[5],[17]			Sep. 14, 2024
Principal	[1],[3],[4],[5],[17]			$ 7,084
Amortized Cost	[1],[3],[4],[5],[7],[17]			7,084,000
Fair Value	[1],[3],[4],[5],[17]			$ 6,996,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company OIS Management Services, LLC, Type of Investment Delayed Draw Term Loan, Interest Rate 0.00%, Maturity 11/16/28
Schedule of Investments [Line Items]
Interest Rate *	[1],[2],[3],[4],[5],[6]			0%
Maturity	[1],[2],[3],[4],[5]			Nov. 16, 2028
Principal	[1],[2],[3],[4],[5]			$ 0
Amortized Cost	[1],[2],[3],[4],[5],[7]			(57,000)
Fair Value	[1],[2],[3],[4],[5]			$ (48,000)
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company OIS Management Services, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.75%, Interest Rate 11.20%, Maturity 11/16/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	5.75%
Interest Rate *	[8],[10],[11],[12],[13]	11.20%
Maturity	[8],[10],[11],[12]	Nov. 16, 2028
Principal	[8],[10],[11],[12]	$ 554
Amortized Cost	[8],[10],[11],[12],[14]	540,000
Fair Value	[8],[10],[11],[12]	$ 553,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company OIS Management Services, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.75%, Interest Rate 11.20%, Maturity 11/16/28 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	5.75%
Interest Rate *	[8],[10],[11],[12],[13]	11.20%
Maturity	[8],[10],[11],[12]	Nov. 16, 2028
Principal	[8],[10],[11],[12]	$ 695
Amortized Cost	[8],[10],[11],[12],[14]	677,000
Fair Value	[8],[10],[11],[12]	$ 693,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company OIS Management Services, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.75%, Interest Rate 11.22%, Maturity 11/16/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	5.75%
Interest Rate *	[8],[10],[11],[12],[13]	11.22%
Maturity	[8],[10],[11],[12]	Nov. 16, 2028
Principal	[8],[10],[11],[12]	$ 288
Amortized Cost	[8],[10],[11],[12],[14]	280,000
Fair Value	[8],[10],[11],[12]	$ 287,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company OIS Management Services, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.75%, Interest Rate 11.23%, Maturity 11/16/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	5.75%
Interest Rate *	[8],[10],[11],[12],[13]	11.23%
Maturity	[8],[10],[11],[12]	Nov. 16, 2028
Principal	[8],[10],[11],[12]	$ 378
Amortized Cost	[8],[10],[11],[12],[14]	368,000
Fair Value	[8],[10],[11],[12]	$ 377,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company OIS Management Services, LLC, Type of Investment Revolver, Interest Rate 0.00%, Maturity 11/16/28
Schedule of Investments [Line Items]
Interest Rate *	[1],[2],[3],[4],[5],[6]			0%
Maturity	[1],[2],[3],[4],[5]			Nov. 16, 2028
Principal	[1],[2],[3],[4],[5]			$ 0
Amortized Cost	[1],[2],[3],[4],[5],[7]			(17,000)
Fair Value	[1],[2],[3],[4],[5]			$ (14,000)
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company OIS Management Services, LLC, Type of Investment Revolver, Maturity 11/16/28
Schedule of Investments [Line Items]
Maturity	[8],[9],[10],[11],[12]	Nov. 16, 2028
Principal	[8],[9],[10],[11],[12]	$ 0
Amortized Cost	[8],[9],[10],[11],[12],[14]	(14,000)
Fair Value	[8],[9],[10],[11],[12]	$ (1,000)
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company OIS Management Services, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR + 6.00%, Interest Rate 10.33%, Maturity 11/16/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			6%
Interest Rate *	[1],[3],[4],[5],[6],[17]			10.33%
Maturity	[1],[3],[4],[5],[17]			Nov. 16, 2028
Principal	[1],[3],[4],[5],[17]			$ 5,000
Amortized Cost	[1],[3],[4],[5],[7],[17]			4,853,000
Fair Value	[1],[3],[4],[5],[17]			$ 4,875,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company OIS Management Services, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR+5.75%, Interest Rate 11.20%, Maturity 11/16/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5.75%
Interest Rate *	[8],[10],[12],[13],[15]	11.20%
Maturity	[8],[10],[12],[15]	Nov. 16, 2028
Principal	[8],[10],[12],[15]	$ 4,963
Amortized Cost	[8],[10],[12],[14],[15]	4,836,000
Fair Value	[8],[10],[12],[15]	$ 4,950,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company ORG USME Buyer, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR + 5.75%, Interest Rate 10.79%, Maturity 11/24/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.75%
Interest Rate *	[1],[3],[4],[5],[6],[17]			10.79%
Maturity	[1],[3],[4],[5],[17]			Nov. 24, 2026
Principal	[1],[3],[4],[5],[17]			$ 7,463
Amortized Cost	[1],[3],[4],[5],[7],[17]			7,328,000
Fair Value	[1],[3],[4],[5],[17]			$ 7,257,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company ORG USME Buyer, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR+5.75%, Interest Rate 11.29%, Maturity 11/24/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5.75%
Interest Rate *	[8],[10],[12],[13],[15]	11.29%
Maturity	[8],[10],[12],[15]	Nov. 24, 2026
Principal	[8],[10],[12],[15]	$ 7,388
Amortized Cost	[8],[10],[12],[14],[15]	7,283,000
Fair Value	[8],[10],[12],[15]	$ 6,907,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company Pediatric Home Respiratory Services, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread PRIME+5.25%, Interest Rate 13.75%, Maturity 12/04/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	5.25%
Interest Rate *	[8],[10],[11],[12],[13]	13.75%
Maturity	[8],[10],[11],[12]	Dec. 04, 2025
Principal	[8],[10],[11],[12]	$ 386
Amortized Cost	[8],[10],[11],[12],[14]	384,000
Fair Value	[8],[10],[11],[12]	$ 383,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company Pediatric Home Respiratory Services, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR + 5.75%, Interest Rate 10.17%, Maturity 12/04/24
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.75%
Interest Rate *	[1],[3],[4],[5],[6],[17]			10.17%
Maturity	[1],[3],[4],[5],[17]			Dec. 04, 2024
Principal	[1],[3],[4],[5],[17]			$ 426
Amortized Cost	[1],[3],[4],[5],[7],[17]			421,000
Fair Value	[1],[3],[4],[5],[17]			$ 415,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company Pediatric Home Respiratory Services, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR + 6.25%, Interest Rate 10.67%, Maturity 12/04/24
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[2],[3],[4],[5]			6.25%
Interest Rate *	[1],[2],[3],[4],[5],[6]			10.67%
Maturity	[1],[2],[3],[4],[5]			Dec. 04, 2024
Principal	[1],[2],[3],[4],[5]			$ 1,431
Amortized Cost	[1],[2],[3],[4],[5],[7]			1,417,000
Fair Value	[1],[2],[3],[4],[5]			$ 1,388,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company Pediatric Home Respiratory Services, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.75%, Interest Rate 11.21%, Maturity 12/04/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	5.75%
Interest Rate *	[8],[10],[11],[12],[13]	11.21%
Maturity	[8],[10],[11],[12]	Dec. 04, 2025
Principal	[8],[10],[11],[12]	$ 425
Amortized Cost	[8],[10],[11],[12],[14]	422,000
Fair Value	[8],[10],[11],[12]	$ 418,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company Pediatric Home Respiratory Services, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+6.25%, Interest Rate 11.71%, Maturity 12/04/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	6.25%
Interest Rate *	[8],[10],[11],[12],[13]	11.71%
Maturity	[8],[10],[11],[12]	Dec. 04, 2025
Principal	[8],[10],[11],[12]	$ 2,095
Amortized Cost	[8],[10],[11],[12],[14]	2,087,000
Fair Value	[8],[10],[11],[12]	$ 2,080,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company Pediatric Home Respiratory Services, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR + 5.75%, Interest Rate 10.17%, Maturity 12/04/24
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.75%
Interest Rate *	[1],[3],[4],[5],[6],[17]			10.17%
Maturity	[1],[3],[4],[5],[17]			Dec. 04, 2024
Principal	[1],[3],[4],[5],[17]			$ 4,574
Amortized Cost	[1],[3],[4],[5],[7],[17]			4,512,000
Fair Value	[1],[3],[4],[5],[17]			$ 4,448,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company Pediatric Home Respiratory Services, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR+5.75%, Interest Rate 11.21%, Maturity 12/04/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	5.75%
Interest Rate *	[8],[10],[11],[12],[13]	11.21%
Maturity	[8],[10],[11],[12]	Dec. 04, 2025
Principal	[8],[10],[11],[12]	$ 4,554
Amortized Cost	[8],[10],[11],[12],[14]	4,523,000
Fair Value	[8],[10],[11],[12]	$ 4,486,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company Prelude Fertility, Inc., Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR + 7.00%, Interest Rate 11.70%, Maturity 12/07/23
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			7%
Interest Rate *	[1],[3],[4],[5],[6],[17]			11.70%
Maturity	[1],[3],[4],[5],[17]			Dec. 07, 2023
Principal	[1],[3],[4],[5],[17]			$ 2,116
Amortized Cost	[1],[3],[4],[5],[7],[17]			2,065,000
Fair Value	[1],[3],[4],[5],[17]			$ 2,084,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company Prelude Fertility, Inc., Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+7.00%, Interest Rate 12.69%, Maturity 12/31/24
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	7%
Interest Rate *	[8],[10],[12],[13],[15]	12.69%
Maturity	[8],[10],[12],[15]	Dec. 31, 2024
Principal	[8],[10],[12],[15]	$ 2,089
Amortized Cost	[8],[10],[12],[14],[15]	2,045,000
Fair Value	[8],[10],[12],[15]	$ 2,068,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company Prelude Fertility, Inc., Type of Investment Term Loan, Reference Rate and Spread SOFR + 7.00%, Interest Rate 11.70%, Maturity 12/07/23
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			7%
Interest Rate *	[1],[3],[4],[5],[6],[17]			11.70%
Maturity	[1],[3],[4],[5],[17]			Dec. 07, 2023
Principal	[1],[3],[4],[5],[17]			$ 7,838
Amortized Cost	[1],[3],[4],[5],[7],[17]			7,704,000
Fair Value	[1],[3],[4],[5],[17]			$ 7,720,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company Prelude Fertility, Inc., Type of Investment Term Loan, Reference Rate and Spread SOFR+7.00%, Interest Rate 12.69%, Maturity 12/31/24
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	7%
Interest Rate *	[8],[10],[12],[13],[15]	12.69%
Maturity	[8],[10],[12],[15]	Dec. 31, 2024
Principal	[8],[10],[12],[15]	$ 7,756
Amortized Cost	[8],[10],[12],[14],[15]	7,676,000
Fair Value	[8],[10],[12],[15]	$ 7,678,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company Premier Imaging, LLC, Inc., Type of Investment Term Loan, Reference Rate and Spread SOFR + 6.00%, Interest Rate 11.61%, Maturity 01/02/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	6%
Interest Rate *	[8],[10],[12],[13],[15]	11.61%
Maturity	[8],[10],[12],[15]	Jan. 02, 2025
Principal	[8],[10],[12],[15]	$ 3,583
Amortized Cost	[8],[10],[12],[14],[15]	3,561,000
Fair Value	[8],[10],[12],[15]	$ 3,502,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company Premier Imaging, LLC, Inc., Type of Investment Term Loan, Reference Rate and Spread SOFR+6.00%, Interest Rate 11.61%, Maturity 01/02/25 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	6%
Interest Rate *	[8],[10],[12],[13],[15]	11.61%
Maturity	[8],[10],[12],[15]	Jan. 02, 2025
Principal	[8],[10],[12],[15]	$ 4,363
Amortized Cost	[8],[10],[12],[14],[15]	4,336,000
Fair Value	[8],[10],[12],[15]	$ 4,265,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company Premier Imaging, LLC, Inc., Type of Investment Term Loan, Reference Rate and Spread SOFR+6.00%, Interest Rate 11.61%, Maturity 01/02/25 Two
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	6%
Interest Rate *	[8],[10],[12],[13],[15]	11.61%
Maturity	[8],[10],[12],[15]	Jan. 02, 2025
Principal	[8],[10],[12],[15]	$ 2,979
Amortized Cost	[8],[10],[12],[14],[15]	2,960,000
Fair Value	[8],[10],[12],[15]	$ 2,912,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company Premier Imaging, LLC, Type of Investment Term Loan, Reference Rate and Spread LIBOR+5.75%, Interest Rate 10.13%, Maturity 01/02/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.75%
Interest Rate *	[1],[3],[4],[5],[6],[17]			10.13%
Maturity	[1],[3],[4],[5],[17]			Jan. 02, 2025
Principal	[1],[3],[4],[5],[17]			$ 3,617
Amortized Cost	[1],[3],[4],[5],[7],[17]			3,575,000
Fair Value	[1],[3],[4],[5],[17]			$ 3,563,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company Premier Imaging, LLC, Type of Investment Term Loan, Reference Rate and Spread LIBOR+5.75%, Interest Rate 10.13%, Maturity 01/02/25 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.75%
Interest Rate *	[1],[3],[4],[5],[6],[17]			10.13%
Maturity	[1],[3],[4],[5],[17]			Jan. 02, 2025
Principal	[1],[3],[4],[5],[17]			$ 4,405
Amortized Cost	[1],[3],[4],[5],[7],[17]			4,353,000
Fair Value	[1],[3],[4],[5],[17]			$ 4,338,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company Premier Imaging, LLC, Type of Investment Term Loan, Reference Rate and Spread LIBOR+5.75%, Interest Rate 10.13%, Maturity 01/02/25 Two
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.75%
Interest Rate *	[1],[3],[4],[5],[6],[17]			10.13%
Maturity	[1],[3],[4],[5],[17]			Jan. 02, 2025
Principal	[1],[3],[4],[5],[17]			$ 2,979
Amortized Cost	[1],[3],[4],[5],[7],[17]			2,944,000
Fair Value	[1],[3],[4],[5],[17]			$ 2,934,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company SGA Dental Partners Opco, LLC, Type of Investment Delayed Draw Term Loan, Maturity 12/30/26
Schedule of Investments [Line Items]
Maturity	[8],[9],[10],[11],[12]	Dec. 30, 2026
Principal	[8],[9],[10],[11],[12]	$ 0
Amortized Cost	[8],[9],[10],[11],[12],[14]	(33,000)
Fair Value	[8],[9],[10],[11],[12]	$ (10,000)
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company SGA Dental Partners Opco, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+ 6.00%, Interest Rate 10.43%, Maturity 12/30/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[2],[3],[4],[5]			6%
Interest Rate *	[1],[2],[3],[4],[5],[6]			10.43%
Maturity	[1],[2],[3],[4],[5]			Dec. 30, 2026
Principal	[1],[2],[3],[4],[5]			$ 89
Amortized Cost	[1],[2],[3],[4],[5],[7]			86,000
Fair Value	[1],[2],[3],[4],[5]			$ 83,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company SGA Dental Partners Opco, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+ 6.00%, Interest Rate 10.45%, Maturity 12/30/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[2],[3],[4],[5]			6%
Interest Rate *	[1],[2],[3],[4],[5],[6]			10.45%
Maturity	[1],[2],[3],[4],[5]			Dec. 30, 2026
Principal	[1],[2],[3],[4],[5]			$ 129
Amortized Cost	[1],[2],[3],[4],[5],[7]			124,000
Fair Value	[1],[2],[3],[4],[5]			$ 119,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company SGA Dental Partners Opco, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+ 6.00%, Interest Rate 10.48%, Maturity 12/30/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[2],[3],[4],[5]			6%
Interest Rate *	[1],[2],[3],[4],[5],[6]			10.48%
Maturity	[1],[2],[3],[4],[5]			Dec. 30, 2026
Principal	[1],[2],[3],[4],[5]			$ 68
Amortized Cost	[1],[2],[3],[4],[5],[7]			66,000
Fair Value	[1],[2],[3],[4],[5]			$ 63,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company SGA Dental Partners Opco, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+ 6.00%, Interest Rate 10.49%, Maturity 12/30/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[2],[3],[4],[5]			6%
Interest Rate *	[1],[2],[3],[4],[5],[6]			10.49%
Maturity	[1],[2],[3],[4],[5]			Dec. 30, 2026
Principal	[1],[2],[3],[4],[5]			$ 161
Amortized Cost	[1],[2],[3],[4],[5],[7]			155,000
Fair Value	[1],[2],[3],[4],[5]			$ 149,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company SGA Dental Partners Opco, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+ 6.00%, Interest Rate 10.51%, Maturity 12/30/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[2],[3],[4],[5]			6%
Interest Rate *	[1],[2],[3],[4],[5],[6]			10.51%
Maturity	[1],[2],[3],[4],[5]			Dec. 30, 2026
Principal	[1],[2],[3],[4],[5]			$ 25
Amortized Cost	[1],[2],[3],[4],[5],[7]			24,000
Fair Value	[1],[2],[3],[4],[5]			$ 23,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company SGA Dental Partners Opco, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+ 6.00%, Interest Rate 10.72%, Maturity 12/30/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[2],[3],[4],[5]			6%
Interest Rate *	[1],[2],[3],[4],[5],[6]			10.72%
Maturity	[1],[2],[3],[4],[5]			Dec. 30, 2026
Principal	[1],[2],[3],[4],[5]			$ 61
Amortized Cost	[1],[2],[3],[4],[5],[7]			59,000
Fair Value	[1],[2],[3],[4],[5]			$ 56,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company SGA Dental Partners Opco, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+ 6.00%, Interest Rate 10.76%, Maturity 12/30/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[2],[3],[4],[5]			6%
Interest Rate *	[1],[2],[3],[4],[5],[6]			10.76%
Maturity	[1],[2],[3],[4],[5]			Dec. 30, 2026
Principal	[1],[2],[3],[4],[5]			$ 518
Amortized Cost	[1],[2],[3],[4],[5],[7]			500,000
Fair Value	[1],[2],[3],[4],[5]			$ 481,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company SGA Dental Partners Opco, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+ 6.00%, Interest Rate 10.79%, Maturity 12/30/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[2],[3],[4],[5]			6%
Interest Rate *	[1],[2],[3],[4],[5],[6]			10.79%
Maturity	[1],[2],[3],[4],[5]			Dec. 30, 2026
Principal	[1],[2],[3],[4],[5]			$ 121
Amortized Cost	[1],[2],[3],[4],[5],[7]			117,000
Fair Value	[1],[2],[3],[4],[5]			$ 113,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company SGA Dental Partners Opco, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+ 6.00%, Interest Rate 10.84%, Maturity 12/30/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[2],[3],[4],[5]			6%
Interest Rate *	[1],[2],[3],[4],[5],[6]			10.84%
Maturity	[1],[2],[3],[4],[5]			Dec. 30, 2026
Principal	[1],[2],[3],[4],[5]			$ 43
Amortized Cost	[1],[2],[3],[4],[5],[7]			41,000
Fair Value	[1],[2],[3],[4],[5]			$ 40,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company SGA Dental Partners Opco, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+6.00%, Interest Rate 10.05%, Maturity 12/30/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[2],[3],[4],[5]			6%
Interest Rate *	[1],[2],[3],[4],[5],[6]			10.05%
Maturity	[1],[2],[3],[4],[5]			Dec. 30, 2026
Principal	[1],[2],[3],[4],[5]			$ 143
Amortized Cost	[1],[2],[3],[4],[5],[7]			138,000
Fair Value	[1],[2],[3],[4],[5]			$ 133,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company SGA Dental Partners Opco, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+6.00%, Interest Rate 10.25%, Maturity 12/30/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[2],[3],[4],[5]			6%
Interest Rate *	[1],[2],[3],[4],[5],[6]			10.25%
Maturity	[1],[2],[3],[4],[5]			Dec. 30, 2026
Principal	[1],[2],[3],[4],[5]			$ 371
Amortized Cost	[1],[2],[3],[4],[5],[7]			359,000
Fair Value	[1],[2],[3],[4],[5]			$ 345,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company SGA Dental Partners Opco, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+6.00%, Interest Rate 10.32%, Maturity 12/30/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[2],[3],[4],[5]			6%
Interest Rate *	[1],[2],[3],[4],[5],[6]			10.32%
Maturity	[1],[2],[3],[4],[5]			Dec. 30, 2026
Principal	[1],[2],[3],[4],[5]			$ 161
Amortized Cost	[1],[2],[3],[4],[5],[7]			155,000
Fair Value	[1],[2],[3],[4],[5]			$ 149,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company SGA Dental Partners Opco, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+6.00%, Interest Rate 11.61%, Maturity 12/30/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	6%
Interest Rate *	[8],[10],[11],[12],[13]	11.61%
Maturity	[8],[10],[11],[12]	Dec. 30, 2026
Principal	[8],[10],[11],[12]	$ 3,512
Amortized Cost	[8],[10],[11],[12],[14]	3,464,000
Fair Value	[8],[10],[11],[12]	$ 3,485,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company SGA Dental Partners Opco, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+6.00%, Interest Rate 11.64%, Maturity 12/30/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	6%
Interest Rate *	[8],[10],[11],[12],[13]	11.64%
Maturity	[8],[10],[11],[12]	Dec. 30, 2026
Principal	[8],[10],[11],[12]	$ 3,087
Amortized Cost	[8],[10],[11],[12],[14]	3,045,000
Fair Value	[8],[10],[11],[12]	$ 3,064,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company SGA Dental Partners Opco, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+6.00%, Interest Rate 11.65%, Maturity 12/30/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	6%
Interest Rate *	[8],[10],[11],[12],[13]	11.65%
Maturity	[8],[10],[11],[12]	Dec. 30, 2026
Principal	[8],[10],[11],[12]	$ 331
Amortized Cost	[8],[10],[11],[12],[14]	326,000
Fair Value	[8],[10],[11],[12]	$ 328,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company SGA Dental Partners Opco, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+6.00%, Interest Rate 11.68%, Maturity 12/30/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	6%
Interest Rate *	[8],[10],[11],[12],[13]	11.68%
Maturity	[8],[10],[11],[12]	Dec. 30, 2026
Principal	[8],[10],[11],[12]	$ 164
Amortized Cost	[8],[10],[11],[12],[14]	162,000
Fair Value	[8],[10],[11],[12]	$ 163,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company SGA Dental Partners Opco, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR+6.00%, Interest Rate 11.61%, Maturity 12/30/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	6%
Interest Rate *	[8],[10],[11],[12],[13]	11.61%
Maturity	[8],[10],[11],[12]	Dec. 30, 2026
Principal	[8],[10],[11],[12]	$ 697
Amortized Cost	[8],[10],[11],[12],[14]	681,000
Fair Value	[8],[10],[11],[12]	$ 692,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company TheKey, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread LIBOR+5.00%, Interest Rate 9.38%, Maturity 03/30/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.38%
Maturity	[1],[3],[4],[5],[17]			Mar. 30, 2027
Principal	[1],[3],[4],[5],[17]			$ 786
Amortized Cost	[1],[3],[4],[5],[7],[17]			782,000
Fair Value	[1],[3],[4],[5],[17]			$ 762,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company TheKey, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread LIBOR+5.00%, Interest Rate 9.38%, Maturity 03/30/27 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.38%
Maturity	[1],[3],[4],[5],[17]			Mar. 30, 2027
Principal	[1],[3],[4],[5],[17]			$ 5,530
Amortized Cost	[1],[3],[4],[5],[7],[17]			5,506,000
Fair Value	[1],[3],[4],[5],[17]			$ 5,364,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company TheKey, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR + 5.00%, Interest Rate 10.48%, Maturity 03/30/27 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5%
Interest Rate *	[8],[10],[12],[13],[15]	10.48%
Maturity	[8],[10],[12],[15]	Mar. 30, 2027
Principal	[8],[10],[12],[15]	$ 5,475
Amortized Cost	[8],[10],[12],[14],[15]	5,455,000
Fair Value	[8],[10],[12],[15]	$ 5,269,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company TheKey, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.00%, Interest Rate 10.48%, Maturity 03/30/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5%
Interest Rate *	[8],[10],[12],[13],[15]	10.48%
Maturity	[8],[10],[12],[15]	Mar. 30, 2027
Principal	[8],[10],[12],[15]	$ 778
Amortized Cost	[8],[10],[12],[14],[15]	775,000
Fair Value	[8],[10],[12],[15]	$ 748,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company TheKey, LLC, Type of Investment Term Loan, Reference Rate and Spread LIBOR+5.00%, Interest Rate 9.38%, Maturity 03/30/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.38%
Maturity	[1],[3],[4],[5],[17]			Mar. 30, 2027
Principal	[1],[3],[4],[5],[17]			$ 1,751
Amortized Cost	[1],[3],[4],[5],[7],[17]			1,744,000
Fair Value	[1],[3],[4],[5],[17]			$ 1,699,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company TheKey, LLC, Type of Investment Term Loan, Reference Rate and Spread LIBOR+5.00%, Interest Rate 9.38%, Maturity 03/30/27 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.38%
Maturity	[1],[3],[4],[5],[17]			Mar. 30, 2027
Principal	[1],[3],[4],[5],[17]			$ 504
Amortized Cost	[1],[3],[4],[5],[7],[17]			502,000
Fair Value	[1],[3],[4],[5],[17]			$ 489,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company TheKey, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR+5.00%, Interest Rate 10.48%, Maturity 03/30/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5%
Interest Rate *	[8],[10],[12],[13],[15]	10.48%
Maturity	[8],[10],[12],[15]	Mar. 30, 2027
Principal	[8],[10],[12],[15]	$ 1,733
Amortized Cost	[8],[10],[12],[14],[15]	1,727,000
Fair Value	[8],[10],[12],[15]	$ 1,668,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company TheKey, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR+5.00%, Interest Rate 10.48%, Maturity 03/30/27 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5%
Interest Rate *	[8],[10],[12],[13],[15]	10.48%
Maturity	[8],[10],[12],[15]	Mar. 30, 2027
Principal	[8],[10],[12],[15]	$ 499
Amortized Cost	[8],[10],[12],[14],[15]	497,000
Fair Value	[8],[10],[12],[15]	$ 480,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company USN Opco, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.75%, Interest Rate 10.48%, Maturity 12/21/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[2],[3],[4],[5]			5.75%
Interest Rate *	[1],[2],[3],[4],[5],[6]			10.48%
Maturity	[1],[2],[3],[4],[5]			Dec. 21, 2026
Principal	[1],[2],[3],[4],[5]			$ 567
Amortized Cost	[1],[2],[3],[4],[5],[7]			559,000
Fair Value	[1],[2],[3],[4],[5]			$ 539,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company USN Opco, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.75%, Interest Rate 11.25%, Maturity 12/21/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	5.75%
Interest Rate *	[8],[10],[11],[12],[13]	11.25%
Maturity	[8],[10],[11],[12]	Dec. 21, 2026
Principal	[8],[10],[11],[12]	$ 1,163
Amortized Cost	[8],[10],[11],[12],[14]	1,153,000
Fair Value	[8],[10],[11],[12]	$ 1,154,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company USN Opco, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.75%, Interest Rate 11.28%, Maturity 12/21/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	5.75%
Interest Rate *	[8],[10],[11],[12],[13]	11.28%
Maturity	[8],[10],[11],[12]	Dec. 21, 2026
Principal	[8],[10],[11],[12]	$ 25
Amortized Cost	[8],[10],[11],[12],[14]	25,000
Fair Value	[8],[10],[11],[12]	$ 25,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company USN Opco, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.75%, Interest Rate 9.99%, Maturity 12/21/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[2],[3],[4],[5]			5.75%
Interest Rate *	[1],[2],[3],[4],[5],[6]			9.99%
Maturity	[1],[2],[3],[4],[5]			Dec. 21, 2026
Principal	[1],[2],[3],[4],[5]			$ 35
Amortized Cost	[1],[2],[3],[4],[5],[7]			34,000
Fair Value	[1],[2],[3],[4],[5]			$ 33,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company United Musculoskeletal Partners Acquisition Holdings, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.75%, Interest Rate 10.07%, Maturity 07/15/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[2],[3],[4],[5]			5.75%
Interest Rate *	[1],[2],[3],[4],[5],[6]			10.07%
Maturity	[1],[2],[3],[4],[5]			Jul. 15, 2028
Principal	[1],[2],[3],[4],[5]			$ 869
Amortized Cost	[1],[2],[3],[4],[5],[7]			846,000
Fair Value	[1],[2],[3],[4],[5]			$ 801,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company United Musculoskeletal Partners Acquisition Holdings, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.75%, Interest Rate 11.12%, Maturity 07/15/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[9],[10],[11],[12]	5.75%
Interest Rate *	[8],[9],[10],[11],[12],[13]	11.12%
Maturity	[8],[9],[10],[11],[12]	Jul. 15, 2028
Principal	[8],[9],[10],[11],[12]	$ 90
Amortized Cost	[8],[9],[10],[11],[12],[14]	89,000
Fair Value	[8],[9],[10],[11],[12]	$ 89,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company United Musculoskeletal Partners Acquisition Holdings, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.75%, Interest Rate 11.13%, Maturity 07/15/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[9],[10],[11],[12]	5.75%
Interest Rate *	[8],[9],[10],[11],[12],[13]	11.13%
Maturity	[8],[9],[10],[11],[12]	Jul. 15, 2028
Principal	[8],[9],[10],[11],[12]	$ 593
Amortized Cost	[8],[9],[10],[11],[12],[14]	585,000
Fair Value	[8],[9],[10],[11],[12]	$ 588,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company United Musculoskeletal Partners Acquisition Holdings, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.75%, Interest Rate 11.13%, Maturity 07/15/28 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[9],[10],[11],[12]	5.75%
Interest Rate *	[8],[9],[10],[11],[12],[13]	11.13%
Maturity	[8],[9],[10],[11],[12]	Jul. 15, 2028
Principal	[8],[9],[10],[11],[12]	$ 378
Amortized Cost	[8],[9],[10],[11],[12],[14]	372,000
Fair Value	[8],[9],[10],[11],[12]	$ 374,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company United Musculoskeletal Partners Acquisition Holdings, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.75%, Interest Rate 11.16%, Maturity 07/15/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[9],[10],[11],[12]	5.75%
Interest Rate *	[8],[9],[10],[11],[12],[13]	11.16%
Maturity	[8],[9],[10],[11],[12]	Jul. 15, 2028
Principal	[8],[9],[10],[11],[12]	$ 859
Amortized Cost	[8],[9],[10],[11],[12],[14]	846,000
Fair Value	[8],[9],[10],[11],[12]	$ 850,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company United Musculoskeletal Partners Acquisition Holdings, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR+5.75%, Interest Rate 10.09%, Maturity 07/15/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.75%
Interest Rate *	[1],[3],[4],[5],[6],[17]			10.09%
Maturity	[1],[3],[4],[5],[17]			Jul. 15, 2028
Principal	[1],[3],[4],[5],[17]			$ 4,988
Amortized Cost	[1],[3],[4],[5],[7],[17]			4,988,000
Fair Value	[1],[3],[4],[5],[17]			$ 4,851,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company United Musculoskeletal Partners Acquisition Holdings, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR+5.75%, Interest Rate 11.15%, Maturity 07/15/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5.75%
Interest Rate *	[8],[10],[12],[13],[15]	11.15%
Maturity	[8],[10],[12],[15]	Jul. 15, 2028
Principal	[8],[10],[12],[15]	$ 4,938
Amortized Cost	[8],[10],[12],[14],[15]	4,938,000
Fair Value	[8],[10],[12],[15]	4,901,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Company, IMA Group Management Company LLC, Type of Investment Term Loan, Reference Rate and Spread LIBOR+5.00%, Interest Rate 9.73%, Maturity 05/30/24 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.73%
Maturity	[1],[3],[4],[5],[17]			May 30, 2024
Principal	[1],[3],[4],[5],[17]			$ 868
Amortized Cost	[1],[3],[4],[5],[7],[17]			860,000
Fair Value	[1],[3],[4],[5],[17]			$ 857,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Instruments & Components, Company MWD Management, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.00%, Interest Rate 9.89%, Maturity 06/15/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5]			5%
Interest Rate *	[1],[3],[4],[5],[6]			9.89%
Maturity	[1],[3],[4],[5]			Jun. 15, 2027
Principal	[1],[3],[4],[5]			$ 2,000
Amortized Cost	[1],[3],[4],[5],[7]			1,982,000
Fair Value	[1],[3],[4],[5]			$ 1,930,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Instruments & Components, Company MWD Management, LLC, Type of Investment Revolver, Reference Rate and Spread SOFR+5.00%, Interest Rate 9.68%, Maturity 06/15/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[2],[3],[4],[5]			5%
Interest Rate *	[1],[2],[3],[4],[5],[6]			9.68%
Maturity	[1],[2],[3],[4],[5]			Jun. 15, 2027
Principal	[1],[2],[3],[4],[5]			$ 267
Amortized Cost	[1],[2],[3],[4],[5],[7]			258,000
Fair Value	[1],[2],[3],[4],[5]			$ 249,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Providers & Services, Instruments & Components, Company MWD Management, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR+5.00%, Interest Rate 9.89%, Maturity 06/15/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.89%
Maturity	[1],[3],[4],[5],[17]			Jun. 15, 2027
Principal	[1],[3],[4],[5],[17]			$ 2,494
Amortized Cost	[1],[3],[4],[5],[7],[17]			2,449,000
Fair Value	[1],[3],[4],[5],[17]			2,406,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Technology
Schedule of Investments [Line Items]
Amortized Cost		26,316,000	[8],[12],[14]	23,588,000	[1],[4],[5],[7]
Fair Value		$ 26,303,000	[8],[12]	$ 23,292,000	[1],[4],[5]
Percentage of Net Assets ^		6.52%	[8],[12],[27]	5.77%	[1],[4],[5],[19]
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Technology, Company BRG Acquisition Co., LLC, Type of Investment Revolver, Interest Rate 0.00%, Maturity 07/26/28
Schedule of Investments [Line Items]
Interest Rate *	[1],[2],[3],[4],[5],[6]			0%
Maturity	[1],[2],[3],[4],[5]			Jul. 26, 2028
Principal	[1],[2],[3],[4],[5]			$ 0
Amortized Cost	[1],[2],[3],[4],[5],[7]			(11,000)
Fair Value	[1],[2],[3],[4],[5]			$ (12,000)
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Technology, Company BRG Acquisition Co., LLC, Type of Investment Revolver, Maturity 07/26/28
Schedule of Investments [Line Items]
Maturity	[8],[9],[10],[11],[12]	Jul. 26, 2028
Principal	[8],[9],[10],[11],[12]	$ 0
Amortized Cost	[8],[9],[10],[11],[12],[14]	(9,000)
Fair Value	[8],[9],[10],[11],[12]	$ (2,000)
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Technology, Company BRG Acquisition Co., LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR + 5.50%, Interest Rate 11.00%, Maturity 07/26/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5.50%
Interest Rate *	[8],[10],[12],[13],[15]	11%
Maturity	[8],[10],[12],[15]	Jul. 26, 2028
Principal	[8],[10],[12],[15]	$ 6,814
Amortized Cost	[8],[10],[12],[14],[15]	6,705,000
Fair Value	[8],[10],[12],[15]	$ 6,797,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Technology, Company BRG Acquisition Co., LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR + 6.00%, Interest Rate 11.50%, Maturity 07/26/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	6%
Interest Rate *	[8],[10],[12],[13],[15]	11.50%
Maturity	[8],[10],[12],[15]	Jul. 26, 2028
Principal	[8],[10],[12],[15]	$ 3,000
Amortized Cost	[8],[10],[12],[14],[15]	2,940,000
Fair Value	[8],[10],[12],[15]	$ 2,993,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Technology, Company BRG Acquisition Co., LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR+5.50%, Interest Rate 10.23%, Maturity 07/26/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.50%
Interest Rate *	[1],[3],[4],[5],[6],[17]			10.23%
Maturity	[1],[3],[4],[5],[17]			Jul. 26, 2028
Principal	[1],[3],[4],[5],[17]			$ 6,883
Amortized Cost	[1],[3],[4],[5],[7],[17]			6,755,000
Fair Value	[1],[3],[4],[5],[17]			$ 6,745,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Technology, Company Net Health Acquisition Corp, Type of Investment Term Loan, Reference Rate and Spread LIBOR+5.75%, Interest Rate 10.13%, Maturity 12/21/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.75%
Interest Rate *	[1],[3],[4],[5],[6],[17]			10.13%
Maturity	[1],[3],[4],[5],[17]			Dec. 21, 2025
Principal	[1],[3],[4],[5],[17]			$ 179
Amortized Cost	[1],[3],[4],[5],[7],[17]			179,000
Fair Value	[1],[3],[4],[5],[17]			$ 176,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Technology, Company Net Health Acquisition Corp, Type of Investment Term Loan, Reference Rate and Spread LIBOR+5.75%, Interest Rate 10.13%, Maturity 12/21/25 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.75%
Interest Rate *	[1],[3],[4],[5],[6],[17]			10.13%
Maturity	[1],[3],[4],[5],[17]			Dec. 21, 2025
Principal	[1],[3],[4],[5],[17]			$ 1,479
Amortized Cost	[1],[3],[4],[5],[7],[17]			1,479,000
Fair Value	[1],[3],[4],[5],[17]			$ 1,453,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Technology, Company Net Health Acquisition Corp, Type of Investment Term Loan, Reference Rate and Spread LIBOR+5.75%, Interest Rate 10.13%, Maturity 12/21/25 Two
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.75%
Interest Rate *	[1],[3],[4],[5],[6],[17]			10.13%
Maturity	[1],[3],[4],[5],[17]			Dec. 21, 2025
Principal	[1],[3],[4],[5],[17]			$ 9,257
Amortized Cost	[1],[3],[4],[5],[7],[17]			9,256,000
Fair Value	[1],[3],[4],[5],[17]			$ 9,095,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Technology, Company Net Health Acquisition Corp., Industry Health Care Technology, Type of Investment Term Loan, Reference Rate and Spread SOFR + 5.75%, Interest Rate 11.21%, Maturity 12/21/25 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5.75%
Interest Rate *	[8],[10],[12],[13],[15]	11.21%
Maturity	[8],[10],[12],[15]	Dec. 21, 2025
Principal	[8],[10],[12],[15]	$ 1,464
Amortized Cost	[8],[10],[12],[14],[15]	1,463,000
Fair Value	[8],[10],[12],[15]	$ 1,445,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Technology, Company Net Health Acquisition Corp., Type of Investment Term Loan, Reference Rate and Spread SOFR + 5.75%, Interest Rate 11.21%, Maturity 12/21/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5.75%
Interest Rate *	[8],[10],[12],[13],[15]	11.21%
Maturity	[8],[10],[12],[15]	Dec. 21, 2025
Principal	[8],[10],[12],[15]	$ 177
Amortized Cost	[8],[10],[12],[14],[15]	177,000
Fair Value	[8],[10],[12],[15]	$ 175,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Technology, Company Net Health Acquisition Corp., Type of Investment Term Loan, Reference Rate and Spread SOFR + 5.75%, Interest Rate 11.21%, Maturity 12/21/25 Two
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5.75%
Interest Rate *	[8],[10],[12],[13],[15]	11.21%
Maturity	[8],[10],[12],[15]	Dec. 21, 2025
Principal	[8],[10],[12],[15]	$ 9,161
Amortized Cost	[8],[10],[12],[14],[15]	9,161,000
Fair Value	[8],[10],[12],[15]	$ 9,046,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Technology, Company Q-Centrix, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread LIBOR+ 4.50%, Interest Rate 9.23%, Maturity 05/30/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			4.50%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.23%
Maturity	[1],[3],[4],[5],[17]			May 30, 2025
Principal	[1],[3],[4],[5],[17]			$ 4,886
Amortized Cost	[1],[3],[4],[5],[7],[17]			4,866,000
Fair Value	[1],[3],[4],[5],[17]			$ 4,788,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Technology, Company Q-Centrix, LLC, Type of Investment Term Loan, Reference Rate and Spread LIBOR+ 4.50%, Interest Rate 9.23%, Maturity 05/30/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			4.50%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.23%
Maturity	[1],[3],[4],[5],[17]			May 30, 2025
Principal	[1],[3],[4],[5],[17]			$ 1,069
Amortized Cost	[1],[3],[4],[5],[7],[17]			1,064,000
Fair Value	[1],[3],[4],[5],[17]			1,047,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Technology, Company Q-Centrix, LLC., Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR + 4.50%, Interest Rate 9.99%, Maturity 05/30/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	4.50%
Interest Rate *	[8],[10],[11],[12],[13]	9.99%
Maturity	[8],[10],[11],[12]	May 30, 2025
Principal	[8],[10],[11],[12]	$ 4,836
Amortized Cost	[8],[10],[11],[12],[14]	4,824,000
Fair Value	[8],[10],[11],[12]	$ 4,799,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Health Care Technology, Company Q-Centrix, LLC., Type of Investment Term Loan, Reference Rate and Spread SOFR + 4.50%, Interest Rate 9.99%, Maturity 05/30/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	4.50%
Interest Rate *	[8],[10],[11],[12],[13]	9.99%
Maturity	[8],[10],[11],[12]	May 30, 2025
Principal	[8],[10],[11],[12]	$ 1,057
Amortized Cost	[8],[10],[11],[12],[14]	1,055,000
Fair Value	[8],[10],[11],[12]	1,050,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Hotels, Restaurants & Leisure
Schedule of Investments [Line Items]
Amortized Cost		4,804,000	[8],[12],[14]	4,838,000	[1],[4],[5],[7]
Fair Value		$ 4,938,000	[8],[12]	$ 4,938,000	[1],[4],[5]
Percentage of Net Assets ^		1.22%	[8],[12],[27]	1.22%	[1],[4],[5],[19]
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Hotels, Restaurants & Leisure, Company Taymax Group, L.P., Type of Investment Term Loan, Reference Rate and Spread SOFR+6.00%, Interest Rate 10.97%, Maturity 07/31/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			6%
Interest Rate *	[1],[3],[4],[5],[6],[17]			10.97%
Maturity	[1],[3],[4],[5],[17]			Jul. 31, 2025
Principal	[1],[3],[4],[5],[17]			$ 4,988
Amortized Cost	[1],[3],[4],[5],[7],[17]			4,838,000
Fair Value	[1],[3],[4],[5],[17]			4,938,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Hotels, Restaurants & Leisure, Company Taymax Group, L.P., Type of Investment Term Loan, Reference Rate and Spread SOFR+6.00%, Interest Rate 11.50%, Maturity 07/31/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	6%
Interest Rate *	[8],[10],[12],[13],[15]	11.50%
Maturity	[8],[10],[12],[15]	Jul. 31, 2025
Principal	[8],[10],[12],[15]	$ 4,938
Amortized Cost	[8],[10],[12],[14],[15]	4,804,000
Fair Value	[8],[10],[12],[15]	4,938,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Household Products
Schedule of Investments [Line Items]
Amortized Cost		9,353,000	[8],[12],[14]	9,686,000	[1],[4],[5],[7]
Fair Value		$ 9,177,000	[8],[12]	$ 9,462,000	[1],[4],[5]
Percentage of Net Assets ^		2.28%	[8],[12],[27]	2.34%	[1],[4],[5],[19]
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Household Products, Company Walnut Parent, Inc., Type of Investment Term Loan, Reference Rate and Spread LIBOR+5.50%, Interest Rate 10.24%, Maturity 11/09/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.50%
Interest Rate *	[1],[3],[4],[5],[6],[17]			10.24%
Maturity	[1],[3],[4],[5],[17]			Nov. 09, 2027
Principal	[1],[3],[4],[5],[17]			$ 9,730
Amortized Cost	[1],[3],[4],[5],[7],[17]			9,686,000
Fair Value	[1],[3],[4],[5],[17]			9,462,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Household Products, Company Walnut Parent, Inc., Type of Investment Term Loan, Reference Rate and Spread SOFR + 5.50%, Interest Rate 11.00%, Maturity 11/09/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5.50%
Interest Rate *	[8],[10],[12],[13],[15]	11%
Maturity	[8],[10],[12],[15]	Nov. 09, 2027
Principal	[8],[10],[12],[15]	$ 9,389
Amortized Cost	[8],[10],[12],[14],[15]	9,353,000
Fair Value	[8],[10],[12],[15]	9,177,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry IT Services
Schedule of Investments [Line Items]
Amortized Cost		8,531,000	[8],[12],[14]	8,599,000	[1],[4],[5],[7]
Fair Value		$ 8,502,000	[8],[12]	$ 8,393,000	[1],[4],[5]
Percentage of Net Assets ^		2.11%	[8],[12],[27]	2.08%	[1],[4],[5],[19]
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry IT Services, Company Alta Buyer, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR + 6.00%, Interest Rate 11.50%, Maturity 12/21/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	6%
Interest Rate *	[8],[10],[11],[12],[13]	11.50%
Maturity	[8],[10],[11],[12]	Dec. 21, 2027
Principal	[8],[10],[11],[12]	$ 99
Amortized Cost	[8],[10],[11],[12],[14]	96,000
Fair Value	[8],[10],[11],[12]	$ 98,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry IT Services, Company Alta Buyer, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR+6.00%, Interest Rate 10.73%, Maturity 12/21/27
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			6%
Interest Rate *	[1],[3],[4],[5],[6],[17]			10.73%
Maturity	[1],[3],[4],[5],[17]			Dec. 21, 2027
Principal	[1],[3],[4],[5],[17]			$ 100
Amortized Cost	[1],[3],[4],[5],[7],[17]			97,000
Fair Value	[1],[3],[4],[5],[17]			$ 97,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry IT Services, Company TriMech Acquisition Corp., Type of Investment Term Loan, Reference Rate and Spread SOFR + 4.75%, Interest Rate 10.25%, Maturity 03/10/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	4.75%
Interest Rate *	[8],[10],[12],[13],[15]	10.25%
Maturity	[8],[10],[12],[15]	Mar. 10, 2028
Principal	[8],[10],[12],[15]	$ 8,532
Amortized Cost	[8],[10],[12],[14],[15]	8,435,000
Fair Value	[8],[10],[12],[15]	8,404,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry IT Services, Company TriMech Acquisition Corp., Type of Investment Term Loan, Reference Rate and Spread SOFR+ 4.75%, Interest Rate 9.48%, Maturity 03/10/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			4.75%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.48%
Maturity	[1],[3],[4],[5],[17]			Mar. 10, 2028
Principal	[1],[3],[4],[5],[17]			$ 8,619
Amortized Cost	[1],[3],[4],[5],[7],[17]			8,502,000
Fair Value	[1],[3],[4],[5],[17]			8,296,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Insurance
Schedule of Investments [Line Items]
Amortized Cost		20,752,000	[8],[12],[14]	20,913,000	[1],[4],[5],[7]
Fair Value		$ 20,597,000	[8],[12]	$ 20,672,000	[1],[4],[5]
Percentage of Net Assets ^		5.11%	[8],[12],[27]	5.12%	[1],[4],[5],[19]
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Insurance, Company Integrity Marketing Acquisition, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread LIBOR+6.05%, Interest Rate 10.81%, Maturity 08/27/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			6.05%
Interest Rate *	[1],[3],[4],[5],[6],[17]			10.81%
Maturity	[1],[3],[4],[5],[17]			Aug. 27, 2025
Principal	[1],[3],[4],[5],[17]			$ 3,214
Amortized Cost	[1],[3],[4],[5],[7],[17]			3,214,000
Fair Value	[1],[3],[4],[5],[17]			$ 3,166,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Insurance, Company Integrity Marketing Acquisition, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread LIBOR+6.05%, Interest Rate 9.58%, Maturity 08/27/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			6.05%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.58%
Maturity	[1],[3],[4],[5],[17]			Aug. 27, 2025
Principal	[1],[3],[4],[5],[17]			$ 7,701
Amortized Cost	[1],[3],[4],[5],[7],[17]			7,701,000
Fair Value	[1],[3],[4],[5],[17]			$ 7,586,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Insurance, Company Integrity Marketing Acquisition, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+6.05%, Interest Rate 11.54%, Maturity 08/27/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	6.05%
Interest Rate *	[8],[10],[12],[13],[15]	11.54%
Maturity	[8],[10],[12],[15]	Aug. 27, 2026
Principal	[8],[10],[12],[15]	$ 10,806
Amortized Cost	[8],[10],[12],[14],[15]	10,806,000
Fair Value	[8],[10],[12],[15]	$ 10,671,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Insurance, Company Turbo Buyer, Inc., Type of Investment Delayed Draw Term Loan, Interest Rate 0.00%, Maturity 12/02/25
Schedule of Investments [Line Items]
Maturity	[8],[9],[10],[11],[12]	Dec. 02, 2025
Principal	[8],[9],[10],[11],[12]	$ 0
Amortized Cost	[8],[9],[10],[11],[12],[14]	0
Fair Value	[8],[9],[10],[11],[12]	$ 0
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Insurance, Company Turbo Buyer, Inc., Type of Investment Delayed Draw Term Loan, Reference Rate and Spread LIBOR+6.00%, Interest Rate 11.15%, Maturity 12/02/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[2],[3],[4],[5]			6%
Interest Rate *	[1],[2],[3],[4],[5],[6]			11.15%
Maturity	[1],[2],[3],[4],[5]			Dec. 02, 2025
Principal	[1],[2],[3],[4],[5]			$ 506
Amortized Cost	[1],[2],[3],[4],[5],[7]			480,000
Fair Value	[1],[2],[3],[4],[5]			$ 478,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Insurance, Company Turbo Buyer, Inc., Type of Investment Delayed Draw Term Loan, Reference Rate and Spread LIBOR+6.00%, Interest Rate 11.15%, Maturity 12/02/25 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			6%
Interest Rate *	[1],[3],[4],[5],[6],[17]			11.15%
Maturity	[1],[3],[4],[5],[17]			Dec. 02, 2025
Principal	[1],[3],[4],[5],[17]			$ 1,315
Amortized Cost	[1],[3],[4],[5],[7],[17]			1,296,000
Fair Value	[1],[3],[4],[5],[17]			$ 1,286,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Insurance, Company Turbo Buyer, Inc., Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR + 6.00%, Interest Rate 11.50%, Maturity 12/02/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[9],[10],[11],[12]	6%
Interest Rate *	[8],[9],[10],[11],[12],[13]	11.50%
Maturity	[8],[9],[10],[11],[12]	Dec. 02, 2025
Principal	[8],[9],[10],[11],[12]	$ 435
Amortized Cost	[8],[9],[10],[11],[12],[14]	419,000
Fair Value	[8],[9],[10],[11],[12]	$ 421,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Insurance, Company Turbo Buyer, Inc., Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR + 6.00%, Interest Rate 11.50%, Maturity 12/02/25 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[9],[10],[11],[12]	6%
Interest Rate *	[8],[9],[10],[11],[12],[13]	11.50%
Maturity	[8],[9],[10],[11],[12]	Dec. 02, 2025
Principal	[8],[9],[10],[11],[12]	$ 67
Amortized Cost	[8],[9],[10],[11],[12],[14]	64,000
Fair Value	[8],[9],[10],[11],[12]	$ 64,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Insurance, Company Turbo Buyer, Inc., Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR + 6.00%, Interest Rate 11.50%, Maturity 12/02/25 Two
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	6%
Interest Rate *	[8],[10],[12],[13],[15]	11.50%
Maturity	[8],[10],[12],[15]	Dec. 02, 2025
Principal	[8],[10],[12],[15]	$ 1,302
Amortized Cost	[8],[10],[12],[14],[15]	1,289,000
Fair Value	[8],[10],[12],[15]	$ 1,286,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Insurance, Company Turbo Buyer, Inc., Type of Investment Term Loan, Reference Rate and Spread LIBOR+6.00%, Interest Rate 11.15%, Maturity 12/02/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			6%
Interest Rate *	[1],[3],[4],[5],[6],[17]			11.15%
Maturity	[1],[3],[4],[5],[17]			Dec. 02, 2025
Principal	[1],[3],[4],[5],[17]			$ 1,247
Amortized Cost	[1],[3],[4],[5],[7],[17]			1,229,000
Fair Value	[1],[3],[4],[5],[17]			$ 1,219,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Insurance, Company Turbo Buyer, Inc., Type of Investment Term Loan, Reference Rate and Spread LIBOR+6.00%, Interest Rate 11.15%, Maturity 12/02/25 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			6%
Interest Rate *	[1],[3],[4],[5],[6],[17]			11.15%
Maturity	[1],[3],[4],[5],[17]			Dec. 02, 2025
Principal	[1],[3],[4],[5],[17]			$ 7,097
Amortized Cost	[1],[3],[4],[5],[7],[17]			6,993,000
Fair Value	[1],[3],[4],[5],[17]			6,937,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Insurance, Company Turbo Buyer, Inc., Type of Investment Term Loan, Reference Rate and Spread SOFR + 6.00%, Interest Rate 11.50%, Maturity 12/02/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	6%
Interest Rate *	[8],[10],[12],[13],[15]	11.50%
Maturity	[8],[10],[12],[15]	Dec. 02, 2025
Principal	[8],[10],[12],[15]	$ 1,235
Amortized Cost	[8],[10],[12],[14],[15]	1,222,000
Fair Value	[8],[10],[12],[15]	$ 1,219,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Insurance, Company Turbo Buyer, Inc., Type of Investment Term Loan, Reference Rate and Spread SOFR + 6.00%, Interest Rate 11.50%, Maturity 12/02/25 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	6%
Interest Rate *	[8],[10],[12],[13],[15]	11.50%
Maturity	[8],[10],[12],[15]	Dec. 02, 2025
Principal	[8],[10],[12],[15]	$ 7,023
Amortized Cost	[8],[10],[12],[14],[15]	6,952,000
Fair Value	[8],[10],[12],[15]	6,936,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Life Sciences Tools & Services
Schedule of Investments [Line Items]
Amortized Cost	[1],[4],[5],[7]			97,000
Fair Value	[1],[4],[5]			$ 99,000
Percentage of Net Assets ^	[1],[4],[5],[19]			0.02%
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Life Sciences Tools & Services, Company Corevitas, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR+6.50%, Interest Rate 10.92%, Maturity 12/13/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			6.50%
Interest Rate *	[1],[3],[4],[5],[6],[17]			10.92%
Maturity	[1],[3],[4],[5],[17]			Dec. 13, 2025
Principal	[1],[3],[4],[5],[17]			$ 100
Amortized Cost	[1],[3],[4],[5],[7],[17]			97,000
Fair Value	[1],[3],[4],[5],[17]			99,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Media
Schedule of Investments [Line Items]
Amortized Cost	[1],[4],[5],[7]			7,164,000
Fair Value	[1],[4],[5]			$ 7,076,000
Percentage of Net Assets ^	[1],[4],[5],[19]			1.75%
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Media, Company Cadent, LLC, Type of Investment Revolver, Interest Rate 0.00%, Maturity 09/11/25
Schedule of Investments [Line Items]
Interest Rate *	[1],[2],[3],[4],[5],[6]			0%
Maturity	[1],[2],[3],[4],[5]			Sep. 11, 2025
Principal	[1],[2],[3],[4],[5]			$ 0
Amortized Cost	[1],[2],[3],[4],[5],[7]			(5,000)
Fair Value	[1],[2],[3],[4],[5]			$ (5,000)
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Media, Company Cadent, LLC, Type of Investment Term Loan, Reference Rate and Spread LIBOR+6.50%,Interest Rate 11.23%, Maturity 09/11/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			6.50%
Interest Rate *	[1],[3],[4],[5],[6],[17]			11.23%
Maturity	[1],[3],[4],[5],[17]			Sep. 11, 2025
Principal	[1],[3],[4],[5],[17]			$ 3,765
Amortized Cost	[1],[3],[4],[5],[7],[17]			3,697,000
Fair Value	[1],[3],[4],[5],[17]			$ 3,652,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Media, Company Cadent, LLC, Type of Investment Term Loan, Reference Rate and Spread LIBOR+6.50%,Interest Rate 11.23%, Maturity 09/11/25 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			6.50%
Interest Rate *	[1],[3],[4],[5],[6],[17]			11.23%
Maturity	[1],[3],[4],[5],[17]			Sep. 11, 2025
Principal	[1],[3],[4],[5],[17]			$ 3,535
Amortized Cost	[1],[3],[4],[5],[7],[17]			3,472,000
Fair Value	[1],[3],[4],[5],[17]			3,429,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Personal Products
Schedule of Investments [Line Items]
Amortized Cost		20,755,000	[8],[12],[14]	20,810,000	[1],[4],[5],[7]
Fair Value		$ 19,740,000	[8],[12]	$ 20,298,000	[1],[4],[5]
Percentage of Net Assets ^		4.89%	[8],[12],[27]	5.03%	[1],[4],[5],[19]
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Personal Products, Company Accupac, LLC, Type of Investment Delayed Draw Term Loan, Interest Rate 0.00%, Maturity 01/16/26
Schedule of Investments [Line Items]
Interest Rate *	[1],[2],[3],[4],[5],[6]			0%
Maturity		Jan. 16, 2026	[8],[9],[10],[11],[12]	Jan. 16, 2026	[1],[2],[3],[4],[5]
Principal		$ 0	[8],[9],[10],[11],[12]	$ 0	[1],[2],[3],[4],[5]
Amortized Cost		0	[8],[9],[10],[11],[12],[14]	0	[1],[2],[3],[4],[5],[7]
Fair Value		$ (18,000)	[8],[9],[10],[11],[12]	$ (14,000)	[1],[2],[3],[4],[5]
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Personal Products, Company Accupac, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR+5.50%, Interest Rate 10.16%, Maturity 01/16/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.50%
Interest Rate *	[1],[3],[4],[5],[6],[17]			10.16%
Maturity	[1],[3],[4],[5],[17]			Jan. 16, 2026
Principal	[1],[3],[4],[5],[17]			$ 10,916
Amortized Cost	[1],[3],[4],[5],[7],[17]			10,916,000
Fair Value	[1],[3],[4],[5],[17]			$ 10,643,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Personal Products, Company Accupac, LLC., Type of Investment Term Loan, Reference Rate and Spread SOFR + 6.00%, Interest Rate 11.52%, Maturity 01/16/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	6%
Interest Rate *	[8],[10],[12],[13],[15]	11.52%
Maturity	[8],[10],[12],[15]	Jan. 16, 2026
Principal	[8],[10],[12],[15]	$ 10,804
Amortized Cost	[8],[10],[12],[14],[15]	10,804,000
Fair Value	[8],[10],[12],[15]	$ 10,452,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Personal Products, Company Barnet Products LLC, Type of Investment Term Loan, Reference Rate and Spread LIBOR+5.00%, Interest Rate 9.73%, Maturity 07/28/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.73%
Maturity	[1],[3],[4],[5],[17]			Jul. 28, 2026
Principal	[1],[3],[4],[5],[17]			$ 5,898
Amortized Cost	[1],[3],[4],[5],[7],[17]			5,898,000
Fair Value	[1],[3],[4],[5],[17]			$ 5,765,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Personal Products, Company Barnet Products LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR + 5.25%, Interest Rate 10.82%, Maturity 07/28/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	5.25%
Interest Rate *	[8],[10],[11],[12],[13]	10.82%
Maturity	[8],[10],[11],[12]	Jul. 28, 2026
Principal	[8],[10],[11],[12]	$ 3,315
Amortized Cost	[8],[10],[11],[12],[14]	3,315,000
Fair Value	[8],[10],[11],[12]	$ 3,232,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Personal Products, Company Barnet Products LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR + 5.25%, Interest Rate 10.82%, Maturity 07/28/26 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	5.25%
Interest Rate *	[8],[10],[11],[12],[13]	10.82%
Maturity	[8],[10],[11],[12]	Jul. 28, 2026
Principal	[8],[10],[11],[12]	$ 2,379
Amortized Cost	[8],[10],[11],[12]	2,379,000
Fair Value	[8],[10],[11],[12]	$ 2,320,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Personal Products, Company KL Bronco Acquisition, Inc., Type of Investment Delayed Draw Term Loan, Interest Rate 0.00%, Maturity 06/30/28
Schedule of Investments [Line Items]
Interest Rate *	[1],[2],[3],[4],[5],[6]			0%
Maturity		Jun. 30, 2028	[8],[9],[10],[11],[12]	Jun. 30, 2028	[1],[2],[3],[4],[5]
Principal		$ 0	[8],[9],[10],[11],[12]	$ 0	[1],[2],[3],[4],[5]
Amortized Cost		(14,000)	[8],[9],[10],[11],[12],[14]	16,000	[1],[2],[3],[4],[5],[7]
Fair Value		$ (165,000)	[8],[9],[10],[11],[12]	$ (54,000)	[1],[2],[3],[4],[5]
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Personal Products, Company KL Bronco Acquisition, Inc., Type of Investment Revolver, Reference Rate and Spread SOFR + 5.75%, Interest Rate 11.23%, Maturity 06/30/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[9],[10],[11],[12]	5.75%
Interest Rate *	[8],[9],[10],[11],[12],[13]	11.23%
Maturity	[8],[9],[10],[11],[12]	Jun. 30, 2028
Principal	[8],[9],[10],[11],[12]	$ 464
Amortized Cost	[8],[9],[10],[11],[12],[14]	453,000
Fair Value	[8],[9],[10],[11],[12]	$ 398,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Personal Products, Company KL Bronco Acquisition, Inc., Type of Investment Revolver, Reference Rate and Spread SOFR+5.25%, Interest Rate 9.58%, Maturity 06/30/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[2],[3],[4],[5]			5.25%
Interest Rate *	[1],[2],[3],[4],[5],[6]			9.58%
Maturity	[1],[2],[3],[4],[5]			Jun. 30, 2028
Principal	[1],[2],[3],[4],[5]			$ 71
Amortized Cost	[1],[2],[3],[4],[5],[7]			66,000
Fair Value	[1],[2],[3],[4],[5]			$ 63,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Personal Products, Company KL Bronco Acquisition, Inc., Type of Investment Revolver, Reference Rate and Spread SOFR+5.25%, Interest Rate 9.67%, Maturity 06/30/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[2],[3],[4],[5]			5.25%
Interest Rate *	[1],[2],[3],[4],[5],[6]			9.67%
Maturity	[1],[2],[3],[4],[5]			Jun. 30, 2028
Principal	[1],[2],[3],[4],[5]			$ 107
Amortized Cost	[1],[2],[3],[4],[5],[7]			99,000
Fair Value	[1],[2],[3],[4],[5]			$ 94,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Personal Products, Company KL Bronco Acquisition, Inc., Type of Investment Term Loan, Reference Rate and Spread SOFR + 5.75%, Interest Rate 11.23%, Maturity 06/30/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5.75%
Interest Rate *	[8],[10],[12],[13],[15]	11.23%
Maturity	[8],[10],[12],[15]	Jun. 30, 2028
Principal	[8],[10],[12],[15]	$ 3,879
Amortized Cost	[8],[10],[12],[14],[15]	3,818,000
Fair Value	[8],[10],[12],[15]	3,521,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Personal Products, Company KL Bronco Acquisition, Inc., Type of Investment Term Loan, Reference Rate and Spread SOFR+5.25%, Interest Rate 9.67%, Maturity 06/30/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.25%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.67%
Maturity	[1],[3],[4],[5],[17]			Jun. 30, 2028
Principal	[1],[3],[4],[5],[17]			$ 3,919
Amortized Cost	[1],[3],[4],[5],[7],[17]			3,847,000
Fair Value	[1],[3],[4],[5],[17]			3,801,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Pharmaceuticals
Schedule of Investments [Line Items]
Amortized Cost	[8],[12],[14]	466,000
Fair Value	[8],[12]	$ 483,000
Percentage of Net Assets ^	[8],[12],[27]	0.12%
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Pharmaceuticals, Company Leiters, Inc., Type of Investment Revolver, Interest Rate 0.00%, Maturity 06/29/28
Schedule of Investments [Line Items]
Maturity	[8],[9],[10],[11],[12]	Jun. 29, 2028
Principal	[8],[9],[10],[11],[12]	$ 0
Amortized Cost	[8],[9],[10],[11],[12],[14]	(7,000)
Fair Value	[8],[9],[10],[11],[12]	$ (1,000)
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Pharmaceuticals, Company Leiters, Inc., Type of Investment Term Loan, Reference Rate and Spread SOFR + 6.00%, Interest Rate 11.46%, Maturity 06/29/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	6%
Interest Rate *	[8],[10],[11],[12],[13]	11.46%
Maturity	[8],[10],[11],[12]	Jun. 29, 2028
Principal	[8],[10],[11],[12]	$ 152
Amortized Cost	[8],[10],[11],[12],[14]	148,000
Fair Value	[8],[10],[11],[12]	$ 151,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Pharmaceuticals, Company Leiters, Inc., Type of Investment Term Loan, Reference Rate and Spread SOFR + 6.00%, Interest Rate 11.57%, Maturity 06/29/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	6%
Interest Rate *	[8],[10],[11],[12],[13]	11.57%
Maturity	[8],[10],[11],[12]	Jun. 29, 2028
Principal	[8],[10],[11],[12]	$ 335
Amortized Cost	[8],[10],[11],[12],[14]	325,000
Fair Value	[8],[10],[11],[12]	333,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Professional Services
Schedule of Investments [Line Items]
Amortized Cost		11,547,000	[8],[12],[14]	11,600,000	[1],[4],[5],[7]
Fair Value		$ 11,543,000	[8],[12]	$ 11,448,000	[1],[4],[5]
Percentage of Net Assets ^		2.86%	[8],[12],[27]	2.84%	[1],[4],[5],[19]
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Professional Services, Company The Chartis Group, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR + 5.00%, Interest Rate 10.53%, Maturity 05/01/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5%
Interest Rate *	[8],[10],[12],[13],[15]	10.53%
Maturity	[8],[10],[12],[15]	May 01, 2025
Principal	[8],[10],[12],[15]	$ 817
Amortized Cost	[8],[10],[12],[14],[15]	812,000
Fair Value	[8],[10],[12],[15]	$ 811,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Professional Services, Company The Chartis Group, LLC, Type of Investment Term Loan, Reference Rate and Spread LIBOR+5.00%, Interest Rate 9.77%, Maturity 05/01/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.77%
Maturity	[1],[3],[4],[5],[17]			May 01, 2025
Principal	[1],[3],[4],[5],[17]			$ 10,916
Amortized Cost	[1],[3],[4],[5],[7],[17]			10,784,000
Fair Value	[1],[3],[4],[5],[17]			10,643,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Professional Services, Company The Chartis Group, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR + 5.00%, Interest Rate 10.52%, Maturity 05/01/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5%
Interest Rate *	[8],[10],[12],[13],[15]	10.52%
Maturity	[8],[10],[12],[15]	May 01, 2025
Principal	[8],[10],[12],[15]	$ 10,803
Amortized Cost	[8],[10],[12],[14],[15]	10,725,000
Fair Value	[8],[10],[12],[15]	$ 10,722,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Professional Services, Company The Chartis Group, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR + 6.50%, Interest Rate 12.04%, Maturity 05/01/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	6.50%
Interest Rate *	[8],[10],[11],[12],[13]	12.04%
Maturity	[8],[10],[11],[12]	May 01, 2025
Principal	[8],[10],[11],[12]	$ 10
Amortized Cost	[8],[10],[11],[12],[14]	10,000
Fair Value	[8],[10],[11],[12]	10,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Road & Rail
Schedule of Investments [Line Items]
Amortized Cost		16,629,000	[8],[12],[14]	16,702,000	[1],[4],[5],[7]
Fair Value		$ 16,389,000	[8],[12]	$ 16,541,000	[1],[4],[5]
Percentage of Net Assets ^		4.06%	[8],[12],[27]	4.10%	[1],[4],[5],[19]
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Road & Rail, Company A&R Logistics Holdings, Inc., Type of Investment Term Loan, Reference Rate and Spread SOFR + 6.00%, Interest Rate 11.54%, Maturity 05/03/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	6%
Interest Rate *	[8],[10],[12],[13],[15]	11.54%
Maturity	[8],[10],[12],[15]	May 03, 2025
Principal	[8],[10],[12],[15]	$ 4,971
Amortized Cost	[8],[10],[12],[14],[15]	4,947,000
Fair Value	[8],[10],[12],[15]	$ 4,871,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Road & Rail, Company A&R Logistics Holdings, Inc., Type of Investment Term Loan, Reference Rate and Spread SOFR + 6.00%, Interest Rate 11.54%, Maturity 05/03/25 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	6%
Interest Rate *	[8],[10],[12],[13],[15]	11.54%
Maturity	[8],[10],[12],[15]	May 03, 2025
Principal	[8],[10],[12],[15]	$ 937
Amortized Cost	[8],[10],[12],[14],[15]	932,000
Fair Value	[8],[10],[12],[15]	$ 918,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Road & Rail, Company A&R Logistics Holdings, Inc., Type of Investment Term Loan, Reference Rate and Spread SOFR+5.75%, Interest Rate 9.46%, Maturity 05/03/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.75%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.46%
Maturity	[1],[3],[4],[5],[17]			May 03, 2025
Principal	[1],[3],[4],[5],[17]			$ 5,023
Amortized Cost	[1],[3],[4],[5],[7],[17]			4,982,000
Fair Value	[1],[3],[4],[5],[17]			$ 4,872,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Road & Rail, Company A&R Logistics Holdings, Inc., Type of Investment Term Loan, Reference Rate and Spread SOFR+5.75%, Interest Rate 9.99%, Maturity 05/03/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.75%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.99%
Maturity	[1],[3],[4],[5],[17]			May 03, 2025
Principal	[1],[3],[4],[5],[17]			$ 946
Amortized Cost	[1],[3],[4],[5],[7],[17]			939,000
Fair Value	[1],[3],[4],[5],[17]			$ 918,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Road & Rail, Company Beacon Mobility Corp., Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR + 6.25%, Interest Rate 11.74%, Maturity 05/22/24
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	6.25%
Interest Rate *	[8],[10],[12],[13],[15]	11.74%
Maturity	[8],[10],[12],[15]	May 22, 2024
Principal	[8],[10],[12],[15]	$ 8,839
Amortized Cost	[8],[10],[12],[14],[15]	8,807,000
Fair Value	[8],[10],[12],[15]	$ 8,684,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Road & Rail, Company Beacon Mobility Corp., Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR + 6.25%, Interest Rate 11.74%, Maturity 05/22/24 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	6.25%
Interest Rate *	[8],[10],[12],[13],[15]	11.74%
Maturity	[8],[10],[12],[15]	May 22, 2024
Principal	[8],[10],[12],[15]	$ 1,951
Amortized Cost	[8],[10],[12],[14],[15]	1,943,000
Fair Value	[8],[10],[12],[15]	1,916,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Road & Rail, Company Beacon Mobility Corp., Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.50%, Interest Rate 9.92%, Maturity 05/22/24
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.50%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.92%
Maturity	[1],[3],[4],[5],[17]			May 22, 2024
Principal	[1],[3],[4],[5],[17]			$ 8,943
Amortized Cost	[1],[3],[4],[5],[7],[17]			8,832,000
Fair Value	[1],[3],[4],[5],[17]			$ 8,808,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Road & Rail, Company Beacon Mobility Corp., Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR+5.50%, Interest Rate 9.92%, Maturity 05/22/24 One
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.50%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.92%
Maturity	[1],[3],[4],[5],[17]			May 22, 2024
Principal	[1],[3],[4],[5],[17]			$ 1,973
Amortized Cost	[1],[3],[4],[5],[7],[17]			1,949,000
Fair Value	[1],[3],[4],[5],[17]			1,943,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Software
Schedule of Investments [Line Items]
Amortized Cost		20,415,000	[8],[12],[14]	16,939,000	[1],[4],[5],[7]
Fair Value		$ 20,389,000	[8],[12]	$ 16,654,000	[1],[4],[5]
Percentage of Net Assets ^		5.06%	[8],[12],[27]	4.13%	[1],[4],[5],[19]
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Software Company Project Leopard Holdings, Inc., Type of Investment Term Loan, Reference Rate and Spread SOFR+5.25%, Interest Rate 9.80%, Maturity 07/20/29
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17],[30]			5.25%
Interest Rate *	[1],[3],[4],[5],[6],[17],[30]			9.80%
Maturity	[1],[3],[4],[5],[17],[30]			Jul. 20, 2029
Principal	[1],[3],[4],[5],[17],[30]			$ 100
Amortized Cost	[1],[3],[4],[5],[7],[17],[30]			93,000
Fair Value	[1],[3],[4],[5],[17],[30]			$ 91,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Software, Company Concord III, L.L.C., Type of Investment Revolver, Interest Rate 0.00%, Maturity 12/20/28
Schedule of Investments [Line Items]
Maturity	[8],[9],[10],[11],[12]	Dec. 20, 2028
Principal	[8],[9],[10],[11],[12]	$ 0
Amortized Cost	[8],[9],[10],[11],[12],[14]	(5,000)
Fair Value	[8],[9],[10],[11],[12]	$ (2,000)
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Software, Company Concord III, L.L.C., Type of Investment Term Loan, Reference Rate and Spread SOFR + 6.25%, Interest Rate 11.62%, Maturity 12/20/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	6.25%
Interest Rate *	[8],[10],[11],[12],[13]	11.62%
Maturity	[8],[10],[11],[12]	Dec. 20, 2028
Principal	[8],[10],[11],[12]	$ 3,734
Amortized Cost	[8],[10],[11],[12],[14]	3,650,000
Fair Value	[8],[10],[11],[12]	$ 3,692,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Software, Company Pegasus Global Enterprise Holdings, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread LIBOR + 5.25%, Interest Rate 9.98%, Maturity 05/29/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.25%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.98%
Maturity	[1],[3],[4],[5],[17]			May 29, 2025
Principal	[1],[3],[4],[5],[17]			$ 356
Amortized Cost	[1],[3],[4],[5],[7],[17]			356,000
Fair Value	[1],[3],[4],[5],[17]			$ 351,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Software, Company Pegasus Global Enterprise Holdings, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR + 5.25%, Interest Rate 10.75%, Maturity 05/29/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5.25%
Interest Rate *	[8],[10],[12],[13],[15]	10.75%
Maturity	[8],[10],[12],[15]	May 29, 2025
Principal	[8],[10],[12],[15]	$ 352
Amortized Cost	[8],[10],[12],[14],[15]	352,000
Fair Value	[8],[10],[12],[15]	$ 349,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Software, Company Pegasus Global Enterprise Holdings, LLC, Type of Investment Term Loan, Reference Rate and Spread LIBOR + 5.25%, Interest Rate 9.98%, Maturity 05/29/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.25%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.98%
Maturity	[1],[3],[4],[5],[17]			May 29, 2025
Principal	[1],[3],[4],[5],[17]			$ 5,598
Amortized Cost	[1],[3],[4],[5],[7],[17]			5,598,000
Fair Value	[1],[3],[4],[5],[17]			$ 5,514,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Software, Company Pegasus Global Enterprise Holdings, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR + 5.25%, Interest Rate 10.75%, Maturity 05/29/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5.25%
Interest Rate *	[8],[10],[12],[13],[15]	10.75%
Maturity	[8],[10],[12],[15]	May 29, 2025
Principal	[8],[10],[12],[15]	$ 5,540
Amortized Cost	[8],[10],[12],[14],[15]	5,539,000
Fair Value	[8],[10],[12],[15]	$ 5,484,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Software, Company Project Leopard Holdings, Inc., Type of Investment Term Loan, Reference Rate and Spread SOFR + 5.25%, Interest Rate 10.73%, Maturity 07/20/29
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12],[25]	5.25%
Interest Rate *	[8],[10],[11],[12],[13],[25]	10.73%
Maturity	[8],[10],[11],[12],[25]	Jul. 20, 2029
Principal	[8],[10],[11],[12],[25]	$ 99
Amortized Cost	[8],[10],[11],[12],[14],[25]	93,000
Fair Value	[8],[10],[11],[12],[25]	$ 89,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Software, Company TimeClock Plus, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread LIBOR+5.25%, Interest Rate 9.98%, Maturity 08/28/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			5.25%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.98%
Maturity	[1],[3],[4],[5],[17]			Aug. 28, 2026
Principal	[1],[3],[4],[5],[17]			$ 4,386
Amortized Cost	[1],[3],[4],[5],[7],[17]			4,376,000
Fair Value	[1],[3],[4],[5],[17]			4,298,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Software, Company TimeClock Plus, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR + 5.50%, Interest Rate 11.00%, Maturity 08/28/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5.50%
Interest Rate *	[8],[10],[12],[13],[15]	11%
Maturity	[8],[10],[12],[15]	Aug. 28, 2026
Principal	[8],[10],[12],[15]	$ 4,341
Amortized Cost	[8],[10],[12],[14],[15]	4,334,000
Fair Value	[8],[10],[12],[15]	$ 4,330,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Software, Company TimeClock Plus, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR + 5.50%, Interest Rate 11.00%, Maturity 08/28/26
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5.50%
Interest Rate *	[8],[10],[12],[13],[15]	11%
Maturity	[8],[10],[12],[15]	Aug. 28, 2026
Principal	[8],[10],[12],[15]	$ 6,463
Amortized Cost	[8],[10],[12],[14],[15]	6,452,000
Fair Value	[8],[10],[12],[15]	6,447,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Trading Companies & Distributors
Schedule of Investments [Line Items]
Amortized Cost		9,310,000	[8],[12],[14]	18,312,000	[1],[4],[5],[7]
Fair Value		$ 9,407,000	[8],[12]	$ 18,188,000	[1],[4],[5]
Percentage of Net Assets ^		2.33%	[8],[12],[27]	4.51%	[1],[4],[5],[19]
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Trading Companies & Distributors, Company Easy Ice, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread LIBOR+4.75%, Interest Rate 8.28%, Maturity 12/13/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			4.75%
Interest Rate *	[1],[3],[4],[5],[6],[17]			8.28%
Maturity	[1],[3],[4],[5],[17]			Dec. 31, 2025
Principal	[1],[3],[4],[5],[17]			$ 3,966
Amortized Cost	[1],[3],[4],[5],[7],[17]			3,958,000
Fair Value	[1],[3],[4],[5],[17]			$ 3,906,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Trading Companies & Distributors, Company Easy Ice, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread LIBOR+4.75%, Interest Rate 9.90%, Maturity 12/13/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			4.75%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.90%
Maturity	[1],[3],[4],[5],[17]			Dec. 31, 2025
Principal	[1],[3],[4],[5],[17]			$ 1,669
Amortized Cost	[1],[3],[4],[5],[7],[17]			1,665,000
Fair Value	[1],[3],[4],[5],[17]			$ 1,644,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Trading Companies & Distributors, Company Easy Ice, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread LIBOR+4.75%, Interest Rate 9.96%, Maturity 12/13/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			4.75%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.96%
Maturity	[1],[3],[4],[5],[17]			Dec. 31, 2025
Principal	[1],[3],[4],[5],[17]			$ 421
Amortized Cost	[1],[3],[4],[5],[7],[17]			420,000
Fair Value	[1],[3],[4],[5],[17]			$ 414,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Trading Companies & Distributors, Company Easy Ice, LLC, Type of Investment Delayed Draw Term Loan, Reference Rate and Spread SOFR + 5.25%, Interest Rate 11.78% (1.00% PIK), Maturity 12/31/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5.25%
Interest Rate *	[8],[10],[12],[13],[15]	11.78%
Interest Rate * PIK	[8],[10],[12],[13],[15]	1%
Maturity	[8],[10],[12],[15]	Dec. 31, 2025
Principal	[8],[10],[12],[15]	$ 6,007
Amortized Cost	[8],[10],[12],[14],[15]	5,998,000
Fair Value	[8],[10],[12],[15]	$ 6,007,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Trading Companies & Distributors, Company Easy Ice, LLC, Type of Investment Term Loan, Reference Rate and Spread LIBOR+4.75%, Interest Rate 8.92%, Maturity 12/13/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			4.75%
Interest Rate *	[1],[3],[4],[5],[6],[17]			8.92%
Maturity	[1],[3],[4],[5],[17]			Dec. 31, 2025
Principal	[1],[3],[4],[5],[17]			$ 1,357
Amortized Cost	[1],[3],[4],[5],[7],[17]			1,354,000
Fair Value	[1],[3],[4],[5],[17]			$ 1,336,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Trading Companies & Distributors, Company Easy Ice, LLC, Type of Investment Term Loan, Reference Rate and Spread SOFR + 5.25%, Interest Rate 11.78% (1.00% PIK), Maturity 12/31/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[12],[15]	5.25%
Interest Rate *	[8],[10],[12],[13],[15]	11.78%
Interest Rate * PIK	[8],[10],[12],[13],[15]	1%
Maturity	[8],[10],[12],[15]	Dec. 31, 2025
Principal	[8],[10],[12],[15]	$ 1,345
Amortized Cost	[8],[10],[12],[14],[15]	1,343,000
Fair Value	[8],[10],[12],[15]	$ 1,345,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Trading Companies & Distributors, Company Krayden Holdings, Inc., Type of Investment Delayed Draw Term Loan, Interest Rate 0.00%, Maturity 03/01/29
Schedule of Investments [Line Items]
Maturity	[8],[9],[10],[11],[12]	Mar. 01, 2029
Principal	[8],[9],[10],[11],[12]	$ 0
Amortized Cost	[8],[9],[10],[11],[12],[14]	(10,000)
Fair Value	[8],[9],[10],[11],[12]	$ 0
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Trading Companies & Distributors, Company Krayden Holdings, Inc., Type of Investment Delayed Draw Term Loan, Interest Rate 0.00%, Maturity 03/01/29 One
Schedule of Investments [Line Items]
Maturity	[8],[9],[10],[11],[12]	Mar. 01, 2029
Principal	[8],[9],[10],[11],[12]	$ 0
Amortized Cost	[8],[9],[10],[11],[12],[14]	(10,000)
Fair Value	[8],[9],[10],[11],[12]	$ 0
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Trading Companies & Distributors, Company Krayden Holdings, Inc., Type of Investment Revolver, Interest Rate 0.00%, Maturity 03/01/29
Schedule of Investments [Line Items]
Maturity	[8],[9],[10],[11],[12]	Mar. 01, 2029
Principal	[8],[9],[10],[11],[12]	$ 0
Amortized Cost	[8],[9],[10],[11],[12],[14]	(10,000)
Fair Value	[8],[9],[10],[11],[12]	$ 0
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Trading Companies & Distributors, Company Krayden Holdings, Inc., Type of Investment Term Loan, Reference Rate and Spread SOFR + 5.75%, Interest Rate 11.20%, Maturity 03/01/29
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	5.75%
Interest Rate *	[8],[10],[11],[12],[13]	11.20%
Maturity	[8],[10],[11],[12]	Mar. 01, 2029
Principal	[8],[10],[11],[12]	$ 2,055
Amortized Cost	[8],[10],[11],[12],[14]	1,999,000
Fair Value	[8],[10],[11],[12]	2,055,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Trading Companies & Distributors, Company Resolute Industrial, LLC, Type of Investment Term Loan, Reference Rate and Spread LIBOR+ 4.50%, Interest Rate 9.23%, Maturity 03/07/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			4.50%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.23%
Maturity	[1],[3],[4],[5],[17]			Mar. 07, 2025
Principal	[1],[3],[4],[5],[17]			$ 10,350
Amortized Cost	[1],[3],[4],[5],[7],[17]			10,350,000
Fair Value	[1],[3],[4],[5],[17]			$ 10,324,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Trading Companies & Distributors, Company Resolute Industrial, LLC, Type of Investment Term Loan, Reference Rate and Spread LIBOR+ 4.50%, Interest Rate 9.23%, Maturity 03/07/25, One
Schedule of Investments [Line Items]
Reference Rate and Spread	[1],[3],[4],[5],[17]			4.50%
Interest Rate *	[1],[3],[4],[5],[6],[17]			9.23%
Maturity	[1],[3],[4],[5],[17]			Mar. 07, 2025
Principal	[1],[3],[4],[5],[17]			$ 565
Amortized Cost	[1],[3],[4],[5],[7],[17]			565,000
Fair Value	[1],[3],[4],[5],[17]			564,000
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Transportation Infrastructure
Schedule of Investments [Line Items]
Amortized Cost	[8],[12],[14]	469,000
Fair Value	[8],[12]	$ 480,000
Percentage of Net Assets ^	[8],[12],[27]	0.12%
Investment, Identifier [Axis]: Non-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Transportation Infrastructure, Company G2 Secure Staff, L.L.C., Type of Investment Term Loan, Reference Rate and Spread SOFR + 5.50%, Interest Rate 11.03%, Maturity 07/02/25
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	5.50%
Interest Rate *	[8],[10],[11],[12],[13]	11.03%
Maturity	[8],[10],[11],[12]	Jul. 02, 2025
Principal	[8],[10],[11],[12]	$ 480
Amortized Cost	[8],[10],[11],[12],[14]	469,000
Fair Value	[8],[10],[11],[12]	480,000
Investment, Identifier [Axis]: Subtotal Controlled Investments
Schedule of Investments [Line Items]
Amortized Cost		188,471,000	[8],[12],[14],[24]	182,007,000	[1],[4],[5],[7],[18]
Fair Value		$ 184,485,000	[8],[12],[24]	$ 178,367,000	[1],[4],[5],[18]
Percentage of Net Assets ^		45.75%	[8],[12],[24],[27]	44.19%	[1],[4],[5],[18],[19]
Investment, Identifier [Axis]: Subtotal Non-Controlled/Non-Affiliated Investments
Schedule of Investments [Line Items]
Amortized Cost		$ 510,142,000	[8],[12],[14]	$ 496,688,000	[1],[4],[5],[7]
Fair Value		$ 501,552,000	[8],[12]	$ 487,769,000	[1],[4],[5]
Percentage of Net Assets ^		124.37%	[8],[12],[27]	120.83%	[1],[4],[5],[19]
Investment, Identifier [Axis]: Total Equity
Schedule of Investments [Line Items]
Amortized Cost		$ 3,989,000	[8],[12],[14]	$ 3,938,000	[1],[4],[5],[7]
Fair Value		$ 3,641,000	[8],[12]	$ 3,938,000	[1],[4],[5]
Percentage of Net Assets ^		0.91%	[8],[12],[27]	0.98%	[1],[4],[5],[19]
Investment, Identifier [Axis]: Total Investments, December 31, 2022
Schedule of Investments [Line Items]
Amortized Cost	[1],[4],[5],[7],[18]			$ 678,695,000
Fair Value	[1],[4],[5],[18]			$ 666,136,000
Percentage of Net Assets ^	[1],[4],[5],[18],[19]			165.02%
Investment, Identifier [Axis]: Total Investments, December 31, 2023
Schedule of Investments [Line Items]
Amortized Cost	[8],[12],[14],[24]	$ 698,613,000
Fair Value	[8],[12],[24]	$ 686,037,000
Percentage of Net Assets ^	[8],[12],[24],[27]	170.12%
Investment, Identifier [Axis]: Total Senior Direct Lending Program
Schedule of Investments [Line Items]
Amortized Cost	[8],[12]	$ 188,471,000
Fair Value	[8],[12]	$ 184,485,000
Percentage of Net Assets ^	[8],[12]	45.75%
Investment, Identifier [Axis]: Total Senior Secured First Lien Loans
Schedule of Investments [Line Items]
Amortized Cost		$ 506,153,000	[8],[12],[14]	$ 492,750,000	[1],[4],[5],[7]
Fair Value		$ 497,911,000	[8],[12]	$ 483,831,000	[1],[4],[5]
Percentage of Net Assets ^		123.46%	[8],[12],[27]	119.86%	[1],[4],[5],[19]
Investment, Identifier [Axis]: on-Controlled/Non-Affiliated Investments, Senior Secured First Lien Loans, Industry Auto Components, Company Arrowhead Holdco Company, Type of Investment Term Loan, Reference Rate and Spread SOFR+2.50%, Interest Rate 10.04% (2.75% PIK), Maturity 08/31/28
Schedule of Investments [Line Items]
Reference Rate and Spread	[8],[10],[11],[12]	2.50%
Interest Rate *	[8],[10],[11],[12],[13]	10.04%
Interest Rate * PIK	[8],[10],[11],[12],[13]	2.75%
Maturity	[8],[10],[11],[12]	Aug. 31, 2028
Principal	[8],[10],[11],[12]	$ 1,059
Amortized Cost	[8],[10],[11],[12],[14]	1,046,000
Fair Value	[8],[10],[11],[12]	$ 887,000
[1] # Unless otherwise indicated, all securities are valued using significant unobservable inputs, which are categorized as Level 3 assets under the definition of ASC 820 fair value hierarchy (See "Note 4. Fair Value Measurements"). (2) The investment has an unfunded commitment as of December 31, 2022 (See "Note 8. Commitments"). Fair value includes an analysis of the unfunded commitment. (6) Loan includes interest rate floor feature. + All of the issuers of the investments held by the Company are domiciled in the United States. Certain investments also have international operations. The December 31, 2022 presentation has been revised to conform to the December 31, 2023 presentation. * Variable rate loans to the Company’s portfolio companies bear interest at a rate that may be determined by reference to the Secured Overnight Financing Rate (“SOFR”), the London Interbank Offered Rate (“LIBOR”), or an alternate base rate (commonly based on the Federal Funds Rate or the Prime Rate), at the borrower’s option, which reset semi-annually (S), quarterly (Q) or monthly (M). For each such loan, the Company has provided the interest rate in effect as o f December 31, 2022. (++) Negative costs, if applicable, results from unamortized fees on unfunded commitments, which are capitalized to the investment cost. The negative fair value, if applicable, results from the fair valuation of the unfunded commitment. # Unless otherwise indicated, all securities are valued using significant unobservable inputs, which are categorized as Level 3 assets under the definition of ASC 820 fair value hierarchy (See "Note 4. Fair Value Measurements"). (2) The investment has an unfunded commitment as of December 31, 2023 (See "Note 8. Commitments"). Fair value includes an analysis of the unfunded commitment. (6) Loan includes interest rate floor feature. (9) The Company's investment or a portion thereof is pledged as collateral under the CIBC Facility (See "Note 6. Borrowings"). + All of the issuers of the investments held by the Company are domiciled in the United States. Certain investments also have international operations. * Variable rate loans to the Company’s portfolio companies bear interest at a rate that may be determined by reference to the Secured Overnight Financing Rate (“SOFR”) or an alternate base rate (commonly based on the Federal Funds Rate or the Prime Rate), at the borrower’s option, which reset semi-annually (S), quarterly (Q) or monthly (M). For each such loan, the Company has provided the interest rate in effect as of December 31, 2023 . (++) Negative costs, if applicable, results from unamortized fees on unfunded commitments, which are capitalized to the investment cost. The negative fair value, if applicable, results from the fair valuation of the unfunded commitment. (1) The Company's investment or a portion thereof is pledged as collateral under the JPM Facility (See "Note 6. Borrowings"). (8) Par Amount, Amortized Cost, and Fair value are less than $1,000. (1) The Company's investment or a portion thereof is pledged as collateral under the JPM Facility (See "Note 6. Borrowings"). (+) Controlled Investments are defined by the 1940 Act, as investments in companies in which the Company owns more than 25 % of the voting securities or maintains greater than 50 % of the board representation. ^ Percentage is based on net assets of $ 403,677 as of December 31, 2022. (4) The investment is not considered a "qualifying asset" under Section 55(a) of the 1940 Act. Under the 1940 Act, the Company may not acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70 % of the Company's total assets. As of December 31, 2022, total qualifying assets at fair value represented 73.9 % of the Company's total assets calculated in accordance with the 1940 Act. (5) In addition to the interest earned based on the stated contractual interest rate of this securit y, the certificates entitle the holders thereof to receive a portion of the excess cash flow from the SDLP’s loan portfolio, after expenses, which may result in a return to the Company greater than the contractual stated interest rate. (4) The investment is not considered a "qualifying asset" under Section 55(a) of the 1940 Act. Under the 1940 Act, the Company may not acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70 % of the Company's total assets. As of December 31, 2023, total qualifying assets at fair value represented 74.0 % of the Company's total assets calculated in accordance with the 1940 Act. (5) In addition to the interest earned based on the stated contractual interest rate of this securit y, the certificates entitle the holders thereof to receive a portion of the excess cash flow from the SDLP’s loan portfolio, after expenses, which may result in a return to the Company greater than the contractual stated interest rate. (+) Controlled Investments are defined by the Investment Company Act of 1940 Act, as amended (the "1940 Act"), as investments in companies in which the Company owns more than 25 % of the voting securities or maintains greater than 50 % of the board representation. (7) This investment represents a Level 2 security in the ASC 820 fair value hierarchy as of December 31, 2023 (See "Note 4. Fair Value Measurements"). (3) Security is non-income producing. ^ Percentage is based on net assets of $ 403,150 as of December 31, 2023 . (3) Security is non-income producing. Investment was measured at f air value using the net asset value per share (or its equivalent) as a practical expedient. (7) This investment represents a Level 2 security in the ASC 820 fair value hierarchy as of December 31, 2022 (See "Note 4. Fair Value Measurements").

CONSOLIDATED SCHEDULE OF INVE_2

CONSOLIDATED SCHEDULE OF INVESTMENTS (Parenthetical) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022
Schedule of Investments [Line Items]
Net assets	[1],[2]	$ 403,150	$ 403,677
Maximum [Member]
Schedule of Investments [Line Items]
Qualifying assets at fair value represented percentage		74%	73.90%
Maximum [Member] | Controlled Affiliated Investments [Member]
Schedule of Investments [Line Items]
Investment company voting securities percentage		50%	50%
Minimum [Member]
Schedule of Investments [Line Items]
Minimum required percentage for qualifying asset to represent		70%	70%
Minimum [Member] | Controlled Affiliated Investments [Member]
Schedule of Investments [Line Items]
Investment company voting securities percentage		25%	25%
[1] (1) The per share data for 2023 was derived by using the weighted average shares outstanding. The per share data for 2022 was derived by using the weighted average shares outstanding from June 2, 2022 (commencement of investment operations) through December 31, 2022. (2) Per share data for the year ended December 31, 2022 based upon the weighted average shares outstanding from March 29, 2022 (first issuance of common stock) through December 31, 2022 were as follows: Net investment income of $ 0.71 per share, net unrealized loss of $ 0.30 per share, net increase in net assets resulting from operations of $ 0.41 per share, distributions of net investment income of $ 0.68 per share, and net asset value per share at the end of the period of $ 9.73 per share.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Pay vs Performance Disclosure
Net Income (Loss)	$ 42,242	$ 9,242

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Dec. 31, 2023
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false

Insider Trading Policies and Pr

Insider Trading Policies and Procedures	3 Months Ended
	Dec. 31, 2023
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted	true

N-2

N-2 - $ / shares	12 Months Ended
	Dec. 31, 2023		Dec. 31, 2022	[1],[2],[3]	Jun. 02, 2022
Cover [Abstract]
Entity Central Index Key	0001784700
Amendment Flag	false
Securities Act File Number	814-01538
Document Type	10-K
Entity Registrant Name	VARAGON CAPITAL CORPORATION
Entity Address, Address Line One	151 West 42nd Street
Entity Address, Address Line Two	53rd Floor
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10036
City Area Code	212
Local Phone Number	235-2600
Entity Well-known Seasoned Issuer	No
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
General Description of Registrant [Abstract]
Risk Factors [Table Text Block]	Item 1A. Risk Factors Investments in the Company involve a high degree of risk. There can be no assurance that our investment objectives will be achieved, or that a shareholder will receive a return of its capital. In addition, there will be occasions when the Adviser and its affiliates may encounter potential conflicts of interest in connection with us. The following considerations should be carefully evaluated before making an investment in the Company. The following is a summary of the principal risks that you should carefully consider before investing in our common stock. • We have a limited operating history and the Adviser has no prior experience managing a BDC. • Capital markets are experiencing a period of disruption and instability. • Economic recessions or downturns could impair our portfolio companies and harm our operating results. • We are subject to risks related to changes in interest rates. • The lack of liquidity in our investments may adversely affect our business. • We borrow money, which magnifies the potential for gain or loss and may increase the risk of investing in us. • Our ability to enter into transactions with our affiliates is restricted. • The Company will be subject to U.S. federal income tax imposed at corporate rates if it is unable to qualify as a RIC. • There is currently no public market for our common stock, and a market for our common stock may never develop. • Shareholders may not redeem their shares of common stock. • We may compete for investment opportunities with other entities managed by Varagon, subjecting our Adviser to certain conflicts of interest. • Our fee structure may create incentives for our Adviser to make speculative investments or use substantial leverage. • Our investments in middle market companies may be risky, and we could lose all or part of our investments. Risks Related to the Company’s Business and Structure. Limited Operating History and No Prior Experience Managing a BDC. VF1 began operations in July 2016 as a limited partnership with a more focused investment mandate and less capital than the Company has. The Company merged with VF1, with the Company as the surviving entity, at the Initial Closing and immediately prior to our election to be regulated as a BDC on June 2, 2022, when the Company began operations. Therefore, we have limited financial information on which a prospective investor can evaluate an investment in our common stock or our prior performance. As a result, we are subject to the business risks and uncertainties associated with recently formed businesses, including the risk that we will not achieve our investment objective and the value of a shareholder’s investment could decline substantially or become worthless. In addition, the Adviser has not previously managed a BDC. While we believe that the past professional experiences, including investment and financial experience, will allow the Adviser to manage the Company successfully, there can be no assurance that this will be the case. Non-Specified Investments and Discretion in Determining Use of Drawdown Amounts. Capital drawn will be used to finance or invest in portfolio companies and investment vehicles that will not be meaningfully described to the shareholders prior to such financing or investment. We also intend to conduct repurchase offers, from time to time, beginning after the end of the Fundraising Period, and we may use a portion of the capital drawn for the repurchase of the common stock pursuant to such repurchase offers. Further, the Adviser will have broad discretion in determining the specific uses of Drawdown Amounts. The Adviser is neither obligated to allocate the Company’s resources to any particular subset or niche market, nor precluded from allocation any of such resources to a particular subset or niche market. Shareholders will not have opportunity to evaluate the economic, financial or other information on which the Adviser bases its decisions on how to use Drawdown Amounts. Shareholders must rely on the judgment and ability of the Adviser with respect to the investment of the Company’s capital. The Company also will pay operating expenses, and may pay other expenses such as due diligence expenses of potential new investments, from Drawdown Amounts. The Company’s ability to achieve the Company’s investment objective may be limited to the extent that Drawdown Amounts are used to pay operating expenses. No assurance can be given that the Company will be successful in identifying portfolio companies suitable for financing or investment or that, if such financings or investments are made, the objectives of the Company will be achieved. These factors increase the uncertainty, and thus the risk, of investing in the Company. The Company’s investments may be materially affected by conditions in the financial markets and overall economic conditions occurring globally and in particular markets where the Company may invest its assets. The Adviser’s methods of minimizing such risks may not accurately predict future risk exposures. Risk management techniques are based in part on the observation of historical market behavior, which may not predict market divergences that are larger than historical indicators. Also, information used to manage risks may not be accurate, complete or current, and such information may be misinterpreted. Although the Adviser intends to utilize appropriate risk management strategies, such strategies cannot fully insulate the Company from the risks inherent in its planned activities. Moreover, in certain situations the Adviser may be unable to, or may choose not to, implement risk management strategies because of the costs involved or other relevant factors. General Market and Economic Conditions. General economic conditions may affect the Company’s activities. Changing economic, political, regulatory or market conditions, interest rates, general levels of economic activity, the price of securities and debt instruments and participation by other investors in the financial markets may affect the value and number of investments made by the Company or considered for prospective investment. The Company’s investment strategy and the availability of opportunities satisfying its risk-adjusted return parameters rely in part on the continuation of certain trends and conditions observed in the market for originated debt as well as the larger financial markets. No assurance can be given that such conditions, trends or opportunities will arise or continue, as applicable. Trends and historical events do not imply, forecast or predict future events and, in any event, past performance is not necessarily indicative of future results. There can be no assurance that the assumptions made, or the beliefs and expectations currently held, by the Company will prove correct and actual events and circumstances could vary significantly. While the Company expects that the current environment will yield attractive investment opportunities, investments are expected to be sensitive to the performance of the overall economy. A negative impact on U.S. or global economic fundamentals or consumer or business confidence will likely increase market volatility and reduce liquidity, both of which could adversely affect the overall performance of borrowers to which the Company may have extended loans, and these or similar events will affect the ability to execute the investment strategy pursued by the Company. The value of investments may fluctuate in accordance with changes in the financial condition of portfolio companies and other factors that affect the markets in which the Company invests. Economic, political, global health, regulatory or market developments can affect a single obligor, obligors within an industry, economic sector or geographic region, or the market as a whole. Different parts of the market and different types of investments can react differently to these developments. Every investment has some level of market volatility risk. Economic slowdowns or downturns could lead to financial losses in the Company’s investments. In addition, many portfolio companies may be similarly subject to the same economic conditions, which could adversely impact the ability to repay loans made or acquired by the Company. As a result, companies that the Company expected to be stable may operate, or expect to operate, at a loss or have significant variations in operating results, may require substantial additional capital to support their operations or maintain their competitive position, or may otherwise have a weak financial condition or be experiencing financial distress. Market conditions, including increased competition, also may cause the Company’s portfolio to comprise assets that differ significantly from the Adviser’s expectations at the time of the initial offering of common stock. Capital Markets are Experiencing a Period of Disruption and Instability. As a BDC, we must maintain our ability to raise additional capital for investment purposes. Without sufficient access to the capital markets or credit markets, we may be forced to curtail our business operations or we may not be able to pursue new business opportunities. The U.S. capital markets have experienced extreme volatility and disruption following the global outbreak of COVID-19 that began in December 2019, the conflict between Russia and Ukraine that began in late February 2022, and the ongoing war in the Middle East (see “Terrorist Attacks, Acts of War, Natural Disasters or Pandemics” for more information). Even after the COVID-19 pandemic subsided, the U.S. economy, as well as most other major economies, have continued to experience unpredictable economic conditions, and we anticipate our businesses would be materially and adversely affected by any prolonged economic downturn or recession in the United States and other major markets. In addition, disruptions in the capital markets have increased the spread between the yields realized on risk-free and higher risk securities, resulting in illiquidity in parts of the capital markets. The current economic conditions have resulted in an adverse impact on the ability of lenders to originate loans, the volume and type of loans originated, the ability of borrowers to make payments and the volume and type of amendments and waivers granted to borrowers and remedial actions taken in the event of a borrower default, each of which could negatively impact the amount and quality of loans available for investment by the Company and returns to the Company, among other things. The U.S. credit markets (in particular for middle-market loans) have experienced the following among other things: (i) increased draws by borrowers on revolving lines of credit and other financing instruments; (ii) increased requests by borrowers for amendments and waivers of their credit agreements to avoid default, increased defaults by such borrowers and/or increased difficulty in obtaining refinancing at the maturity dates of their loans and increased uses of PIK features; and (iii) greater volatility in pricing and spreads and difficulty in valuing loans during periods of increased volatility, and liquidity issues. These conditions and future market disruptions and/or illiquidity could have an adverse effect on our (and our portfolio companies') business, financial condition, results of operations and cash flows. Ongoing unfavorable economic conditions also could increase our funding costs, limit our access to the capital markets or result in a decision by lenders not to extend credit to our portfolio companies and/or us. These events have limited and could continue to limit our investment originations, limit our ability to grow and have a material negative impact on our operating results and the fair values of our portfolio investments. We may have to access, if available, alternative markets for debt and equity capital, and a severe disruption in the global financial markets, deterioration in credit and financing conditions, continued increase in interest rates or uncertainty regarding U.S. government spending and deficit levels or other global economic conditions could have a material adverse effect on our business, financial condition and results of operations. Even if capital markets remain stable or improve, conditions could deteriorate again in the future. Past economic downturns or recessions have had a significant negative impact on the operating performance and fair value of middle market companies. For example, between 2008 and 2009, the U.S. and global capital markets were unstable as evidenced by periodic disruptions in liquidity in the debt capital markets, significant write-offs in the financial services sector, the re-pricing of credit risk in the broadly syndicated credit market and the failure of major financial institutions. Despite actions of the U.S. federal government and foreign governments, these events contributed to worsening general economic conditions that materially and adversely impacted the broader financial and credit markets and reduced the availability of debt and equity capital for the market as a whole and financial services firms in particular. Economic Recessions or Downturns Could Impair our Portfolio Companies and Harm our Operating Results. The companies in which we have invested and intend to invest may be susceptible to economic slowdowns or recessions, including as a result of, among other things, the COVID-19 pandemic, elevated levels of inflation, and a rising interest rate environment, and may be unable to repay our debt investments during these periods. In the past, instability in the global capital markets resulted in disruptions in liquidity in the debt capital markets, significant write-offs in the financial services sector, the re-pricing of credit risk in the broadly syndicated credit market and the failure of major domestic and international financial institutions. In particular, in past periods of instability, the financial services sector was negatively impacted by significant write-offs as the value of the assets held by financial firms declined, impairing their capital positions and abilities to lend and invest. Our portfolio companies may be susceptible to economic downturns or recessions. During these periods, the value of our portfolio may decrease if we are required to write down the values of our investments, and we may have non-performing assets or non-performing assets may increase, and the value of our portfolio is likely to decrease during these periods. Adverse economic conditions also may decrease the value of any collateral securing our loans, and decrease the value of our equity investments. A severe recession may further decrease the value of such collateral and result in losses of value in our portfolio and a decrease in our revenues, net income, assets and net worth. Unfavorable economic conditions also could increase our funding costs, limit our access to the capital markets or result in a decision by lenders not to extend credit to us on terms we deem acceptable. In addition, a prolonged economic downturn or recession could extend our investment time horizon by limiting our ability to achieve timely liquidity events, such as a sale, merger or IPO, or the refinancing of our debt investments, and could ultimately impact our ability to realize anticipated investment returns. These events could prevent us from increasing investments and adversely impact our operating results. The occurrence of recessionary conditions and/or negative developments in the domestic and international credit markets may significantly affect the markets in which we do business, the value of our investments, and our ongoing operations, costs and profitability. Any such unfavorable economic conditions, including rising interest rates, also may increase our funding costs, limit our access to capital markets or negatively impact our ability to obtain financing, particularly from the debt markets. In addition, any future financial market uncertainty could lead to financial market disruptions and could further impact our ability to obtain financing. These events could limit our investment originations, limit our ability to grow and negatively impact our operating results and financial condition. Risks Related to Changes in Interest Rates. Because we may borrow money to make investments, our net investment income will depend, in part, upon the difference between the rate at which we borrow funds and the rate at which we invest those funds. As a result, we can offer no assurance that a significant change in interest rates would not have a material adverse effect on our net investment income in the event we use debt to finance our investments. In periods of rising interest rates, our cost of funds would increase, which could reduce our net investment income. Rising borrowing costs may contribute to the difficulty of companies in servicing their debt obligations and may lead to increases in default rates. Certain changes in interest rates could have a material adverse effect on the Company and its investments. Moreover, changes in interest rates could have a material negative impact on the financial condition of borrowers, the valuations for loans, the unanticipated repayments of loans, and pressure to renegotiate terms on existing loans. In response to recent market indicators showing a rise in inflation, the Federal Reserve has raised certain benchmark interest rates in an effort to slow inflation. This rising interest rate environment may impact our cost of capital and net investment income. Since March 2022, the Federal Reserve has been rapidly raising interest rates and has indicated that it may consider additional rate hikes in response to ongoing inflation concerns. Increases in interest rates can make it more expensive to use debt to finance our investments. General interest rate fluctuations may have a substantial negative impact on our investments and investment opportunities and, accordingly, may have a material adverse effect on our ability to achieve our investment objective and the rate of return on invested capital. As a result, there can be no assurance that a significant change in market interest rates will not have a material adverse effect on our net investment income. Risks Relating to Hedging Transactions. We may seek to hedge against interest rate and currency exchange rate fluctuations and credit risk by using structured financial instruments such as futures, options, interest rate swaps, and forward contracts, subject to the requirements of the 1940 Act. Use of structured financial instruments for hedging purposes may present significant risks, including the risk of loss of the amounts invested. Defaults by the other party to a hedging transaction can result in losses in the hedging transaction. Hedging activities also involve the risk of an imperfect correlation between the hedging instrument and the asset being hedged, which could result in losses both on the hedging transaction and on the instrument being hedged. Use of hedging activities may not prevent significant losses and could increase our losses. Further, hedging transactions may reduce cash available to pay distributions to our shareholders. The success of our hedging strategy will depend on our ability to correctly identify appropriate exposures for hedging. In connection with our issuance of the Company’s Series A Senior Notes, Tranche A, due December 21, 2026, and Series A Senior Notes, Tranche B, due December 21, 2028, which bear interest at a fixed rate, we entered into interest rate swaps to continue to align the interest rates of our liabilities with our investment portfolio, which consists of predominately floating rate loans. In addition, the degree of correlation between price movements of the instruments used in a hedging strategy and price movements in the portfolio positions being hedged may vary, as may the time period in which the hedge is effective relative to the time period of the related exposure. Also, where a put or call option on a particular security is purchased to hedge against price movements in a related security, the price of the put or call option may move more or less than the price of the related security. If restrictions on exercise were imposed, we might be unable to exercise an option we had purchased. If we were unable to close out an option that we had purchased on a security, it would have to exercise the option in order to realize any profit or the option may expire worthless. The Alternative Reference Rates That Have Replaced LIBOR in Our Credit Arrangements and Other Financial Instruments May Not Yield the Same or Similar Economic Results as LIBOR Over the Life of Such Transactions . LIBOR is an index rate that historically was widely used in lending transactions and was a common reference rate for setting the floating interest rate on private loans. LIBOR was typically the reference rate used in floating-rate loans extended to our portfolio companies. The ICE Benchmark Administration (“IBA”) (the entity that is responsible for calculating LIBOR) ceased providing overnight, one, three, six and twelve months USD LIBOR tenors on June 30, 2023. In addition, the United Kingdom's Financial Conduct Authority ("FCA"), which oversees the IBA, now prohibits entities supervised by the FCA from using LIBOR, including USD LIBOR, except in very limited circumstances. In the United States, SOFR is the preferred alternative rate for LIBOR. SOFR is a measure of the cost of borrowing cash overnight, collateralized by U.S. Treasury securities, and is based on directly observable U.S. Treasury-backed repurchase transactions. SOFR is published by the Federal Reserve Bank of New York each U.S. Government Securities Business Day, for transactions made on the immediately preceding U.S. Government Securities Business Day. Alternative reference rates that may replace LIBOR, including SOFR for USD transactions, may not yield the same or similar economic results as LIBOR over the lives of such transactions. Our loans that referenced LIBOR have been amended to reference the forward-looking term rate published by CME Group Benchmark Administration Limited based on the secured overnight financing rate (“CME Term SOFR”). CME Term SOFR rates are forward-looking rates that are derived by compounding projected overnight SOFR rates over one, three, and six months taking into account the values of multiple consecutive, executed, one-month and three-month CME Group traded SOFR futures contracts and, in some cases, over-the-counter SOFR Overnight Indexed Swaps as an indicator of CME Term SOFR reference rate values. CME Term SOFR and the inputs on which it is based are derived from SOFR. Because CME Term SOFR is a relatively new market rate, there will likely be no established trading market for credit agreements or other financial instruments when they are issued, and an established market may never develop or may not be liquid. Market terms for instruments referencing CME Term SOFR rates may be different than those of later-issued CME Term SOFR indexed instruments. Similarly, if CME Term SOFR does not prove to be widely used, the trading price of instruments referencing CME Term SOFR may be lower than those of instruments indexed to indices that are more widely used. Our Business is Dependent on Bank Relationships and Recent Strain on the Banking System May Adversely Impact Us. The financial markets recently have encountered volatility associated with concerns about the balance sheets of banks, especially small and regional banks that may have significant losses associated with investments that make it difficult to fund demands to withdraw deposits and other liquidity needs. Although the federal government has announced measures to assist these banks and protect depositors, some banks have already been impacted and others may be materially and adversely impacted. Our business is dependent on bank relationships, including small and regional banks, and we are proactively monitoring the financial health of banks with which we (or our portfolio companies) do or may in the future do business. To the extent that our portfolio companies work with banks that are negatively impacted by the foregoing, such portfolio companies’ ability to access their own cash, cash equivalents and investments may be threatened. In addition, such affected portfolio companies may not be able to enter into new banking arrangements or credit facilities, or receive the benefits of their existing banking arrangements or facilities. Any such developments could harm our business, financial condition, and operating results, and prevent us from fully implementing our investment plan. Continued strain on the banking system may adversely impact our business, financial condition and results of operations. Price Declines in the Corporate Leveraged Loan Market. Conditions in the medium- and large-sized U.S. corporate debt market may experience disruption or deterioration in the future, which may cause pricing levels to decline or be volatile. As a result, our NAV could decline through an increase in unrealized depreciation and incurrence of realized losses in connection with the sale of our investments, which could have a material adverse impact on our business, financial condition and results of operations. Defaults Under a Credit Facility. In the event we default under the JPM Facility, the CIBC Facility (together, the "Credit Facilities"), or other borrowings, our business could be adversely affected as we may be forced to sell a portion of our investments quickly and prematurely at what may be disadvantageous prices to us in order to meet our outstanding payment obligations and/or support working capital requirements under such borrowings, any of which would have a material adverse effect on our business, financial condition, results of operations and cash flows. In addition, following any such default, the agent for the lenders under a borrowing facility could assume control of the disposition of any or all of our assets, including the selection of such assets to be disposed and the timing of such disposition, which would have a material adverse effect on our business, financial condition, results of operations and cash flows. As part of certain credit facilities, the right to make capital calls of shareholders may be pledged as collateral to the lender, which will be able to call for capital contributions upon the occurrence of an event of default under such credit facility. To the extent such an event of default does occur, shareholders could therefore be required to fund any shortfall up to their remaining Capital Commitments, without regard to the underlying value of their investment. Provisions in our Credit Facilities May Limit Discretion. We currently have in place the JPM Facility and the CIBC Facility, and in the future may enter into additional borrowings. Our Credit Facilities are backed by a portion of our loans and securities on which the lenders have a security interest. We may pledge up to 100% of our assets and may grant a security interest in all of our assets under the terms of any debt instrument we enter into with lenders. We expect that any security interests we grant will be set forth in a pledge and security agreement and evidenced by the filing of financing statements by the agent for the lenders. In addition, we expect that the custodian for our securities serving as collateral for such loan would include in its electronic systems notices indicating the existence of such security interests and, following notice of occurrence of an event of default, if any, and during its continuance, will only accept transfer instructions with respect to any such securities from the lender or its designee. If we breach a covenant under the terms of any of our Credit Facilities and seek a waiver, we may not be able to obtain a waiver from the required lenders. If we were to default under the terms of any debt instrument relating to any of our Credit Facilities and do not obtain a waiver, the agent for the applicable lenders would be able to assume control of the timing of disposition of any or all of our assets securing such debt, which would have a material adverse effect on our business, financial condition, results of operations and cash flows. In addition, our Credit Facilities may have customary cross-default provisions. If the indebtedness under our Credit Facilities or under any future borrowings is accelerated, we may be unable to repay or finance the amounts due. The terms of certain credit facilities that we enter into may provide (and, in the case of the JPM Facility and the CIBC Facility, provide) that, if we do not draw a minimum funding amount based on the borrowings available under such credit facility, then we must make additional payments to the lender for the difference between that minimum funding amount and the actual amounts we have then borrowed. To the extent that draw amounts are significantly below the stated minimum funding amount, we could be required to make a sizable “make whole” payment to the applicable lender. In addition, the terms of certain credit facilities that we enter into may provide (and, in the case of the JPM Facility, provide) that an optional termination of that credit facility or reduction, in full or in part, of the borrowings available under that credit facility generally will require us to may a “make whole” payment and pay a fee based on the amount of borrowings terminated or reduced, as applicable, under that credit facility. In each of these circumstances, our ability to pay such fees depends largely on our financial performance and is subject to prevailing economic conditions and competitive pressures. This, in certain circumstances, could have a material adverse effect on our business, financial condition, results of operations and cash flows. In addition, any security interests and/or negative covenants required by our Credit Facilities may limit our ability to create liens on assets to secure additional debt and may make it difficult for us to restructure or refinance indebtedness at or prior to maturity or obtain additional debt or equity financing. In addition, if our borrowing base under our Credit Facilities were to decrease, we may be required to secure additional assets in an amount sufficient to cure any borrowing base deficiency. In the event that all of our assets are secured at the time of such a borrowing base deficiency, we could be required to repay advances under our Credit Facilities or make deposits to a collection account, either of which could have a material adverse impact on our ability to fund future investments and to make distributions. We also may be subject to limitations as to how borrowed funds may be used, which may include restrictions on geographic and industry concentrations, loan size, payment frequency and status, average life, collateral interests and investment ratings, as well as regulatory restrictions on leverage which may affect the amount of funding that may be obtained. There also may be certain requirements relating to portfolio performance, including required minimum portfolio yield and limitations on delinquencies and charge-offs, a violation of which could limit further advances and, in some cases, result in an event of default. An event of default under our Credit Facilities could result in an accelerated maturity date for all amounts outstanding thereunder, which could have a material adverse effect on our business and financial condition. This could reduce our liquidity and cash flow and impair our ability to grow our business. Competition for Investments. Other entities, including commercial banks, commercial financing companies, BDCs and insurance companies compete to make the types of investments that we plan to make in middle market loans. Certain of these competitors may be substantially larger, have considerably greater financial, technical and marketing resources than we will have and offer a wider array of financial services. For example, some competitors may have a lower cost of funds or access to funding sources that are not available to us. We may lose investment opportunities if we do not match our competitors’ pricing, terms and structure. There may be intense competition for financings or investments of the type we intend to make, and such competition may result in less favorable financing or investment terms than might otherwise exist. Furthermore, many of our competitors are not subject to the regulatory res
NAV Per Share	$ 9.71	[1],[2]	$ 9.73		$ 810.39
Business and Structure
General Description of Registrant [Abstract]
Risk [Text Block]	Risks Related to the Company’s Business and Structure. Limited Operating History and No Prior Experience Managing a BDC. VF1 began operations in July 2016 as a limited partnership with a more focused investment mandate and less capital than the Company has. The Company merged with VF1, with the Company as the surviving entity, at the Initial Closing and immediately prior to our election to be regulated as a BDC on June 2, 2022, when the Company began operations. Therefore, we have limited financial information on which a prospective investor can evaluate an investment in our common stock or our prior performance. As a result, we are subject to the business risks and uncertainties associated with recently formed businesses, including the risk that we will not achieve our investment objective and the value of a shareholder’s investment could decline substantially or become worthless. In addition, the Adviser has not previously managed a BDC. While we believe that the past professional experiences, including investment and financial experience, will allow the Adviser to manage the Company successfully, there can be no assurance that this will be the case. Non-Specified Investments and Discretion in Determining Use of Drawdown Amounts. Capital drawn will be used to finance or invest in portfolio companies and investment vehicles that will not be meaningfully described to the shareholders prior to such financing or investment. We also intend to conduct repurchase offers, from time to time, beginning after the end of the Fundraising Period, and we may use a portion of the capital drawn for the repurchase of the common stock pursuant to such repurchase offers. Further, the Adviser will have broad discretion in determining the specific uses of Drawdown Amounts. The Adviser is neither obligated to allocate the Company’s resources to any particular subset or niche market, nor precluded from allocation any of such resources to a particular subset or niche market. Shareholders will not have opportunity to evaluate the economic, financial or other information on which the Adviser bases its decisions on how to use Drawdown Amounts. Shareholders must rely on the judgment and ability of the Adviser with respect to the investment of the Company’s capital. The Company also will pay operating expenses, and may pay other expenses such as due diligence expenses of potential new investments, from Drawdown Amounts. The Company’s ability to achieve the Company’s investment objective may be limited to the extent that Drawdown Amounts are used to pay operating expenses. No assurance can be given that the Company will be successful in identifying portfolio companies suitable for financing or investment or that, if such financings or investments are made, the objectives of the Company will be achieved. These factors increase the uncertainty, and thus the risk, of investing in the Company. The Company’s investments may be materially affected by conditions in the financial markets and overall economic conditions occurring globally and in particular markets where the Company may invest its assets. The Adviser’s methods of minimizing such risks may not accurately predict future risk exposures. Risk management techniques are based in part on the observation of historical market behavior, which may not predict market divergences that are larger than historical indicators. Also, information used to manage risks may not be accurate, complete or current, and such information may be misinterpreted. Although the Adviser intends to utilize appropriate risk management strategies, such strategies cannot fully insulate the Company from the risks inherent in its planned activities. Moreover, in certain situations the Adviser may be unable to, or may choose not to, implement risk management strategies because of the costs involved or other relevant factors. General Market and Economic Conditions. General economic conditions may affect the Company’s activities. Changing economic, political, regulatory or market conditions, interest rates, general levels of economic activity, the price of securities and debt instruments and participation by other investors in the financial markets may affect the value and number of investments made by the Company or considered for prospective investment. The Company’s investment strategy and the availability of opportunities satisfying its risk-adjusted return parameters rely in part on the continuation of certain trends and conditions observed in the market for originated debt as well as the larger financial markets. No assurance can be given that such conditions, trends or opportunities will arise or continue, as applicable. Trends and historical events do not imply, forecast or predict future events and, in any event, past performance is not necessarily indicative of future results. There can be no assurance that the assumptions made, or the beliefs and expectations currently held, by the Company will prove correct and actual events and circumstances could vary significantly. While the Company expects that the current environment will yield attractive investment opportunities, investments are expected to be sensitive to the performance of the overall economy. A negative impact on U.S. or global economic fundamentals or consumer or business confidence will likely increase market volatility and reduce liquidity, both of which could adversely affect the overall performance of borrowers to which the Company may have extended loans, and these or similar events will affect the ability to execute the investment strategy pursued by the Company. The value of investments may fluctuate in accordance with changes in the financial condition of portfolio companies and other factors that affect the markets in which the Company invests. Economic, political, global health, regulatory or market developments can affect a single obligor, obligors within an industry, economic sector or geographic region, or the market as a whole. Different parts of the market and different types of investments can react differently to these developments. Every investment has some level of market volatility risk. Economic slowdowns or downturns could lead to financial losses in the Company’s investments. In addition, many portfolio companies may be similarly subject to the same economic conditions, which could adversely impact the ability to repay loans made or acquired by the Company. As a result, companies that the Company expected to be stable may operate, or expect to operate, at a loss or have significant variations in operating results, may require substantial additional capital to support their operations or maintain their competitive position, or may otherwise have a weak financial condition or be experiencing financial distress. Market conditions, including increased competition, also may cause the Company’s portfolio to comprise assets that differ significantly from the Adviser’s expectations at the time of the initial offering of common stock. Capital Markets are Experiencing a Period of Disruption and Instability. As a BDC, we must maintain our ability to raise additional capital for investment purposes. Without sufficient access to the capital markets or credit markets, we may be forced to curtail our business operations or we may not be able to pursue new business opportunities. The U.S. capital markets have experienced extreme volatility and disruption following the global outbreak of COVID-19 that began in December 2019, the conflict between Russia and Ukraine that began in late February 2022, and the ongoing war in the Middle East (see “Terrorist Attacks, Acts of War, Natural Disasters or Pandemics” for more information). Even after the COVID-19 pandemic subsided, the U.S. economy, as well as most other major economies, have continued to experience unpredictable economic conditions, and we anticipate our businesses would be materially and adversely affected by any prolonged economic downturn or recession in the United States and other major markets. In addition, disruptions in the capital markets have increased the spread between the yields realized on risk-free and higher risk securities, resulting in illiquidity in parts of the capital markets. The current economic conditions have resulted in an adverse impact on the ability of lenders to originate loans, the volume and type of loans originated, the ability of borrowers to make payments and the volume and type of amendments and waivers granted to borrowers and remedial actions taken in the event of a borrower default, each of which could negatively impact the amount and quality of loans available for investment by the Company and returns to the Company, among other things. The U.S. credit markets (in particular for middle-market loans) have experienced the following among other things: (i) increased draws by borrowers on revolving lines of credit and other financing instruments; (ii) increased requests by borrowers for amendments and waivers of their credit agreements to avoid default, increased defaults by such borrowers and/or increased difficulty in obtaining refinancing at the maturity dates of their loans and increased uses of PIK features; and (iii) greater volatility in pricing and spreads and difficulty in valuing loans during periods of increased volatility, and liquidity issues. These conditions and future market disruptions and/or illiquidity could have an adverse effect on our (and our portfolio companies') business, financial condition, results of operations and cash flows. Ongoing unfavorable economic conditions also could increase our funding costs, limit our access to the capital markets or result in a decision by lenders not to extend credit to our portfolio companies and/or us. These events have limited and could continue to limit our investment originations, limit our ability to grow and have a material negative impact on our operating results and the fair values of our portfolio investments. We may have to access, if available, alternative markets for debt and equity capital, and a severe disruption in the global financial markets, deterioration in credit and financing conditions, continued increase in interest rates or uncertainty regarding U.S. government spending and deficit levels or other global economic conditions could have a material adverse effect on our business, financial condition and results of operations. Even if capital markets remain stable or improve, conditions could deteriorate again in the future. Past economic downturns or recessions have had a significant negative impact on the operating performance and fair value of middle market companies. For example, between 2008 and 2009, the U.S. and global capital markets were unstable as evidenced by periodic disruptions in liquidity in the debt capital markets, significant write-offs in the financial services sector, the re-pricing of credit risk in the broadly syndicated credit market and the failure of major financial institutions. Despite actions of the U.S. federal government and foreign governments, these events contributed to worsening general economic conditions that materially and adversely impacted the broader financial and credit markets and reduced the availability of debt and equity capital for the market as a whole and financial services firms in particular. Economic Recessions or Downturns Could Impair our Portfolio Companies and Harm our Operating Results. The companies in which we have invested and intend to invest may be susceptible to economic slowdowns or recessions, including as a result of, among other things, the COVID-19 pandemic, elevated levels of inflation, and a rising interest rate environment, and may be unable to repay our debt investments during these periods. In the past, instability in the global capital markets resulted in disruptions in liquidity in the debt capital markets, significant write-offs in the financial services sector, the re-pricing of credit risk in the broadly syndicated credit market and the failure of major domestic and international financial institutions. In particular, in past periods of instability, the financial services sector was negatively impacted by significant write-offs as the value of the assets held by financial firms declined, impairing their capital positions and abilities to lend and invest. Our portfolio companies may be susceptible to economic downturns or recessions. During these periods, the value of our portfolio may decrease if we are required to write down the values of our investments, and we may have non-performing assets or non-performing assets may increase, and the value of our portfolio is likely to decrease during these periods. Adverse economic conditions also may decrease the value of any collateral securing our loans, and decrease the value of our equity investments. A severe recession may further decrease the value of such collateral and result in losses of value in our portfolio and a decrease in our revenues, net income, assets and net worth. Unfavorable economic conditions also could increase our funding costs, limit our access to the capital markets or result in a decision by lenders not to extend credit to us on terms we deem acceptable. In addition, a prolonged economic downturn or recession could extend our investment time horizon by limiting our ability to achieve timely liquidity events, such as a sale, merger or IPO, or the refinancing of our debt investments, and could ultimately impact our ability to realize anticipated investment returns. These events could prevent us from increasing investments and adversely impact our operating results. The occurrence of recessionary conditions and/or negative developments in the domestic and international credit markets may significantly affect the markets in which we do business, the value of our investments, and our ongoing operations, costs and profitability. Any such unfavorable economic conditions, including rising interest rates, also may increase our funding costs, limit our access to capital markets or negatively impact our ability to obtain financing, particularly from the debt markets. In addition, any future financial market uncertainty could lead to financial market disruptions and could further impact our ability to obtain financing. These events could limit our investment originations, limit our ability to grow and negatively impact our operating results and financial condition. Risks Related to Changes in Interest Rates. Because we may borrow money to make investments, our net investment income will depend, in part, upon the difference between the rate at which we borrow funds and the rate at which we invest those funds. As a result, we can offer no assurance that a significant change in interest rates would not have a material adverse effect on our net investment income in the event we use debt to finance our investments. In periods of rising interest rates, our cost of funds would increase, which could reduce our net investment income. Rising borrowing costs may contribute to the difficulty of companies in servicing their debt obligations and may lead to increases in default rates. Certain changes in interest rates could have a material adverse effect on the Company and its investments. Moreover, changes in interest rates could have a material negative impact on the financial condition of borrowers, the valuations for loans, the unanticipated repayments of loans, and pressure to renegotiate terms on existing loans. In response to recent market indicators showing a rise in inflation, the Federal Reserve has raised certain benchmark interest rates in an effort to slow inflation. This rising interest rate environment may impact our cost of capital and net investment income. Since March 2022, the Federal Reserve has been rapidly raising interest rates and has indicated that it may consider additional rate hikes in response to ongoing inflation concerns. Increases in interest rates can make it more expensive to use debt to finance our investments. General interest rate fluctuations may have a substantial negative impact on our investments and investment opportunities and, accordingly, may have a material adverse effect on our ability to achieve our investment objective and the rate of return on invested capital. As a result, there can be no assurance that a significant change in market interest rates will not have a material adverse effect on our net investment income. Risks Relating to Hedging Transactions. We may seek to hedge against interest rate and currency exchange rate fluctuations and credit risk by using structured financial instruments such as futures, options, interest rate swaps, and forward contracts, subject to the requirements of the 1940 Act. Use of structured financial instruments for hedging purposes may present significant risks, including the risk of loss of the amounts invested. Defaults by the other party to a hedging transaction can result in losses in the hedging transaction. Hedging activities also involve the risk of an imperfect correlation between the hedging instrument and the asset being hedged, which could result in losses both on the hedging transaction and on the instrument being hedged. Use of hedging activities may not prevent significant losses and could increase our losses. Further, hedging transactions may reduce cash available to pay distributions to our shareholders. The success of our hedging strategy will depend on our ability to correctly identify appropriate exposures for hedging. In connection with our issuance of the Company’s Series A Senior Notes, Tranche A, due December 21, 2026, and Series A Senior Notes, Tranche B, due December 21, 2028, which bear interest at a fixed rate, we entered into interest rate swaps to continue to align the interest rates of our liabilities with our investment portfolio, which consists of predominately floating rate loans. In addition, the degree of correlation between price movements of the instruments used in a hedging strategy and price movements in the portfolio positions being hedged may vary, as may the time period in which the hedge is effective relative to the time period of the related exposure. Also, where a put or call option on a particular security is purchased to hedge against price movements in a related security, the price of the put or call option may move more or less than the price of the related security. If restrictions on exercise were imposed, we might be unable to exercise an option we had purchased. If we were unable to close out an option that we had purchased on a security, it would have to exercise the option in order to realize any profit or the option may expire worthless. The Alternative Reference Rates That Have Replaced LIBOR in Our Credit Arrangements and Other Financial Instruments May Not Yield the Same or Similar Economic Results as LIBOR Over the Life of Such Transactions . LIBOR is an index rate that historically was widely used in lending transactions and was a common reference rate for setting the floating interest rate on private loans. LIBOR was typically the reference rate used in floating-rate loans extended to our portfolio companies. The ICE Benchmark Administration (“IBA”) (the entity that is responsible for calculating LIBOR) ceased providing overnight, one, three, six and twelve months USD LIBOR tenors on June 30, 2023. In addition, the United Kingdom's Financial Conduct Authority ("FCA"), which oversees the IBA, now prohibits entities supervised by the FCA from using LIBOR, including USD LIBOR, except in very limited circumstances. In the United States, SOFR is the preferred alternative rate for LIBOR. SOFR is a measure of the cost of borrowing cash overnight, collateralized by U.S. Treasury securities, and is based on directly observable U.S. Treasury-backed repurchase transactions. SOFR is published by the Federal Reserve Bank of New York each U.S. Government Securities Business Day, for transactions made on the immediately preceding U.S. Government Securities Business Day. Alternative reference rates that may replace LIBOR, including SOFR for USD transactions, may not yield the same or similar economic results as LIBOR over the lives of such transactions. Our loans that referenced LIBOR have been amended to reference the forward-looking term rate published by CME Group Benchmark Administration Limited based on the secured overnight financing rate (“CME Term SOFR”). CME Term SOFR rates are forward-looking rates that are derived by compounding projected overnight SOFR rates over one, three, and six months taking into account the values of multiple consecutive, executed, one-month and three-month CME Group traded SOFR futures contracts and, in some cases, over-the-counter SOFR Overnight Indexed Swaps as an indicator of CME Term SOFR reference rate values. CME Term SOFR and the inputs on which it is based are derived from SOFR. Because CME Term SOFR is a relatively new market rate, there will likely be no established trading market for credit agreements or other financial instruments when they are issued, and an established market may never develop or may not be liquid. Market terms for instruments referencing CME Term SOFR rates may be different than those of later-issued CME Term SOFR indexed instruments. Similarly, if CME Term SOFR does not prove to be widely used, the trading price of instruments referencing CME Term SOFR may be lower than those of instruments indexed to indices that are more widely used. Our Business is Dependent on Bank Relationships and Recent Strain on the Banking System May Adversely Impact Us. The financial markets recently have encountered volatility associated with concerns about the balance sheets of banks, especially small and regional banks that may have significant losses associated with investments that make it difficult to fund demands to withdraw deposits and other liquidity needs. Although the federal government has announced measures to assist these banks and protect depositors, some banks have already been impacted and others may be materially and adversely impacted. Our business is dependent on bank relationships, including small and regional banks, and we are proactively monitoring the financial health of banks with which we (or our portfolio companies) do or may in the future do business. To the extent that our portfolio companies work with banks that are negatively impacted by the foregoing, such portfolio companies’ ability to access their own cash, cash equivalents and investments may be threatened. In addition, such affected portfolio companies may not be able to enter into new banking arrangements or credit facilities, or receive the benefits of their existing banking arrangements or facilities. Any such developments could harm our business, financial condition, and operating results, and prevent us from fully implementing our investment plan. Continued strain on the banking system may adversely impact our business, financial condition and results of operations. Price Declines in the Corporate Leveraged Loan Market. Conditions in the medium- and large-sized U.S. corporate debt market may experience disruption or deterioration in the future, which may cause pricing levels to decline or be volatile. As a result, our NAV could decline through an increase in unrealized depreciation and incurrence of realized losses in connection with the sale of our investments, which could have a material adverse impact on our business, financial condition and results of operations. Defaults Under a Credit Facility. In the event we default under the JPM Facility, the CIBC Facility (together, the "Credit Facilities"), or other borrowings, our business could be adversely affected as we may be forced to sell a portion of our investments quickly and prematurely at what may be disadvantageous prices to us in order to meet our outstanding payment obligations and/or support working capital requirements under such borrowings, any of which would have a material adverse effect on our business, financial condition, results of operations and cash flows. In addition, following any such default, the agent for the lenders under a borrowing facility could assume control of the disposition of any or all of our assets, including the selection of such assets to be disposed and the timing of such disposition, which would have a material adverse effect on our business, financial condition, results of operations and cash flows. As part of certain credit facilities, the right to make capital calls of shareholders may be pledged as collateral to the lender, which will be able to call for capital contributions upon the occurrence of an event of default under such credit facility. To the extent such an event of default does occur, shareholders could therefore be required to fund any shortfall up to their remaining Capital Commitments, without regard to the underlying value of their investment. Provisions in our Credit Facilities May Limit Discretion. We currently have in place the JPM Facility and the CIBC Facility, and in the future may enter into additional borrowings. Our Credit Facilities are backed by a portion of our loans and securities on which the lenders have a security interest. We may pledge up to 100% of our assets and may grant a security interest in all of our assets under the terms of any debt instrument we enter into with lenders. We expect that any security interests we grant will be set forth in a pledge and security agreement and evidenced by the filing of financing statements by the agent for the lenders. In addition, we expect that the custodian for our securities serving as collateral for such loan would include in its electronic systems notices indicating the existence of such security interests and, following notice of occurrence of an event of default, if any, and during its continuance, will only accept transfer instructions with respect to any such securities from the lender or its designee. If we breach a covenant under the terms of any of our Credit Facilities and seek a waiver, we may not be able to obtain a waiver from the required lenders. If we were to default under the terms of any debt instrument relating to any of our Credit Facilities and do not obtain a waiver, the agent for the applicable lenders would be able to assume control of the timing of disposition of any or all of our assets securing such debt, which would have a material adverse effect on our business, financial condition, results of operations and cash flows. In addition, our Credit Facilities may have customary cross-default provisions. If the indebtedness under our Credit Facilities or under any future borrowings is accelerated, we may be unable to repay or finance the amounts due. The terms of certain credit facilities that we enter into may provide (and, in the case of the JPM Facility and the CIBC Facility, provide) that, if we do not draw a minimum funding amount based on the borrowings available under such credit facility, then we must make additional payments to the lender for the difference between that minimum funding amount and the actual amounts we have then borrowed. To the extent that draw amounts are significantly below the stated minimum funding amount, we could be required to make a sizable “make whole” payment to the applicable lender. In addition, the terms of certain credit facilities that we enter into may provide (and, in the case of the JPM Facility, provide) that an optional termination of that credit facility or reduction, in full or in part, of the borrowings available under that credit facility generally will require us to may a “make whole” payment and pay a fee based on the amount of borrowings terminated or reduced, as applicable, under that credit facility. In each of these circumstances, our ability to pay such fees depends largely on our financial performance and is subject to prevailing economic conditions and competitive pressures. This, in certain circumstances, could have a material adverse effect on our business, financial condition, results of operations and cash flows. In addition, any security interests and/or negative covenants required by our Credit Facilities may limit our ability to create liens on assets to secure additional debt and may make it difficult for us to restructure or refinance indebtedness at or prior to maturity or obtain additional debt or equity financing. In addition, if our borrowing base under our Credit Facilities were to decrease, we may be required to secure additional assets in an amount sufficient to cure any borrowing base deficiency. In the event that all of our assets are secured at the time of such a borrowing base deficiency, we could be required to repay advances under our Credit Facilities or make deposits to a collection account, either of which could have a material adverse impact on our ability to fund future investments and to make distributions. We also may be subject to limitations as to how borrowed funds may be used, which may include restrictions on geographic and industry concentrations, loan size, payment frequency and status, average life, collateral interests and investment ratings, as well as regulatory restrictions on leverage which may affect the amount of funding that may be obtained. There also may be certain requirements relating to portfolio performance, including required minimum portfolio yield and limitations on delinquencies and charge-offs, a violation of which could limit further advances and, in some cases, result in an event of default. An event of default under our Credit Facilities could result in an accelerated maturity date for all amounts outstanding thereunder, which could have a material adverse effect on our business and financial condition. This could reduce our liquidity and cash flow and impair our ability to grow our business. Competition for Investments. Other entities, including commercial banks, commercial financing companies, BDCs and insurance companies compete to make the types of investments that we plan to make in middle market loans. Certain of these competitors may be substantially larger, have considerably greater financial, technical and marketing resources than we will have and offer a wider array of financial services. For example, some competitors may have a lower cost of funds or access to funding sources that are not available to us. We may lose investment opportunities if we do not match our competitors’ pricing, terms and structure. There may be intense competition for financings or investments of the type we intend to make, and such competition may result in less favorable financing or investment terms than might otherwise exist. Furthermore, many of our competitors are not subject to the regulatory restrictions that the 1940 Act imposes on us as a BDC or the source-of-income, asset diversification and distribution requirements we must satisfy to maintain our RIC tax treatment. There can be no assurance that there will be a sufficient number of attractive potential investments available to us to achieve target returns. In addition, some of our competitors may have higher risk tolerances or different risk assessments, which could allow them to consider a wider variety of investments and establish more relationships than us. The competitive pressures we face may have a material adverse effect on our business, financial condition, results of operations and cash flows. Downgrades of the U.S. Credit Rating, Impending Automatic Spending Cuts or Government Shutdowns could Negatively Impact our Liquidity, Financial Condition and Earnings. U.S. debt ceiling and budget deficit concerns have increased the possibility of credit-rating downgrades or a recession in the United States. U.S. lawmakers have passed legislation to raise the federal debt ceiling on multiple occasions, including, most recently, in June 2023, which suspended the debt ceiling through early 2025 unless Congress takes legislative action to further extend or defer it. Despite taking action to suspend the debt ceiling, ratings agencies have threatened to lower the long-term sovereign credit rating on the United States, including Fitch downgrading the U.S. government’s long-term rating from AAA to AA+ in August 2023 and Moody’s lowering the U.S. government’s credit rating outlook from “stable” to “negative” in November 2023. The impact of the increased debt ceiling and/or downgrades to the U.S. government’s sovereign credit rating or its perceived creditworthiness could adversely affect the U.S. and global financial markets and economic conditions. Absent further
Risks Related to RICs and BDCs
General Description of Registrant [Abstract]
Risk [Text Block]	Risks Related to RICs and BDCs The Company will be Subject to U.S. Federal Income Tax at Corporate Rates if it is Unable to Qualify as a RIC. Although we have elected to be treated, and intend to qualify annually, as a RIC, no assurance can be given that we will be able to qualify for and maintain our qualification as a RIC. To obtain and maintain our qualification as a RIC, we must meet the following source-of-income, asset diversification, and distribution requirements. The source-of-income requirement will be satisfied if we obtain at least 90% of our gross income for each year from dividends, interest, foreign currency, payments with respect to loans of certain securities, gains from the sale of stock or other securities, net income from certain “qualified publicly traded partnerships,” or similar sources. The asset diversification requirement will be satisfied if (i) at least 50% of the value of our total assets are represented by cash and cash items, U.S. government securities, the securities of other RICs and “other securities,” provided that such “other securities” will not include any securities of any one issuer, if our holdings of such issuer constitute greater in value than 5% of our total assets or if we hold greater than 10% of the outstanding voting securities of such issuer, and (ii) no more than 25% of the value of our assets are invested in securities of any one issuer (other than U.S. government securities and securities of other RICs), the securities (other than securities of other RICs) of any two or more issuers that are controlled by the Company and are engaged in the same or similar or related trades or business, or the securities of one or more “qualified publicly traded partnerships.” Failure to meet those requirements may result in us having to dispose of certain investments quickly in order to prevent the loss of our qualification as a RIC. Because most of our investments will be in private companies, and therefore will be relatively illiquid, any such dispositions could be made at disadvantageous prices and could result in substantial losses. We may have difficulty satisfying the diversification requirement during our ramp-up phase until we have a portfolio of investments. The annual distribution requirement generally will be satisfied if we distribute to our shareholders on an annual basis at least 90% of our net ordinary income and realized net short-term capital gains in excess of realized net long-term capital losses, if any. Because we may use debt financing, we are subject to certain asset coverage ratio requirements under the 1940 Act and financial covenants under loan and credit agreements that could, under certain circumstances, restrict us from making distributions necessary to satisfy the distribution requirement. If we are unable to obtain cash from other sources, we could fail to qualify as a RIC. If we fail to qualify as a RIC for any reason and therefore become subject to U.S. federal income tax, the resulting taxes could substantially reduce our net assets, the amount of income available for distribution and the amount of our distributions. Limits on Capital Raising; Asset Coverage Ratio. Our business will require a substantial amount of capital. However, we may not be able to raise additional capital in the future on favorable terms or at all. We may issue debt securities, other evidences of indebtedness or preferred stock, and may borrow money from banks or other financial institutions, which are referred to collectively herein as “senior securities,” up to the maximum amount permitted by the 1940 Act. The 1940 Act permits us to issue senior securities in amounts such that our asset coverage, as defined in the 1940 Act, equals at least 200% (or 150% if certain requirements under the 1940 Act are met, which we met in connection with our Initial Closing) after each issuance of senior securities. Our ability to pay dividends or issue additional senior securities would be restricted if our asset coverage ratio were not at least 200% (or 150% if certain requirements under the 1940 Act are met, which we met in connection with our Initial Closing). If the value of our assets declines, we may be unable to satisfy this requirement. If that happens, we may be required to liquidate a portion of our investments and repay a portion of our indebtedness at a time when such sales or repayment may be disadvantageous. As a result of issuing senior securities, we also will be exposed to typical risks associated with leverage, including an increased risk of loss. If we issue preferred stock, such preferred stock will rank “senior” to our common stock in our capital structure, preferred shareholders will have separate voting rights for certain purposes and may have rights, preferences or privileges more favorable than those of our common stock and the issuance of common stock could have the effect of delaying, deferring or preventing a transaction or a change of control that might involve a premium price for our shareholders or otherwise be in the best interest of our shareholders. To the extent we are constrained in our ability to issue debt or other senior securities, we will depend on issuances of common stock to finance our operations. As a BDC, we will not generally be able to issue our common stock at a price below NAV without first obtaining required approvals of our shareholders and our Independent Directors. If we raise additional funds by issuing more of our common stock or senior securities convertible into, or exchangeable for, our common stock, the percentage ownership of our shareholders at that time would decrease and our shareholders may experience dilution. In addition to issuing securities to raise capital as described above, we could, in the future, securitize our loans to generate cash for funding new investments. An inability to successfully securitize our loan portfolio could limit our ability to grow our business, fully execute our business strategy and improve our profitability. The 1940 Act Permits us to Incur Additional Leverage with Certain Consents. The 1940 Act generally prohibits us from incurring indebtedness unless immediately after such borrowing we have an asset coverage for total borrowings of at least 200% or 150%, if certain requirements are met. Under the 1940 Act, we are allowed to increase our leverage capacity if shareholders representing at least a majority of the votes cast, when a quorum is present, approve a proposal to do so. If we receive shareholder approval, we would be allowed to increase our leverage capacity on the first day after such approval. Alternatively, the 1940 Act allows the majority of our Independent Directors to approve an increase in our leverage capacity, and such approval would become effective after one year. In addition, the 1940 Act requires non-listed BDCs, like the Company, to offer to repurchase 25% of its securities each quarter following the calendar quarter in which the BDC obtains such approval. In either case, we would be required to make certain disclosures on our website and in SEC filings regarding, among other things, the receipt of approval to increase our leverage, our leverage capacity and usage, and risks related to leverage. In connection with the Initial Closing, investors both consented to the minimum asset coverage ratio of 150% and agreed not to seek to redeem their shares of common stock in connection therewith, in each case in the subscription agreements. Leverage magnifies the potential for loss on investments in our indebtedness and on invested equity capital. As we use leverage to partially finance our investments, you will experience increased risks of investing in our securities. If the value of our assets increases, then leveraging would cause the NAV attributable to our common stock to increase more sharply than it would have had we not leveraged. Conversely, if the value of our assets decreases, leveraging would cause NAV to decline more sharply than it otherwise would have had we not leveraged our business. Similarly, any increase in our income in excess of interest payable on the borrowed funds would cause our net investment income to increase more than it would without the leverage, while any decrease in our income would cause net investment income to decline more sharply than it would have had we not borrowed. Such a decline could negatively affect our ability to pay common stock dividends, scheduled debt payments or other payments related to our securities. Leverage is generally considered a speculative investment technique. The Company May Have Difficulty Paying its Required Distributions if the Company Recognizes Income Before or Without Receiving Cash Representing Such Income. For U.S. federal income tax purposes, the Company will include in its taxable income certain amounts that the Company has not yet received in cash, such as original issue discount, which may arise if the Company receives warrants in connection with the origination of a loan or possibly in other circumstances, or contractual PIK interest, which represents contractual interest added to the loan balance and due at the end of the loan term. Such original issue discount or increases in loan balances as a result of contractual PIK arrangements will be included in the Company’s taxable income before the Company receives any corresponding cash payments. The Company also may be required to include in its taxable income certain other amounts that it will not receive in cash. Since, in certain cases, the Company may recognize taxable income before or without receiving corresponding cash payments, the Company may have difficulty meeting the annual distribution requirement necessary to maintain its qualification as a RIC. Accordingly, to satisfy its RIC distribution requirements, the Company may have to sell some of its investments at times and/or at prices that it would not consider advantageous, raise additional debt or equity capital or forgo new investment opportunities. If the Company is not able to obtain cash from other sources, it may fail to qualify as a RIC and thus become subject to U.S. federal income tax. For additional discussion regarding the tax implications of the Company’s election to be taxed as a RIC, please see “Item 1. Business — Certain U.S. Federal Income Tax Considerations.” Distribution and Asset Coverage Ratio Requirements May Impact the Company’s Ability to Grow. In order to satisfy the requirements applicable to RICs and to avoid payment of excise taxes, we intend to distribute to our shareholders substantially all of our ordinary income and capital gain net income except for certain net capital gains, which we intend to retain and to elect to treat as deemed distributions to our shareholders. As a BDC, we are generally required to meet a coverage ratio of total assets to total senior securities, which would include all of our borrowings and any preferred stock that we may issue in the future, of at least 200% (or 150% if certain requirements under the 1940 Act are met, which we met in connection with our Initial Closing). This requirement will limit the amount that we may borrow. Because we will continue to need capital to grow our loan and investment portfolio, this limitation may prevent us from incurring debt and require us to raise additional equity at a time when it may be disadvantageous to do so. While we expect to be able to borrow and to issue additional debt and equity securities, there is no assurance that debt and equity financing will be available to us on favorable terms or at all. In addition, as a BDC, we are not permitted to issue equity securities priced below NAV without shareholder and Independent Director approval. However, if we do obtain the necessary approvals to issue securities at prices below their NAVs, a shareholder’s investment in our common stock will experience dilution as a result of such issuance. If additional funds are not available to us, we could be forced to curtail or cease our lending and investment activities, and our NAV could decrease. Unrealized Depreciation on Our Loan Portfolio Indicating Future Realized Losses and Reduction in Income Available for Distribution. As a BDC, we are required to carry our investments at market value or, if no market value is ascertainable, at fair value as determined in good faith by the Board. Decreases in the market values or fair values of our investments will be recorded as unrealized depreciation. Any unrealized depreciation in our loan portfolio could be an indication of a portfolio company’s inability to meet its repayment obligations to us with respect to the loans whose market values or fair values decreased. This could result in realized losses in the future and ultimately in reductions of our income available for distribution in future periods. Qualifying Asset Requirement. As a BDC, we may not acquire any assets other than “qualifying assets” unless, at the time of such acquisition, at least 70% of our total assets are qualifying assets. Therefore, we may be precluded from investing in what we believe are attractive investments if such investments are not qualifying assets. Similarly, this requirement could prevent us from making additional investments in existing portfolio companies, which could result in the dilution of our position, or could require us to dispose of investments at an inopportune time to comply with the 1940 Act. If we were forced to sell non-qualifying investments for compliance purposes, the proceeds from such sale could be significantly less than the current value of such investments. Conversely, if we failed to invest a sufficient portion of our assets in qualifying assets, we could lose our status as a BDC, which would subject us to substantially more regulatory restrictions and significantly decrease our operating flexibility. Our ability to enter into transactions involving derivatives and unfunded commitment transactions may be limited. In 2020, the SEC adopted Rule 18f-4 under the 1940 Act, which relates to the use of derivatives and other transactions that create future payment or delivery obligations by BDCs (and other funds that are registered investment companies). Under Rule 18f-4, for which compliance was required beginning in August 2022, BDCs that use derivatives are subject to a value-at-risk (“VaR”) leverage limit, certain derivatives risk management program and testing requirements, and requirements related to board reporting. These requirements apply unless the BDC qualifies as a “limited derivatives user,” as defined in Rule 18f-4. A BDC that enters into reverse repurchase agreements or similar financing transactions could either (i) comply with the asset coverage requirements of Section 18, as modified by Section 61 of the 1940 Act, when engaging in reverse repurchase agreements or (ii) choose to treat such agreements as derivatives transactions under Rule 18f-4. In addition, under Rule 18f-4, a BDC may enter into an unfunded commitment agreement that is not a derivatives transaction, such as an agreement to provide financing to a portfolio company, if the BDC has a reasonable belief, at the time it enters into such an agreement, that it will have sufficient cash and cash equivalents to meet its obligations with respect to all of its unfunded commitment agreements, in each case as it becomes due. If the BDC cannot meet this requirement, it is required to treat the unfunded commitment as a derivatives transaction subject to the aforementioned requirements of Rule 18f-4. Collectively, these requirements may limit our ability to use derivatives and/or enter into certain other financial contracts. We qualify as a “limited derivatives user,” and as a result the requirements applicable to us under Rule 18f-4 may limit our ability to use derivatives and enter into certain other financial contracts. However, if we fail to qualify as a limited derivatives user and become subject to the additional requirements under Rule 18f-4, compliance with such requirements may increase cost of doing business, which could have a material adverse effect on our business, financial condition, results of operations, and cash flows. Limits on Transactions with Affiliates. We are prohibited under the 1940 Act from participating in certain transactions with certain of our affiliates without the prior approval of a majority of the Independent Directors of the Board and, in some cases, the SEC. Any person that owns, directly or indirectly, 5% or more of our outstanding voting securities will be our affiliate for purposes of the 1940 Act, and we generally will be prohibited from buying or selling any securities from or to such affiliate, absent the prior approval of the Board. The 1940 Act also prohibits certain “joint transactions” with certain of our affiliates, which could include investments in the same portfolio company (whether at the same or different times), without prior approval of the Board and, in some cases, the SEC. If a person acquires more than 25% of our voting securities, we will be prohibited from buying or selling any security from or to such person or certain of that person’s affiliates or entering into prohibited joint transactions with such persons absent the prior approval of the SEC. Similar restrictions limit our ability to transact business with our officers or directors or their affiliates. We have received an exemptive order from the SEC that allows us, subject to the satisfaction of certain conditions, to enter into transactions with certain of our affiliates. These restrictions may limit the scope of investment opportunities that would otherwise be available to us and there can be no assurance that we will be able to participate in all investment opportunities that are suitable to us. Our Status as an “Emerging Growth Company” under the JOBS Act May Make it More Difficult to Raise Capital as and When We Need it. Because of the exemptions from various reporting requirements provided to us as an “emerging growth company” and because we will have an extended transition period for complying with new or revised financial accounting standards, we may be less attractive to investors and it may be difficult for us to raise additional capital as and when we need it. Investors may be unable to compare our business with other companies in our industry if they believe that our financial accounting is not as transparent as other companies in our industry. If we are unable to raise additional capital as and when we need it, our financial condition and results of operations may be materially and adversely affected.
Risks Related to the Private Placement of Common Stock
General Description of Registrant [Abstract]
Risk [Text Block]	Risks Related to the Private Placement of Common Stock Capital Commitments and Drawdowns. Until the earlier of a Liquidity Event and a repurchase of all common stock of a shareholder or such later time as set forth under “Item 1. Business — The Private Offering , ” each such shareholder will be obligated to fund Drawdowns to purchase additional common stock based on its Capital Commitment at the time the Company makes such financing or investment. To satisfy such obligations, shareholders may need to maintain a substantial portion of their Capital Commitments in assets that can be readily converted to cash. Failure by a shareholder to timely fund its Capital Commitment may result in some of its common stock being forfeited or subject the shareholder to other remedies available to the Company. Failure of shareholders to contribute their Capital Commitments also could cause the Company to be unable to realize its investment objectives. A default by a substantial number of shareholders or by one or more shareholders who have made substantial Capital Commitments would limit the Company’s opportunities for investment or diversification and would likely reduce returns to the Company. In addition, the Adviser will have broad discretion in determining the specific uses of Drawdown Amounts. See “Non-Specified Investments and Discretion in Determining Use of Drawdown Amounts” for more information. Exchange Act Filing Requirements. Because the common stock is registered under the Exchange Act, ownership information for any person who beneficially owns 5% or more of the common stock will have to be disclosed in a Schedule 13G or other filings with the SEC. Beneficial ownership for these purposes is determined in accordance with the rules of the SEC, and includes having voting or investment power over the securities. Our shareholders who subscribe for over 5% of our common stock or, in some circumstances, our shareholders who choose to reinvest their dividends and who therefore see their percentage stake in the Company increased to more than 5% of our common stock, will trigger this filing requirement. Each shareholder is responsible for determining their filing obligations and preparing the filings. In addition, our shareholders who hold more than 10% of a class of our common stock may be subject to Section 16(b) of the Exchange Act, which recaptures for the benefit of the Company profits from the purchase and sale of registered stock within a six-month period. Common Counsel; Interest of Counsel. Eversheds Sutherland (US) LLP, counsel for the Company in connection with the offering of our common stock, advises the Adviser and its affiliates on various matters. Prospective investors should be aware that, to the extent the Company and the Offering would benefit from a review by independent counsel, such benefit has not been provided by the Company. Investment by ERISA Plans. We intend to conduct our operations so that they will not trigger “prohibited transactions” for benefit plan investors. We will use reasonable efforts to conduct our affairs so that our assets will not be deemed to be “plan assets” under the plan asset regulations promulgated by the Department of Labor. The fiduciary of each prospective benefit plan investor must independently determine that our common stock is an appropriate investment for such plan, taking into account the fiduciary’s obligations under the Employee Retirement Income Security Act of 1974 and the facts and circumstances of each investing benefit plan. Limited Liquidity. There is currently no public market for our common stock, and a market for the common stock may never develop. The common stock is not registered under the 1933 Act, or any state securities law and is restricted as to transfer by law and the terms of the Subscription Agreement. Shareholders generally may not Transfer common stock unless (i) the Adviser provides prior written consent, which the Adviser may grant or withhold in its sole discretion, (ii) the Transfer is in compliance with the restrictions set forth in the Subscription Agreement, and (iii) the Transfer is made in accordance with applicable laws. Except in limited circumstances for legal or regulatory purposes or in connection with repurchase offers, as described below, shareholders are not entitled to redeem their common stock. While we may undertake a Liquidity Event, there can be no assurance that any potential liquidity event can be achieved. Furthermore, a Public Listing does not ensure that an actual market will develop for a listed security. In addition, following a Public Listing, shareholders may be restricted from selling or disposing of their shares of common stock by applicable securities laws or contractually by a lock-up agreement with the underwriters of any public offering of the common stock conducted in connection with a Public Listing or otherwise. Accordingly, the shareholders must be prepared to bear the economic risk of an investment in the common stock for an indefinite period of time, as there is no guarantee that any liquidity event other than the ultimate dissolution of the Company will occur, and it cannot be determined when such dissolution can be achieved. Absence of SEC and Applicable State Securities Commission Reviews. Because we are conducting a private offering that will not be registered under the 1933 Act or under applicable state securities or “blue sky” laws, any offering material will not be reviewed by the SEC or by the equivalent agency of any state or governmental entity. Review by any such agency might result in additional disclosures or substantially different disclosures from those actually included in any offering material. Certain Regulatory Considerations, Securities Act of 1933. Pursuant to Rule 506 of Regulation D promulgated under the 1933 Act, the Company’s reliance on the “private placement” exemption from registration provided under Regulation D may become unavailable if “covered persons” become subject to a “disqualifying event.” “Covered persons” include beneficial owners of 20% or more of the Company’s outstanding equity securities, calculated on the basis of total voting power rather than on the basis of ownership of any single class of securities (a “20% Beneficial Owner”). In the event that a shareholder that is a 20% Beneficial Owner becomes subject to a disqualifying event, the Company may treat such shareholder as a Defaulting shareholder or take such other equitable measures as it may determine. Shareholders May Experience Dilution. Shareholders will not have preemptive rights to subscribe to or purchase any common stock issued in the future. To the extent we issue additional equity interests, including in a public offering or at subsequent closings during the Fundraising Period, a shareholder’s percentage ownership interest in the Company will be diluted. In addition, depending upon the terms and pricing of any additional offerings and the value of our investments, a shareholder also may experience dilution in the NAV and fair value of our common stock. P re ferred Stock Could be Issued. Although we have no current intention to do so, under the terms of the Charter, the Board is authorized, to the fullest extent permitted by the 1940 Act, to authorize us to issue preferred stock in one or more classes or series without shareholder approval. The Board, subject to the terms of any class or series of stock outstanding at the time, is required to set the preferences, conversion, and other rights, voting powers, restrictions, limitations as to dividends and other distributions, qualifications and terms and conditions of redemption of each class or series, including preferred stock with terms that might adversely affect the interest of our existing shareholders. If we issue preferred stock, there can be no assurance that such issuance would result in a higher yield or return to the shareholders. The issuance of preferred stock would likely cause the NAV of the common stock to become more volatile. Significant Financial and Other Resources to Comply with the Requirements of Being a Public Reporting Entity. We will be subject to the reporting requirements of the Exchange Act and requirements of the Sarbanes-Oxley Act. These requirements may place a strain on our systems and resources. The Exchange Act requires the Company to file annual, quarterly and current reports with respect to its business and financial condition. The Sarbanes-Oxley Act requires that the Company maintain effective disclosure controls and procedures and internal controls over financial reporting, which are discussed below. In order to maintain and improve the effectiveness of disclosure controls and procedures and internal controls, significant resources and management oversight will be required. The Company has implemented disclosure controls and procedures, processes, policies and practices for the purpose of addressing the standards and requirements applicable to public companies. These activities may divert management’s attention from other business concerns, which could have a material adverse effect on business, financial condition, results of operations and cash flows. The Company expects to incur significant additional annual expenses related to these steps and, among other things, directors’ and officers’ liability insurance, director fees, reporting requirements of the SEC, transfer agent fees, additional administrative expenses payable to the Administrator to compensate them for hiring additional accounting, legal and administrative personnel, increased auditing and legal fees and similar expenses. The systems and resources necessary to comply with public company reporting requirements will increase further once the Company ceases to be an “emerging growth company” under the JOBS Act. As long as the Company remains an emerging growth company, it intends to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies, including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act. This may increase the risk that material weaknesses or other deficiencies in the Company’s internal control over financial reporting go undetected. The Company will remain an emerging growth company for up to five years following an IPO, although if the market value of its common stock that is held by non-affiliates exceeds $700 million as of any June 30 before that time, it would cease to be an emerging growth company as of the following December 31.
Risks and Conflicts Related to the Adviser
General Description of Registrant [Abstract]
Risk [Text Block]	Risks and Conflicts Related to the Adviser Limited Experience Managing a BDC. The personnel of Varagon and the Adviser have limited prior experience managing a BDC. The 1940 Act and the Code impose numerous constraints on the operations of BDCs that do not apply to the other types of investment vehicles. For example, under the 1940 Act, BDCs are generally required to invest at least 70% of their total assets primarily in securities of U.S. private or thinly traded companies that satisfy certain provisions of the 1940 Act. The failure to comply with these provisions in a timely manner could prevent us from qualifying as a BDC, which could be material. The Adviser’s limited experience in managing a portfolio of assets under such constraints may hinder the Company’s ability to take advantage of attractive investment opportunities and, accordingly, the Company’s investment returns could be substantially lower than the returns achieved by other vehicles managed by Varagon. Conflicts Related to Obligations the Adviser Has to Other Clients. Certain Adviser personnel serve, or may serve, as officers, directors, members, or principals of entities that operate in the same or a related line of business as we do, or of investment funds, accounts, or investment vehicles managed by the Adviser or affiliates of the Adviser. Similarly, the Adviser may have other clients with similar, different or competing investment objectives. In serving in these multiple capacities, the Adviser and certain personnel may have obligations to other clients or investors in those entities, the fulfillment of which may not be in the best interests of the Company or our shareholders. The Adviser intends to allocate any investment opportunities in a fair and equitable manner over time; however, there is no assurance that we will be able to participate in all investment opportunities or that investment opportunities will be allocated in a fair and equitable manner over time. Our investment strategy primarily includes investments in senior secured loans, but we may selectively make investments in second lien and subordinated or mezzanine loans, and equity and equity-related securities. As a result, members of the Adviser’s senior investment team and the IC, in their roles at the Adviser, may face conflicts in the allocation of investment opportunities among us and other entities sponsored or managed by the Adviser, Varagon and its affiliates with similar or overlapping investment objectives in a manner that is fair and equitable over time and consistent with the Adviser’s allocation policy. Generally, when a particular investment would be appropriate for us as well as other entities sponsored or managed by the Adviser, Varagon and its affiliates, such investment will be apportioned by the Adviser’s senior investment team in accordance with (1) the Adviser’s internal conflict of interest and allocation policies, (2) the requirements of the Advisers Act and (3) certain restrictions under the 1940 Act regarding co-investments with affiliates. Such apportionment may not be strictly pro rata, depending on the good faith determination of all relevant factors, including without limitation differing investment objectives, diversification considerations and the terms of our or the respective governing documents of such investment funds, accounts or investment vehicles. These procedures could, in certain circumstances, limit whether a co-investment opportunity is available to us, the timing of acquisitions and dispositions of investments, the price paid or received by us for investments or the size of the investment purchased or sold by us. The Adviser believes this allocation system is fair and equitable, and consistent with its fiduciary duty to us. In particular, we have disclosed to investors how allocation determinations are made among any investment vehicles sponsored or managed by the Adviser or its affiliates. As a BDC, the Company may be prohibited under the 1940 Act from conducting certain transactions with its affiliates without the prior approval of the Independent Directors and, in some cases, the prior approval of the SEC. We generally will only be permitted to co-invest with such investment funds, accounts and vehicles where the only term that is negotiated is price. The Company has received an exemptive order from the SEC that permits it, among other things, to co-invest with certain other persons and certain funds managed and controlled by Varagon or an affiliate, subject to the satisfaction of certain conditions. However, there can be no assurance that we will be able to participate in all investment opportunities that are suitable to us. Fee-Related and Other Economic Potential Conflicts. As a BDC, we are generally limited in our ability to invest in any portfolio company in which the Adviser or any of its affiliates currently has an investment or to make any co-investments with other funds managed by our investment adviser or other affiliates without an exemptive order from the SEC, subject to certain exceptions. Nonetheless, potential conflicts may arise when the Adviser or its affiliates manage accounts that make performance payments or base management fees to the Adviser or its affiliates at different net rates or subject to different types of calculation methodologies from arrangements with the Company. The Adviser and its affiliates may have an economic incentive to allocate more favorable investment opportunities to, or otherwise for, an account from which the Adviser or an affiliate receives a higher performance payment or in which the Adviser or an affiliate has an ownership or other economic interests. In connection with certain investments made by the Company and investments made by certain clients, the Adviser or its affiliates may receive transaction fees and/or other consideration from portfolio investments in which one or more clients may invest or propose to invest, including portions of investments held by the Company or its subsidiaries, which may create additional conflicts of interest in connection with the structuring and allocation of investments. Potential Conflicts Arising from the Ability of Varagon to Appoint Members of the IC. Varagon is responsible for appointing the members of the IC, which may include Varagon employees and independent members, and Varagon may replace members of the IC in its sole discretion. Therefore, a conflict may arise in the future to the extent that Varagon appoints an individual to the IC who has conflicts with the Company. Potential Conflicts Arising from the Placement Agent. Man Group is the ultimate parent company of Man Investments, which is also the ultimate parent of the Adviser. Man Investments is acting as the placement agent in connection with the Offering and will receive compensation relating to such services from Varagon or its affiliates. Potential conflicts may arise in connection with the foregoing. Possession of Material Non-Public Information, Limiting the Adviser’s Investment Discretion. Adviser personnel, including members of the IC, may serve as directors of, or in a similar capacity with, portfolio companies in which we invest, the securities of which are purchased or sold on our behalf. In the event that material non-public information is obtained with respect to such companies, or we become subject to trading restrictions under the internal trading policies of those companies or as a result of applicable law or regulations, we could be prohibited for a period of time from purchasing or selling the securities of such companies, and this prohibition may have an adverse effect on us. Management Fees and Incentive Fees. Even if the value of a shareholder’s investment declines, the management fee and, in certain cases, the incentive fee payable by us to the Adviser still will be payable to the Adviser. The management fee payable to the Adviser is calculated as a percentage of the Company’s adjusted gross assets, excluding cash and cash equivalents but including assets purchased with borrowed amounts. This management fee calculation may create an incentive for the Adviser to purchase assets with borrowed funds when it is unwise to do so or to pursue investments on our behalf that are riskier or more speculative than would be the case in the absence of such compensation arrangement. The incentive fee payable to the Adviser is calculated based on a percentage of our return on invested capital. The incentive fee arrangement may encourage the Adviser to use leverage to increase the return on our investments. Under certain circumstances, the use of leverage may increase the likelihood of default, which would impair the value of our common stock. In addition, in the event of a Public Listing, the Management Fee will increase from 0.75% to 1.00% of the average of the Company’s adjusted gross assets (for these purposes, “adjusted gross assets” exclude undrawn capital commitments and cash and cash equivalents but include assets purchased with borrowed amounts). Further, in the event of a Public Listing, the Income Incentive Fee and the Capital Gains Incentive Fees will increase from 12.5% to 20%, but otherwise will be calculated as set forth herein. Limitation on Liability of the Adviser. The Adviser does not assume any responsibility to us other than to render the services described in, and on the terms of, the Investment Advisory Agreement, and will not be responsible for any action of our Board in declining to follow the advice or recommendations of the Adviser. The Investment Advisory Agreement provides that the Adviser, its officers, members and personnel, and any person controlling or controlled by the Adviser will not be liable to us or our shareholders for acts or omissions performed in accordance with and pursuant to the Investment Advisory Agreement, except those resulting from acts constituting willful misfeasance, bad faith or gross negligence, in the performance of his or her duties, or by reason of his or her reckless disregard of his or her obligations and duties under the Investment Advisory Agreement. In addition, as part of the Investment Advisory Agreement, we have agreed to indemnify the Adviser and each of its officers, directors, members, managers and employees from and against any claims or liabilities, including reasonable legal fees and other expenses reasonably incurred, arising out of or in connection with our business and operations or any action taken or omitted on our behalf pursuant to authority granted by the Investment Advisory Agreement, except where attributable to willful misfeasance, bad faith or gross negligence, in the performance of his or her duties, or by reason of his or her reckless disregard of his or her obligations and duties under the Investment Advisory Agreement. These protections may lead the Adviser to act in a riskier manner when acting on our behalf than it would when acting for its own account.
Risks Associated with the Companys Investments
General Description of Registrant [Abstract]
Risk [Text Block]	Risks Associated with the Company’s Investments Nature of Investments. We primarily invest in senior secured loans, but also may selectively invest in second lien and subordinated or mezzanine loans, and equity and equity-related securities. Senior Secured Loans. There is a risk that the collateral securing our senior secured loans may decrease in value over time, may be difficult to sell in a timely manner, may be difficult to appraise and may fluctuate in value based upon the success of the business and market conditions, including as a result of the inability of the portfolio company to raise additional capital. In some circumstances, our liens on the collateral securing our loans could be subordinated to claims of other creditors. In addition, deterioration in a portfolio company’s financial condition and prospects, including its inability to raise additional capital, may be accompanied by deterioration in the value of the collateral for the loan. Consequently, the fact that a loan is secured does not guarantee that we will receive principal and interest payments according to the loan’s terms, or at all, or that we will be able to collect on the loan should we be compelled to enforce our remedies. Second Lien and Subordinated Loans. We may invest in secured subordinated loans, including second and lower lien loans. Second lien loans are generally second in line in terms of repayment priority. A second lien loan may have a claim on the same collateral pool as the first lien or it may be secured by a separate set of assets. Second lien loans generally give investors priority over general unsecured creditors in the event of an asset sale. The priority of the collateral claims of third or lower lien loans ranks below holders of second lien loans and so on. Such junior loans are subject to the same general risks inherent to any loan investment, including credit risk, market and liquidity risk, and interest rate risk. Due to their lower place in the borrower’s capital structure and possible unsecured or partially secured status, such loans involve a higher degree of overall risk than senior secured loans of the same borrower. Mezzanine Loans. Our mezzanine loans generally will be subordinated to senior secured loans on a payment basis, are typically unsecured and rank pari passu with other unsecured creditors. As such, other creditors may rank senior to us in the event of insolvency. This may result in an above average amount of risk and loss of principal. Lower Grade Obligations . In addition, our investments will be in lower grade obligations. The lower grade investments in which we invest may be rated below investment grade (often referred to as “junk”) by one or more nationally recognized statistical rating agencies at the time of investment or may be unrated but determined by the Adviser to be of comparable quality. Loans or debt securities rated below investment grade are considered speculative with respect to the issuer’s capacity to pay interest and repay principal. The major risks of non-investment grade investments include: • Non-investment grade securities may be issued by less creditworthy issuers. Issuers of non-investment grade securities may have a larger amount of outstanding debt relative to their assets than issuers of investment grade securities. In the event of an issuer’s bankruptcy, claims of other creditors may have priority over the claims of holders of non-investment grade securities, leaving few or no assets available to repay holders of non-investment grade securities. • Prices of non-investment grade securities are subject to extreme price fluctuations. Adverse changes in an issuer’s industry and general economic conditions may have a greater impact on the prices of non-investment grade securities than on other higher rated fixed-income securities. • Issuers of non-investment grade securities may be unable to meet their interest or principal payment obligations because of an economic downturn, specific issuer developments, or the unavailability of additional financing. • Non-investment grade securities frequently have redemption features that permit an issuer to repurchase the security from us before it matures. If the issuer redeems non-investment grade securities, we may have to invest the proceeds in securities with lower yields and may reduce income. • Non-investment grade securities may be less liquid than higher rated fixed-income securities, even under normal economic conditions. There are fewer dealers in the non-investment grade securities market, and there may be significant differences in the prices quoted by the dealers. Judgment may play a greater role in valuing these securities and we may be unable to sell these securities at an advantageous time or price. • We may incur expenses to the extent necessary to seek recovery upon default or to negotiate new terms with a defaulting issuer. The credit rating of a high yield security does not necessarily address its market value risk. Ratings and market value may change from time to time, positively or negatively, to reflect new developments regarding the issuer. Equity and Equity-related Investments . When we invest in senior secured loans, second lien and subordinated or mezzanine loans, we may acquire equity and equity-related securities in a portfolio company, such as rights and warrants that may be converted into or exchanged for the issuer’s common stock or the cash value of the issuer’s common stock. In addition, we may invest directly in the equity securities of portfolio companies. Our goal is ultimately to dispose of such equity interests and realize gains upon our disposition of such interests. However, the equity interests we receive may not appreciate in value and, in fact, may decline in value. Accordingly, we may not be able to realize gains from our equity interests, and any gains that we do realize on the disposition of any equity interests may not be sufficient to offset any other losses we experience. We will generally have little, if any, control over the timing of any gains we may realize from our equity investments. We also may be unable to realize any value if a portfolio company does not have a liquidity event, such as a sale of the business, recapitalization or public offering, which would allow us to sell the underlying equity interests. We may be unable to exercise any put rights we acquire, which would grant us the right to sell our equity securities back to the portfolio company, for the consideration provided in its investment documents if the issuer is in financial distress. Investments in the Subordinated Certificates and Subordinated Interests of Structured Vehicles. The Company invests in the Subordinated Certificates, and in the future may invest in similar first loss or subordinated interests of other structured investment vehicles, including without limitation CLOs (together with other structured investment vehicles, “Structured Vehicles”). Structured Vehicles have leverage embedded in their structures, which can affect the risk and return profile of various tranches of such structures. The Company expects to invest, directly or indirectly, in the unrated or most subordinated tranches of Structured Vehicles that own middle market or other loans and that may be advised by affiliates of the Adviser. The Company’s rights with respect to first loss or subordinated interest investments in Structured Vehicles, such as the SDLP and CLO equity investments, differ from other types of investments. For example, the Company will not have recourse against the issuers or obligors of the underlying asset pools. If proceeds from the underlying asset pools are not sufficient to provide payments on, or reduce the residual value of, the tranches that the Company, directly or indirectly, holds, the Company will lose money. In addition, the amount of distributions on the Subordinated Certificates will be affected by, among other things, the timing of purchases of underlying loans, the rates of repayment of or distributions on the underlying loans, the rates of delinquencies and defaults on and liquidations of the underlying loans and any unexpected significant expenses incurred by the Structured Vehicle. Moreover, upon the Structured Vehicle’s failure to satisfy its financial covenants or other covenants or upon the occurrence of any other event of default, proceeds otherwise available for distribution to the subordinated tranches of Structured Vehicle (such as the Subordinated Certificates) may be required instead to redeem senior tranches or held to satisfy applicable covenants. Interests of the holders of the senior tranches of a Structured Vehicle, in the event of a default or otherwise, may diverge from the interest of the holders of the subordinated tranches, including the Company. In an event of default, payment to the Company may be deferred or significantly reduced and the Company may be unable to exercise additional remedies under the governing documents. Certificates, including the Subordinated Certificates, issued in connection with Structured Vehicles may not be registered under the 1933 Act, and may have a limited market or no market, and the Company may not be able to sell such certificates at favorable prices, if at all. Generally, certificates in which the Company invests would be unrated (as is the case with the Subordinated Certificates); however, a downgrade in more senior tranches could still negatively impact the value of the unrated tranches. In addition, certain downgrades in the ratings of the rated tranches, or a withdrawal of the ratings of a tranche, may result in an event of default under the Structured Vehicle’s governing documents. Moreover, there is no assurance that any holder of any of the issued securities of a Structured Vehicle will fund its respective capital contributions when required. A failure by any such holder to fund any commitment when required, including in the case of the SDLP, may impair the ability of the Structured Vehicle to fund amounts required, resulting in an impairment in the value of the Structured Vehicle, and therefore the Company’s investment in its certificates. In the case of the SDLP, the Company, as a minority indirect holder of the Subordinated Certificates, in numerous instances will not control the timing of a redemption or refinancing of, or purchase of certain assets from, the SDLP following certain trigger events, as these rights are reserved to the majority Certificate holder. In the event that the majority Certificate holder elects to direct a redemption or refinancing or exercises its right to purchase those assets from SDLP, the Company will have the right to participate ratably in the proceeds allocated to the Subordinated Certificates and the right to purchase its pro rata portion of any assets sold to the majority Certificate holder on the same terms. Nonetheless, investment and other material decisions of the SDLP require the approval of the SDLP’s investment committee, on which investment committee each of the Company and ARCC exercises two votes. As a result, the Company does not have sole discretionary authority in respect of actions of the SDLP. The Company has no current plan or intent to sell the Subordinated Certificates within the five-year period beginning on the date of the Initial Closing, although the Company, in its sole discretion acting in the best interest of the Company, may determine to so sell the Subordinated Certificates at any time in the future. In October 2014, six federal agencies adopted joint final rules implementing the credit risk retention requirements of Section 941 of the Dodd-Frank Act (the “Final U.S. Risk Retention Rules”) in respect of a variety of financing securitization structures. There is uncertainty as to whether or not the Final U.S. Risk Retention Rules would apply to the SDLP and similar CLOs. While we believe that the SDLP has been structured to comply with the Final U.S. Risk Retention Rules (the “RR Structure”) were they to apply, there can be no assurance that the applicable governmental authorities will agree that the RR Structure, will satisfy any such requirements of the Final U.S. Risk Retention Rules. To the extent the Final U.S. Risk Retention Rules were determined to apply to the SDLP and the RR Structure was determined to not be compliant with the Final U.S. Risk Retention Rules, the Company, through its indirect interest in the Subordinated Certificates, could be required to pay damages, transfer interests, be subject to cease and desist orders or other regulatory action, which could materially adversely affect the value of the Subordinated Certificates. Risks Associated with Investments in Middle Market Companies. Investment in private and middle market companies involves a number of significant risks including: • such companies may have limited financial resources and may be unable to meet their obligations under their debt securities that we hold, which may be accompanied by a deterioration in the value of any collateral and a reduction in the likelihood of us realizing any guarantees we may have obtained in connection with its investment; • such companies typically have shorter operating histories, narrower product lines and smaller market shares than larger businesses, which tend to render them more vulnerable to competitors’ actions and market conditions, as well as to general economic downturns; • such companies are more likely to depend on the management talents and efforts of a small group of persons; therefore, the death, disability, resignation or termination of one or more of these persons could have a material adverse impact on the portfolio company and, in turn, on us; • such companies generally have less predictable operating results, may be engaged in rapidly changing businesses with products subject to a substantial risk of obsolescence, and may require substantial additional capital to support their operations, finance expansion or maintain their competitive position; • debt investments in such companies generally may have a significant portion of principal due at the maturity of the investment, which would result in a substantial loss to us if such borrowers are unable to refinance or repay their debt at maturity; • our executive officers, directors and the Adviser may, in the ordinary course of business, be named as defendants in litigation arising from our investments in such companies; • such companies generally have less publicly available information about their businesses, operations and financial condition and, if we are unable to uncover all material information about these companies, we may not make a fully informed investment decision; and • such companies may have difficulty accessing the capital markets to meet future capital needs, which may limit their ability to grow or to repay their outstanding indebtedness upon maturity. Portfolio Company Debt and Equity. Our portfolio companies may have, or may be permitted to incur, other debt or issue equity securities that rank equally with, or senior to, the debt in which we invest. By their terms, such debt instruments or equity securities may entitle the holders to receive payment of dividends, interest or principal on or before the dates on which we are entitled to receive payments with respect to our investments. These debt instruments or equity securities would usually prohibit the portfolio companies from paying interest on or repaying our investments in the event and during the continuance of a default under such debt or equity securities. Also, in the event of insolvency, liquidation, dissolution, reorganization or bankruptcy of a portfolio company, holders of debt instruments or equity securities ranking senior to our investment in that portfolio company would typically be entitled to receive payment in full before we receive any distribution in respect of our investment. After repaying such senior creditors, such portfolio company may not have any remaining assets to use for repaying its obligation to us. In the case of debt or equity securities ranking equally with debt instruments in which we invest, we would have to share on an equal basis any distributions with other creditors holding such debt or equity in the event of an insolvency, liquidation, dissolution, reorganization or bankruptcy of the relevant portfolio company.
Risks Relating to our Investment in SDLP
General Description of Registrant [Abstract]
Risk [Text Block]	Risks Relating to our Investment in SDLP. We may make indirect investments in portfolio companies through joint ventures, including SDLP. In general, the risks associated with indirect investments in portfolio companies through a joint venture are similar to those associated with a direct investment in a portfolio company. While we intend to analyze the credit and business of a potential portfolio company in determining whether to make an investment in SDLP, we will nonetheless be exposed to the creditworthiness of SDLP. In the event of a bankruptcy proceeding against the portfolio company, the assets of the portfolio company may be used to satisfy its obligations prior to the satisfaction of our investment in the SDLP (i.e., our investment in SDLP could be structurally subordinated to the other obligations of the portfolio company). In addition, we may be required to rely on ARCC, our joint venture partner in SDLP, when making decisions regarding SDLP’s investments, accordingly, the value of the investment could be adversely affected if our interests diverge from those of ARCC in SDLP. See “Risks Associated with the Company’s Investments – Investments in the Subordinated Certificates and Subordinated Interests of Structured Vehicles” for more information relating to risks associated with the Subordinated Certificates. Subordinated Liens on Collateral. Certain debt investments that we may make in portfolio companies will be secured on a subordinated priority basis by the same collateral securing more senior secured debt of such companies. A significant portion of our first lien and unitranche loans may be subordinated to “first-out” revolving loans following certain events with respect to such loans. While such first lien and unitranche loans are expected to have many attributes of senior secured loans, these investments may involve additional risks that could adversely affect such investments. In addition, certain loans that we may make in portfolio companies will be secured on a second priority basis by the same collateral securing senior secured debt of such companies. The first priority liens on the collateral will secure the portfolio company’s obligations under any outstanding senior debt and may secure certain other future debt that may be permitted to be incurred by the company under the agreements governing the debt. The holders of obligations secured by the first priority liens on the collateral will generally control the liquidation of and be entitled to receive proceeds from any realization of the collateral to repay their obligations in full before we are so entitled. In addition, the value of the collateral in the event of liquidation will depend on market and economic conditions, the availability of buyers and other factors. There can be no assurance that the proceeds, if any, from the sale or sales of all of the collateral would be sufficient to satisfy the debt obligations secured by the second priority liens after payment in full of all obligations secured by the first priority liens on the collateral. If such proceeds are not sufficient to repay amounts outstanding under the debt obligations secured by the second priority liens, then, to the extent not repaid from the proceeds of the sale of the collateral, we will only have an unsecured claim against the company’s remaining assets, if any. We also may make unsecured debt investments in portfolio companies, meaning that such investments may not benefit from any interest in collateral of such companies. Liens on such portfolio companies’ collateral, if any, will secure the portfolio company’s obligations under its outstanding secured debt and may secure certain future debt that is permitted to be incurred by the portfolio company under its secured debt agreements. The holders of obligations secured by such liens will generally control the liquidation of, and be entitled to receive proceeds from, any realization of such collateral to repay their obligations in full before we are so entitled. In addition, the value of such collateral in the event of liquidation will depend on market and economic conditions, the availability of buyers and other factors. There can be no assurance that the proceeds, if any, from sales of such collateral would be sufficient to satisfy its unsecured debt obligations after payment in full of all secured debt obligations. If such proceeds were not sufficient to repay the outstanding secured debt obligations, then its unsecured claims would rank equally with the unpaid portion of such secured creditors’ claims against the portfolio company’s remaining assets, if any. The rights we may have with respect to the collateral securing the debt investments we make in portfolio companies with senior debt outstanding also may be limited pursuant to the terms of one or more inter-creditor agreements that we enter into with the holders of senior debt. Under such an inter-creditor agreement, at any time that obligations that have the benefit of the first priority liens are outstanding, any of the following actions that may be taken in respect of the collateral will be at the direction of the holders of the obligations secured by the first priority liens: the ability to cause the commencement of enforcement proceedings against the collateral; the ability to control the conduct of such proceedings; the approval of amendments to collateral documents; releases of liens on the collateral; and waivers of past defaults under collateral documents. We may not have the ability to control or direct such actions, even if our rights are adversely affected. The Company’s Investments Will Be Illiquid and Long Term. We generally will make loans to private companies that are illiquid and may be difficult for us to sell if the need arises. Although portfolio financings and investments by us may generate current income, the return of capital and the realization of gains, if any, from a financing or investment generally will occur only upon the partial or complete satisfaction of the financing conditions or disposition of such investment, which may not occur for a number of years after the investment is made. If we are required to liquidate all or a portion of our portfolio quickly, we may realize significantly less than the value at which we had previously recorded such investments. In addition, we will not be able to sell securities we purchase publicly, if we hold any, unless the sale of such securities is registered under applicable securities laws, or unless an exemption from such registration requirements is available. In addition, in some cases, we may be prohibited by contract from selling certain securities we invest in for a period of time or we may face other restrictions on our ability to liquidate an investment in a portfolio company to the extent that we hold a significant portion of a company’s equity or if we have material non-public information regarding that company. Furthermore, under the 1940 Act, if there is no readily available market for these investments, we are required to carry these investments at fair value as determined by the Board. As a result, if we are required to liquidate all or a portion of our portfolio quickly, we may realize significantly less than the value at which we had previously recorded these investments. Risks Relating to Covenant-Lite Loans. On occasion, the Company and/or SDLP may invest in covenant-lite loans if the investment’s credit merits are particularly strong (e.g., high recurring revenue, strong retention rates, market leader, compelling value proposition, highly diversified customer base, etc.), the sponsors are highly reputable and relationship-oriented, and the economic profile is highly favorable (e.g., large established company with greater than $50 million of EBITDA and strong EBITDA margins). We use the term “covenant-lite” loans to refer generally to loans that do not have a complete set of financial maintenance covenants. Generally, “covenant-lite” loans provide borrower companies more freedom to negatively impact lenders because their covenants are incurrence-based, which means they are only tested and can only be breached following an affirmative action of the borrower, rather than by a deterioration in the borrower’s financial condition. Accordingly, to the extent the Company and/or SDLP invests in “covenant-lite” loans, the Company and/or SDLP may have fewer rights against a borrower and may have a greater risk of loss on such investments as compared to investments in or exposure to loans with financial maintenance covenants. Limited Number of Portfolio Companies. To the extent we assume large positions in the securities of a small number of issuers or industries, our NAV may fluctuate to a greater extent than that of a more diversified investment company as a result of changes in the financial condition or the market’s assessment of the issuer. In addition, the aggregate returns we realize may be significantly adversely affected if a small number of investments perform poorly or if we need to write down the value of any one investment. Additionally, a downturn in any particular industry in which we are invested could significantly affect our aggregate returns. Follow-on Investments in Portfolio Companies. Following an initial investment in a portfolio company, we may make additional investments in that portfolio company as “follow-on” investments, in seeking to: • increase or maintain in whole or in part our position as a creditor or equity ownership percentage in a portfolio company; • exercise warrants, options or convertible securities that were acquired in the original or subsequent financing; or • preserve or enhance the value of our investment. We have discretion to make follow-on investments, subject to the availability of capital resources. Failure on our part to make follow-on investments may, in some circumstances, jeopardize the continued viability of a portfolio company and our initial investment, or may result in a missed opportunity for us to increase our participation in a successful operation. Portfolio Company Leverage. Our portfolio companies will typically have capital structures with significant leverage. Leveraged companies in which we invest may have limited financial resources and may be unable to meet their obligations under their loans and debt securities that we hold. Although the Adviser will seek to structure transactions in an attempt to minimize these risks, such leverage may increase our exposure to adverse economic factors such as rising interest rates, downturns in the general economy or deterioration in the condition of the portfolio company or its sector in its particular industry. Such developments may be accompanied by a deterioration in the value of any collateral and a reduction in the likelihood of us realizing any guarantees that we may have obtained in connection with our investment. Smaller leveraged companies also may have less predictable operating results and may require substantial additional capital to support their operations, finance their expansion or maintain their competitive position. A portfolio company’s failure to satisfy financial or operating covenants imposed by us or other lenders could lead to defaults and, potentially, acceleration of the time when the loans are due and foreclosure on its assets representing collateral for its obligations, which could trigger cross defaults under other agreements and jeopardize the value of any equity securities we own and the portfolio company’s ability to meet its obligations under any debt that we hold. We may incur expenses to the extent necessary to seek recovery upon default or to negotiate new terms with a defaulting portfolio company. Defaults by Portfolio Companies. Our business is at risk if one of our borrowers defaults. A portfolio company’s failure to satisfy financial or operating covenants imposed by us or other lenders could lead to defaults and, potentially, termination of its loans and foreclosure on its assets. This could trigger cross-defaults under other agreements and jeopardize such portfolio company’s ability to meet its obligations under the loans or debt or equity securities that we hold. We may incur expenses to the extent necessary to seek recovery upon default or to negotiate new terms, which may include the waiver of certain financial covenants, with a defaulting portfolio company. Additionally, the return of principal of loans will depend in large part on the creditworthiness and financial strength of borrowers. If there is a default by the borrower under a loan, we will, in many circumstances, have contractual remedies pursuant to the loan agreements, including, in many cases, the sale of collateral. However, exercising such contractual rights may involve delays or costs, and any available collateral may prove to be unsaleable or saleable only at a price less than the loaned amount, which could result in a loss to the Company. There can be no guarantee that legal action will allow for the recovery of all outstanding loan balances due to the Company. We may choose to enter into forbearance agreements or delay legal action if it believes that such action improves the opportunity for a better outcome. The pursuit or delay of legal action may significantly increase the amount of time required to collect principal balances or lead to principal losses. Prepayments by Portfolio Companies. We will be subject to the risk that the debt investments we make in portfolio companies may be repaid prior to maturity. The Adviser expects that our investments will generally allow for repayment at any time subject to certain penalties. When this occurs, the Adviser may reinvest a portion of these proceeds in temporary investments, pending their future investment in accordance with our investment strategy. These temporary investments will typically have substantially lower yields than the debt being prepaid, and we could experience significant delays in reinvesting these amounts. Any future investment also may be at lower yields than the debt that was repaid. As a result, our results of operations could be materially adversely affected if one or more of our portfolio companies elect to prepay amounts owed to us. Risks Related to Non-Controlling Investments. We expect that at least a majority of investments we make will be non-controlling investments, meaning we will not be in a position to control the management, operation and strategic decision-making of the companies in which we invest. As a result, we will be subject to the risk that a portfolio company we do not control, or in which we do not have a majority ownership position, may make business decisions with which we disagree, and the equity holders and management of such a portfolio company may take risks or otherwise act in ways that are adverse to our interests. Due to the lack of liquidity for the debt investments that we will typically hold in our portfolio companies, we may not be able to dispose of our investments in the event that we disagree with the actions of a portfolio company, and may therefore suffer a decrease in the value of such portfolio company. Risks Associated with Bankruptcy Cases. As part of the Company’s lending activities, the Company may originate loans to companies that are experiencing significant financial or business difficulties, including companies involved in bankruptcy or other reorganization and liquidation proceedings. While the Company expects that the terms of such financing may result in significant financial returns to the Company, it involves a substantial degree of risk. The level of analytical sophistication, both financial and legal, necessary for successful financing to companies experiencing significant business and financial difficulties is unusually high. There is no assurance that the Company will correctly evaluate the value of the assets collateralizing the Company’s loans or the prospects for a successful reorganization or similar action. In any reorganization or liquidation proceeding relating to a company that the Company invests in, the Company may lose all or part of the amounts advanced to the portfolio company or may be required to accept collateral with a value less than the amount of the loan advanced by the Company to the portfolio company. Many of the events within a bankruptcy case are adversarial and often beyond the control of the creditors. While creditors generally are afforded an opportunity to object to significant actions, there can be no assurance that a bankruptcy court would not approve actions that may be contrary to the interests of the Company. Furthermore, there are instances where creditors and equity holders lose their ranking and priority as such if they are considered to have taken over management and functional operation of a debtor. Generally, the duration of a bankruptcy case can only be roughly estimated. The reorganization of a company usually involves the development and negotiation of a plan of reorganization, plan approval by the creditors and confirmation by a bankruptcy court. This process can involve substantial legal, professional and administrative costs to the debtor company and the Company; it is subject to unpredictable and lengthy delays; and during the process the Company’s competitive position may erode, key management may depart and the debtor company may not be able to operate adequately. In some cases, the debtor company may not be able to reorganize and may be required to liquidate assets. The debt of companies in financial reorganization, in most cases, will not pay current interest, may not accrue interest during reorganization and may be adversely affected by an erosion of the issuer’s fundamental value. Such investments can result in a total loss of principal. U.S. bankruptcy law permits the classification of “substantially similar” claims in determining the classification of claims in reorganization for purposes of voting on a plan of reorganization. Because the standard for classification is vague, there exists a significant risk that the Company’s influence with respect to a class of securities can be lost by the inflation of the number and amount of claims in, or other gerrymandering of, the class. In addition, certain administrative costs and claims that have priority by law over the claims of certain creditors (for example, claims for taxes) may be quite high. Furthermore, there are instances where creditors and equity holders lose their ranking and priority as such when they take over management and functional operating control of a debtor. Therefore, depending on the facts and circumstances, including the extent to which the Company actually provided managerial assistance to a portfolio company or its representative or the Adviser sat on the board of directors of such portfolio company, a bankruptcy court might re-characterize the Company’s debt investment and subordinate all or a portion of its claim to that of other creditors. A representative of the Company may serve on creditors’ committees or other groups to ensure preservation or enhancement of its position as a creditor or equity holder. A member of any such committee or group may owe certain obligations generally to all parties similarly situated that the committee represents. If the Company’s representative concludes that the obligations they owe to other parties as a committee or group member conflict with the duties they owe to the Company, they will resign from that committee or group, and the Company will not realize the benefits, if any, of participating on the committee or group. In addition, and also as discussed above, if the Company is represented on a committee or group, it may be restricted or prohibited under applicable law from, disposing of or increasing its investments in such debtor company while it continues to be represented on such committee or group. In addition, lenders can be subject to lender liability claims for actions taken by them where they become too involved in the borrower’s business or exercise control over the borrower. For example, the Company could become subject to a lender’s liability claim, if, among other things, the Company actually renders significant managerial assistance.
Limited Operating History and No Prior Experience Managing a BDC
General Description of Registrant [Abstract]
Risk [Text Block]	Limited Operating History and No Prior Experience Managing a BDC. VF1 began operations in July 2016 as a limited partnership with a more focused investment mandate and less capital than the Company has. The Company merged with VF1, with the Company as the surviving entity, at the Initial Closing and immediately prior to our election to be regulated as a BDC on June 2, 2022, when the Company began operations. Therefore, we have limited financial information on which a prospective investor can evaluate an investment in our common stock or our prior performance. As a result, we are subject to the business risks and uncertainties associated with recently formed businesses, including the risk that we will not achieve our investment objective and the value of a shareholder’s investment could decline substantially or become worthless. In addition, the Adviser has not previously managed a BDC. While we believe that the past professional experiences, including investment and financial experience, will allow the Adviser to manage the Company successfully, there can be no assurance that this will be the case.
Non-Specified Investments and Discretion in Determining Use of Drawdown Amounts
General Description of Registrant [Abstract]
Risk [Text Block]	Non-Specified Investments and Discretion in Determining Use of Drawdown Amounts. Capital drawn will be used to finance or invest in portfolio companies and investment vehicles that will not be meaningfully described to the shareholders prior to such financing or investment. We also intend to conduct repurchase offers, from time to time, beginning after the end of the Fundraising Period, and we may use a portion of the capital drawn for the repurchase of the common stock pursuant to such repurchase offers. Further, the Adviser will have broad discretion in determining the specific uses of Drawdown Amounts. The Adviser is neither obligated to allocate the Company’s resources to any particular subset or niche market, nor precluded from allocation any of such resources to a particular subset or niche market. Shareholders will not have opportunity to evaluate the economic, financial or other information on which the Adviser bases its decisions on how to use Drawdown Amounts. Shareholders must rely on the judgment and ability of the Adviser with respect to the investment of the Company’s capital. The Company also will pay operating expenses, and may pay other expenses such as due diligence expenses of potential new investments, from Drawdown Amounts. The Company’s ability to achieve the Company’s investment objective may be limited to the extent that Drawdown Amounts are used to pay operating expenses. No assurance can be given that the Company will be successful in identifying portfolio companies suitable for financing or investment or that, if such financings or investments are made, the objectives of the Company will be achieved. These factors increase the uncertainty, and thus the risk, of investing in the Company.
General Market and Economic Conditions [Member]
General Description of Registrant [Abstract]
Risk [Text Block]	General Market and Economic Conditions. General economic conditions may affect the Company’s activities. Changing economic, political, regulatory or market conditions, interest rates, general levels of economic activity, the price of securities and debt instruments and participation by other investors in the financial markets may affect the value and number of investments made by the Company or considered for prospective investment. The Company’s investment strategy and the availability of opportunities satisfying its risk-adjusted return parameters rely in part on the continuation of certain trends and conditions observed in the market for originated debt as well as the larger financial markets. No assurance can be given that such conditions, trends or opportunities will arise or continue, as applicable. Trends and historical events do not imply, forecast or predict future events and, in any event, past performance is not necessarily indicative of future results. There can be no assurance that the assumptions made, or the beliefs and expectations currently held, by the Company will prove correct and actual events and circumstances could vary significantly. While the Company expects that the current environment will yield attractive investment opportunities, investments are expected to be sensitive to the performance of the overall economy. A negative impact on U.S. or global economic fundamentals or consumer or business confidence will likely increase market volatility and reduce liquidity, both of which could adversely affect the overall performance of borrowers to which the Company may have extended loans, and these or similar events will affect the ability to execute the investment strategy pursued by the Company. The value of investments may fluctuate in accordance with changes in the financial condition of portfolio companies and other factors that affect the markets in which the Company invests. Economic, political, global health, regulatory or market developments can affect a single obligor, obligors within an industry, economic sector or geographic region, or the market as a whole. Different parts of the market and different types of investments can react differently to these developments. Every investment has some level of market volatility risk. Economic slowdowns or downturns could lead to financial losses in the Company’s investments. In addition, many portfolio companies may be similarly subject to the same economic conditions, which could adversely impact the ability to repay loans made or acquired by the Company. As a result, companies that the Company expected to be stable may operate, or expect to operate, at a loss or have significant variations in operating results, may require substantial additional capital to support their operations or maintain their competitive position, or may otherwise have a weak financial condition or be experiencing financial distress. Market conditions, including increased competition, also may cause the Company’s portfolio to comprise assets that differ significantly from the Adviser’s expectations at the time of the initial offering of common stock.
Capital Markets are Experiencing a Period of Disruption and Instability
General Description of Registrant [Abstract]
Risk [Text Block]	Capital Markets are Experiencing a Period of Disruption and Instability. As a BDC, we must maintain our ability to raise additional capital for investment purposes. Without sufficient access to the capital markets or credit markets, we may be forced to curtail our business operations or we may not be able to pursue new business opportunities. The U.S. capital markets have experienced extreme volatility and disruption following the global outbreak of COVID-19 that began in December 2019, the conflict between Russia and Ukraine that began in late February 2022, and the ongoing war in the Middle East (see “Terrorist Attacks, Acts of War, Natural Disasters or Pandemics” for more information). Even after the COVID-19 pandemic subsided, the U.S. economy, as well as most other major economies, have continued to experience unpredictable economic conditions, and we anticipate our businesses would be materially and adversely affected by any prolonged economic downturn or recession in the United States and other major markets. In addition, disruptions in the capital markets have increased the spread between the yields realized on risk-free and higher risk securities, resulting in illiquidity in parts of the capital markets. The current economic conditions have resulted in an adverse impact on the ability of lenders to originate loans, the volume and type of loans originated, the ability of borrowers to make payments and the volume and type of amendments and waivers granted to borrowers and remedial actions taken in the event of a borrower default, each of which could negatively impact the amount and quality of loans available for investment by the Company and returns to the Company, among other things. The U.S. credit markets (in particular for middle-market loans) have experienced the following among other things: (i) increased draws by borrowers on revolving lines of credit and other financing instruments; (ii) increased requests by borrowers for amendments and waivers of their credit agreements to avoid default, increased defaults by such borrowers and/or increased difficulty in obtaining refinancing at the maturity dates of their loans and increased uses of PIK features; and (iii) greater volatility in pricing and spreads and difficulty in valuing loans during periods of increased volatility, and liquidity issues. These conditions and future market disruptions and/or illiquidity could have an adverse effect on our (and our portfolio companies') business, financial condition, results of operations and cash flows. Ongoing unfavorable economic conditions also could increase our funding costs, limit our access to the capital markets or result in a decision by lenders not to extend credit to our portfolio companies and/or us. These events have limited and could continue to limit our investment originations, limit our ability to grow and have a material negative impact on our operating results and the fair values of our portfolio investments. We may have to access, if available, alternative markets for debt and equity capital, and a severe disruption in the global financial markets, deterioration in credit and financing conditions, continued increase in interest rates or uncertainty regarding U.S. government spending and deficit levels or other global economic conditions could have a material adverse effect on our business, financial condition and results of operations. Even if capital markets remain stable or improve, conditions could deteriorate again in the future. Past economic downturns or recessions have had a significant negative impact on the operating performance and fair value of middle market companies. For example, between 2008 and 2009, the U.S. and global capital markets were unstable as evidenced by periodic disruptions in liquidity in the debt capital markets, significant write-offs in the financial services sector, the re-pricing of credit risk in the broadly syndicated credit market and the failure of major financial institutions. Despite actions of the U.S. federal government and foreign governments, these events contributed to worsening general economic conditions that materially and adversely impacted the broader financial and credit markets and reduced the availability of debt and equity capital for the market as a whole and financial services firms in particular.
Economic Recessions or Downturns Could Impair our Portfolio Companies and Harm our Operating Results
General Description of Registrant [Abstract]
Risk [Text Block]	Economic Recessions or Downturns Could Impair our Portfolio Companies and Harm our Operating Results. The companies in which we have invested and intend to invest may be susceptible to economic slowdowns or recessions, including as a result of, among other things, the COVID-19 pandemic, elevated levels of inflation, and a rising interest rate environment, and may be unable to repay our debt investments during these periods. In the past, instability in the global capital markets resulted in disruptions in liquidity in the debt capital markets, significant write-offs in the financial services sector, the re-pricing of credit risk in the broadly syndicated credit market and the failure of major domestic and international financial institutions. In particular, in past periods of instability, the financial services sector was negatively impacted by significant write-offs as the value of the assets held by financial firms declined, impairing their capital positions and abilities to lend and invest. Our portfolio companies may be susceptible to economic downturns or recessions. During these periods, the value of our portfolio may decrease if we are required to write down the values of our investments, and we may have non-performing assets or non-performing assets may increase, and the value of our portfolio is likely to decrease during these periods. Adverse economic conditions also may decrease the value of any collateral securing our loans, and decrease the value of our equity investments. A severe recession may further decrease the value of such collateral and result in losses of value in our portfolio and a decrease in our revenues, net income, assets and net worth. Unfavorable economic conditions also could increase our funding costs, limit our access to the capital markets or result in a decision by lenders not to extend credit to us on terms we deem acceptable. In addition, a prolonged economic downturn or recession could extend our investment time horizon by limiting our ability to achieve timely liquidity events, such as a sale, merger or IPO, or the refinancing of our debt investments, and could ultimately impact our ability to realize anticipated investment returns. These events could prevent us from increasing investments and adversely impact our operating results. The occurrence of recessionary conditions and/or negative developments in the domestic and international credit markets may significantly affect the markets in which we do business, the value of our investments, and our ongoing operations, costs and profitability. Any such unfavorable economic conditions, including rising interest rates, also may increase our funding costs, limit our access to capital markets or negatively impact our ability to obtain financing, particularly from the debt markets. In addition, any future financial market uncertainty could lead to financial market disruptions and could further impact our ability to obtain financing. These events could limit our investment originations, limit our ability to grow and negatively impact our operating results and financial condition.
Risks Related to Hedging Transactions
General Description of Registrant [Abstract]
Risk [Text Block]	Risks Relating to Hedging Transactions. We may seek to hedge against interest rate and currency exchange rate fluctuations and credit risk by using structured financial instruments such as futures, options, interest rate swaps, and forward contracts, subject to the requirements of the 1940 Act. Use of structured financial instruments for hedging purposes may present significant risks, including the risk of loss of the amounts invested. Defaults by the other party to a hedging transaction can result in losses in the hedging transaction. Hedging activities also involve the risk of an imperfect correlation between the hedging instrument and the asset being hedged, which could result in losses both on the hedging transaction and on the instrument being hedged. Use of hedging activities may not prevent significant losses and could increase our losses. Further, hedging transactions may reduce cash available to pay distributions to our shareholders. The success of our hedging strategy will depend on our ability to correctly identify appropriate exposures for hedging. In connection with our issuance of the Company’s Series A Senior Notes, Tranche A, due December 21, 2026, and Series A Senior Notes, Tranche B, due December 21, 2028, which bear interest at a fixed rate, we entered into interest rate swaps to continue to align the interest rates of our liabilities with our investment portfolio, which consists of predominately floating rate loans. In addition, the degree of correlation between price movements of the instruments used in a hedging strategy and price movements in the portfolio positions being hedged may vary, as may the time period in which the hedge is effective relative to the time period of the related exposure. Also, where a put or call option on a particular security is purchased to hedge against price movements in a related security, the price of the put or call option may move more or less than the price of the related security. If restrictions on exercise were imposed, we might be unable to exercise an option we had purchased. If we were unable to close out an option that we had purchased on a security, it would have to exercise the option in order to realize any profit or the option may expire worthless.
The Alternative Reference Rates That Have Replaced LIBOR in Our Credit Arrangements and Other Financial Instruments May Not Yield the Same or Similar Economic Results as LIBOR Over the Life of Such Transactions
General Description of Registrant [Abstract]
Risk [Text Block]	The Alternative Reference Rates That Have Replaced LIBOR in Our Credit Arrangements and Other Financial Instruments May Not Yield the Same or Similar Economic Results as LIBOR Over the Life of Such Transactions . LIBOR is an index rate that historically was widely used in lending transactions and was a common reference rate for setting the floating interest rate on private loans. LIBOR was typically the reference rate used in floating-rate loans extended to our portfolio companies. The ICE Benchmark Administration (“IBA”) (the entity that is responsible for calculating LIBOR) ceased providing overnight, one, three, six and twelve months USD LIBOR tenors on June 30, 2023. In addition, the United Kingdom's Financial Conduct Authority ("FCA"), which oversees the IBA, now prohibits entities supervised by the FCA from using LIBOR, including USD LIBOR, except in very limited circumstances. In the United States, SOFR is the preferred alternative rate for LIBOR. SOFR is a measure of the cost of borrowing cash overnight, collateralized by U.S. Treasury securities, and is based on directly observable U.S. Treasury-backed repurchase transactions. SOFR is published by the Federal Reserve Bank of New York each U.S. Government Securities Business Day, for transactions made on the immediately preceding U.S. Government Securities Business Day. Alternative reference rates that may replace LIBOR, including SOFR for USD transactions, may not yield the same or similar economic results as LIBOR over the lives of such transactions. Our loans that referenced LIBOR have been amended to reference the forward-looking term rate published by CME Group Benchmark Administration Limited based on the secured overnight financing rate (“CME Term SOFR”). CME Term SOFR rates are forward-looking rates that are derived by compounding projected overnight SOFR rates over one, three, and six months taking into account the values of multiple consecutive, executed, one-month and three-month CME Group traded SOFR futures contracts and, in some cases, over-the-counter SOFR Overnight Indexed Swaps as an indicator of CME Term SOFR reference rate values. CME Term SOFR and the inputs on which it is based are derived from SOFR. Because CME Term SOFR is a relatively new market rate, there will likely be no established trading market for credit agreements or other financial instruments when they are issued, and an established market may never develop or may not be liquid. Market terms for instruments referencing CME Term SOFR rates may be different than those of later-issued CME Term SOFR indexed instruments. Similarly, if CME Term SOFR does not prove to be widely used, the trading price of instruments referencing CME Term SOFR may be lower than those of instruments indexed to indices that are more widely used.
Our Business is Dependent on Bank Relationships and Recent Strain on the Banking System May Adversely Impact
General Description of Registrant [Abstract]
Risk [Text Block]	Our Business is Dependent on Bank Relationships and Recent Strain on the Banking System May Adversely Impact Us. The financial markets recently have encountered volatility associated with concerns about the balance sheets of banks, especially small and regional banks that may have significant losses associated with investments that make it difficult to fund demands to withdraw deposits and other liquidity needs. Although the federal government has announced measures to assist these banks and protect depositors, some banks have already been impacted and others may be materially and adversely impacted. Our business is dependent on bank relationships, including small and regional banks, and we are proactively monitoring the financial health of banks with which we (or our portfolio companies) do or may in the future do business. To the extent that our portfolio companies work with banks that are negatively impacted by the foregoing, such portfolio companies’ ability to access their own cash, cash equivalents and investments may be threatened. In addition, such affected portfolio companies may not be able to enter into new banking arrangements or credit facilities, or receive the benefits of their existing banking arrangements or facilities. Any such developments could harm our business, financial condition, and operating results, and prevent us from fully implementing our investment plan. Continued strain on the banking system may adversely impact our business, financial condition and results of operations.
Price Declines in the Corporate Leveraged Loan Market
General Description of Registrant [Abstract]
Risk [Text Block]	Price Declines in the Corporate Leveraged Loan Market. Conditions in the medium- and large-sized U.S. corporate debt market may experience disruption or deterioration in the future, which may cause pricing levels to decline or be volatile. As a result, our NAV could decline through an increase in unrealized depreciation and incurrence of realized losses in connection with the sale of our investments, which could have a material adverse impact on our business, financial condition and results of operations.
Defaults Under a Credit Facility.
General Description of Registrant [Abstract]
Risk [Text Block]	Defaults Under a Credit Facility. In the event we default under the JPM Facility, the CIBC Facility (together, the "Credit Facilities"), or other borrowings, our business could be adversely affected as we may be forced to sell a portion of our investments quickly and prematurely at what may be disadvantageous prices to us in order to meet our outstanding payment obligations and/or support working capital requirements under such borrowings, any of which would have a material adverse effect on our business, financial condition, results of operations and cash flows. In addition, following any such default, the agent for the lenders under a borrowing facility could assume control of the disposition of any or all of our assets, including the selection of such assets to be disposed and the timing of such disposition, which would have a material adverse effect on our business, financial condition, results of operations and cash flows. As part of certain credit facilities, the right to make capital calls of shareholders may be pledged as collateral to the lender, which will be able to call for capital contributions upon the occurrence of an event of default under such credit facility. To the extent such an event of default does occur, shareholders could therefore be required to fund any shortfall up to their remaining Capital Commitments, without regard to the underlying value of their investment.
Provisions in our Credit Facilities May Limit Discretion
General Description of Registrant [Abstract]
Risk [Text Block]	Provisions in our Credit Facilities May Limit Discretion. We currently have in place the JPM Facility and the CIBC Facility, and in the future may enter into additional borrowings. Our Credit Facilities are backed by a portion of our loans and securities on which the lenders have a security interest. We may pledge up to 100% of our assets and may grant a security interest in all of our assets under the terms of any debt instrument we enter into with lenders. We expect that any security interests we grant will be set forth in a pledge and security agreement and evidenced by the filing of financing statements by the agent for the lenders. In addition, we expect that the custodian for our securities serving as collateral for such loan would include in its electronic systems notices indicating the existence of such security interests and, following notice of occurrence of an event of default, if any, and during its continuance, will only accept transfer instructions with respect to any such securities from the lender or its designee. If we breach a covenant under the terms of any of our Credit Facilities and seek a waiver, we may not be able to obtain a waiver from the required lenders. If we were to default under the terms of any debt instrument relating to any of our Credit Facilities and do not obtain a waiver, the agent for the applicable lenders would be able to assume control of the timing of disposition of any or all of our assets securing such debt, which would have a material adverse effect on our business, financial condition, results of operations and cash flows. In addition, our Credit Facilities may have customary cross-default provisions. If the indebtedness under our Credit Facilities or under any future borrowings is accelerated, we may be unable to repay or finance the amounts due. The terms of certain credit facilities that we enter into may provide (and, in the case of the JPM Facility and the CIBC Facility, provide) that, if we do not draw a minimum funding amount based on the borrowings available under such credit facility, then we must make additional payments to the lender for the difference between that minimum funding amount and the actual amounts we have then borrowed. To the extent that draw amounts are significantly below the stated minimum funding amount, we could be required to make a sizable “make whole” payment to the applicable lender. In addition, the terms of certain credit facilities that we enter into may provide (and, in the case of the JPM Facility, provide) that an optional termination of that credit facility or reduction, in full or in part, of the borrowings available under that credit facility generally will require us to may a “make whole” payment and pay a fee based on the amount of borrowings terminated or reduced, as applicable, under that credit facility. In each of these circumstances, our ability to pay such fees depends largely on our financial performance and is subject to prevailing economic conditions and competitive pressures. This, in certain circumstances, could have a material adverse effect on our business, financial condition, results of operations and cash flows. In addition, any security interests and/or negative covenants required by our Credit Facilities may limit our ability to create liens on assets to secure additional debt and may make it difficult for us to restructure or refinance indebtedness at or prior to maturity or obtain additional debt or equity financing. In addition, if our borrowing base under our Credit Facilities were to decrease, we may be required to secure additional assets in an amount sufficient to cure any borrowing base deficiency. In the event that all of our assets are secured at the time of such a borrowing base deficiency, we could be required to repay advances under our Credit Facilities or make deposits to a collection account, either of which could have a material adverse impact on our ability to fund future investments and to make distributions. We also may be subject to limitations as to how borrowed funds may be used, which may include restrictions on geographic and industry concentrations, loan size, payment frequency and status, average life, collateral interests and investment ratings, as well as regulatory restrictions on leverage which may affect the amount of funding that may be obtained. There also may be certain requirements relating to portfolio performance, including required minimum portfolio yield and limitations on delinquencies and charge-offs, a violation of which could limit further advances and, in some cases, result in an event of default. An event of default under our Credit Facilities could result in an accelerated maturity date for all amounts outstanding thereunder, which could have a material adverse effect on our business and financial condition. This could reduce our liquidity and cash flow and impair our ability to grow our business.
Competition for Investments
General Description of Registrant [Abstract]
Risk [Text Block]	Competition for Investments. Other entities, including commercial banks, commercial financing companies, BDCs and insurance companies compete to make the types of investments that we plan to make in middle market loans. Certain of these competitors may be substantially larger, have considerably greater financial, technical and marketing resources than we will have and offer a wider array of financial services. For example, some competitors may have a lower cost of funds or access to funding sources that are not available to us. We may lose investment opportunities if we do not match our competitors’ pricing, terms and structure. There may be intense competition for financings or investments of the type we intend to make, and such competition may result in less favorable financing or investment terms than might otherwise exist. Furthermore, many of our competitors are not subject to the regulatory restrictions that the 1940 Act imposes on us as a BDC or the source-of-income, asset diversification and distribution requirements we must satisfy to maintain our RIC tax treatment. There can be no assurance that there will be a sufficient number of attractive potential investments available to us to achieve target returns. In addition, some of our competitors may have higher risk tolerances or different risk assessments, which could allow them to consider a wider variety of investments and establish more relationships than us. The competitive pressures we face may have a material adverse effect on our business, financial condition, results of operations and cash flows.
Broad Authority for Board Action
General Description of Registrant [Abstract]
Risk [Text Block]	Broad Authority for Board Action. The Board has the authority to modify or waive certain of our operating policies and strategies without prior notice (except as required by the 1940 Act) and without approval. However, absent shareholder approval, the Board may not change the nature of our business so as to cease to be, or withdraw our election as, a BDC. We cannot predict the effect any changes to our current operating policies and strategies would have on our business, operating results and value of our common stock. Nevertheless, the effects may adversely affect our business and impact our ability to make distributions.
Changes in Law, Regulation or Policies
General Description of Registrant [Abstract]
Risk [Text Block]	Changes in Law, Regulation or Policies. Our portfolio companies and we are subject to regulation at the local, state, and federal levels. Changes to the laws and regulations governing our operations may cause us to alter our investment strategy in order to avail ourselves of new or different opportunities. These changes could result in material differences to the strategies and plans described herein and may result in a shift in investment focus. Thus, any such changes, if they occur, could have a material adverse effect on our results of operations and the value of your investment in us.
Changes in Tax Legislation
General Description of Registrant [Abstract]
Risk [Text Block]	Changes in Tax Legislation. Legislative or other actions relating to taxes could have a negative effect on us. The rules dealing with U.S. federal income taxation are constantly under review by persons involved in the legislative process and by the Internal Revenue Service and the U.S. Treasury Department. The Biden Administration has proposed significant changes to the existing U.S. tax rules, and there are a number of proposals in Congress that would similarly modify the existing U.S. tax rules. The likelihood of any such legislation being enacted is uncertain. New legislation and any U.S. Treasury regulations, administrative interpretations or court decisions interpreting such legislation could result in adverse tax consequences to us and our shareholders, such as significantly and negatively affecting our ability to qualify for tax treatment as a RIC. Shareholders are urged to consult with their tax advisor regarding tax legislative, regulatory, or administrative developments and proposals and their potential effect on an investment in our common stock.
Reliance on Personnel
General Description of Registrant [Abstract]
Risk [Text Block]	Reliance on Personnel. The Company's success depends upon the diligence, skill and network of business contacts of the Adviser's investment professionals. They will evaluate, negotiate, structure, close and monitor our investments in accordance with the terms of the Investment Advisory Agreement. There can be no assurance that the Adviser’s personnel will continue to be associated with the Adviser throughout the life of the Company. Adviser personnel, and any investment professionals that the Adviser may subsequently retain, will identify, evaluate, negotiate, structure, close, monitor and manage our investments. The Company's future success will depend to a significant extent on the continued service and coordination of Adviser personnel. If the Adviser does not maintain its existing relationships with sources of investment opportunities and does not develop new relationships with other sources of investment opportunities available to us, the Adviser may not be able to grow the Company's investment portfolio. In addition, individuals with whom Adviser personnel have relationships are not obligated to provide us with investment opportunities. Therefore, the Company and the Adviser can offer no assurance that such relationships will generate investment opportunities for us. Our ability to achieve our investment objective also will depend on the Adviser’s ability to manage the Company and to grow our investments and earnings. This will depend, in turn, on the Adviser’s ability to identify, invest in and monitor portfolio companies that meet our investment criteria. The achievement of our investment objective will depend upon the Adviser’s execution of our investment process, its ability to provide competent, attentive and efficient services to us and, to a lesser extent, our access to financing on acceptable terms. The Adviser’s team of investment professionals will have substantial responsibilities in connection with the management of other investment funds, accounts and investment vehicles. The personnel of the Adviser may be called upon to provide managerial assistance to our portfolio companies. These activities may distract them from servicing new investment opportunities for us or slow our rate of investment. Any failure to manage our business and our future growth effectively could have a material adverse effect on our business, financial condition, results of operations and cash flows. Similarly, the success of the SDLP, in which we hold the Subordinated Certificates, depends upon the diligence, skill and network of business contacts of the Company, and in the case of the SDLP, also of ARCC, our joint venture partner to the SDLP.
Resignation of Adviser
General Description of Registrant [Abstract]
Risk [Text Block]	Resignation of Adviser. Generally, the Adviser has the right, under the Investment Advisory Agreement, to resign at any time upon not less than 60 days’ written notice, regardless of whether we have found a replacement. In certain circumstances, the Adviser may only be able to terminate the Investment Advisory Agreement upon 60 days’ written notice. If the Adviser resigns, we may not be able to find a new investment adviser or hire internal management with similar expertise and ability to provide the same or equivalent services on acceptable terms within 60 days, as applicable, or at all. If we are unable to do so quickly, our operations are likely to experience a disruption, our financial condition, business and results of operations as well as our ability to pay distributions are likely to be adversely affected, and the value of our common stock may decline.
Lack of Diversification and Risks Associated with Significant Investments
General Description of Registrant [Abstract]
Risk [Text Block]	Lack of Diversification and Risks Associated with Significant Investments. Our portfolio may hold a limited number of investments. Beyond the asset diversification requirements associated with our qualification as a RIC, we do not have fixed guidelines for diversification, and our investments may be concentrated in a relatively limited number of portfolio companies and industries from time to time. As our portfolio is less diversified than the portfolios of some larger funds, we are more susceptible to failure if a single loan or investment fails. Similarly, the aggregate returns we realize may be significantly adversely affected if a small number of investments perform poorly or if we need to write down the value of any one investment. Moreover, even if we invest in a large number of investments, our portfolio is expected to include investments that may be significant, individually or in the aggregate. If a significant investment in one or more companies fails to perform as expected, such a failure could have a material adverse effect on our financial condition and results of operations, and the magnitude of such effect could be more significant than if we had further diversified our portfolio.
Valuation of Portfolio Securities
General Description of Registrant [Abstract]
Risk [Text Block]	Valuation of Portfolio Securities. Investments are valued at the end of each calendar quarter. Most of our investments may be in loans that do not have readily available market quotations. Assets that are not publicly traded or whose market prices are not readily available are valued at fair value as determined in good faith by the Board. In connection with that determination, portfolio company valuations will be prepared using sources, preliminary valuations obtained from independent valuation firms depending on the availability of information on our assets and the type of asset being valued, all in accordance with our valuation policy. The participation of the Adviser in the valuation process could result in a conflict of interest because the Adviser’s management fee is based in part on our gross assets. Because fair values, and particularly fair values of private securities and private companies, are inherently uncertain, may fluctuate over short periods of time, and are often based to a large extent on estimates, comparisons and qualitative evaluations of private information, our determinations of fair value may differ materially from the values that would have been determined if a ready market for these securities existed. This could make it more difficult for our shareholders to value accurately our portfolio investments and could lead to undervaluation or overvaluation of our interests. In addition, the valuation of these types of securities may result in substantial write-downs and earnings volatility. NAV as of a particular date may be materially greater than or less than the value that would be realized if assets were to be liquidated as of such date. For example, if we were required to sell a certain asset or all or a substantial portion of our assets on a particular date, the actual price that we would realize upon the disposition of such asset or assets could be materially less than the value of such asset or assets as reflected in our NAV. Volatile market conditions could also cause reduced liquidity in the market for certain assets, which could result in liquidation values that are materially less than the values of such assets as reflected in NAV.
Potential Fluctuations in Quarterly Results
General Description of Registrant [Abstract]
Risk [Text Block]	Potential Fluctuations in Quarterly Results. We could experience fluctuations in our quarterly operating results due to a number of factors, including our ability or inability to make investments in companies that meet our investment criteria, the interest rate payable and default rates on the debt securities we acquire, the level of our expenses, variations in and the timing of the recognition of realized and unrealized gains or losses, the degree to which we encounter competition in our markets, and general economic conditions. As a result of these factors, results for any previous period should not be relied upon as indicative of performance in future periods. These factors could have a material adverse effect on our results of operations, the value of an investment in our common stock and our ability to pay distributions.
Certain Provisions of the MGCL, the Charter and the Companys Bylaws Could Deter Takeover Attempts
General Description of Registrant [Abstract]
Risk [Text Block]	Certain Provisions of the MGCL, the Charter and the Company’s Bylaws Could Deter Takeover Attempts. The Charter and the Bylaws as well as the Maryland General Corporation Law (the “MGCL”) contain provisions that may have the effect of discouraging a third party from making an acquisition proposal for the Company. Among other things, the Charter and the Bylaws: • provide that the Board is classified, which may delay the ability of shareholders to change the membership of a majority of the Board; • do not provide for cumulative voting; • provide that, except for vacancies on the Board caused by the removal of a director by shareholders before the time that the Company has three Independent Directors, newly created directorships and vacancies on the Board may be filled only by a majority vote of directors then in office; • provide that directors may be removed only for cause, and only by a supermajority vote of the shareholders entitled to elect such directors; • provide that shareholders may only take action (i) at an annual or special meeting of shareholders or (ii) by unanimous written consent; • require a supermajority vote of shareholders to effect amendments to certain provisions of the Charter; • vest in the Board the exclusive power to amend the Bylaws; and • require shareholders to provide advance notice of new business proposals and director nominations under specific procedures. In addition, except as otherwise provided in the Charter, the affirmative vote of at least 75% of the votes entitled to be cast thereon, with each class or series of stock voting as a separate class, as well as the affirmative vote of at least 75% of the Board is required to effect a number of actions, including certain business combinations, that the holders of shares of common stock may view as desirable or in their best interest. Under the MGCL, certain “business combinations,” including mergers, consolidations, share exchanges, or, in circumstances specified in the statute, asset transfers or issuances or reclassifications of equity securities, between a Maryland corporation and any person who owns 10% or more of the voting power of the corporation’s outstanding voting stock, and certain other parties (each an “interested shareholder”), or an affiliate of the interested shareholder, are prohibited for five years after the most recent date on which the interested shareholder becomes an interested shareholder to the extent such statute is not superseded by applicable requirements of the 1940 Act. Thereafter, any of the specified business combinations must be approved by two supermajority votes of the shareholders unless, among other conditions, holders of the corporation’s common stock receive a minimum price for their shares. However, the Board intends to adopt a resolution exempting from the above restrictions any business combination between the Company and any other person, provided that such business combination is first approved by the Board (including a majority of the Independent Directors). This resolution, however, may be altered or repealed in whole or in part at any time. These anti-takeover provisions may inhibit a change of control in circumstances that could give the shareholders the opportunity to realize a premium over the market price for the common stock.
Terrorist Attacks, Acts of War, Natural Disasters or Pandemics
General Description of Registrant [Abstract]
Risk [Text Block]	Terrorist Attacks, Acts of War, Natural Disasters or Pandemics. Terrorist acts, acts of war, natural disasters, epidemics, pandemics, conflicts, social unrest and other social, political and economic conditions may disrupt our operations, as well as the operations of the businesses in which we invest. Such acts have created, and continue to create, economic and political uncertainties and have contributed to recent global economic instability. Future terrorist activities, military or security operations, natural disasters, pandemics could further weaken the domestic/global economies and create additional uncertainties, which may negatively impact the businesses in which we invest directly or indirectly and, in turn, could have a material adverse impact on our business, operating results and financial condition. Losses from terrorist attacks and natural disasters are generally uninsurable. The ongoing invasion of Ukraine by Russia and related sanctions have increased global political and economic uncertainty. In late February 2022, Russia launched a large-scale military attack on Ukraine. The invasion significantly amplified already existing geopolitical tensions among Russia, Ukraine, Europe, NATO and the West, including the United States. In response to the ongoing military action by Russia, various countries, including the United States, the United Kingdom, and European Union issued broad-ranging economic sanctions against Russia. Such sanctions included, among other things, a prohibition on doing business with certain Russian companies, large financial institutions, officials and oligarchs; a commitment by certain countries and the European Union to remove selected Russian banks from the Society for Worldwide Interbank Financial Telecommunications (“SWIFT”), the electronic banking network that connects banks globally; and restrictive measures to prevent the Russian Central Bank from undermining the impact of the sanctions. Additional sanctions may be imposed in the future. Such sanctions (and any future sanctions) and other actions against Russia may adversely impact, among other things, the Russian economy and various sectors of the economy, including, but not limited to, financials, energy, metals and mining, engineering and defense and defense-related materials sectors; result in a decline in the value and liquidity of Russian securities; result in boycotts, tariffs, and purchasing and financing restrictions on Russia’s government, companies and certain individuals; weaken the value of the ruble; downgrade the country’s credit rating; freeze Russian securities and/or funds invested in prohibited assets and impair the ability to trade in Russian securities and/or other assets; and have other adverse consequences on the Russian government, economy, companies and region. Further, several large corporations and U.S. states have announced plans to divest interests or otherwise curtail business dealings with certain Russian businesses. In addition, the recent outbreak of hostilities in the Middle East and escalating tensions in the region may create volatility and disruption of global markets. The ramifications of the hostilities and sanctions, however, may not be limited to Russia and the Middle East and Russian and Middle Eastern companies, respectively, but may spill over to and negatively impact other regional and global economic markets (including Europe and the United States), companies in other countries (particularly those that have done business with Russia) and on various sectors, industries and markets for securities and commodities globally, such as oil and natural gas. Accordingly, the actions discussed above and the potential for a wider conflict could increase financial market volatility, cause severe negative effects on regional and global economic markets, industries, and companies and have a negative effect on the Company’s investments and performance, which may, in turn, impact the valuation of such portfolio companies. In addition, parties in such conflicts may take retaliatory actions and other countermeasures, including cyberattacks and espionage against other countries and companies around the world, which may negatively impact such countries and the companies in which the Company invests. The extent and duration of the military action or future escalation of such hostilities, the extent and impact of existing and future sanctions, market disruptions and volatility, and the result of any diplomatic negotiations cannot be predicted. These and any related events could have a significant impact on the Company’s performance and the value of an investment in the Company.
Cybersecurity Risks
General Description of Registrant [Abstract]
Risk [Text Block]	Cybersecurity Risks. We, and others in our industry, are the targets of malicious cyber activity. A successful cyber-attack, whether perpetrated by criminal or state-sponsored actors, against us or our service providers, or an accidental disclosure of non-public information could have an adverse effect on our ability to communicate or conduct business, negatively impacting our operations and financial condition. This adverse effect can become particularly acute if those events affect our electronic data processing, transmission, storage, and retrieval systems, or impact the availability, integrity, or confidentiality of our data, especially personal and other confidential information. We depend heavily upon computer systems to perform necessary business functions. Despite our implementation of a variety of security measures, our computer systems, networks, and data, like those of other companies, could be subject to unauthorized access, acquisition, use, alteration, or destruction, such as from the insertion of malware (including ransomware), physical and electronic break-ins or unauthorized tampering, or system failures and disruptions of our computer systems, networks and data. If one or more of these events occurs, it could potentially jeopardize the confidential, proprietary, personal and other information processed, stored in, and transmitted through our computer systems and networks. Such an attack could cause, among other adverse effects, interruptions or malfunctions in our operations, misstated or unreliable financial data, misappropriation of assets, loss of personal information, liability for stolen information, any of which could result in financial losses, litigation, regulatory enforcement action and penalties, client dissatisfaction or loss, reputational damage, and increased costs associated with mitigation of damages and remediation. We may have to make a significant investment to fix or replace any inoperable or compromised systems or to modify or enhance its cybersecurity controls, procedures and measures. Similarly, the public perception that we or our affiliates may have been the target of a cybersecurity threat, whether successful or not, also could have a material adverse effect on our reputation and lead to financial losses from loss of business, depending on the nature and severity of the threat. Third parties with which we do business (including vendors that provide us with services) are sources of cybersecurity or other technological risks. We outsource certain functions and these relationships allow for the storage and processing of our information, as well as client, counterparty, employee and borrower information. Cybersecurity failures or breaches to service providers (including, but not limited to, accountants and custodians), and the issuers of securities in which we invest, also have the ability to cause disruptions and impact business operations, potentially resulting in financial losses, interference with our ability to calculate its NAV, impediments to trading, the inability of our shareholders to transact business, violations of applicable privacy and other laws, regulatory fines, penalties, reputation damages, reimbursement of other compensation costs, or additional compliance costs. While we engage in actions to reduce our exposure resulting from outsourcing, ongoing threats may result in unauthorized access, acquisition, use, alteration or destruction of data, or other cybersecurity incidents that affects our data, resulting in increased costs and other consequences, as described above. The Company does not control the cybersecurity measures put in place by such third parties, and such third parties could have limited indemnification obligations to the Company and its affiliates. If such a third party fails to adopt or adhere to adequate cybersecurity procedures, or if despite such procedures its networks or systems are breached, information relating to investor transactions and/or personal information of investors may be lost or improperly accessed, used or disclosed. The Company, the Adviser and its affiliates have implemented processes, procedures and internal controls to mitigate cybersecurity risks and cyber intrusions, including in its vendors, but these measures, as well as the Company’s increased awareness of the nature and extent of a risk of a cyber-incident, may be ineffective and do not guarantee that a cyber-incident will not occur or that the Company’s financial results, operations or confidential information will not be negatively impacted by a cybersecurity or cyber intrusion incident. Substantial costs may be incurred in order to prevent any cyber incidents in the future. Privacy and information security laws and regulatory changes (including any regulations to report material cybersecurity incidents to the SEC), and compliance with those changes, may result in cost increases due to system changes and the development of new administrative processes. In addition, we may be required to expend significant additional resources to modify our protective measures and to investigate and remediate vulnerabilities or other exposures arising from operational and security risks.
California Consumer Privacy Act (CCPA) Considerations
General Description of Registrant [Abstract]
Risk [Text Block]	California Consumer Privacy Act (“CCPA”) Considerations. The Company and the Adviser are subject to the requirements of the CCPA. The CCPA imposes a number of obligations on covered businesses, including, among others: (a) obligations to comply with certain privacy requests made by California residents; (b) requirements to provide enhanced privacy notice disclosures; and (c) a requirement to ensure that all individuals responsible for handling consumer inquiries about the business’s privacy practices are informed of the CCPA’s requirements. The CCPA is enforceable by the California Attorney General as of July 1, 2020 and authorizes civil penalties for domestic and intentional violations. The CCPA also provides a private right of action but only in connection with certain “unauthorized access and exfiltration, theft, or disclosure” of a California resident’s non-encrypted or non-redacted personal information, if the business failed to implement and maintain reasonable security procedures and practices appropriate to the nature of the information to protect the personal information. There is a risk that the measures taken to comply with the CCPA will not be implemented correctly or that individuals within the business will not be fully compliant with the new procedures. If there are breaches of these measures, the Company and the Adviser and their respective affiliates (as relevant) could face significant administrative and monetary sanctions as well as reputational damage which could have a material adverse effect on the operations, financial condition and prospects of the Company. The above considerations also apply to the portfolio companies of the Company and other counterparties with which the Company conducts investment activities.
Exposure to Financial Institutions
General Description of Registrant [Abstract]
Risk [Text Block]	Exposure to Financial Institutions . The Company may invest in financial instruments issued by financial institutions, such as investment and commercial banks, insurance companies, savings and loan associations, mortgage originators and other companies engaged in the financial services industry (collectively, “financial institutions”). In addition, financial institutions will act as counterparties to the Company in connection with the Company’s investment activities and may provide certain services to the Company. The Company also may gain exposure to these entities through derivative transactions, including, without limitation, interest rate swaps, options, credit default swaps and credit linked notes, and through long and short strategies. In the course of conducting their business operations, financial institutions are exposed to a variety of risks that are inherent to the financial services industry. Significant risks that could affect the financial condition and results of operations of financial institutions include, but are not limited to, fluctuations in interest rates, exchange rates, equity and commodity prices and credit spreads caused by global and local market and economic conditions; credit-related losses that can occur as a result of an individual, counterparty or issuer being unable or unwilling to honor its contractual obligations; the potential inability to repay short-term borrowings with new borrowings or assets that can be quickly converted into cash while meeting other obligations; operational failures or unfavorable external events; potential changes to the established rules and policies of various U.S. and non-U.S. legislative bodies and regulatory and exchange authorities, such as federal and state securities, bank regulators and industry participants; risks associated with litigation, investigations and/or proceedings by private claimants and governmental and self-regulatory agencies arising in connection with a financial institution’s activities; and its continuing ability to compete effectively in the market.
Litigation Risks
General Description of Registrant [Abstract]
Risk [Text Block]	Litigation Risks . The Company is subject to a variety of litigation risks, particularly if one or more of its portfolio companies face financial or other difficulties. It is by no means unusual for participants to use the threat of, as well as actual, litigation as a negotiating technique. Legal disputes, involving any or all of the Company, the Adviser, or their respective affiliates, may arise from their activities and investments and could have a significant adverse effect on the Company, including the expense of defending against claims by third parties and paying any amounts pursuant to settlements or judgments.
Legal and Regulatory Risks, Generally
General Description of Registrant [Abstract]
Risk [Text Block]	Legal and Regulatory Risks, Generally . Legal and regulatory changes could occur that may adversely affect the Company. For example, the Company may invest in a number of different industries, some of which are or may become subject to regulation by one or more government agencies in the jurisdictions in which they operate. New and existing regulations, changing regulatory schemes and the burdens of regulatory compliance all may have a material negative impact on the performance of companies that operate in these industries. The Adviser cannot predict whether new legislation or regulation governing those industries will be enacted by legislative bodies or governmental agencies, or the effect that such legislation or regulation might have. There can be no assurance that new legislation or regulation, including changes to existing laws and regulations, will not have a material negative impact on the Company’s investment performance.
State Licensing Requirements
General Description of Registrant [Abstract]
Risk [Text Block]	State Licensing Requirements. We may be required to obtain various state licenses in order to, among other things, originate commercial loans. Applying for and obtaining required licenses can be costly and take several months. There is no assurance that we will obtain all of the licenses that we need on a timely basis. Furthermore, we will be subject to various information and other requirements in order to obtain and maintain these licenses, and there is no assurance that we will satisfy those requirements. Our failure to obtain or maintain licenses might restrict investment options and have other adverse consequences.
U.S. Federal Income Tax at Corporate Rates if it is Unable to Qualify as a RIC
General Description of Registrant [Abstract]
Risk [Text Block]	The Company will be Subject to U.S. Federal Income Tax at Corporate Rates if it is Unable to Qualify as a RIC. Although we have elected to be treated, and intend to qualify annually, as a RIC, no assurance can be given that we will be able to qualify for and maintain our qualification as a RIC. To obtain and maintain our qualification as a RIC, we must meet the following source-of-income, asset diversification, and distribution requirements. The source-of-income requirement will be satisfied if we obtain at least 90% of our gross income for each year from dividends, interest, foreign currency, payments with respect to loans of certain securities, gains from the sale of stock or other securities, net income from certain “qualified publicly traded partnerships,” or similar sources. The asset diversification requirement will be satisfied if (i) at least 50% of the value of our total assets are represented by cash and cash items, U.S. government securities, the securities of other RICs and “other securities,” provided that such “other securities” will not include any securities of any one issuer, if our holdings of such issuer constitute greater in value than 5% of our total assets or if we hold greater than 10% of the outstanding voting securities of such issuer, and (ii) no more than 25% of the value of our assets are invested in securities of any one issuer (other than U.S. government securities and securities of other RICs), the securities (other than securities of other RICs) of any two or more issuers that are controlled by the Company and are engaged in the same or similar or related trades or business, or the securities of one or more “qualified publicly traded partnerships.” Failure to meet those requirements may result in us having to dispose of certain investments quickly in order to prevent the loss of our qualification as a RIC. Because most of our investments will be in private companies, and therefore will be relatively illiquid, any such dispositions could be made at disadvantageous prices and could result in substantial losses. We may have difficulty satisfying the diversification requirement during our ramp-up phase until we have a portfolio of investments. The annual distribution requirement generally will be satisfied if we distribute to our shareholders on an annual basis at least 90% of our net ordinary income and realized net short-term capital gains in excess of realized net long-term capital losses, if any. Because we may use debt financing, we are subject to certain asset coverage ratio requirements under the 1940 Act and financial covenants under loan and credit agreements that could, under certain circumstances, restrict us from making distributions necessary to satisfy the distribution requirement. If we are unable to obtain cash from other sources, we could fail to qualify as a RIC. If we fail to qualify as a RIC for any reason and therefore become subject to U.S. federal income tax, the resulting taxes could substantially reduce our net assets, the amount of income available for distribution and the amount of our distributions.
Limits on Capital Raising; Asset Coverage Ratio
General Description of Registrant [Abstract]
Risk [Text Block]	Limits on Capital Raising; Asset Coverage Ratio. Our business will require a substantial amount of capital. However, we may not be able to raise additional capital in the future on favorable terms or at all. We may issue debt securities, other evidences of indebtedness or preferred stock, and may borrow money from banks or other financial institutions, which are referred to collectively herein as “senior securities,” up to the maximum amount permitted by the 1940 Act. The 1940 Act permits us to issue senior securities in amounts such that our asset coverage, as defined in the 1940 Act, equals at least 200% (or 150% if certain requirements under the 1940 Act are met, which we met in connection with our Initial Closing) after each issuance of senior securities. Our ability to pay dividends or issue additional senior securities would be restricted if our asset coverage ratio were not at least 200% (or 150% if certain requirements under the 1940 Act are met, which we met in connection with our Initial Closing). If the value of our assets declines, we may be unable to satisfy this requirement. If that happens, we may be required to liquidate a portion of our investments and repay a portion of our indebtedness at a time when such sales or repayment may be disadvantageous. As a result of issuing senior securities, we also will be exposed to typical risks associated with leverage, including an increased risk of loss. If we issue preferred stock, such preferred stock will rank “senior” to our common stock in our capital structure, preferred shareholders will have separate voting rights for certain purposes and may have rights, preferences or privileges more favorable than those of our common stock and the issuance of common stock could have the effect of delaying, deferring or preventing a transaction or a change of control that might involve a premium price for our shareholders or otherwise be in the best interest of our shareholders. To the extent we are constrained in our ability to issue debt or other senior securities, we will depend on issuances of common stock to finance our operations. As a BDC, we will not generally be able to issue our common stock at a price below NAV without first obtaining required approvals of our shareholders and our Independent Directors. If we raise additional funds by issuing more of our common stock or senior securities convertible into, or exchangeable for, our common stock, the percentage ownership of our shareholders at that time would decrease and our shareholders may experience dilution. In addition to issuing securities to raise capital as described above, we could, in the future, securitize our loans to generate cash for funding new investments. An inability to successfully securitize our loan portfolio could limit our ability to grow our business, fully execute our business strategy and improve our profitability.
The 1940 Act Permits us to Incur Additional Leverage with Certain Consents
General Description of Registrant [Abstract]
Risk [Text Block]	The 1940 Act Permits us to Incur Additional Leverage with Certain Consents. The 1940 Act generally prohibits us from incurring indebtedness unless immediately after such borrowing we have an asset coverage for total borrowings of at least 200% or 150%, if certain requirements are met. Under the 1940 Act, we are allowed to increase our leverage capacity if shareholders representing at least a majority of the votes cast, when a quorum is present, approve a proposal to do so. If we receive shareholder approval, we would be allowed to increase our leverage capacity on the first day after such approval. Alternatively, the 1940 Act allows the majority of our Independent Directors to approve an increase in our leverage capacity, and such approval would become effective after one year. In addition, the 1940 Act requires non-listed BDCs, like the Company, to offer to repurchase 25% of its securities each quarter following the calendar quarter in which the BDC obtains such approval. In either case, we would be required to make certain disclosures on our website and in SEC filings regarding, among other things, the receipt of approval to increase our leverage, our leverage capacity and usage, and risks related to leverage. In connection with the Initial Closing, investors both consented to the minimum asset coverage ratio of 150% and agreed not to seek to redeem their shares of common stock in connection therewith, in each case in the subscription agreements. Leverage magnifies the potential for loss on investments in our indebtedness and on invested equity capital. As we use leverage to partially finance our investments, you will experience increased risks of investing in our securities. If the value of our assets increases, then leveraging would cause the NAV attributable to our common stock to increase more sharply than it would have had we not leveraged. Conversely, if the value of our assets decreases, leveraging would cause NAV to decline more sharply than it otherwise would have had we not leveraged our business. Similarly, any increase in our income in excess of interest payable on the borrowed funds would cause our net investment income to increase more than it would without the leverage, while any decrease in our income would cause net investment income to decline more sharply than it would have had we not borrowed. Such a decline could negatively affect our ability to pay common stock dividends, scheduled debt payments or other payments related to our securities. Leverage is generally considered a speculative investment technique.
The Company May Have Difficulty Paying its Required Distributions if the Company Recognizes Income Before or Without Receiving Cash Representing Such Income
General Description of Registrant [Abstract]
Risk [Text Block]	The Company May Have Difficulty Paying its Required Distributions if the Company Recognizes Income Before or Without Receiving Cash Representing Such Income. For U.S. federal income tax purposes, the Company will include in its taxable income certain amounts that the Company has not yet received in cash, such as original issue discount, which may arise if the Company receives warrants in connection with the origination of a loan or possibly in other circumstances, or contractual PIK interest, which represents contractual interest added to the loan balance and due at the end of the loan term. Such original issue discount or increases in loan balances as a result of contractual PIK arrangements will be included in the Company’s taxable income before the Company receives any corresponding cash payments. The Company also may be required to include in its taxable income certain other amounts that it will not receive in cash. Since, in certain cases, the Company may recognize taxable income before or without receiving corresponding cash payments, the Company may have difficulty meeting the annual distribution requirement necessary to maintain its qualification as a RIC. Accordingly, to satisfy its RIC distribution requirements, the Company may have to sell some of its investments at times and/or at prices that it would not consider advantageous, raise additional debt or equity capital or forgo new investment opportunities. If the Company is not able to obtain cash from other sources, it may fail to qualify as a RIC and thus become subject to U.S. federal income tax. For additional discussion regarding the tax implications of the Company’s election to be taxed as a RIC, please see “Item 1. Business — Certain U.S. Federal Income Tax Considerations.”
Distribution and Asset Coverage Ratio Requirements May Impact the Companys Ability to Grow
General Description of Registrant [Abstract]
Risk [Text Block]	Distribution and Asset Coverage Ratio Requirements May Impact the Company’s Ability to Grow. In order to satisfy the requirements applicable to RICs and to avoid payment of excise taxes, we intend to distribute to our shareholders substantially all of our ordinary income and capital gain net income except for certain net capital gains, which we intend to retain and to elect to treat as deemed distributions to our shareholders. As a BDC, we are generally required to meet a coverage ratio of total assets to total senior securities, which would include all of our borrowings and any preferred stock that we may issue in the future, of at least 200% (or 150% if certain requirements under the 1940 Act are met, which we met in connection with our Initial Closing). This requirement will limit the amount that we may borrow. Because we will continue to need capital to grow our loan and investment portfolio, this limitation may prevent us from incurring debt and require us to raise additional equity at a time when it may be disadvantageous to do so. While we expect to be able to borrow and to issue additional debt and equity securities, there is no assurance that debt and equity financing will be available to us on favorable terms or at all. In addition, as a BDC, we are not permitted to issue equity securities priced below NAV without shareholder and Independent Director approval. However, if we do obtain the necessary approvals to issue securities at prices below their NAVs, a shareholder’s investment in our common stock will experience dilution as a result of such issuance. If additional funds are not available to us, we could be forced to curtail or cease our lending and investment activities, and our NAV could decrease.
Unrealized Depreciation on Our Loan Portfolio Indicating Future Realized Losses and Reduction in Income Available for Distribution
General Description of Registrant [Abstract]
Risk [Text Block]	Unrealized Depreciation on Our Loan Portfolio Indicating Future Realized Losses and Reduction in Income Available for Distribution. As a BDC, we are required to carry our investments at market value or, if no market value is ascertainable, at fair value as determined in good faith by the Board. Decreases in the market values or fair values of our investments will be recorded as unrealized depreciation. Any unrealized depreciation in our loan portfolio could be an indication of a portfolio company’s inability to meet its repayment obligations to us with respect to the loans whose market values or fair values decreased. This could result in realized losses in the future and ultimately in reductions of our income available for distribution in future periods.
Qualifying Asset Requirement
General Description of Registrant [Abstract]
Risk [Text Block]	Qualifying Asset Requirement. As a BDC, we may not acquire any assets other than “qualifying assets” unless, at the time of such acquisition, at least 70% of our total assets are qualifying assets. Therefore, we may be precluded from investing in what we believe are attractive investments if such investments are not qualifying assets. Similarly, this requirement could prevent us from making additional investments in existing portfolio companies, which could result in the dilution of our position, or could require us to dispose of investments at an inopportune time to comply with the 1940 Act. If we were forced to sell non-qualifying investments for compliance purposes, the proceeds from such sale could be significantly less than the current value of such investments. Conversely, if we failed to invest a sufficient portion of our assets in qualifying assets, we could lose our status as a BDC, which would subject us to substantially more regulatory restrictions and significantly decrease our operating flexibility.
Transactions involving derivatives and Unfunded Commitment Transactions
General Description of Registrant [Abstract]
Risk [Text Block]	Our ability to enter into transactions involving derivatives and unfunded commitment transactions may be limited. In 2020, the SEC adopted Rule 18f-4 under the 1940 Act, which relates to the use of derivatives and other transactions that create future payment or delivery obligations by BDCs (and other funds that are registered investment companies). Under Rule 18f-4, for which compliance was required beginning in August 2022, BDCs that use derivatives are subject to a value-at-risk (“VaR”) leverage limit, certain derivatives risk management program and testing requirements, and requirements related to board reporting. These requirements apply unless the BDC qualifies as a “limited derivatives user,” as defined in Rule 18f-4. A BDC that enters into reverse repurchase agreements or similar financing transactions could either (i) comply with the asset coverage requirements of Section 18, as modified by Section 61 of the 1940 Act, when engaging in reverse repurchase agreements or (ii) choose to treat such agreements as derivatives transactions under Rule 18f-4. In addition, under Rule 18f-4, a BDC may enter into an unfunded commitment agreement that is not a derivatives transaction, such as an agreement to provide financing to a portfolio company, if the BDC has a reasonable belief, at the time it enters into such an agreement, that it will have sufficient cash and cash equivalents to meet its obligations with respect to all of its unfunded commitment agreements, in each case as it becomes due. If the BDC cannot meet this requirement, it is required to treat the unfunded commitment as a derivatives transaction subject to the aforementioned requirements of Rule 18f-4. Collectively, these requirements may limit our ability to use derivatives and/or enter into certain other financial contracts. We qualify as a “limited derivatives user,” and as a result the requirements applicable to us under Rule 18f-4 may limit our ability to use derivatives and enter into certain other financial contracts. However, if we fail to qualify as a limited derivatives user and become subject to the additional requirements under Rule 18f-4, compliance with such requirements may increase cost of doing business, which could have a material adverse effect on our business, financial condition, results of operations, and cash flows.
Limits on Transactions with Affiliates
General Description of Registrant [Abstract]
Risk [Text Block]	Limits on Transactions with Affiliates. We are prohibited under the 1940 Act from participating in certain transactions with certain of our affiliates without the prior approval of a majority of the Independent Directors of the Board and, in some cases, the SEC. Any person that owns, directly or indirectly, 5% or more of our outstanding voting securities will be our affiliate for purposes of the 1940 Act, and we generally will be prohibited from buying or selling any securities from or to such affiliate, absent the prior approval of the Board. The 1940 Act also prohibits certain “joint transactions” with certain of our affiliates, which could include investments in the same portfolio company (whether at the same or different times), without prior approval of the Board and, in some cases, the SEC. If a person acquires more than 25% of our voting securities, we will be prohibited from buying or selling any security from or to such person or certain of that person’s affiliates or entering into prohibited joint transactions with such persons absent the prior approval of the SEC. Similar restrictions limit our ability to transact business with our officers or directors or their affiliates. We have received an exemptive order from the SEC that allows us, subject to the satisfaction of certain conditions, to enter into transactions with certain of our affiliates. These restrictions may limit the scope of investment opportunities that would otherwise be available to us and there can be no assurance that we will be able to participate in all investment opportunities that are suitable to us.
Emerging Growth Company under the JOBS Act
General Description of Registrant [Abstract]
Risk [Text Block]	Our Status as an “Emerging Growth Company” under the JOBS Act May Make it More Difficult to Raise Capital as and When We Need it. Because of the exemptions from various reporting requirements provided to us as an “emerging growth company” and because we will have an extended transition period for complying with new or revised financial accounting standards, we may be less attractive to investors and it may be difficult for us to raise additional capital as and when we need it. Investors may be unable to compare our business with other companies in our industry if they believe that our financial accounting is not as transparent as other companies in our industry. If we are unable to raise additional capital as and when we need it, our financial condition and results of operations may be materially and adversely affected.
Capital Commitments and Drawdowns
General Description of Registrant [Abstract]
Risk [Text Block]	Capital Commitments and Drawdowns. Until the earlier of a Liquidity Event and a repurchase of all common stock of a shareholder or such later time as set forth under “Item 1. Business — The Private Offering , ” each such shareholder will be obligated to fund Drawdowns to purchase additional common stock based on its Capital Commitment at the time the Company makes such financing or investment. To satisfy such obligations, shareholders may need to maintain a substantial portion of their Capital Commitments in assets that can be readily converted to cash. Failure by a shareholder to timely fund its Capital Commitment may result in some of its common stock being forfeited or subject the shareholder to other remedies available to the Company. Failure of shareholders to contribute their Capital Commitments also could cause the Company to be unable to realize its investment objectives. A default by a substantial number of shareholders or by one or more shareholders who have made substantial Capital Commitments would limit the Company’s opportunities for investment or diversification and would likely reduce returns to the Company. In addition, the Adviser will have broad discretion in determining the specific uses of Drawdown Amounts. See “Non-Specified Investments and Discretion in Determining Use of Drawdown Amounts” for more information.
Exchange Act Filing Requirements
General Description of Registrant [Abstract]
Risk [Text Block]	Exchange Act Filing Requirements. Because the common stock is registered under the Exchange Act, ownership information for any person who beneficially owns 5% or more of the common stock will have to be disclosed in a Schedule 13G or other filings with the SEC. Beneficial ownership for these purposes is determined in accordance with the rules of the SEC, and includes having voting or investment power over the securities. Our shareholders who subscribe for over 5% of our common stock or, in some circumstances, our shareholders who choose to reinvest their dividends and who therefore see their percentage stake in the Company increased to more than 5% of our common stock, will trigger this filing requirement. Each shareholder is responsible for determining their filing obligations and preparing the filings. In addition, our shareholders who hold more than 10% of a class of our common stock may be subject to Section 16(b) of the Exchange Act, which recaptures for the benefit of the Company profits from the purchase and sale of registered stock within a six-month period.
Common Counsel; Interest of Counsel
General Description of Registrant [Abstract]
Risk [Text Block]	Common Counsel; Interest of Counsel. Eversheds Sutherland (US) LLP, counsel for the Company in connection with the offering of our common stock, advises the Adviser and its affiliates on various matters. Prospective investors should be aware that, to the extent the Company and the Offering would benefit from a review by independent counsel, such benefit has not been provided by the Company.
Investment by ERISA Plans
General Description of Registrant [Abstract]
Risk [Text Block]	Investment by ERISA Plans. We intend to conduct our operations so that they will not trigger “prohibited transactions” for benefit plan investors. We will use reasonable efforts to conduct our affairs so that our assets will not be deemed to be “plan assets” under the plan asset regulations promulgated by the Department of Labor. The fiduciary of each prospective benefit plan investor must independently determine that our common stock is an appropriate investment for such plan, taking into account the fiduciary’s obligations under the Employee Retirement Income Security Act of 1974 and the facts and circumstances of each investing benefit plan.
Limited Liquidity
General Description of Registrant [Abstract]
Risk [Text Block]	Limited Liquidity. There is currently no public market for our common stock, and a market for the common stock may never develop. The common stock is not registered under the 1933 Act, or any state securities law and is restricted as to transfer by law and the terms of the Subscription Agreement. Shareholders generally may not Transfer common stock unless (i) the Adviser provides prior written consent, which the Adviser may grant or withhold in its sole discretion, (ii) the Transfer is in compliance with the restrictions set forth in the Subscription Agreement, and (iii) the Transfer is made in accordance with applicable laws. Except in limited circumstances for legal or regulatory purposes or in connection with repurchase offers, as described below, shareholders are not entitled to redeem their common stock. While we may undertake a Liquidity Event, there can be no assurance that any potential liquidity event can be achieved. Furthermore, a Public Listing does not ensure that an actual market will develop for a listed security. In addition, following a Public Listing, shareholders may be restricted from selling or disposing of their shares of common stock by applicable securities laws or contractually by a lock-up agreement with the underwriters of any public offering of the common stock conducted in connection with a Public Listing or otherwise. Accordingly, the shareholders must be prepared to bear the economic risk of an investment in the common stock for an indefinite period of time, as there is no guarantee that any liquidity event other than the ultimate dissolution of the Company will occur, and it cannot be determined when such dissolution can be achieved.
Absence of SEC and Applicable State Securities Commission Reviews
General Description of Registrant [Abstract]
Risk [Text Block]	Absence of SEC and Applicable State Securities Commission Reviews. Because we are conducting a private offering that will not be registered under the 1933 Act or under applicable state securities or “blue sky” laws, any offering material will not be reviewed by the SEC or by the equivalent agency of any state or governmental entity. Review by any such agency might result in additional disclosures or substantially different disclosures from those actually included in any offering material.
Certain Regulatory Considerations, Securities Act of 1933
General Description of Registrant [Abstract]
Risk [Text Block]	Certain Regulatory Considerations, Securities Act of 1933. Pursuant to Rule 506 of Regulation D promulgated under the 1933 Act, the Company’s reliance on the “private placement” exemption from registration provided under Regulation D may become unavailable if “covered persons” become subject to a “disqualifying event.” “Covered persons” include beneficial owners of 20% or more of the Company’s outstanding equity securities, calculated on the basis of total voting power rather than on the basis of ownership of any single class of securities (a “20% Beneficial Owner”). In the event that a shareholder that is a 20% Beneficial Owner becomes subject to a disqualifying event, the Company may treat such shareholder as a Defaulting shareholder or take such other equitable measures as it may determine.
Shareholders May Experience Dilution
General Description of Registrant [Abstract]
Risk [Text Block]	Shareholders May Experience Dilution. Shareholders will not have preemptive rights to subscribe to or purchase any common stock issued in the future. To the extent we issue additional equity interests, including in a public offering or at subsequent closings during the Fundraising Period, a shareholder’s percentage ownership interest in the Company will be diluted. In addition, depending upon the terms and pricing of any additional offerings and the value of our investments, a shareholder also may experience dilution in the NAV and fair value of our common stock.
Preferred Stock Could be Issued
General Description of Registrant [Abstract]
Risk [Text Block]	P re ferred Stock Could be Issued. Although we have no current intention to do so, under the terms of the Charter, the Board is authorized, to the fullest extent permitted by the 1940 Act, to authorize us to issue preferred stock in one or more classes or series without shareholder approval. The Board, subject to the terms of any class or series of stock outstanding at the time, is required to set the preferences, conversion, and other rights, voting powers, restrictions, limitations as to dividends and other distributions, qualifications and terms and conditions of redemption of each class or series, including preferred stock with terms that might adversely affect the interest of our existing shareholders. If we issue preferred stock, there can be no assurance that such issuance would result in a higher yield or return to the shareholders. The issuance of preferred stock would likely cause the NAV of the common stock to become more volatile.
Significant Financial and Other Resources to Comply with the Requirements of Being a Public Reporting Entity
General Description of Registrant [Abstract]
Risk [Text Block]	Significant Financial and Other Resources to Comply with the Requirements of Being a Public Reporting Entity. We will be subject to the reporting requirements of the Exchange Act and requirements of the Sarbanes-Oxley Act. These requirements may place a strain on our systems and resources. The Exchange Act requires the Company to file annual, quarterly and current reports with respect to its business and financial condition. The Sarbanes-Oxley Act requires that the Company maintain effective disclosure controls and procedures and internal controls over financial reporting, which are discussed below. In order to maintain and improve the effectiveness of disclosure controls and procedures and internal controls, significant resources and management oversight will be required. The Company has implemented disclosure controls and procedures, processes, policies and practices for the purpose of addressing the standards and requirements applicable to public companies. These activities may divert management’s attention from other business concerns, which could have a material adverse effect on business, financial condition, results of operations and cash flows. The Company expects to incur significant additional annual expenses related to these steps and, among other things, directors’ and officers’ liability insurance, director fees, reporting requirements of the SEC, transfer agent fees, additional administrative expenses payable to the Administrator to compensate them for hiring additional accounting, legal and administrative personnel, increased auditing and legal fees and similar expenses. The systems and resources necessary to comply with public company reporting requirements will increase further once the Company ceases to be an “emerging growth company” under the JOBS Act. As long as the Company remains an emerging growth company, it intends to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies, including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act. This may increase the risk that material weaknesses or other deficiencies in the Company’s internal control over financial reporting go undetected. The Company will remain an emerging growth company for up to five years following an IPO, although if the market value of its common stock that is held by non-affiliates exceeds $700 million as of any June 30 before that time, it would cease to be an emerging growth company as of the following December 31.
Limited Experience Managing a BDC
General Description of Registrant [Abstract]
Risk [Text Block]	Limited Experience Managing a BDC. The personnel of Varagon and the Adviser have limited prior experience managing a BDC. The 1940 Act and the Code impose numerous constraints on the operations of BDCs that do not apply to the other types of investment vehicles. For example, under the 1940 Act, BDCs are generally required to invest at least 70% of their total assets primarily in securities of U.S. private or thinly traded companies that satisfy certain provisions of the 1940 Act. The failure to comply with these provisions in a timely manner could prevent us from qualifying as a BDC, which could be material. The Adviser’s limited experience in managing a portfolio of assets under such constraints may hinder the Company’s ability to take advantage of attractive investment opportunities and, accordingly, the Company’s investment returns could be substantially lower than the returns achieved by other vehicles managed by Varagon.
Conflicts Related to Obligations the Adviser Has to Other Clients
General Description of Registrant [Abstract]
Risk [Text Block]	Conflicts Related to Obligations the Adviser Has to Other Clients. Certain Adviser personnel serve, or may serve, as officers, directors, members, or principals of entities that operate in the same or a related line of business as we do, or of investment funds, accounts, or investment vehicles managed by the Adviser or affiliates of the Adviser. Similarly, the Adviser may have other clients with similar, different or competing investment objectives. In serving in these multiple capacities, the Adviser and certain personnel may have obligations to other clients or investors in those entities, the fulfillment of which may not be in the best interests of the Company or our shareholders. The Adviser intends to allocate any investment opportunities in a fair and equitable manner over time; however, there is no assurance that we will be able to participate in all investment opportunities or that investment opportunities will be allocated in a fair and equitable manner over time. Our investment strategy primarily includes investments in senior secured loans, but we may selectively make investments in second lien and subordinated or mezzanine loans, and equity and equity-related securities. As a result, members of the Adviser’s senior investment team and the IC, in their roles at the Adviser, may face conflicts in the allocation of investment opportunities among us and other entities sponsored or managed by the Adviser, Varagon and its affiliates with similar or overlapping investment objectives in a manner that is fair and equitable over time and consistent with the Adviser’s allocation policy. Generally, when a particular investment would be appropriate for us as well as other entities sponsored or managed by the Adviser, Varagon and its affiliates, such investment will be apportioned by the Adviser’s senior investment team in accordance with (1) the Adviser’s internal conflict of interest and allocation policies, (2) the requirements of the Advisers Act and (3) certain restrictions under the 1940 Act regarding co-investments with affiliates. Such apportionment may not be strictly pro rata, depending on the good faith determination of all relevant factors, including without limitation differing investment objectives, diversification considerations and the terms of our or the respective governing documents of such investment funds, accounts or investment vehicles. These procedures could, in certain circumstances, limit whether a co-investment opportunity is available to us, the timing of acquisitions and dispositions of investments, the price paid or received by us for investments or the size of the investment purchased or sold by us. The Adviser believes this allocation system is fair and equitable, and consistent with its fiduciary duty to us. In particular, we have disclosed to investors how allocation determinations are made among any investment vehicles sponsored or managed by the Adviser or its affiliates. As a BDC, the Company may be prohibited under the 1940 Act from conducting certain transactions with its affiliates without the prior approval of the Independent Directors and, in some cases, the prior approval of the SEC. We generally will only be permitted to co-invest with such investment funds, accounts and vehicles where the only term that is negotiated is price. The Company has received an exemptive order from the SEC that permits it, among other things, to co-invest with certain other persons and certain funds managed and controlled by Varagon or an affiliate, subject to the satisfaction of certain conditions. However, there can be no assurance that we will be able to participate in all investment opportunities that are suitable to us.
Fee-Related and Other Economic Potential Conflicts
General Description of Registrant [Abstract]
Risk [Text Block]	Fee-Related and Other Economic Potential Conflicts. As a BDC, we are generally limited in our ability to invest in any portfolio company in which the Adviser or any of its affiliates currently has an investment or to make any co-investments with other funds managed by our investment adviser or other affiliates without an exemptive order from the SEC, subject to certain exceptions. Nonetheless, potential conflicts may arise when the Adviser or its affiliates manage accounts that make performance payments or base management fees to the Adviser or its affiliates at different net rates or subject to different types of calculation methodologies from arrangements with the Company. The Adviser and its affiliates may have an economic incentive to allocate more favorable investment opportunities to, or otherwise for, an account from which the Adviser or an affiliate receives a higher performance payment or in which the Adviser or an affiliate has an ownership or other economic interests. In connection with certain investments made by the Company and investments made by certain clients, the Adviser or its affiliates may receive transaction fees and/or other consideration from portfolio investments in which one or more clients may invest or propose to invest, including portions of investments held by the Company or its subsidiaries, which may create additional conflicts of interest in connection with the structuring and allocation of investments.
Potential Conflicts Arising from the Ability of Varagon to Appoint Members of the IC
General Description of Registrant [Abstract]
Risk [Text Block]	Potential Conflicts Arising from the Ability of Varagon to Appoint Members of the IC. Varagon is responsible for appointing the members of the IC, which may include Varagon employees and independent members, and Varagon may replace members of the IC in its sole discretion. Therefore, a conflict may arise in the future to the extent that Varagon appoints an individual to the IC who has conflicts with the Company.
Potential Conflicts Arising from the Placement Agent
General Description of Registrant [Abstract]
Risk [Text Block]	Potential Conflicts Arising from the Placement Agent. Man Group is the ultimate parent company of Man Investments, which is also the ultimate parent of the Adviser. Man Investments is acting as the placement agent in connection with the Offering and will receive compensation relating to such services from Varagon or its affiliates. Potential conflicts may arise in connection with the foregoing.
Possession of Material Non-Public Information, Limiting the Adviser's Investment Discretion
General Description of Registrant [Abstract]
Risk [Text Block]	Possession of Material Non-Public Information, Limiting the Adviser’s Investment Discretion. Adviser personnel, including members of the IC, may serve as directors of, or in a similar capacity with, portfolio companies in which we invest, the securities of which are purchased or sold on our behalf. In the event that material non-public information is obtained with respect to such companies, or we become subject to trading restrictions under the internal trading policies of those companies or as a result of applicable law or regulations, we could be prohibited for a period of time from purchasing or selling the securities of such companies, and this prohibition may have an adverse effect on us.
Management Fees and Incentive Fees
General Description of Registrant [Abstract]
Risk [Text Block]	Management Fees and Incentive Fees. Even if the value of a shareholder’s investment declines, the management fee and, in certain cases, the incentive fee payable by us to the Adviser still will be payable to the Adviser. The management fee payable to the Adviser is calculated as a percentage of the Company’s adjusted gross assets, excluding cash and cash equivalents but including assets purchased with borrowed amounts. This management fee calculation may create an incentive for the Adviser to purchase assets with borrowed funds when it is unwise to do so or to pursue investments on our behalf that are riskier or more speculative than would be the case in the absence of such compensation arrangement. The incentive fee payable to the Adviser is calculated based on a percentage of our return on invested capital. The incentive fee arrangement may encourage the Adviser to use leverage to increase the return on our investments. Under certain circumstances, the use of leverage may increase the likelihood of default, which would impair the value of our common stock. In addition, in the event of a Public Listing, the Management Fee will increase from 0.75% to 1.00% of the average of the Company’s adjusted gross assets (for these purposes, “adjusted gross assets” exclude undrawn capital commitments and cash and cash equivalents but include assets purchased with borrowed amounts). Further, in the event of a Public Listing, the Income Incentive Fee and the Capital Gains Incentive Fees will increase from 12.5% to 20%, but otherwise will be calculated as set forth herein.
Limitation on Liability of the Adviser
General Description of Registrant [Abstract]
Risk [Text Block]	Limitation on Liability of the Adviser. The Adviser does not assume any responsibility to us other than to render the services described in, and on the terms of, the Investment Advisory Agreement, and will not be responsible for any action of our Board in declining to follow the advice or recommendations of the Adviser. The Investment Advisory Agreement provides that the Adviser, its officers, members and personnel, and any person controlling or controlled by the Adviser will not be liable to us or our shareholders for acts or omissions performed in accordance with and pursuant to the Investment Advisory Agreement, except those resulting from acts constituting willful misfeasance, bad faith or gross negligence, in the performance of his or her duties, or by reason of his or her reckless disregard of his or her obligations and duties under the Investment Advisory Agreement. In addition, as part of the Investment Advisory Agreement, we have agreed to indemnify the Adviser and each of its officers, directors, members, managers and employees from and against any claims or liabilities, including reasonable legal fees and other expenses reasonably incurred, arising out of or in connection with our business and operations or any action taken or omitted on our behalf pursuant to authority granted by the Investment Advisory Agreement, except where attributable to willful misfeasance, bad faith or gross negligence, in the performance of his or her duties, or by reason of his or her reckless disregard of his or her obligations and duties under the Investment Advisory Agreement. These protections may lead the Adviser to act in a riskier manner when acting on our behalf than it would when acting for its own account.
Nature of Investments
General Description of Registrant [Abstract]
Risk [Text Block]	Nature of Investments. We primarily invest in senior secured loans, but also may selectively invest in second lien and subordinated or mezzanine loans, and equity and equity-related securities. Senior Secured Loans. There is a risk that the collateral securing our senior secured loans may decrease in value over time, may be difficult to sell in a timely manner, may be difficult to appraise and may fluctuate in value based upon the success of the business and market conditions, including as a result of the inability of the portfolio company to raise additional capital. In some circumstances, our liens on the collateral securing our loans could be subordinated to claims of other creditors. In addition, deterioration in a portfolio company’s financial condition and prospects, including its inability to raise additional capital, may be accompanied by deterioration in the value of the collateral for the loan. Consequently, the fact that a loan is secured does not guarantee that we will receive principal and interest payments according to the loan’s terms, or at all, or that we will be able to collect on the loan should we be compelled to enforce our remedies. Second Lien and Subordinated Loans. We may invest in secured subordinated loans, including second and lower lien loans. Second lien loans are generally second in line in terms of repayment priority. A second lien loan may have a claim on the same collateral pool as the first lien or it may be secured by a separate set of assets. Second lien loans generally give investors priority over general unsecured creditors in the event of an asset sale. The priority of the collateral claims of third or lower lien loans ranks below holders of second lien loans and so on. Such junior loans are subject to the same general risks inherent to any loan investment, including credit risk, market and liquidity risk, and interest rate risk. Due to their lower place in the borrower’s capital structure and possible unsecured or partially secured status, such loans involve a higher degree of overall risk than senior secured loans of the same borrower. Mezzanine Loans. Our mezzanine loans generally will be subordinated to senior secured loans on a payment basis, are typically unsecured and rank pari passu with other unsecured creditors. As such, other creditors may rank senior to us in the event of insolvency. This may result in an above average amount of risk and loss of principal. Lower Grade Obligations . In addition, our investments will be in lower grade obligations. The lower grade investments in which we invest may be rated below investment grade (often referred to as “junk”) by one or more nationally recognized statistical rating agencies at the time of investment or may be unrated but determined by the Adviser to be of comparable quality. Loans or debt securities rated below investment grade are considered speculative with respect to the issuer’s capacity to pay interest and repay principal. The major risks of non-investment grade investments include: • Non-investment grade securities may be issued by less creditworthy issuers. Issuers of non-investment grade securities may have a larger amount of outstanding debt relative to their assets than issuers of investment grade securities. In the event of an issuer’s bankruptcy, claims of other creditors may have priority over the claims of holders of non-investment grade securities, leaving few or no assets available to repay holders of non-investment grade securities. • Prices of non-investment grade securities are subject to extreme price fluctuations. Adverse changes in an issuer’s industry and general economic conditions may have a greater impact on the prices of non-investment grade securities than on other higher rated fixed-income securities. • Issuers of non-investment grade securities may be unable to meet their interest or principal payment obligations because of an economic downturn, specific issuer developments, or the unavailability of additional financing. • Non-investment grade securities frequently have redemption features that permit an issuer to repurchase the security from us before it matures. If the issuer redeems non-investment grade securities, we may have to invest the proceeds in securities with lower yields and may reduce income. • Non-investment grade securities may be less liquid than higher rated fixed-income securities, even under normal economic conditions. There are fewer dealers in the non-investment grade securities market, and there may be significant differences in the prices quoted by the dealers. Judgment may play a greater role in valuing these securities and we may be unable to sell these securities at an advantageous time or price. • We may incur expenses to the extent necessary to seek recovery upon default or to negotiate new terms with a defaulting issuer. The credit rating of a high yield security does not necessarily address its market value risk. Ratings and market value may change from time to time, positively or negatively, to reflect new developments regarding the issuer. Equity and Equity-related Investments . When we invest in senior secured loans, second lien and subordinated or mezzanine loans, we may acquire equity and equity-related securities in a portfolio company, such as rights and warrants that may be converted into or exchanged for the issuer’s common stock or the cash value of the issuer’s common stock. In addition, we may invest directly in the equity securities of portfolio companies. Our goal is ultimately to dispose of such equity interests and realize gains upon our disposition of such interests. However, the equity interests we receive may not appreciate in value and, in fact, may decline in value. Accordingly, we may not be able to realize gains from our equity interests, and any gains that we do realize on the disposition of any equity interests may not be sufficient to offset any other losses we experience. We will generally have little, if any, control over the timing of any gains we may realize from our equity investments. We also may be unable to realize any value if a portfolio company does not have a liquidity event, such as a sale of the business, recapitalization or public offering, which would allow us to sell the underlying equity interests. We may be unable to exercise any put rights we acquire, which would grant us the right to sell our equity securities back to the portfolio company, for the consideration provided in its investment documents if the issuer is in financial distress. Investments in the Subordinated Certificates and Subordinated Interests of Structured Vehicles. The Company invests in the Subordinated Certificates, and in the future may invest in similar first loss or subordinated interests of other structured investment vehicles, including without limitation CLOs (together with other structured investment vehicles, “Structured Vehicles”). Structured Vehicles have leverage embedded in their structures, which can affect the risk and return profile of various tranches of such structures. The Company expects to invest, directly or indirectly, in the unrated or most subordinated tranches of Structured Vehicles that own middle market or other loans and that may be advised by affiliates of the Adviser. The Company’s rights with respect to first loss or subordinated interest investments in Structured Vehicles, such as the SDLP and CLO equity investments, differ from other types of investments. For example, the Company will not have recourse against the issuers or obligors of the underlying asset pools. If proceeds from the underlying asset pools are not sufficient to provide payments on, or reduce the residual value of, the tranches that the Company, directly or indirectly, holds, the Company will lose money. In addition, the amount of distributions on the Subordinated Certificates will be affected by, among other things, the timing of purchases of underlying loans, the rates of repayment of or distributions on the underlying loans, the rates of delinquencies and defaults on and liquidations of the underlying loans and any unexpected significant expenses incurred by the Structured Vehicle. Moreover, upon the Structured Vehicle’s failure to satisfy its financial covenants or other covenants or upon the occurrence of any other event of default, proceeds otherwise available for distribution to the subordinated tranches of Structured Vehicle (such as the Subordinated Certificates) may be required instead to redeem senior tranches or held to satisfy applicable covenants. Interests of the holders of the senior tranches of a Structured Vehicle, in the event of a default or otherwise, may diverge from the interest of the holders of the subordinated tranches, including the Company. In an event of default, payment to the Company may be deferred or significantly reduced and the Company may be unable to exercise additional remedies under the governing documents. Certificates, including the Subordinated Certificates, issued in connection with Structured Vehicles may not be registered under the 1933 Act, and may have a limited market or no market, and the Company may not be able to sell such certificates at favorable prices, if at all. Generally, certificates in which the Company invests would be unrated (as is the case with the Subordinated Certificates); however, a downgrade in more senior tranches could still negatively impact the value of the unrated tranches. In addition, certain downgrades in the ratings of the rated tranches, or a withdrawal of the ratings of a tranche, may result in an event of default under the Structured Vehicle’s governing documents. Moreover, there is no assurance that any holder of any of the issued securities of a Structured Vehicle will fund its respective capital contributions when required. A failure by any such holder to fund any commitment when required, including in the case of the SDLP, may impair the ability of the Structured Vehicle to fund amounts required, resulting in an impairment in the value of the Structured Vehicle, and therefore the Company’s investment in its certificates. In the case of the SDLP, the Company, as a minority indirect holder of the Subordinated Certificates, in numerous instances will not control the timing of a redemption or refinancing of, or purchase of certain assets from, the SDLP following certain trigger events, as these rights are reserved to the majority Certificate holder. In the event that the majority Certificate holder elects to direct a redemption or refinancing or exercises its right to purchase those assets from SDLP, the Company will have the right to participate ratably in the proceeds allocated to the Subordinated Certificates and the right to purchase its pro rata portion of any assets sold to the majority Certificate holder on the same terms. Nonetheless, investment and other material decisions of the SDLP require the approval of the SDLP’s investment committee, on which investment committee each of the Company and ARCC exercises two votes. As a result, the Company does not have sole discretionary authority in respect of actions of the SDLP. The Company has no current plan or intent to sell the Subordinated Certificates within the five-year period beginning on the date of the Initial Closing, although the Company, in its sole discretion acting in the best interest of the Company, may determine to so sell the Subordinated Certificates at any time in the future. In October 2014, six federal agencies adopted joint final rules implementing the credit risk retention requirements of Section 941 of the Dodd-Frank Act (the “Final U.S. Risk Retention Rules”) in respect of a variety of financing securitization structures. There is uncertainty as to whether or not the Final U.S. Risk Retention Rules would apply to the SDLP and similar CLOs. While we believe that the SDLP has been structured to comply with the Final U.S. Risk Retention Rules (the “RR Structure”) were they to apply, there can be no assurance that the applicable governmental authorities will agree that the RR Structure, will satisfy any such requirements of the Final U.S. Risk Retention Rules. To the extent the Final U.S. Risk Retention Rules were determined to apply to the SDLP and the RR Structure was determined to not be compliant with the Final U.S. Risk Retention Rules, the Company, through its indirect interest in the Subordinated Certificates, could be required to pay damages, transfer interests, be subject to cease and desist orders or other regulatory action, which could materially adversely affect the value of the Subordinated Certificates.
Risks Associated with Investments in Middle Market Companies
General Description of Registrant [Abstract]
Risk [Text Block]	Risks Associated with Investments in Middle Market Companies. Investment in private and middle market companies involves a number of significant risks including: • such companies may have limited financial resources and may be unable to meet their obligations under their debt securities that we hold, which may be accompanied by a deterioration in the value of any collateral and a reduction in the likelihood of us realizing any guarantees we may have obtained in connection with its investment; • such companies typically have shorter operating histories, narrower product lines and smaller market shares than larger businesses, which tend to render them more vulnerable to competitors’ actions and market conditions, as well as to general economic downturns; • such companies are more likely to depend on the management talents and efforts of a small group of persons; therefore, the death, disability, resignation or termination of one or more of these persons could have a material adverse impact on the portfolio company and, in turn, on us; • such companies generally have less predictable operating results, may be engaged in rapidly changing businesses with products subject to a substantial risk of obsolescence, and may require substantial additional capital to support their operations, finance expansion or maintain their competitive position; • debt investments in such companies generally may have a significant portion of principal due at the maturity of the investment, which would result in a substantial loss to us if such borrowers are unable to refinance or repay their debt at maturity; • our executive officers, directors and the Adviser may, in the ordinary course of business, be named as defendants in litigation arising from our investments in such companies; • such companies generally have less publicly available information about their businesses, operations and financial condition and, if we are unable to uncover all material information about these companies, we may not make a fully informed investment decision; and such companies may have difficulty accessing the capital markets to meet future capital needs, which may limit their ability to grow or to repay their outstanding indebtedness upon maturity.
Portfolio Company Debt and Equity
General Description of Registrant [Abstract]
Risk [Text Block]	Portfolio Company Debt and Equity. Our portfolio companies may have, or may be permitted to incur, other debt or issue equity securities that rank equally with, or senior to, the debt in which we invest. By their terms, such debt instruments or equity securities may entitle the holders to receive payment of dividends, interest or principal on or before the dates on which we are entitled to receive payments with respect to our investments. These debt instruments or equity securities would usually prohibit the portfolio companies from paying interest on or repaying our investments in the event and during the continuance of a default under such debt or equity securities. Also, in the event of insolvency, liquidation, dissolution, reorganization or bankruptcy of a portfolio company, holders of debt instruments or equity securities ranking senior to our investment in that portfolio company would typically be entitled to receive payment in full before we receive any distribution in respect of our investment. After repaying such senior creditors, such portfolio company may not have any remaining assets to use for repaying its obligation to us. In the case of debt or equity securities ranking equally with debt instruments in which we invest, we would have to share on an equal basis any distributions with other creditors holding such debt or equity in the event of an insolvency, liquidation, dissolution, reorganization or bankruptcy of the relevant portfolio company.
Subordinated Liens on Collateral
General Description of Registrant [Abstract]
Risk [Text Block]	Subordinated Liens on Collateral. Certain debt investments that we may make in portfolio companies will be secured on a subordinated priority basis by the same collateral securing more senior secured debt of such companies. A significant portion of our first lien and unitranche loans may be subordinated to “first-out” revolving loans following certain events with respect to such loans. While such first lien and unitranche loans are expected to have many attributes of senior secured loans, these investments may involve additional risks that could adversely affect such investments. In addition, certain loans that we may make in portfolio companies will be secured on a second priority basis by the same collateral securing senior secured debt of such companies. The first priority liens on the collateral will secure the portfolio company’s obligations under any outstanding senior debt and may secure certain other future debt that may be permitted to be incurred by the company under the agreements governing the debt. The holders of obligations secured by the first priority liens on the collateral will generally control the liquidation of and be entitled to receive proceeds from any realization of the collateral to repay their obligations in full before we are so entitled. In addition, the value of the collateral in the event of liquidation will depend on market and economic conditions, the availability of buyers and other factors. There can be no assurance that the proceeds, if any, from the sale or sales of all of the collateral would be sufficient to satisfy the debt obligations secured by the second priority liens after payment in full of all obligations secured by the first priority liens on the collateral. If such proceeds are not sufficient to repay amounts outstanding under the debt obligations secured by the second priority liens, then, to the extent not repaid from the proceeds of the sale of the collateral, we will only have an unsecured claim against the company’s remaining assets, if any. We also may make unsecured debt investments in portfolio companies, meaning that such investments may not benefit from any interest in collateral of such companies. Liens on such portfolio companies’ collateral, if any, will secure the portfolio company’s obligations under its outstanding secured debt and may secure certain future debt that is permitted to be incurred by the portfolio company under its secured debt agreements. The holders of obligations secured by such liens will generally control the liquidation of, and be entitled to receive proceeds from, any realization of such collateral to repay their obligations in full before we are so entitled. In addition, the value of such collateral in the event of liquidation will depend on market and economic conditions, the availability of buyers and other factors. There can be no assurance that the proceeds, if any, from sales of such collateral would be sufficient to satisfy its unsecured debt obligations after payment in full of all secured debt obligations. If such proceeds were not sufficient to repay the outstanding secured debt obligations, then its unsecured claims would rank equally with the unpaid portion of such secured creditors’ claims against the portfolio company’s remaining assets, if any. The rights we may have with respect to the collateral securing the debt investments we make in portfolio companies with senior debt outstanding also may be limited pursuant to the terms of one or more inter-creditor agreements that we enter into with the holders of senior debt. Under such an inter-creditor agreement, at any time that obligations that have the benefit of the first priority liens are outstanding, any of the following actions that may be taken in respect of the collateral will be at the direction of the holders of the obligations secured by the first priority liens: the ability to cause the commencement of enforcement proceedings against the collateral; the ability to control the conduct of such proceedings; the approval of amendments to collateral documents; releases of liens on the collateral; and waivers of past defaults under collateral documents. We may not have the ability to control or direct such actions, even if our rights are adversely affected.
The Company's Investments Will Be Illiquid and Long Term
General Description of Registrant [Abstract]
Risk [Text Block]	The Company’s Investments Will Be Illiquid and Long Term. We generally will make loans to private companies that are illiquid and may be difficult for us to sell if the need arises. Although portfolio financings and investments by us may generate current income, the return of capital and the realization of gains, if any, from a financing or investment generally will occur only upon the partial or complete satisfaction of the financing conditions or disposition of such investment, which may not occur for a number of years after the investment is made. If we are required to liquidate all or a portion of our portfolio quickly, we may realize significantly less than the value at which we had previously recorded such investments. In addition, we will not be able to sell securities we purchase publicly, if we hold any, unless the sale of such securities is registered under applicable securities laws, or unless an exemption from such registration requirements is available. In addition, in some cases, we may be prohibited by contract from selling certain securities we invest in for a period of time or we may face other restrictions on our ability to liquidate an investment in a portfolio company to the extent that we hold a significant portion of a company’s equity or if we have material non-public information regarding that company. Furthermore, under the 1940 Act, if there is no readily available market for these investments, we are required to carry these investments at fair value as determined by the Board. As a result, if we are required to liquidate all or a portion of our portfolio quickly, we may realize significantly less than the value at which we had previously recorded these investments.
Risks Relating to Covenant-Lite Loans
General Description of Registrant [Abstract]
Risk [Text Block]	Risks Relating to Covenant-Lite Loans. On occasion, the Company and/or SDLP may invest in covenant-lite loans if the investment’s credit merits are particularly strong (e.g., high recurring revenue, strong retention rates, market leader, compelling value proposition, highly diversified customer base, etc.), the sponsors are highly reputable and relationship-oriented, and the economic profile is highly favorable (e.g., large established company with greater than $50 million of EBITDA and strong EBITDA margins). We use the term “covenant-lite” loans to refer generally to loans that do not have a complete set of financial maintenance covenants. Generally, “covenant-lite” loans provide borrower companies more freedom to negatively impact lenders because their covenants are incurrence-based, which means they are only tested and can only be breached following an affirmative action of the borrower, rather than by a deterioration in the borrower’s financial condition. Accordingly, to the extent the Company and/or SDLP invests in “covenant-lite” loans, the Company and/or SDLP may have fewer rights against a borrower and may have a greater risk of loss on such investments as compared to investments in or exposure to loans with financial maintenance covenants.
Limited Number of Portfolio Companies
General Description of Registrant [Abstract]
Risk [Text Block]	Limited Number of Portfolio Companies. To the extent we assume large positions in the securities of a small number of issuers or industries, our NAV may fluctuate to a greater extent than that of a more diversified investment company as a result of changes in the financial condition or the market’s assessment of the issuer. In addition, the aggregate returns we realize may be significantly adversely affected if a small number of investments perform poorly or if we need to write down the value of any one investment. Additionally, a downturn in any particular industry in which we are invested could significantly affect our aggregate returns.
Follow-on Investments in Portfolio Companies
General Description of Registrant [Abstract]
Risk [Text Block]	Follow-on Investments in Portfolio Companies. Following an initial investment in a portfolio company, we may make additional investments in that portfolio company as “follow-on” investments, in seeking to: • increase or maintain in whole or in part our position as a creditor or equity ownership percentage in a portfolio company; • exercise warrants, options or convertible securities that were acquired in the original or subsequent financing; or preserve or enhance the value of our investment.
Portfolio Company Leverage
General Description of Registrant [Abstract]
Risk [Text Block]	Portfolio Company Leverage. Our portfolio companies will typically have capital structures with significant leverage. Leveraged companies in which we invest may have limited financial resources and may be unable to meet their obligations under their loans and debt securities that we hold. Although the Adviser will seek to structure transactions in an attempt to minimize these risks, such leverage may increase our exposure to adverse economic factors such as rising interest rates, downturns in the general economy or deterioration in the condition of the portfolio company or its sector in its particular industry. Such developments may be accompanied by a deterioration in the value of any collateral and a reduction in the likelihood of us realizing any guarantees that we may have obtained in connection with our investment. Smaller leveraged companies also may have less predictable operating results and may require substantial additional capital to support their operations, finance their expansion or maintain their competitive position. A portfolio company’s failure to satisfy financial or operating covenants imposed by us or other lenders could lead to defaults and, potentially, acceleration of the time when the loans are due and foreclosure on its assets representing collateral for its obligations, which could trigger cross defaults under other agreements and jeopardize the value of any equity securities we own and the portfolio company’s ability to meet its obligations under any debt that we hold. We may incur expenses to the extent necessary to seek recovery upon default or to negotiate new terms with a defaulting portfolio company.
Defaults by Portfolio Companies
General Description of Registrant [Abstract]
Risk [Text Block]	Defaults by Portfolio Companies. Our business is at risk if one of our borrowers defaults. A portfolio company’s failure to satisfy financial or operating covenants imposed by us or other lenders could lead to defaults and, potentially, termination of its loans and foreclosure on its assets. This could trigger cross-defaults under other agreements and jeopardize such portfolio company’s ability to meet its obligations under the loans or debt or equity securities that we hold. We may incur expenses to the extent necessary to seek recovery upon default or to negotiate new terms, which may include the waiver of certain financial covenants, with a defaulting portfolio company. Additionally, the return of principal of loans will depend in large part on the creditworthiness and financial strength of borrowers. If there is a default by the borrower under a loan, we will, in many circumstances, have contractual remedies pursuant to the loan agreements, including, in many cases, the sale of collateral. However, exercising such contractual rights may involve delays or costs, and any available collateral may prove to be unsaleable or saleable only at a price less than the loaned amount, which could result in a loss to the Company. There can be no guarantee that legal action will allow for the recovery of all outstanding loan balances due to the Company. We may choose to enter into forbearance agreements or delay legal action if it believes that such action improves the opportunity for a better outcome. The pursuit or delay of legal action may significantly increase the amount of time required to collect principal balances or lead to principal losses.
Prepayments by Portfolio Companies
General Description of Registrant [Abstract]
Risk [Text Block]	Prepayments by Portfolio Companies. We will be subject to the risk that the debt investments we make in portfolio companies may be repaid prior to maturity. The Adviser expects that our investments will generally allow for repayment at any time subject to certain penalties. When this occurs, the Adviser may reinvest a portion of these proceeds in temporary investments, pending their future investment in accordance with our investment strategy. These temporary investments will typically have substantially lower yields than the debt being prepaid, and we could experience significant delays in reinvesting these amounts. Any future investment also may be at lower yields than the debt that was repaid. As a result, our results of operations could be materially adversely affected if one or more of our portfolio companies elect to prepay amounts owed to us.
Risks Related to Non-Controlling Investments [Member]
General Description of Registrant [Abstract]
Risk [Text Block]	Risks Related to Non-Controlling Investments. We expect that at least a majority of investments we make will be non-controlling investments, meaning we will not be in a position to control the management, operation and strategic decision-making of the companies in which we invest. As a result, we will be subject to the risk that a portfolio company we do not control, or in which we do not have a majority ownership position, may make business decisions with which we disagree, and the equity holders and management of such a portfolio company may take risks or otherwise act in ways that are adverse to our interests. Due to the lack of liquidity for the debt investments that we will typically hold in our portfolio companies, we may not be able to dispose of our investments in the event that we disagree with the actions of a portfolio company, and may therefore suffer a decrease in the value of such portfolio company.
Risks Associated with Bankruptcy Cases
General Description of Registrant [Abstract]
Risk [Text Block]	Risks Associated with Bankruptcy Cases. As part of the Company’s lending activities, the Company may originate loans to companies that are experiencing significant financial or business difficulties, including companies involved in bankruptcy or other reorganization and liquidation proceedings. While the Company expects that the terms of such financing may result in significant financial returns to the Company, it involves a substantial degree of risk. The level of analytical sophistication, both financial and legal, necessary for successful financing to companies experiencing significant business and financial difficulties is unusually high. There is no assurance that the Company will correctly evaluate the value of the assets collateralizing the Company’s loans or the prospects for a successful reorganization or similar action. In any reorganization or liquidation proceeding relating to a company that the Company invests in, the Company may lose all or part of the amounts advanced to the portfolio company or may be required to accept collateral with a value less than the amount of the loan advanced by the Company to the portfolio company. Many of the events within a bankruptcy case are adversarial and often beyond the control of the creditors. While creditors generally are afforded an opportunity to object to significant actions, there can be no assurance that a bankruptcy court would not approve actions that may be contrary to the interests of the Company. Furthermore, there are instances where creditors and equity holders lose their ranking and priority as such if they are considered to have taken over management and functional operation of a debtor. Generally, the duration of a bankruptcy case can only be roughly estimated. The reorganization of a company usually involves the development and negotiation of a plan of reorganization, plan approval by the creditors and confirmation by a bankruptcy court. This process can involve substantial legal, professional and administrative costs to the debtor company and the Company; it is subject to unpredictable and lengthy delays; and during the process the Company’s competitive position may erode, key management may depart and the debtor company may not be able to operate adequately. In some cases, the debtor company may not be able to reorganize and may be required to liquidate assets. The debt of companies in financial reorganization, in most cases, will not pay current interest, may not accrue interest during reorganization and may be adversely affected by an erosion of the issuer’s fundamental value. Such investments can result in a total loss of principal. U.S. bankruptcy law permits the classification of “substantially similar” claims in determining the classification of claims in reorganization for purposes of voting on a plan of reorganization. Because the standard for classification is vague, there exists a significant risk that the Company’s influence with respect to a class of securities can be lost by the inflation of the number and amount of claims in, or other gerrymandering of, the class. In addition, certain administrative costs and claims that have priority by law over the claims of certain creditors (for example, claims for taxes) may be quite high. Furthermore, there are instances where creditors and equity holders lose their ranking and priority as such when they take over management and functional operating control of a debtor. Therefore, depending on the facts and circumstances, including the extent to which the Company actually provided managerial assistance to a portfolio company or its representative or the Adviser sat on the board of directors of such portfolio company, a bankruptcy court might re-characterize the Company’s debt investment and subordinate all or a portion of its claim to that of other creditors. A representative of the Company may serve on creditors’ committees or other groups to ensure preservation or enhancement of its position as a creditor or equity holder. A member of any such committee or group may owe certain obligations generally to all parties similarly situated that the committee represents. If the Company’s representative concludes that the obligations they owe to other parties as a committee or group member conflict with the duties they owe to the Company, they will resign from that committee or group, and the Company will not realize the benefits, if any, of participating on the committee or group. In addition, and also as discussed above, if the Company is represented on a committee or group, it may be restricted or prohibited under applicable law from, disposing of or increasing its investments in such debtor company while it continues to be represented on such committee or group. In addition, lenders can be subject to lender liability claims for actions taken by them where they become too involved in the borrower’s business or exercise control over the borrower. For example, the Company could become subject to a lender’s liability claim, if, among other things, the Company actually renders significant managerial assistance.
Interest Rate Risk [Member]
General Description of Registrant [Abstract]
Risk [Text Block]	Risks Related to Changes in Interest Rates. Because we may borrow money to make investments, our net investment income will depend, in part, upon the difference between the rate at which we borrow funds and the rate at which we invest those funds. As a result, we can offer no assurance that a significant change in interest rates would not have a material adverse effect on our net investment income in the event we use debt to finance our investments. In periods of rising interest rates, our cost of funds would increase, which could reduce our net investment income. Rising borrowing costs may contribute to the difficulty of companies in servicing their debt obligations and may lead to increases in default rates. Certain changes in interest rates could have a material adverse effect on the Company and its investments. Moreover, changes in interest rates could have a material negative impact on the financial condition of borrowers, the valuations for loans, the unanticipated repayments of loans, and pressure to renegotiate terms on existing loans. In response to recent market indicators showing a rise in inflation, the Federal Reserve has raised certain benchmark interest rates in an effort to slow inflation. This rising interest rate environment may impact our cost of capital and net investment income. Since March 2022, the Federal Reserve has been rapidly raising interest rates and has indicated that it may consider additional rate hikes in response to ongoing inflation concerns. Increases in interest rates can make it more expensive to use debt to finance our investments. General interest rate fluctuations may have a substantial negative impact on our investments and investment opportunities and, accordingly, may have a material adverse effect on our ability to achieve our investment objective and the rate of return on invested capital. As a result, there can be no assurance that a significant change in market interest rates will not have a material adverse effect on our net investment income.
[1] (1) The per share data for 2023 was derived by using the weighted average shares outstanding. The per share data for 2022 was derived by using the weighted average shares outstanding from June 2, 2022 (commencement of investment operations) through December 31, 2022. (2) Per share data for the year ended December 31, 2022 based upon the weighted average shares outstanding from March 29, 2022 (first issuance of common stock) through December 31, 2022 were as follows: Net investment income of $ 0.71 per share, net unrealized loss of $ 0.30 per share, net increase in net assets resulting from operations of $ 0.41 per share, distributions of net investment income of $ 0.68 per share, and net asset value per share at the end of the period of $ 9.73 per share. (3) Net asset value at the beginning of the period from June 2, 2022 (commencement of investment operations) through December 31, 2022 is adjusted to reverse the initial share issuance of 100 shares of common stock in connection with the Company's seed audit, as well as $ 81,049 of accrued expenses. Net asset value after the Company's seed audit was $( 810.39 ) per share.

Organization

Organization	12 Months Ended
	Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization	Note 1. Organization Varagon Capital Corporation (the “Company”) was formed on July 31, 2019 as a corporation under the laws of Maryland. The Company is an externally managed, non-diversified closed-end management investment company that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). In addition, for U.S. federal income tax purposes, the Company elected, and intends to qualify annually, to be treated as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”). The Company’s fiscal year end is December 31. VCC Advisors, LLC (the “Adviser”) serves as the Company’s investment adviser. The Adviser is registered with the Securities and Exchange Commission (the “SEC”) under the Investment Advisers Act of 1940, as amended (the “Advisers Act”), and is a subsidiary of Varagon Capital Partners, L.P. (“Varagon”), which is also registered with the SEC as an investment adviser under the Advisers Act. Subject to the overall supervision of the Company’s board of directors (the “Board”), the Adviser manages the day-to-day operation of, and provides investment advisory and management services to, the Company. The Company’s investment objective is to generate current income with a focus on capital preservation and, to a lesser extent, capital appreciation by investing primarily in directly originated leveraged loans to U.S. middle market companies. The Company intends to achieve its investment objective by investing primarily in senior secured loans to performing middle market companies controlled by private equity sponsors. The Company focuses on loans to middle market companies that have sustainable competitive advantages, experienced management teams, solid financial performance, stable and recurring cash flow and strong enterprise value. The Company expects that such companies and their sponsors will require financing from the Company for growth, acquisitions, recapitalizations, refinancings or leveraged buyouts, among other things. The Company generally intends to directly originate its investments as a lead lender to allow for deeper diligence, greater control over terms and structure, and superior economics. The Company has a wholly owned subsidiary, VCC Equity Holdings, LLC ("VCCEH”), that is taxed as a corporation for federal income tax purposes. VCCEH was formed to hold equity securities of portfolio companies organized as pass-through entities while continuing to satisfy the requirements of a RIC under the Code, and the assets held by VCCEH are pledged as collateral supporting the amounts outstanding under the CIBC Facility (as discussed below). In addition, the Company has two other wholly owned subsidiaries, VCC Funding, LLC ("VCCF"), a bankruptcy remote special purpose entity, whose assets are pledged as collateral supporting the amounts outstanding under the JPM Facility (See "Note 6. Borrowings"), and Varagon SDLP, LLC (“VSDLP”), which holds the Company’s interest in the SDLP (as defined below). VCCEH, VCCF and VSDLP are each wholly owned subsidiaries of the Company, and as such are consolidated in its consolidated financial statements from June 2, 2022, the commencement of investment operations, in accordance with the Company’s consolidation policy. Formation Transactions On March 29, 2022, in connection with its seed audit, the Company issued 100 shares of the Company's common stock for $ 10.00 to Varagon, which were subsequently redeemed on June 2, 2022, in connection with the Merger (as described below). On June 2, 2022 , Varagon Fund I, L.P., a Delaware limited partnership and a private fund exempt from registration pursuant to Section 3(c)(7) of the 1940 Act (“VF1”), merged with and into the Company (the “Merger”), with the Company continuing as the surviving entity. As a result of the Merger, the Company acquired all of VF1’s assets and liabilities (the “Existing Portfolio”), including all of VF1’s interests in the joint venture, Senior Direct Lending Program (“SDLP”), in exchange for shares of the Company’s common stock. Accordingly, the Company received $ 40.9 million in cash and $ 145.2 million in investments at fair value, which consisted of a non-cash purchase of a $ 142.1 million investment and $ 3.1 million of total accumulated earnings. In addition, $ 191.3 million of VF1 investor commitments were converted into capital commitments to the Company (of which, $ 185.5 million was funded). In addition, the Company issued 18.6 million of shares of common stock at $ 10.00 per share to the limited partners of VF1 in exchange for the assets and liabilities of VF1. Additionally, on June 2, 2022, the Company received $ 296.9 million of capital commitments (of which, $ 175.2 million was funded) (the “Initial Closing”) and the Company issued 17.5 million shares of common stock at $ 10.00 per share to new investors. The Company also became the sole member of its wholly owned subsidiaries VCCF and VSDLP. On June 2, 2022, immediately prior to its election to be regulated as a BDC, the Company purchased a portfolio of existing loans for $ 449.4 million (the “Warehoused Portfolio” and together with the Existing Portfolio, the “Initial Portfolio”) from certain affiliates of the Adviser using proceeds from the Initial Closing and borrowings under the JPM Facility pursuant to loan sale and purchase agreements. In connection with the purchase of the Initial Portfolio, the Board reviewed and approved the fair value of the Initial Portfolio based on the Adviser’s internal analysis and input from third-party valuation firms. Varagon Transaction with Man Group plc On July 5, 2023, Varagon entered into an Agreement and Plan of Merger (the “Merger Agreement”) with affiliates of Man Group plc (“Man Group”), pursuant to which a newly formed indirect subsidiary of Man Group merged with and into Varagon, with Varagon surviving the merger as an indirect subsidiary of Man Group (the “Transaction”). The Transaction closed on September 6, 2023. As a result, following the Transaction, Man Group owns a majority interest in Varagon and Varagon management continues to own, directly or indirectly, a minority interest in Varagon. Although the ownership of Varagon changed as a result of the Transaction, there are no material changes to the investment advisory or administrative services performed by the Adviser or Varagon in its capacity as the Company’s administrator.

Significant Accounting Policies

Significant Accounting Policies	12 Months Ended
	Dec. 31, 2023
Accounting Policies [Abstract]
Significant Accounting Policies	Note 2. Significant Accounting Policies Basis of Presentation The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) and pursuant to Regulation S-X and include the accounts of the Company and its consolidated subsidiaries. As an investment company, the Company applies the accounting and reporting guidance in Accounting Standards Codification (“ASC”) Topic 946, Financial Services – Investment Companies (“ASC 946”) issued by the Financial Accounting Standards Board (“FASB”). The consolidated financial statements reflect all adjustments and reclassifications that, in the opinion of management, are necessary for the fair presentation of the results of operations and financial condition as of and for the period presented. All significant intercompany balances and transactions have been eliminated. Cash Cash consists of deposits held at a custodian bank and, at times, may exceed the insured limits under applicable law. As of December 31, 2023, the Company held approximately $ 20.0 million in cash. As of December 31, 2022, the Company held approximately $ 20.4 million in ca sh. Organizational and Offering Expenses Organizational and offering expenses consist of all costs and expenses, whether incurred before, on or after the date of the private placement memorandum relating to the Company’s private offering of shares of common stock (the “Offering”), pertaining to the organization and establishment of the Company (including any subsidiaries of the Company and the transactions contemplated by the Merger and the acquisition of the Initial Portfolio), including, without limitation, any related third-party legal, tax and accounting advisory fees and expenses, capital raising expenses, including printing expenses and other similar costs, fees and expenses, and regulatory, compliance, and administrative filings, and other organizational and offering expenses, but excluding the fees of any placement agent engaged on behalf of the Company. The Adviser elected to incur the organizational and offering expenses associated with the Company (See "Note 7. Related Party Transactions”) for the period from July 31, 2019 through March 29, 2022. Such organizational and offering expenses are not reimbursable by the Company. For the period from July 31, 2019 through December 31, 2019, the Adviser incurred $ 46,384 of organizational and offering expenses. For the year ended December 31, 2020, the Adviser incurred $ 11,805 of organization costs. For the year ended December 31, 2021, the Adviser incurred $ 0.1 million of organizational and offering expenses. For the period of January 1, 2022 through March 29, 2022, the Adviser incurred $ 0.4 million of organizational and offering expenses. For the year ended December 31, 2023, the Company incurred and expensed $ 0.4 million of organizational expenses. For the year ended December 31, 2022 , the Company incurred and expensed $ 0.2 million of organizational expenses. Use of Estimates in the Preparation of Financial Statements The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Actual results could differ from those estimates. Deferred Financing Costs Deferred financing costs, incurred in connection with any revolving credit facility are presented as an asset on the Company’s Consolidated Statement of Assets and Liabilities and are deferred and amortized over the life of the respective credit facility (See "Note 6. Borrowings”). Indemnifications In the normal course of its business, the Company may enter into contracts that contain a variety of representations and warranties, which provide general indemnifications. The Company’s maximum exposure under these arrangements is unknown, as this would involve future claims that may be made against the Company that have not yet occurred. However, management believes the risk of loss to be remote. Revenue Recognition Investment transactions are accounted for on a trade-date basis. Realized gains or losses on investments are measured by the difference between the net proceeds from the disposition and the amortized cost basis of investment, without regard to unrealized gains or losses previously recognized. The Company reports current period changes in fair value of investments that are measured at fair value as a component of the net change in unrealized appreciation (depreciation) on investments in the Consolidated Statement of Operations. Investment Income Interest income, including amortization of premium and accretion of discount, is recorded on the accrual basis to the extent that such amounts are expected to be collected. The Company records amortized or accreted discounts or premiums as interest income using the effective interest method and is adjusted only for material amendments or prepayments. Dividend income, which represents dividends from equity investments and distributions from subsidiaries, if any, is recognized on an accrual basis to the extent that the Company expects to collect such amount. Interest income from investments in the Subordinated Certificates (as defined below) of SDLP is recorded based on an estimate of an effective yield to expected maturity utilizing assumed cash flows in accordance with ASC Topic 325-40, Beneficial Interests in Securitized Financial Assets . The Company monitors the expected cash flows from these investments, including the expected residual payments, and the effective yield is determined and updated periodically. Any difference between the cash distribution received and the amount calculated pursuant to the effective interest method is recorded as an adjustment to the cost basis of such investments. PIK Interest The Company may, from time to time, hold loans in its portfolio that contain a payment-in-kind ("PIK") interest provision. PIK interest, computed at the contractual rate specified in each loan agreement, is periodically added to the principal balance of the loan, rather than being paid to the Company in cash, and is recorded as interest income. Thus, the actual collection of PIK interest may be deferred until the time of debt principal repayment. PIK interest, which is a non-cash source of income at the time of recognition, is included in the Company’s taxable income, and therefore affects the amount the Company would be required to distribute to its shareholders to maintain its tax treatment as a RIC for U.S. federal income tax purposes, even though the Company would have not yet collected the cash. For the year ended December 31, 2023 , the Company earned PIK interest of $ 0.5 million. For the year ended December 31, 2022 , the Company earned PIK interest of $ 0.1 million. Fee Income Origination fees received are recorded as deferred income and recognized as investment income over the term of the loan. Upon prepayment of a loan, any unamortized origination fees are recorded as investment income. The Company receives certain fees from portfolio companies, which are non-recurring in nature. Such fees include loan prepayment penalties, structuring fees, covenant waiver fees and loan amendment fees, and are recorded as investment income when earned. Some of the fees earned by the Company may be PIK fee income. For the year ended December 31, 2023 , the Company earned $ 7,524 of PIK fee income. For the year ended December 31, 2022 , the Company earned $ 0.2 million of PIK fee income. Non-accrual loans A loan can be left on accrual status during the period the Company is pursuing repayment of the loan. Management reviews all loans that become 90 days or more past due on principal and interest, or when there is reasonable doubt that principal or interest will be collected, for possible placement on non-accrual status. When a loan is placed on non-accrual status, unpaid interest credited to income is reversed. Additionally, any original issue discount and market discount are no longer accreted to interest income as of the date the loan is placed on non-accrual status. Interest payments received on non-accrual loans are recognized as income or applied to principal depending upon management’s judgment. Non-accrual loans are restored to accrual status when past due principal and interest is paid, and, in management’s judgment, payments are likely to remain current. As of December 31, 2023 and December 31, 2022 , there were no loans on non-accrual. Investment Classification The Company classifies its investments in accordance with the requirements of the 1940 Act. Under the 1940 Act, the C ompany would be deemed to "control" a portfolio company if the Company owned more than 25% of its outstanding voting securities and/or had the power to exercise control over the management or policies of such portfolio company. The Company refers to such investments in portfolio companies that it "controls" as "Control Investments." Under the 1940 Act, the Company would be deemed to be an "Affiliated Person" of a portfolio company if it owned between 5 % and 25 % of the portfolio company's outstanding voting securities or the Company was under common control with such portfolio company. The Company refers to such investments in Affiliated Persons as "Affiliated Investments." Investments which are neither Control Investments nor Affiliated Investments are referred to as "Non-Controlled/Non-Affiliated investments." Fair Value Measurements The Company applies fair value accounting to all of its investments in accordance with the 1940 Act and ASC Topic 820, Fair Value Measurements (“ASC 820”), which defines fair value, sets a framework for measuring fair value, and requires certain disclosures about fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (i.e. exit price). Investments are reflected on the Consolidated Statement of Assets and Liabilities at fair value, with the changes in unrealized gains and losses resulting from changes in fair value, if any, reflected on the accompanying Consolidated Statement of Operations as a change in unrealized gain (loss) on investments. In accordance with ASC 820, the Company discloses the fair value of its investments in a hierarchy that prioritizes the inputs applied to valuation techniques used to measure the fair value. The hierarchy gives the highest priority to valuations based upon unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to valuations based upon unobservable inputs that are significant to the valuation (Level 3 measurements). Investments with readily available market quotations or for which fair value can be measured from quoted prices in active markets will typically have a higher degree of input observability and a lesser degree of judgment applied in determining the fair value. The guidance establishes three levels of the fair value hierarchy as follows: Level 1 – Valuations based on quoted prices in active markets for identical assets and liabilities that the Company can access as of the measurement date. Valuation utilizing Level 1 inputs do not require any degree of judgment. The type of investments generally included in Level 1 are publicly-traded securities. Level 2 – Valuations based on (i) quoted prices for similar instruments in active markets; (ii) quoted prices for which identical or similar instruments in markets that are not active that are reflective of recent market transactions; or (iii) models in which all significant inputs are observable, either directly or indirectly. The types of investments generally included in Level 2 are restricted securities listed in active markets, corporate bonds, and certain loans. Level 3 – Valuations based on indicative quotes that do not reflect recent market transactions and models or other valuation techniques in which the inputs are unobservable and significant to the fair value measurement, which includes situations where there is little, if any, market activity for the asset or liability. The inputs used in determination of fair value require significant judgment and estimation. The types of investments generally included in Level 3 are privately held debt and equity securities. The Company has established policies and procedures to ensure that valuation methodologies for investments that are categorized within all levels of the fair value hierarchy are fair and consistent. Valuations of the investments are reviewed and approved quarterly by the Adviser’s Valuation Committee, which is responsible for establishing the valuation policies and procedures and evaluating the overall fairness and consistent application of those policies. The valuation process may include a review or analysis by an independent, third-party valuation firm. The Adviser then recommends the valuations of the Company’s investments to the Board, which is responsible for determining the fair value of the Company's investments on a quarterly basis. The Company is subject to the valuation policies and procedures of the Adviser. Any changes to the valuation methodology are reviewed by management and the Board to confirm that the changes are appropriate. As markets change, new products develop and the pricing for products becomes more or less transparent, the Company will continue to refine its valuation methodologies. Currently, the Company uses interest rate swaps to manage our interest rate risk. The valuation of these instruments is determined using widely accepted valuation techniques, including discounted cash flow analysis on the expected cash flows of each derivative. This analysis reflects the contractual terms of the derivatives, including the period to maturity, and uses observable market-based inputs, including interest rate curves and implied volatilities. To comply with the provisions of ASC 820, the Company incorporates credit valuation adjustments to appropriately reflect both its own nonperformance risk and the respective counterparty’s nonperformance risk in the fair value measurements. In adjusting the fair value of the Company's derivative contracts for the effect of nonperformance risk, the Company has considered the impact of netting and any applicable credit enhancements, such as collateral postings, thresholds, mutual puts and guarantees. Rule 2a-5 under the 1940 Act (the "Rule 2a-5") establishes a regulatory framework for determining fair value in good faith for purposes of the 1940 Act. Rule 2a-5 permits boards, subject to board oversight and certain other conditions, to designate certain parties to perform the fair value determinations. Rule 2a-5 also defines when market quotations are “readily available” for purposes of the 1940 Act and the threshold for determining whether a fund must determine the fair value of a security. Rule 31a-4 under the 1940 Act (“Rule 31a-4”), provides the recordkeeping requirements associated with fair value determinations. While the Board has not designated the Adviser as the valuation designee, the Company has established policies and procedures in compliance with the applicable requirements of Rule 2a-5 and Rule 31a-4. Derivative Instruments For its current derivative instruments, the Company does not utilize hedge accounting and values such derivatives at fair value with the unrealized appreciation (depreciation) recorded in "net change in unrealized appreciation (depreciation) on derivatives" in the Company's consolidated statements of operations. See Note 5. "Derivative Instruments" for more information. Recent Accounting Pronouncements The Company considers the applicability and impact of all accounting standard updates (“ASU”) issued by FASB. ASUs not listed below were assessed and either determined to be not applicable or expected to have minimal impact on its consolidated financial statements. In March 2020, the FASB issued ASU 2020-04, “Reference Rate Reform (Topic 848)—Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” This update provides temporary optional expedients and exceptions to the U.S. GAAP guidance on contract modifications and hedge accounting to ease the financial reporting burdens of the expected market transition from LIBOR and other interbank offered rates to alternative reference rates, such as SOFR. Entities can elect not to apply certain modification accounting requirements to contracts affected by what the guidance calls reference rate reform, if certain criteria are met. This guidance became effective upon issuance for all entities and generally was applied through December 31, 2022. As of December 31, 2023, the Company has amended its agreements with LIBOR as a reference rate to reference the forward-looking term rate published by CME Group Benchmark Administration Limited based on the secured overnight financing rate CME Term SOFR. Contract modifications are required to be evaluated in determining whether the modifications result in the establishment of new contracts or the continuation of existing contracts. The Company does not believe the adoption of ASU 2020-04 and ASU 2021-01 will have a material impact on its consolidated financial statements and disclosures when applied. In December 2022, the FASB issued ASU 2022-06, Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848 (“ASU 2022-06”). The amendments in ASU 2022-06 extend the period of time preparers can utilize the reference rate reform relief guidance. ASU 2022-06 became effective for all entities upon issuance. To ensure the relief in Topic 848 covers the period of time during which a significant number of modifications may take place, the ASU defers the sunset date of Topic 848 from December 31, 2022 to December 31, 2024, after which entities will no longer be permitted to apply the relief in Topic 848. The Company continues to evaluate the impact that the amendments in this update will have on the Company's consolidated financial statements and disclosures when applied. Segments The Company invests in various industries. The Company separately evaluates the performance of each of its investment relationships. However, because each of these investment relationships has similar business and economic characteristics, they have been aggregated into a single investment segment. All applicable segment disclosures are included in or can be derived from the Company’s consolidated financial statements (See "Note 3. Investments"). Company Investment Risk, Concentration of Credit Risk, and Liquidity Risk The Company has broad discretion in making investments. Investments generally consist of debt instruments that may be affected by business, financial market or legal uncertainties. Prices of investments may be volatile, and a variety of factors that are inherently difficult to predict, such as economic conditions in the United States, may significantly affect the results of the Company’s activities and the value of its investments. In addition, the value of the Company’s portfolio may fluctuate as the general level of interest rates fluctuate. The value of the Company’s investments in loans may be detrimentally affected to the extent, among other things, that a borrower defaults on its obligations, there is insufficient collateral and/or there are extensive legal and other costs incurred in collecting on a defaulted loan, observable secondary or primary market yields for similar instruments issued by comparable companies increase materially or risk premiums required in the market between smaller companies, such as the Company's borrowers, and those for which market yields are observable increase materially. The Company’s assets may, at any time, include securities and other financial instruments or obligations that are illiquid or thinly traded, making purchase or sale of such securities and financial instruments at desired prices or in desired quantities difficult. Furthermore, the sale of any such investments may be possible only at substantial discounts, and it may be extremely difficult to value any such investments accurately.

Investments

Investments	12 Months Ended
	Dec. 31, 2023
Schedule of Investments [Abstract]
Investments	Note 3. Investments The following table shows the amortized cost and the fair value of the Company’s portfolio investments as of December 31, 2023 (dollars in thousands): As of December 31, 2023 Amortized Cost Percentage Fair Value Percentage Senior Secured First Lien Loans $ 506,153 72.5 % $ 497,911 72.6 % Equity 3,989 0.6 3,641 0.5 Subordinated Certificates of the SDLP 188,471 26.9 184,485 26.9 Total Investments $ 698,613 100.0 % $ 686,037 100.0 % The following table shows the amortized cost and the fair value of the Company’s portfolio investments as of December 31, 2022 (dollars in thousands): As of December 31, 2022 Amortized Cost Percentage Fair Value Percentage Senior Secured First Lien Loans $ 492,750 72.6 % $ 483,831 72.6 % Equity 3,938 0.6 3,938 0.6 Subordinated Certificates of the SDLP 182,007 26.8 178,367 26.8 Total Investments $ 678,695 100.0 % $ 666,136 100.0 % The following table shows the composition of the Company’s portfolio investments by industry grouping at amortized cost and the fair value as of December 31, 2023 (dollars in thousands): As of December 31, 2023 Amortized Cost Percentage Fair Value Percentage Investment Funds and Vehicles (1) $ 188,471 26.9 % $ 184,485 26.9 % Health Care Providers & Services 113,201 16.2 112,463 16.4 Auto Components 39,394 5.6 37,685 5.5 Diversified Consumer Services 37,219 5.3 36,881 5.4 Aerospace & Defense 28,706 4.1 28,341 4.1 Distributors 26,990 3.9 25,892 3.8 Commercial Services & Supplies 26,923 3.9 25,799 3.8 Health Care Technology 26,816 3.8 26,788 3.9 Personal Products 21,256 3.0 20,133 2.9 Insurance 20,752 3.0 20,597 3.0 Software 20,415 2.9 20,389 3.0 Containers & Packaging 19,008 2.7 18,100 2.6 Food Products 17,389 2.5 16,899 2.5 Health Care Equipment & Supplies 17,053 2.5 16,965 2.5 Road & Rail 16,629 2.4 16,389 2.4 Electronic Equipment, Instruments & Components 13,579 2.0 13,510 2.0 Professional Services 11,547 1.7 11,543 1.7 Household Products 9,353 1.3 9,177 1.3 Trading Companies & Distributors 9,310 1.3 9,407 1.4 IT Services 8,531 1.2 8,502 1.2 Energy Equipment & Services 8,320 1.2 8,392 1.2 Chemicals 8,129 1.2 7,887 1.1 Hotels, Restaurants & Leisure 4,804 0.7 4,938 0.7 Food & Staples Retailing 2,862 0.4 2,869 0.4 Construction & Engineering 662 0.1 676 0.1 Transportation Infrastructure 469 0.1 480 0.1 Pharmaceuticals 466 0.1 483 0.1 Diversified Telecommunication Services (2) 307 0.0 315 0.0 Capital Markets (2) 52 0.0 52 0.0 Total Investments $ 698,613 100.0 % $ 686,037 100.0 % (1) The following industry is solely comprised of the Subordinated Certificates of the SDLP. The portfolio companies in SDLP represent a diverse set of industry classifications, which are similar to those in which the Company invests directly. See “Senior Direct Lending Program” below. (2) Represents a percentage that is less than 0.1%. The following table shows the composition of the Company’s portfolio investments by industry grouping at amortized cost and the fair value as of December 31, 2022 (dollars in thousands): As of December 31, 2022 Amortized Cost Percentage Fair Value Percentage Investment Funds and Vehicles (1) $ 182,007 26.8 % $ 178,367 26.8 % Health Care Providers & Services 103,707 15.2 102,362 15.4 Auto Components 43,234 6.4 42,129 6.3 Diversified Consumer Services 30,804 4.6 30,400 4.6 Aerospace & Defense 27,894 4.1 27,316 4.1 Health Care Technology 24,088 3.5 23,792 3.6 Commercial Services & Supplies 23,920 3.5 23,433 3.5 Distributors 21,834 3.2 20,742 3.1 Insurance 20,913 3.1 20,672 3.1 Personal Products 20,810 3.1 20,298 3.0 Electronic Equipment, Instruments & Components 19,659 2.9 19,414 2.9 Trading Companies & Distributors 18,312 2.7 18,188 2.7 Health Care Equipment & Supplies 17,171 2.5 17,003 2.6 Software 16,939 2.5 16,654 2.5 Road & Rail 16,702 2.5 16,541 2.5 Containers & Packaging 15,316 2.3 15,119 2.3 Food Products 13,978 2.1 13,208 2.0 Professional Services 11,600 1.7 11,448 1.7 Household Products 9,686 1.4 9,462 1.4 IT Services 8,599 1.3 8,393 1.3 Energy Equipment & Services 7,655 1.1 7,477 1.1 Media 7,164 1.1 7,076 1.1 Chemicals 7,088 1.0 6,992 1.0 Hotels, Restaurants & Leisure 4,838 0.7 4,938 0.7 Food & Staples Retailing 4,144 0.6 4,077 0.6 Personal Products 500 0.1 500 0.1 Life Sciences Tools & Services (2) 97 0.0 99 0.0 Capital Markets (2) 36 0.0 36 0.0 Total Investments $ 678,695 100.0 % $ 666,136 100.0 % (1) The following industry is solely comprised of the Subordinated Certificates of the SDLP. The portfolio companies in SDLP represent a diverse set of industry classifications, which are similar to those in which the Company invests directly. See “Senior Direct Lending Program” below. (2) Represents a percentage that is less than 0.1%. Transactions With Controlled/Affiliated Companies During t he year ended December 31, 2023, the Company had an investment in one portfolio company designated as a controlled investment under the 1940 Act. Transactions with the controlled investment were as follows (dollars in thousands) (1) : Controlled Investment Type of Investment Fair Value at December 31, 2022 Purchases of Investments Payment-in-kind and other adjustments to cost Principal repayments Unrealized appreciation/ Realized Gain/(Loss) Fair Value at December 31, 2023 Income Earned Senior Direct Lending Program Subordinated Certificates of the SDLP $ 178,367 $ 25,562 $ ( 1,230 ) $ ( 17,868 ) $ ( 346 ) $ — $ 184,485 $ 25,933 During the year ended December 31, 2022, the Company had an investment in one portfolio company designated as a controlled investment under the 1940 Act. Transactions with the controlled investment were as follows (dollars in thousands): Controlled Investment Type of Investment Fair Value at December 31, 2021 Purchases of Investments Payment-in-kind and other adjustments to cost Principal repayments Unrealized appreciation/ Realized Gain/(Loss) Fair Value at December 31, 2022 Income Earned Senior Direct Lending Program Subordinated Certificates of the SDLP $ — $ 182,516 $ — $ ( 509 ) $ ( 3,640 ) $ — $ 178,367 $ 12,877 (1) The December 31, 2022 presentation has been revised to conform to the December 31, 2023 presentation. Senior Direct Lending Program In 2015, VSDLP, a wholly owned subsidiary of the Company, and Ares Capital Corporation (“ARCC”) formed SDLP, a joint venture established for the purpose of providing senior stretch and unitranche loan financings to middle market borrowers. The Company received, indirectly through its membership interest in VSDLP, limited liability company membership interests and Subordinated Certificates (as defined below), in each case in SDLP, as a result of the Merger. The SDLP finances its investment activity through the issuance of securities (“SDLP Securities”) backed by its loan portfolio, including, in order of seniority, rated senior notes (the “Senior Note”), a rated intermediate funding note (the “IFN”), and capital provided by the Company and ARCC through subordinated certificates (the “Subordinated Certificates”). The Subordinated Certificates are the most junior securities issued by SDLP and collateralize the profits earned or losses incurred across the SDLP loan portfolio. As of December 31, 2023 and December 31, 2022, the Company and ARCC own 12.5 % and 87.5 %, respectively, of the outstanding Subordinated Certificates. SDLP is capitalized as transactions are completed and all portfolio decisions and generally all other decisions in respect of SDLP must be approved by an investment committee of SDLP consisting of representatives of the Company (and/or VSDLP) and ARCC (the “SDLP Investment Committee”). As of December 31, 2023 and December 31, 2022, the Company and ARCC had agreed to make capital available to the SDLP totaling $ 1.7 billion and $ 1.7 billion, respectively, in the aggregate, of which $ 206.3 million and $ 206.3 million, respectively is to be made available from the Company. The Comp any and ARCC will continue to provide capital to the SDLP in the form of Subordinated Certificates. This capital will only be committed to the SDLP upon approval of transactions by the SDLP Investment Committee as discussed above. As of December 31, 2023 and December 31, 2022, the Company has funded $ 189.7 million and $ 182.0 million, respectively, of its commitment to the SDLP and had $ 16.6 million and $ 24.3 million in unfunded commitments remaining to the SDLP, respectively. The Subordinated Certificates pay a coupon equal to SOFR plus 8.0 % and also entitle the holders thereof to receive a portion of the excess cash flow from the loan portfolio, after expenses, which may result in a return to the holders of the Subordinated Certificates that is greater than the stated coupon. The Subordinated Certificates are junior in right of payment to the Senior Notes and IFNs. The amortized cost and fair value of the Subordinated Certificates held by the Company were $ 188.5 million and $ 184.5 million, respectively, as of December 31, 2023, and $ 182.0 million and $ 178.4 million, respectively, as of December 31, 2022. The C ompany’s yield on its investment in the Subordinated Certificates at amortized cost and fair value was 14.3 % and 14.6 %, respectively, as of December 31, 2023 , and 13.5 % and 13.8 %, respectively, as of December 31, 2022. For the year ended December 31, 2023, the Company earned interest income of $ 25.9 million, from its investment in the Subordinated Certificates. For the year ended December 31, 2022, the Company earned interest income of $ 12.9 million from its investment in the Subordinated Certificates. As of December 31, 2023 and December 31, 2022, $ 6.8 million and $ 6.4 million was in Interest receivable on the Statement of Assets and Liabilities. As of December 31, 2023 and December 31, 2022 , the SDLP’s portfolio was comprised entirely of first lien senior secured loans to U.S. middle-market companies and were in industries similar to the companies in the Company’s portfolio. As of December 31, 2023 and December 31, 2022, loans in one portfolio company were on non-accrual status. Below is a summary of the SDLP’s portfolio as of December 31, 2023 and December 31, 2022 (dollars in millions): As of December 31, 2023 As of December 31, 2022 Total first lien senior secured loans (1) $ 5,431 $ 5,174 Largest loan to a single borrower (1) $ 370 $ 377 Total of five largest loans to borrower (1) $ 1,650 $ 1,631 Number of borrowers in the SDLP 22 22 Commitments to fund delayed draw loans (2) $ 260 $ 294 (1) At principal amount. (2) As discussed above, these commitments have been approved by the SDLP Investment Committee Below is a listing of SDLP’s individual investments as of December 31, 2023 (dollars in thousands): Company Industry Type of Investment Reference Rate and Spread (1) Interest Rate Maturity Par Amortized Cost Fair Value Footnotes Senior Secured First Lien Loans Aerospace & Defense Precinmac (US) Holdings Inc. Aerospace & Defense Term Loan SOFR + 6.00 % (M) 11.46 % 8/31/2027 $ 11,478 $ 11,478 $ 11,363 (2) Precinmac (US) Holdings Inc. Aerospace & Defense Delayed Draw Term Loan SOFR + 6.00 % (M) 11.46 % 8/31/2027 45,911 45,911 45,452 (2) Precinmac (US) Holdings Inc. Aerospace & Defense Term Loan SOFR + 6.00 % (Q) 11.54 % 8/31/2027 157,588 157,588 156,012 (2) Precinmac (US) Holdings Inc. Aerospace & Defense Term Loan SOFR + 6.00 % (M) 11.46 % 8/31/2027 41,110 41,110 40,699 (2) Qnnect, LLC and Connector TopCo, LP Aerospace & Defense Delayed Draw Term Loan SOFR + 7.00 % (Q) 12.38 % 11/2/2029 3,179 3,179 3,179 (2) Qnnect, LLC and Connector TopCo, LP Aerospace & Defense Term Loan SOFR + 7.00 % (Q) 12.38 % 11/2/2029 275,175 275,175 275,175 (2) 534,441 531,880 Auto Components Arrowhead Holdco Company Auto Components Term Loan SOFR + 4.50 % (Q) 10.04 % 8/31/2028 169,531 169,531 152,578 (2) Arrowhead Holdco Company Auto Components Delayed Draw Term Loan SOFR + 4.50 % (Q) 10.05 % 8/31/2028 34,859 34,859 31,373 (2) Arrowhead Holdco Company Auto Components Term Loan SOFR + 4.50 % (Q) 10.05 % 8/31/2028 24,859 24,859 22,374 (2) Arrowhead Holdco Company Auto Components Delayed Draw Term Loan SOFR + 4.50 % (Q) 10.05 % 8/31/2028 2,270 2,270 2,043 (2) Arrowhead Holdco Company Auto Components Delayed Draw Term Loan SOFR + 4.50 % (Q) 10.05 % 8/31/2028 40,033 40,033 36,030 (2) North Haven Falcon Buyer, LLC Auto Components Delayed Draw Term Loan SOFR + 8.00 % (Q) 13.50 % 5/19/2027 32,199 32,199 26,081 (2) North Haven Falcon Buyer, LLC Auto Components Term Loan SOFR + 8.00 % (Q) 13.52 % 5/19/2027 192,273 192,272 155,741 (2) 496,023 426,220 Commercial Services & Supplies ISQ Hawkeye HoldCo, Inc. Commercial Services & Supplies Term Loan SOFR + 6.00 % (M) 11.38 % 8/17/2029 228,385 228,385 228,385 (2) ISQ Hawkeye HoldCo, Inc. Commercial Services & Supplies Delayed Draw Term Loan SOFR + 6.00 % (M) 11.38 % 8/17/2029 67,198 67,198 67,198 (2) Pritchard Industries, LLC Commercial Services & Supplies Delayed Draw Term Loan SOFR + 5.50 % (S) 10.93 % 10/13/2027 47,311 47,311 46,365 (2) Pritchard Industries, LLC Commercial Services & Supplies Term Loan SOFR + 5.50 % (Q) 10.93 % 10/13/2027 197,885 197,885 193,927 (2) Valcourt Holdings II, LLC Commercial Services & Supplies Term Loan SOFR + 5.75 % (S) 11.27 % 11/21/2029 262,536 262,536 257,286 (2) Valcourt Holdings II, LLC Commercial Services & Supplies Delayed Draw Term Loan SOFR + 5.75 % (S) 11.27 % 11/21/2029 — — — (2) 803,315 793,161 Diversified Consumer Services Excelligence Learning Corporation Diversified Consumer Services Term Loan SOFR + 6.00 % (Q) 11.46 % 1/18/2024 145,432 145,429 145,432 (2) 145,429 145,432 Food & Staples Retailing FS Squared Holding Corp. Food & Staples Retailing Delayed Draw Term Loan SOFR + 5.75 % (M) 11.21 % 3/28/2025 83,991 83,991 83,991 (2) FS Squared Holding Corp. Food & Staples Retailing Delayed Draw Term Loan SOFR + 5.25 % (M) 10.71 % 3/28/2025 64,989 64,989 64,989 (2) FS Squared Holding Corp. Food & Staples Retailing Term Loan SOFR + 5.25 % (M) 10.71 % 3/28/2025 170,089 170,089 170,089 (2) FS Squared Holding Corp. Food & Staples Retailing Delayed Draw Term Loan SOFR + 5.25 % (M) 10.71 % 3/28/2025 4,252 4,252 4,252 (2) 323,321 323,321 Food Products Manna Pro Products, LLC Food Products Term Loan SOFR + 6.00 % (M) 11.46 % 12/10/2026 13,970 13,970 13,132 (2) Manna Pro Products, LLC Food Products Delayed Draw Term Loan SOFR + 6.00 % (M) 11.46 % 12/10/2026 29,294 29,294 27,536 (2) Manna Pro Products, LLC Food Products Term Loan SOFR + 6.00 % (M) 11.46 % 12/10/2026 47,131 47,131 44,303 (2) Manna Pro Products, LLC Food Products Term Loan SOFR + 6.00 % (M) 11.46 % 12/10/2026 177,136 177,136 166,508 (2) 267,531 251,479 Health Care Providers and Services Center for Autism and Related Disorders, LLC Health Care Providers and Services Term Loan SOFR + 6.50 % (Q) 12.00 % 11/21/2024 4,820 — — (2)(3) Center for Autism and Related Disorders, LLC Health Care Providers and Services Term Loan SOFR + 6.50 % (Q) 12.00 % 11/21/2024 19,452 — — (2)(3) Center for Autism and Related Disorders, LLC Health Care Providers and Services Term Loan SOFR + 6.50 % (Q) 12.00 % 11/21/2024 132,765 — — (2)(3) Center for Autism and Related Disorders, LLC Health Care Providers and Services Delayed Draw Term Loan SOFR + 6.50 % (Q) 12.00 % 11/21/2024 7,307 — — (2)(3) — — Hotels, Restaurants & Leisure Triwizard Holdings, Inc. Hotels, Restaurants & Leisure Term Loan SOFR + 6.25 % (Q) 11.72 % 6/29/2029 169,150 169,150 169,150 (2) Triwizard Holdings, Inc. Hotels, Restaurants & Leisure Delayed Draw Term Loan SOFR + 6.25 % (Q) 11.72 % 6/29/2029 — — — (2) Concert Golf Partners Holdco LLC Hotels, Restaurants, & Leisure Term Loan SOFR + 5.50 % (Q) 11.25 % 4/2/2029 233,445 233,445 233,445 (2) Concert Golf Partners Holdco LLC Hotels, Restaurants, & Leisure Delayed Draw Term Loan SOFR + 5.50 % (Q) 11.25 % 4/2/2029 40,012 40,012 40,012 (2) HGC Holdings, LLC Hotels, Restaurants, & Leisure Delayed Draw Term Loan SOFR + 5.50 % (Q) 11.03 % 6/8/2026 24,670 24,670 24,670 (2) HGC Holdings, LLC Hotels, Restaurants, & Leisure Term Loan SOFR + 5.50 % (Q) 11.04 % 6/8/2026 103,425 103,425 103,425 (2) HGC Holdings, LLC Hotels, Restaurants, & Leisure Delayed Draw Term Loan SOFR + 5.50 % (Q) 11.08 % 6/8/2026 50,000 50,000 50,000 (2) HGC Holdings, LLC Hotels, Restaurants, & Leisure Delayed Draw Term Loan SOFR + 6.25 % (Q) 11.62 % 6/8/2026 53,865 53,865 53,865 (2) 674,567 674,567 Household Products Walnut Parent, Inc. Household Products Term Loan SOFR + 5.50 % (Q) 11.00 % 11/9/2027 303,188 303,188 300,156 (2) Walnut Parent, Inc. Household Products Term Loan SOFR + 5.50 % (Q) 11.00 % 11/9/2027 40,367 40,367 39,963 (2) Walnut Parent, Inc. Household Products Term Loan SOFR + 5.50 % (Q) 11.00 % 11/9/2027 26,670 26,670 26,403 (2) 370,225 366,522 Insurance Benecon Midco II, LLC Insurance Term Loan SOFR + 5.25 % (M) 10.71 % 12/4/2026 170,188 170,188 170,188 (2) THG Acquisition, LLC Insurance Delayed Draw Term Loan SOFR + 5.75 % (M) 11.21 % 12/2/2026 24,463 24,463 24,463 (2) THG Acquisition, LLC Insurance Term Loan SOFR + 5.75 % (M) 11.21 % 12/2/2026 14,550 14,550 14,550 (2) THG Acquisition, LLC Insurance Term Loan SOFR + 5.75 % (M) 11.21 % 12/2/2026 206,190 206,190 206,190 (2) THG Acquisition, LLC Insurance Delayed Draw Term Loan SOFR + 5.75 % (M) 11.21 % 12/2/2026 58,320 58,320 58,320 (2) THG Acquisition, LLC Insurance Delayed Draw Term Loan SOFR + 5.75 % (M) 11.21 % 12/2/2026 22,025 22,025 21,805 (2) 495,736 495,516 Machinery Harvey Tool Company, LLC Machinery Delayed Draw Term Loan SOFR + 5.50 % (Q) 11.03 % 10/26/2027 34,940 34,940 34,591 (2) Harvey Tool Company, LLC Machinery Term Loan SOFR + 5.50 % (Q) 11.00 % 10/26/2027 221,631 221,631 219,415 (2) NCWS Intermediate, Inc. Machinery Delayed Draw Term Loan SOFR + 6.00 % (Q) 11.53 % 12/29/2026 61,696 61,696 61,696 (2) NCWS Intermediate, Inc. Machinery Term Loan SOFR + 6.00 % (Q) 11.53 % 12/29/2026 205,398 205,398 205,398 (2) NCWS Intermediate, Inc. Machinery Delayed Draw Term Loan SOFR + 6.50 % (Q) 12.03 % 12/29/2026 12,600 12,600 12,600 (2) 536,265 533,700 Software Emergency Communications Network, LLC Software Term Loan SOFR + 8.75 % (Q) 14.13 % 6/30/2024 252,313 252,295 219,512 (2) Pegasus Global Enterprise Holdings, LLC Software Term Loan SOFR + 5.25 % (Q) 10.75 % 5/29/2025 259,306 259,306 259,306 (2) Pegasus Global Enterprise Holdings, LLC Software Delayed Draw Term Loan SOFR + 5.25 % (Q) 10.75 % 5/29/2025 75,601 75,601 75,601 (2) 587,202 554,419 Trading Companies & Distributors Penn Detroit Diesel Allison, LLC Trading Companies & Distributors Term Loan SOFR + 6.25 % (M) 11.71 % 12/14/2027 32,913 32,913 32,913 (2) 32,913 32,913 Total Investments, December 31, 2023 $ 5,266,968 $ 5,129,130 (1) Variable rate loans to the portfolio companies bear interest at a rate that may be determined by reference to SOFR, or an alternate base rate (commonly based on the Federal Funds Rate or the Prime Rate), at the borrower’s option, w hich reset semi-annually (S), quarterly (Q), or monthly (M). For each such loan, the interest rate provided was the rate in effect as of December 31, 2023 . (2) Loan includes interest rate floor feature. (3) The investment was on non-accrual status as of December 31, 2023 . Below is a listing of SDLP’s individual investments as of December 31, 2022 (dollars in thousands): Company Type of Investment Reference Rate and Spread (1) Interest Rate Maturity Par Amortized Cost Fair Value Footnotes Senior Secured First Lien Loans Aerospace & Defense Precinmac (US) Holdings Inc. Term Loan SOFR + 6.00 % (M) 10.42 % 8/31/2027 $ 11,595 $ 11,595 $ 11,363 (2) Precinmac (US) Holdings Inc. Delayed Draw Term Loan SOFR + 6.00 % (M) 10.42 % 8/31/2027 46,379 46,379 45,451 (2) Precinmac (US) Holdings Inc. Term Loan SOFR + 6.00 % (M) 10.42 % 8/31/2027 159,200 159,200 156,016 (2) Precinmac (US) Holdings Inc. Term Loan SOFR + 6.00 % (M) 10.42 % 8/31/2027 41,530 41,530 40,700 (2) Qnnect, LLC and Connector TopCo, LP Term Loan SOFR + 7.00 % (S) 11.11 % 11/2/2029 277,255 277,255 268,937 (2) 535,959 522,467 Auto Components Arrowhead Holdco Company Term Loan SOFR + 4.50 % (Q) 9.05 % 8/31/2028 171,265 171,265 162,702 (2) Arrowhead Holdco Company Delayed Draw Term Loan SOFR + 4.50 % (Q) 8.61 % 8/31/2028 35,215 35,215 33,454 (2) Arrowhead Holdco Company Term Loan LIBOR + 4.50 % (Q) 8.61 % 8/31/2028 25,113 25,113 23,857 (2) Arrowhead Holdco Company Delayed Draw Term Loan LIBOR + 4.50 % (Q) 8.61 % 8/31/2028 2,293 2,293 2,179 (2) Arrowhead Holdco Company Delayed Draw Term Loan LIBOR + 4.50 % (Q) 8.61 % 8/31/2028 40,442 40,442 38,420 (2) North Haven Falcon Buyer, LLC Delayed Draw Term Loan LIBOR + 6.50 % (Q) 11.65 % 5/19/2027 31,155 31,155 28,974 (2) North Haven Falcon Buyer, LLC Term Loan LIBOR + 6.50 % (Q) 11.18 % 5/19/2027 186,042 186,042 173,019 (2) 491,525 462,605 Commercial Services & Supplies ISQ Hawkeye HoldCo, Inc. Term Loan SOFR + 6.25 % (M) 10.63 % 8/17/2029 230,698 230,698 226,084 (2) ISQ Hawkeye HoldCo, Inc. Delayed Draw Term Loan SOFR + 6.25 % (M) 10.63 % 8/17/2029 55,816 55,816 54,700 (2) Pritchard Industries, LLC Delayed Draw Term Loan SOFR + 5.50 % (S) 10.54 % 10/13/2027 42,384 42,384 41,113 (2) Pritchard Industries, LLC Term Loan SOFR + 5.50 % (S) 10.54 % 10/13/2027 199,904 199,904 193,907 (2) 528,802 515,804 Diversified Consumer Services Excelligence Learning Corporation Term Loan LIBOR + 6.00 % (Q) 9.67 % 1/18/2024 146,348 146,289 146,348 (2) 146,289 146,348 Food & Staples Retailing FS Squared Holding Corp. Delayed Draw Term Loan SOFR + 5.75 % (Q) 9.99 % 3/28/2025 66,164 66,164 66,164 (2) FS Squared Holding Corp. Delayed Draw Term Loan SOFR + 5.25 % (Q) 9.49 % 3/28/2025 65,659 65,659 65,659 (2) FS Squared Holding Corp. Term Loan SOFR + 5.25 % (Q) 9.49 % 3/28/2025 171,875 171,875 171,875 (2) FS Squared Holding Corp. Delayed Draw Term Loan SOFR + 5.25 % (Q) 9.49 % 3/28/2025 4,297 4,297 4,297 (2) 307,995 307,995 Food Products Manna Pro Products, LLC Term Loan LIBOR + 6.00 % (M) 10.29 % 12/10/2026 14,114 14,114 13,126 (2) Manna Pro Products, LLC Delayed Draw Term Loan LIBOR + 6.00 % (M) 10.38 % 12/10/2026 29,641 29,641 27,566 (2) Manna Pro Products, LLC Term Loan LIBOR + 6.00 % (M) 10.07 % 12/10/2026 47,565 47,565 44,236 (2) Manna Pro Products, LLC Term Loan LIBOR + 6.00 % (M) 10.07 % 12/10/2026 178,962 178,962 166,435 (2) 270,282 251,363 Health Care Providers and Services Center for Autism and Related Disorders, LLC Term Loan LIBOR + 6.50 % (Q) 11.34 % 11/21/2024 4,551 4,340 1,911 (2)(3) Center for Autism and Related Disorders, LLC Term Loan LIBOR + 6.50 % (Q) 11.34 % 11/21/2024 18,369 17,518 7,715 (2)(3) Center for Autism and Related Disorders, LLC Term Loan SOFR + 6.50 % (Q) 11.34 % ( 4.00 % PIK) 11/21/2024 125,369 119,560 52,655 (2)(3) Center for Autism and Related Disorders, LLC Delayed Draw Term Loan LIBOR + 6.50 % (Q) 10.17 % 11/21/2024 6,900 6,580 2,898 (2)(3) 147,998 65,179 Hotels, Restaurants, & Leisure Concert Golf Partners Holdco LLC Term Loan SOFR + 5.50 % (Q) 10.28 % 4/2/2029 235,815 235,815 235,815 (2) Concert Golf Partners Holdco LLC Delayed Draw Term Loan SOFR + 5.50 % (Q) 6.25 % 4/2/2029 19,507 19,507 19,507 (2) HGC Holdings, LLC Delayed Draw Term Loan SOFR + 5.00 % (S) 9.87 % 6/8/2026 24,920 24,920 24,920 (2) HGC Holdings, LLC Term Loan SOFR + 5.00 % (Q) 9.55 % 6/8/2026 104,475 104,475 104,475 (2) HGC Holdings, LLC Delayed Draw Term Loan SOFR + 5.25 % (Q) 8.89 % 6/8/2026 12,000 12,000 12,000 (2) Towne Holdings, Inc. Term Loan SOFR + 8.75 % (Q) 13.79 % 8/31/2023 146,866 146,866 143,929 (2) 543,583 540,646 Household Products Walnut Parent, Inc. Term Loan LIBOR + 5.50 % (Q) 10.24 % 11/9/2027 308,000 308,000 298,760 (2) Walnut Parent, Inc. Term Loan LIBOR + 5.50 % (Q) 10.24 % 11/9/2027 41,834 41,834 40,579 (2) Walnut Parent, Inc. Term Loan LIBOR + 5.50 % (Q) 10.24 % 11/9/2027 27,171 27,171 26,355 (2) 377,005 365,694 Insurance Benecon Midco II, LLC Term Loan LIBOR + 5.25 % (Q) 9.98 % 12/4/2026 171,938 171,938 171,938 (2) THG Acquisition, LLC Delayed Draw Term Loan LIBOR + 5.75 % (M) 10.13 % 12/2/2026 24,713 24,713 24,466 (2) THG Acquisition, LLC Term Loan LIBOR + 5.75 % (M) 10.13 % 12/2/2026 14,700 14,700 14,553 (2) THG Acquisition, LLC Term Loan LIBOR + 5.75 % (M) 10.13 % 12/2/2026 208,338 208,338 206,254 (2) THG Acquisition, LLC Delayed Draw Term Loan LIBOR + 5.75 % (M) 10.13 % 12/2/2026 58,922 58,922 58,333 (2) THG Acquisition, LLC Delayed Draw Term Loan LIBOR + 5.75 % (M) 10.13 % 12/2/2026 14,521 14,521 14,231 (2) 493,132 489,775 Machinery Harvey Tool Company, LLC Delayed Draw Term Loan LIBOR + 5.50 % (Q) 10.69 % 10/26/2027 9,720 9,720 9,623 (2) Harvey Tool Company, LLC Term Loan LIBOR + 5.50 % (Q) 10.23 % 10/26/2027 223,893 223,893 221,654 (2) NCWS Intermediate, Inc. Delayed Draw Term Loan LIBOR + 6.00 % (M) 10.38 % 12/29/2026 62,329 62,329 61,082 (2) NCWS Intermediate, Inc. Term Loan LIBOR + 6.00 % (M) 10.38 % 12/29/2026 207,515 207,515 203,365 (2) 503,457 495,724 Software Emergency Communications Network, LLC Term Loan SOFR + 7.75 % (Q) 11.84 % 6/30/2024 238,820 238,766 214,938 (2) n2y Holdings, LLC Term Loan LIBOR + 5.75 % (M) 10.14 % 11/13/2026 66,150 66,150 65,489 (2) n2y Holdings, LLC Term Loan LIBOR + 5.75 % (M) 10.14 % 11/13/2026 127,313 127,313 126,039 (2) Pegasus Global Enterprise Holdings, LLC Term Loan LIBOR + 5.25 % (Q) 9.98 % 5/29/2025 262,021 262,021 262,021 (2) Pegasus Global Enterprise Holdings, LLC Delayed Draw Term Loan LIBOR + 5.25 % (Q) 6.25 % 5/29/2025 76,382 76,382 76,382 (2) 770,632 744,869 Trading Companies & Distributors Penn Detroit Diesel Allison, LLC Term Loan SOFR + 7.00 % (M) 11.42 % 12/14/2027 49,614 49,614 49,614 (2) 49,614 49,614 Total Investments, December 31, 2022 $ 5,166,273 $ 4,958,083 (1) Variable rate loans to the portfolio companies bear interest at a rate that may be determined by reference to LIBOR, SOFR, or an alternate base rate (commonly based on the Federal Funds Rate or the Prime Rate), at the borrower’s option, w hich reset semi-annually (S), quarterly (Q), or monthly (M). For each such loan, the interest rate provided was the rate in effect as of December 31, 2022 . (2) Loan includes interest rate floor feature. (3) The investment was on non-accrual status as of December 31, 2022 . In accordance with Rules 3-09 and 4-08(g) of Regulation S-X, the Company must determine if any of its portfolio companies is considered a “significant subsidiary.” Pursuant to the definition of “significant subsidiary” applicable to investment companies set forth in Rule 1-02(w) of Regulation S-X, a portfolio company will meet the definition of “significant subsidiary” if either the investment test or the income test is triggered. Rule 3-09 of Regulation S-X requires the Company to include separate audited financial statements of any unconsolidated majority-owned subsidiary (portfolio company in which the Company owns greater than 50 % of the unconsolidated subsidiary) in the Company's annual report on Form 10-K if one of the following conditions are met: (i) if the portfolio investment’s fair value exceeds 20 % of the Company’s total investments fair value (the investment test); or (ii) either (A) if the income from the portfolio investment exceeds 80 % of the Company’s absolute value of the change in net assets from operations of the Company and its subsidiaries (the income test) or (B) if the income from the portfolio investment exceeds 20 % of the Company’s absolute value of the change in net assets from operations of the Company and its subsidiaries and have a fair value exceeding 5 % of the Company’s total investment fair value (the alternate income test). If the Company has an unconsolidated majority-owned subsidiary and does not satisfy any Rule 3-09 significant subsidiary conditions during a quarter end, the Company must include a summarized income statement within the notes to the quarterly financial statements. Rule 4-08(g) of Regulation S-X requires the Company to include summarized financial information of any unconsolidated controlled subsidiary (portfolio company in which the Company owns greater than 25 % of the voting securities of the unconsolidated subsidiary or otherwise controls the subsidiary) in the Company's annual report on Form 10-K if one of the following conditions are met: (i) if the portfolio investment’s fair value exceeds 10 % of the Company’s total investments fair value (the investment test); or (ii) either (A) if the income from the portfolio investment exceeds 80 % of the Company’s absolute value of the change in net assets from operations of the Company and its subsidiaries (the income test) or (B) if the income from the portfolio investment income exceeds 10 % of the Company’s absolute value of the change in net assets from operations of the Company and its subsidiaries and have a fair value exceeding 5 % of the Company’s total investment fair value (the alternate income test). After performing the investment analysis and income analysis for the year ended December 31, 2023 , the Company determined that the fair value of the SDLP represented greater than 20 % of the Company's total investments (at fair value) and also generated more than 20 % of the Company’s total income. According to Rule 3-09 of Regulation S-X, the audited financial statements of SDLP are attached as an exhibit to this Annual Report on Form 10-K.

Fair Value Measurements

Fair Value Measurements	12 Months Ended
	Dec. 31, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	Note 4. Fair Value Measurements The following table presents the fair value measurements of the Company's investments, by major class according to the fair value hierarchy, as o f December 31, 2023 (dollars in thousands): As of December 31, 2023 Investments Level 1 Level 2 Level 3 Total Senior Secured First Lien Loans $ — $ 89 $ 497,822 $ 497,911 Equity — — 3,641 3,641 Subordinated Certificates of the SDLP — — 184,485 184,485 Total $ — $ 89 $ 685,948 $ 686,037 Total investments at fair value $ 686,037 Derivative contracts payable, at fair value — 91 — 91 Total Derivative contracts payable, at fair value $ — $ 91 $ — $ 91 The following table presents the fair value measurements of the Company's investments, by major class according to the fair value hierarchy, as of December 31, 2022 (dollars in thousands): As of December 31, 2022 Investments Level 1 Level 2 Level 3 Total Senior Secured First Lien Loans $ — $ 91 $ 483,740 $ 483,831 Equity — — 2,633 2,633 Subordinated Certificates of the SDLP — — 178,367 178,367 Total $ — $ 91 $ 664,740 $ 664,831 Investments measured at NAV (1) 1,305 Total $ 666,136 (1) Certain investments that are measured at fair value using the NAV practical expedient have not been categorized in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amount presented in the Consolidated Statements of Assets and Liabilities. The following table provides a reconciliation of the begin ning and ending balances for investments that use Level 3 inputs for the year ended December 31, 2023 (dollars in thousands): Senior Secured First Lien Loans Equity Subordinated Certificates of the SDLP Total Balance as of December 31, 2022 $ 483,740 $ 2,633 $ 178,367 $ 664,740 Purchases 64,281 51 25,562 89,894 Payment-in-kind and other adjustments to cost 656 — ( 1,230 ) ( 574 ) Principal repayments ( 53,083 ) — ( 17,868 ) ( 70,951 ) Net realized gains/(losses) ( 289 ) — — ( 289 ) Net amortization of premium/discount 1,838 — — 1,838 Net change unrealized gains/(losses) 679 ( 348 ) ( 346 ) ( 15 ) Transfers into Level 3 — 1,305 — 1,305 Balance as of December 31, 2023 $ 497,822 $ 3,641 $ 184,485 $ 685,948 Net change unrealized appreciation/(depreciation) for $ ( 8,237 ) $ ( 348 ) $ ( 3,987 ) $ ( 12,572 ) The following table provides a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the year ended December 31, 2022 (dollars in thousands): Senior Secured First Lien Loans Equity Subordinated Certificates of the SDLP Total Balance as of December 31, 2021 $ — $ — $ — $ — Purchases 543,253 3,633 182,516 729,402 Payment-in-kind and other adjustments to cost 265 — — 265 Principal repayments ( 52,263 ) — ( 509 ) ( 52,772 ) Net amortization of premium/discount 1,401 — — 1,401 Net change unrealized gains/(losses) ( 8,916 ) — ( 3,640 ) ( 12,556 ) Transfer out of Level 3 — ( 1,000 ) — ( 1,000 ) Balance as of December 31, 2022 $ 483,740 $ 2,633 $ 178,367 $ 664,740 Net change unrealized appreciation/(depreciation) for $ ( 8,916 ) $ — $ ( 3,640 ) $ ( 12,556 ) The Company conducts a review of the fair value hierarchy classifications on a quarterly basis. The Company monitors the availability of observable market data to assess the appropriate classification of financial instruments within the fair value hierarchy. Changes in the observability of valuation inputs may result in a reclassification for certain financial assets or liabilities. Changes in economic conditions or model based valuation techniques may require the transfer of financial instruments from one fair value level to another. Reclassifications impacting Level 3 of the fair value hierarc hy are reported as transfers in/out of the Level 3 category as of the beginning of the quarter in which the reclassifications occur. During the year ended December 31, 2023, the Company had two equity investments with an aggregate fair value of $ 1.3 million transfer from being measured at NAV to Level 3 as a result of changes in the observability of significant inputs. The following table presents the quantitative information about Level 3 fair value measurements of the Company's investments, as of December 31, 2023 (dollars in thousands): As of December 31, 2023 Fair Value Valuation Techniques Significant Unobservable Inputs Range of Significant Unobservable Inputs Weighted Average (1) Senior Secured First Lien Term Loans $ 476,551 Income Approach (DCF) Discount Rate 8.4 % - 16.5 % 10.5 % Senior Secured First Lien Term Loans 21,271 Recent Transaction Transactions Prices 97.0 % - 98.9 % 97.7 % Equity 1,735 Income Approach (DCF) Long Term Growth Rate, Discount Rate 7.5 % - 10.5 % 8.8 % Market Approach EBIDTA Multiple 10.5 x - 17.6 x 13.5 x Equity 1,101 Market Approach EBIDTA Multiple 11.0 x - 20.0 x 14.4 x Equity 805 Recent Transaction Transactions Price 100.0 % - 100.0 % 100.0 % Subordinated Certificates of the SDLP 184,485 Income Approach (DCF) Discount Rate 8.5 % - 9.5 % 9.5 % Total $ 685,948 (1) Unobservable inputs were weighted by the relative fair value of the investments. The following table presents the quantitative information about Level 3 fair value measurements of the Company's investments, as of December 31, 2022 (dollars in thousands): As of December 31, 2022 Fair Value Valuation Techniques Significant Unobservable Inputs Range of Significant Unobservable Inputs Weighted Average (1) Senior Secured First Lien Term Loans $ 459,838 Income Approach (DCF) Discount Rate 8.0 % - 13.3 % 9.8 % Senior Secured First Lien Term Loans 21,628 Recent Transaction Transaction Prices 96.2 % - 99.0 % 97.3 % Senior Secured First Lien Term Loans 2,274 Market Approach EBITDA Multiple 7.9 x - 14.0 x 11.8 x Equity 2,633 Income Approach (DCF), EBITDA Multiple, 6.3 % - 10.3 % 8.3 % Subordinated Certificates of the SDLP 178,367 Income Approach (DCF) Discount Rate 10.0 % - 11.0 % 10.7 % Total $ 664,740 (1) Unobservable inputs were weighted by the relative fair value of the investments. Increases or decreases in any of the above unobservable inputs in isolation would result in a lower or higher fair value measurement for such assets.

Derivative Instruments

Derivative Instruments	12 Months Ended
	Dec. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments	Note 5. Derivative Instruments The Company enters into derivative instruments from time to time to help mitigate interest rate risk exposures. Derivatives not designated as hedges are not speculative and are used to manage the Company’s exposure to interest rate movements but do not meet the strict hedge accounting requirements. Changes in the fair value of derivatives not designated in hedging relationships are recorded directly in earnings. As of December 31, 2023, the Company had two outstanding interest rates swaps that were not designated as hedges in qualifying hedging relationships (as detailed below). The counterparty to these interest rate swap contracts was CIBC Bank USA ("CIBC"). Certain information related to the Company's derivative instruments as of December 31, 2023 are presented in the following location in the Consolidated Statement of Assets and Liabilities: December 31, 2023 Derivative Instrument Notional Amount Maturity Date Gross Amount of Recognized Assets Gross Amount of Recognized Liabilities Consolidated Statements of Assets and Liabilities Location Interest rate swap $ 25,000 12/21/2026 $ — $ 20 Derivative contracts payable, at fair value Interest rate swap 25,000 12/21/2028 — $ 71 Derivative contracts payable, at fair value Total $ 50,000 $ — $ 91 The Company records its derivatives on a net basis in the Consolidated Statement of Assets and Liabilities. The Company has a master netting agreement with its derivative counterparty which allows for the right to offset by counterparty. Net unrealized appreciation (depreciation) on derivative instruments recognized by the Company for the year ended December 31, 2023 is presented in the following location in the Consolidated Statements of Operations and Consolidated Statements of Cash Flows: Derivative Instrument Consolidated Statements of Operations and Consolidated Statements of Cash Flows Locations For the Year Ended December 31, 2023 Interest rate swaps Net change in unrealized appreciation (depreciation) on derivatives ( 91 ) Total ( 91 ) The Company had no derivative instruments as of December 31, 2022. The Company has agreements with CIBC that contain a provision where if the Company defaults on any of its indebtedness, including default where repayment of the indebtedness has not been accelerated by the lender, then the Company could also be declared in default on its derivative obligations. As of December 31, 2023, the termination fair value of derivatives in a net liability position related to these agreements was $( 95 ). As of December 31, 2023, the Company has not posted any collateral related to these agreements. If the Company had breached any of these provisions at December 31, 2023, it could have been required to settle its obligations under the agreements at their termination fair value.

Borrowings

Borrowings	12 Months Ended
	Dec. 31, 2023
Debt Disclosure [Abstract]
Borrowings	Note 6. Borrowings The ratio of a BDC’s total assets (less total liabilities other than indebtedness represented by senior securities) to its total indebtedness represented by senior securities plus preferred stock, if any, must be at least 200 % or 150 %, if certain requirements are met. In connection with the Company’s organization and the Initial Closing, the Board and its initial shareholder authorized the Company to adopt the 150 % asset coverage ratio. Additionally, investors both consented to the minimum asset coverage ratio of 150 % and agreed not to seek to redeem their shares of common stock in connection therewith, in each case in the subscription agreement. As of December 31, 2023, the Company's asset coverage ratio was 238.22 % . The Company’s outstanding debt as of December 31, 2023 and December 31, 2022 was as follows (dollars in thousands): As of December 31, 2023 As of December 31, 2022 Aggregate Principal Amount Available Principal Amount Outstanding Carrying Value Fair Value Aggregate Principal Amount Available Principal Amount Outstanding Carrying Value Fair Value JPM Facility $ 300,000 $ 233,900 $ 233,900 $ 233,900 $ 500,000 $ 270,500 $ 270,500 $ 270,500 CIBC Facility 75,000 7,770 7,770 7,770 — — — — Fronting Agreement (1) — — — — 15,000 8,000 8,000 8,000 2026 Notes 25,000 25,000 25,000 25,000 — — — — 2028 Notes 25,000 25,000 25,000 25,000 — — — — Total borrowings outstanding, net of deferred financing costs $ 425,000 $ 291,670 $ 291,670 $ 291,670 $ 515,000 $ 278,500 $ 278,500 $ 278,500 (1) See Note 7. Related Party Transactions for details on the Fronting Amount. JPM Facility On June 2, 2022, the Company's wholly owned subsidiary, VCCF, entered into the Loan and Security Agreement (the "Loan and Security Agreement" and the revolving credit facility thereunder, the "JPM Facility") with JPMorgan Chase Bank, National Association, as administrative agent ("JPMorgan"). The JPM Facility currently allows VCCF to borrow up to $ 300 million, subject to certain leverage and borrowing base restrictions, and may potentially be expanded up to $ 600 million with the consent of the lenders. The JPM Facility’s reinvestment period ends on June 2, 2025 and has a termination date of June 2, 2027 . The JPM Facility bears interest at an annual rate of: (i) with respect to interest based reference rate other than a term SOFR, the reference rate plus a margin equal to 2.375 % per annum; provided that, in the case of advances denominated in British Pounds, the margin shall be 2.494 % per annum (ii) with respect to interest based on a term SOFR, the SOFR plus a margin equal to 2.475% per annum and (iii) with respect to interest based on a Base Rate, the Base Rate plus a margin equal to 2.475 % per annum. JPMorgan determines the reference rate. The Company paid a fee of 0.50 % per annum on the average daily committed but unused amounts under the JPM Facility during its ramp-up period (June 2, 2022 up to but not including March 2, 2023), and, beginning March 3, 2023, pays a fee of 0.75 % on annum. On January 26, 2023, the Company entered into the First Amendment to the Loan and Security Agreement (the “First Amendment”). The First Amendment, among other things: (i) reduces the borrowings available under the JPM Facility from up to $ 500 million to up to $ 300 million, subject to certain leverage and borrowing base restrictions; and (ii) reduces the commitment increase, subject to lender consent, from up to $ 800 million to up to $ 600 million. The reduction was accounted for as a debt modification to a line-of-credit or revolving-debt arrangement in accordance with ASC 470-50, Modifications and Extinguishments , which attributed to an acceleration of debt financing costs in the amount of $ 1.4 million and was recorded on the Consolidated Statement of Operations as a component of "Credit facility fees". On November 20, 2023, the Company entered into a Second Amendment to the Loan and Security Agreement (the "Second Amendment"). The Second Amendment, among other things: (i) permits the inclusion of revolving loans as collateral to the JPM Facility; (ii) decreases the minimum funding amount under the Loan and Agreement from 85 % to 75 % of the financing commitment which commenced November 21, 2023; and (iii) increases the percentage of Collateral Principal Amount (as defined in the Second Amendment) that may consist of portfolio investments the obligors of which have a leverage ratio equal to or greater than 7.0x from 0.0 % to 10.0 %. At December 31, 2023 and December 31, 2022, the carrying amount of the Company's borrowings under the JPM Facility approximated their fair value. The fair values of the Company's debt obligations are determined in accordance with ASC 820, which defines fair value in terms of the price that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date under current market conditions. The fair value of the Company's borrowings under the JPM Facility would be deemed to be Level 3. The following table summarizes the interest expense, non-usage fees and amortization of financing costs incurred on the JPM Facility for the year ended December 31, 2023 and 2022, respectively (dollars in thousands): Year Ended December 31, 2023 2022 JPM Facility interest $ 19,427 $ 8,191 JPM Facility unused fees 374 675 Amortization of debt issuance costs 1,918 471 Total interest and financing expenses related to the JPM Facility $ 21,719 $ 9,337 Weighted average outstanding debt balance of the JPM Facility $ 254,857 $ 272,019 Weighted average interest rate of the JPM Facility (annualized) 7.6 % 5.2 % CIBC Facility On January 31, 2023, the Company entered into a Senior Secured Revolving Credit Agreement (the “Credit Agreement” and the senior secured credit facility thereunder, the “CIBC Facility”) among the Company, as borrower, the lenders party thereto from time to time, the issuing banks party thereto from time to time, and CIBC, as administrative agent and as sole lead arranger. The CIBC Facility is guaranteed by VCCEH, and will be guaranteed by certain domestic subsidiaries of the Company that are formed or acquired by the Company in the future (collectively, the “Guarantors”). Proceeds of the CIBC Facility may be used for general corporate purposes, including the funding of portfolio investments. The initial maximum principal amount of the CIBC Facility is $ 75 million, subject to availability under the borrowing base, which is based on the Company’s and Guarantor’s portfolio investments and other outstanding indebtedness. Maximum capacity under the CIBC Facility may be increased to $ 150 million through the exercise by the Company of an uncommitted accordion feature through which existing and new lenders may, at their option, agree to provide additional financing. The CIBC Facility is secured by a perfected first-priority interest in substantially all of the portfolio investments held by the Company and each Guarantor, subject to certain exceptions. The CIBC Facility's commitment termination date is January 31, 2026 and has a final maturity date of January 31, 2028. The CIBC Facility bears interest from January 1, 2023 to January 31, 2026 (the "Availability Period") at an annual rate of: (i) with respect to interest based on the greatest of (a) the Prime Rate, (b) the Federal Funds Effective Rate plus 1/2 of 1 % and (c) zero (the "ABR"), the ABR plus a margin equal to 1.500 % per annum; and (ii) with respect to interest based on a term SOFR, the SOFR plus a margin equal to 2.500 % per annum and after the Availability Period at an annual rate of: (i) with respect to interest based on the ABR, the ABR plus a margin equal to 1.750 % per annum; and (ii) with respect to interest based on a term SOFR, the SOFR plus a margin equal to 2.750 % per annum. CIBC, as the administrative agent, determines the reference rate. The Company pays a fee of 0.375% per annum on the average daily committed but unused amounts under the CIBC Facility during the first nine months of the CIBC Facility (January 31, 2023 up to but not including October 31, 2023), and thereafter, 0.375% if the average daily used amount of the commitment exceeds 25% of the total commitment or otherwise, 0.50%. At December 31, 2023, the carrying amount of the Company's borrowings under the CIBC Facility approximated their fair value. The fair values of the Company's debt obligations are determined in accordance with ASC 820, which defines fair value in terms of the price that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date under current market conditions. The fair value of our borrowings under the CIBC Facility would be deemed to be Level 3. The following table summarizes the interest expense, non-usage fees and amortization of financing costs incurred on the CIBC Facility for the year ended December 31, 2023 and 2022, respectively (dollars in thousands): Year Ended December 31, 2023 2022 CIBC Facility interest $ 1,647 $ — CIBC Facility unused fees 181 — Amortization of debt issuance costs 199 — Total interest and financing expenses related to the CIBC Facility $ 2,027 $ — Weighted average outstanding debt balance of the CIBC Facility $ 21,184 $ — Weighted average interest rate of the CIBC Facility (annualized) 7.8 % — % Unsecured Notes On December 21, 2023, the Company entered into a Master Note Purchase Agreement (the “Note Purchase Agreement”) governing the issuance of $ 25,000,000 in aggregate principal amount of Series A Senior Notes, Tranche A, due December 21, 2026, with a fixed interest rate of 8.10 % per year (the “2026 Notes”), and $ 25,000,000 in aggregate principal amount of Series A Senior Notes, Tranche B, due December 21, 2028, with a fixed interest rate of 8.20 % per year (the “2028 Notes” and, together with the 2026 Notes, the “Notes”), to qualified institutional investors in a private offering exempt from the registration requirements of the Securities Act of 1933, as amended (the "1933 Act"). The Notes are guaranteed by VCC Equity Holdings, LLC, a wholly owned subsidiary of the Company. Interest on the Notes will be payable semi-annually on June 21 and December 21 each year, beginning on June 21, 2024. The 2026 Notes and the 2028 Notes may be redeemed in whole or in part at any time or from time to time at the Company’s option prior to September 21, 2026 and September 21, 2028, respectively, at par plus accrued interest to the redemption date and a make-whole premium, and thereafter at par plus accrued interest to the redemption date. In addition, the Company is obligated to offer to prepay the Notes at par plus accrued and unpaid interest up to, but excluding, the date of prepayment, if certain change in control events occur. The Notes are general unsecured obligations of the Company that rank pari passu with all outstanding and future unsecured unsubordinated indebtedness issued by the Company. At December 31, 2023, the carrying amount of the Notes approximated their fair value. As of December 31, 2023, the Notes would be deemed to be Level 3, as defined in Note 2. The following table summarizes the interest expenses and amortization of financing costs incurred on the Notes for the year ended December 31, 2023 and 2022 (dollars in thousands): For the Year Ended December 31, 2023 2022 2026 Notes interest $ 56 $ — 2028 Notes interest 57 $ — Amortization of debt issuance costs 4 $ — Total $ 117 $ — Weighted average stated interest rate 8.2 % $ — Weighted average outstanding balance 1,507 $ —

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2023
Related Party Transactions [Abstract]
Related Party Transactions	Note 7. Related Party Transactions Investment Advisory Agreement On June 2, 2022 , the Company entered into an investment advisory agreement with the Adviser. In connection with the Transaction, the Company entered into a new investment agreement between the Company and the Adviser (the "Investment Advisory Agreement"), which became effective on September 6, 2023. The Investment Advisory Agreement is materially identical to the prior investment advisory agreement, dated June 2, 2022. Pursuant to the Investment Advisory Agreement, the Company pays the Adviser a fee for its investment advisory and management services consisting of two components—a base management fee and an incentive fee. The cost of both the base management fee and the incentive fee will ultimately be borne by the shareholders. Base Management Fee Pursuant to the Investment Advisory Agreement, prior to an initial public offering or a listing of the common stock on a national securities exchange (a “Public Listing”), the Company pays to the Adviser a fee (the “Management Fee”) for management services in an amount equal to an annual rate of 0.75 % of the Company's "Adjusted Gross Assets". The Company's Adjusted Gross Assets is the average of the accreted or amortized cost basis of the Company's portfolio investments, excluding cash and cash equivalents and undrawn capital commitments at the end of the two most recently completed fiscal quarters (and, in the case of the first quarter-end following the Initial Closing, at the end of such fiscal quarter-end). The Management Fee is payable quarterly in arrears. Pursuant to the Investment Advisory Agreement, following a Public Listing, the Company will pay to the Adviser the Management Fee in an amount equal to an annual rate of 1.00 % of the Adjusted Gross Assets payable quarterly in arrears (and, in the case of the first quarter-end following a Public Listing, at the end of such fiscal quarter-end). For the year ended December 31, 2023, the Company incurred base management fees to the Adviser of $ 5.1 million. For the year ended December 31, 2022, the Company incurred base management fees to the Adviser of $ 2.8 million. As of December 31, 2023, $ 1.3 million was included in “base management fees payable” in the accompanying Consolidated Statements of Assets and Liabilities. As of December 31, 2022, $ 1.3 millio n was included in “base management fees payable” in the accompanying Consolidated Statements of Assets and Liabilities. Income and Capital Gain Incentive Fee Calculation Pursuant to the Investment Advisory Agreement, the Company pays to the Adviser an incentive fee consisting of two components – an incentive fee based on a percentage of net investment income and an incentive fee based on a percentage of capital gains. The two components of the incentive fee are independent of each other and therefore, one component may be payable to the Adviser even if the other component is not payable to the Adviser. Income Incentive Fee The first part, the income incentive fee (“Income Incentive Fee”), is calculated and payable quarterly in arrears. Prior to a Public Listing, the amounts of Income Incentive Fee payable will be equal to: (i) 100 % of the excess of the Company’s “pre-incentive fee net investment income” (as defined below), expressed as a rate of return on the Company's net assets, before taking into account any Income Incentive Fees payable during such period, for the immediately preceding quarter, over a preferred return of 1.75 % per quarter ( 7 % annualized) (“Incentive Fee Hurdle”), until the Adviser has received a “catch-up” equal to 12.5 % of the pre-incentive fee net investment income for the immediately preceding quarter; and (ii) 12.5 % of all remaining pre-incentive fee net investment income above the “catch-up.” Following a Public Listing, the amount of Income Incentive Fee payable will be equal to: (i) 100 % of the excess of the Company’s pre-incentive fee net investment income for the immediately preceding quarter, over a preferred return of 1.75 % per quarter ( 7 % annualized) (“Incentive Fee Hurdle”), until the Adviser has received a “catch-up” equal to 20 % of the pre-incentive fee net investment income for the immediately preceding quarter; and (ii) 20 % of all remaining pre-incentive fee net investment income above the “catch-up.” “Pre-incentive fee net investment income” means interest income, dividend income, accrued interest on the Subordinated Certificates, and any other income including any other fees (other than fees for providing managerial assistance), such as commitment, origination, structuring, diligence and consulting fees or other fees that the Company receives from portfolio companies accrued during the quarter, minus our operating expenses for the quarter including the Management Fee, expenses payable under the Administration Agreement (as defined below), and any interest expense and any dividends paid on any issued and outstanding preferred stock, but excluding the Income Incentive Fee. Pre-incentive fee net investment income includes, in the case of investments with a deferred interest feature (such as original issue discount, debt instruments with PIK interest and zero coupon securities), accrued income that we have not yet received in cash. Pre-incentive fee net investment income does not include any realized capital gains, realized capital losses or unrealized capital appreciation or depreciation. The Income Incentive Fee for a particular quarter is subject to a cap (the "Incentive Fee Cap"). For periods prior to a Public Listing, the Incentive Fee Cap is equal to the difference between (x) 12.5 % of the Cumulative Net Return (as defined below) from the calendar quarter then ending and the eleven preceding calendar quarters (such period the "Trailing Twelve Quarters") and (y) the aggregate Income Incentive Fees that were paid to the Adviser by the Company in respect of the first eleven calendar quarters (or the portion thereof) included in the relevant Trailing Twelve Quarters. Following a Public Listing, the Incentive Fee Cap will be equal to the difference between (x) 20 % of the Cumulative Net Return during the relevant Trailing Twelve Quarters and (y) the aggregate Income Incentive Fees that were paid to the Adviser by the Company in respect of the first eleven calendar quarters (or the portion thereof) included in the relevant Trailing Twelve Quarters. Cumulative Net Return is defined as the sum of (a) pre-incentive fee net investment income in respect of the relevant Trailing Twelve Quarters and (b) cumulative aggregate realized capital gains, cumulative aggregate realized capital losses, cumulative aggregate unrealized capital depreciation and cumulative aggregate unrealized capital appreciation in respect of the relevant Trailing Twelve Quarters. For the year ended December 31, 2023, the Company incurred an Income Incentive Fee of $ 6.0 million. For the year ended December 31, 2022, the Company incurred an Income Incentive Fee of $ 1.3 million. As of December 31, 2023, $ 2.2 million was included in “Income-based incentive fee payable” in the accompanying Consolidated Statements of Assets and Liabilities. As of December 31, 2022, $ 0.5 million was included in “Income-based incentive fee payable” in the accompanying Consolidated Statements of Assets and Liabilities. Capital Gains Incentive Fee The second part, the capital gains incentive fee (“Capital Gains Incentive Fee”), is determined and payable in arrears as of the end of each fiscal year. Prior to a Public Listing, the amount of Capital Gains Incentive Fee is equal to 12.5 % of the Company’s realized capital gains, if any, on a cumulative basis from inception through the end of the fiscal year, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gain incentive fees. Following a Public Listing, the amount of Capital Gains Incentive Fee will be equal to 20 % of the Company’s realized capital gains, if any, on a cumulative basis from inception through the end of the fiscal year, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gains incentive fees. For the year ended December 31, 2023 and 2022 , the Company did no t incur a Capital Gains Incentive Fee . In addition, the Adviser and its affiliates pay to the Company its allocable portion of any transaction, advisory or similar fees received in connection with the Company’s investment activities. The Adviser determines the Company’s allocable portion of such fees based on the Company’s ownership of the investment or securities related to the activity or investment, as applicable. The Adviser and its affiliates retain a portion of any transaction or transaction-related fee (including break-up fees, structuring fees, monitoring fees, commitment fees, or brokerage or underwriting compensation), advisory fees, or similar fees received in connection with the Company’s investment activities to the extent permitted by the 1940 Act, and may earn other transaction or transaction-related fees, advisory fees, or similar fees from the same transactions from sources other than the Company. Administration Agreement On June 2, 2022, the Company entered into an administration agreement with Varagon (in its capacity as the administrator, the "Administrator"). In connection with the Transaction, and in conjunction with entering into the Investment Advisory Agreement, the Company entered into a new administration agreement between the Company and the Administrator (the "Administration Agreement"), which became effective on September 6, 2023. The Administration Agreement is materially identical to the prior administration agreement, dated June 2, 2022. Pursuant to the Administration Agreement, the Administrator (or one or more delegated service providers) furnishes the Company with office facilities, together with equipment and clerical, bookkeeping and recordkeeping services at such facilities. Under the Administration Agreement, the Administrator also performs, or oversees the performance of, the Company’s required administrative services, which includes being responsible for the financial records that the Company is required to maintain and preparing reports to the Company’s shareholders and reports filed with the SEC and otherwise assists with the Company’s compliance with the rules and regulations applicable to a BDC and RIC. In addition, the Administrator assists the Company in determining and publishing the Company’s net asset value, overseeing the preparation and filing of the Company’s tax returns and the printing and dissemination of reports to the Company’s shareholders, and generally overseeing the payment of the Company’s expenses and the performance of administrative and professional services rendered to the Company by others. The Administrator will charge the Company only for the actual expenses it incurs on its behalf, or its allocable portion thereof, without any profit to the Administrator. For the year ended December 31, 2023, the Company recorded administrator expenses of $ 1.2 million. For the year ended December 31, 2022, the Company recorded administrator expenses of $ 0.7 million. As of December 31, 2023, the Company had $ 0.3 million in "Administrator expenses payable" in the accompanying Consolidated Statements of Assets and Liabilities. As of December 31, 2022, the Company had $ 0.3 million in "Administrator expenses payable" in the accompanying Consolidated Statements of Assets and Liabilities. The Administrator also has entered into a sub-administration agreement with State Street Bank and Trust Company (the “Sub-Administrator”) under which the Sub-Administrator provides various accounting and administrative services to the Company, subject to the oversight of the Administrator, including preparing certain financial information, providing certain treasury services, and providing certain fund accounting services. The Company, on behalf of the Administrator, will pay the Sub-Administrator fees for its services as it determines are commercially reasonable in its sole discretion and for all reasonable expenses. To the extent that the Sub-Administrator outsources any of its functions, the Sub-Administrator pays any compensation associated with such functions. Expense Reimbursement Agreement On June 2, 2022 , the Company and the Adviser entered into an expense reimbursement agreement (the “Expense Reimbursement Agreement”) pursuant to which the Company reimburses the Adviser or Varagon, as applicable, for any organizational and offering expenses incurred by the Company and funded by the Adviser or Varagon. The Adviser elected to incur the organizational and offering expenses associated with the Company for the period from July 31, 2019 through March 29, 2022. Such organizational and offering expenses are not reimbursable by the Compan y (See "Note 2. Significant Accounting Policies"). Any such reimbursement will be made during the first four fiscal quarters following the 24-month period after the Initial Closing (the “Fundraising Period”). The Fundraising Period may be extended by up to an additional 18 months in the sole discretion of the Board (i.e., from 24 months to up to 42 months after the Initial Closing). Subsequent to the year ended December 31, 2023, the Board extended the Fundraising Period. See "Note 13. Subsequent Events" for more information. For the avoidance of doubt, to the extent the Fundraising Period is extended by up to an additional 18 months in the sole discretion of the Board, the Company will reimburse the Adviser or, as applicable, Varagon, for the organizational and offering expenses incurred by the Company during the first four fiscal quarters following the extended Fundraising Period. The Company’s obligation to reimburse the Adviser or Varagon, as applicable, under the Expense Reimbursement Agreement automatically became a liability of the Company on June 2, 2022, when the Company elected to be regulated as a BDC under the 1940 Act. For the avoidance of doubt, reimbursements under the Expense Reimbursement Agreement are not conditioned on any performance threshold and are not considered a contingent liability for accounting purposes. Fronting Letter Agreement On December 15, 2022 , the Company and Varagon entered into a Fronting Letter Agreement (the “Fronting Letter”). Pursuant to the Fronting Letter, for purposes of facilitating the Company’s funding obligations under or in connection with one or more of its portfolio investments, upon request by the Company or the Adviser, and the consent of Varagon, Varagon will advance up to an aggregate amount of $ 15.0 million to the Company (each advance, a "Fronted Amount"). Each Fronted Amount will be reimbursed to Varagon by the Company within 90 days of receipt without any interest or fees. On December, 20, 2022, Varagon advanced a Fronted Amount of $ 10.0 million to the Company. On December 28, 2022, the Company repaid $ 2.0 million thereof to Varagon. As of December 31, 2022, the Company had $ 8.0 million remaining due to Varagon, which is included in “Fronting amount payable” in the accompanying Consolidated Statements of Assets and Liabilities. On January 17, 2023, the Company repaid Varagon the remaining $ 8.0 million due to Varagon under the Fronting Letter. Placement Agent Agreements On May 23, 2022 , the Adviser entered into an agreement with Rondout Partners, LLC ("Rondout") on behalf of the Company, pursuant to which Rondout, assisted the Company in conducting the Offering. Rondout provided notice of the agreement’s termination on July 18, 2023 , which termination became effective on August 17, 2023 (the "Rondout Placement Agent Agreement"). On September 6, 2023 , the Adviser entered into an agreement with Man Investments Inc. on behalf of the Company, pursuant to which Man Investments Inc., assists the Company in conducting the Offering (the "Man Placement Agent Agreement"). On October 13, 2023, the Adviser entered into an agreement with Man Investments Inc. on behalf of the Company, pursuant to which Man Investments Inc. assists the Company in conducting the Offering in Canada ( together with the Rondout Placement Agent Agreement and the Man Placement Agent Agreement, the "Placement Agent Agreements"). For avoidance of doubt, the Adviser or its affiliates are solely responsible for any placement or “finder’s” fees payable to any placement agents engaged by the Adviser on behalf of the Company in connection with the Offering.

Commitments

Commitments	12 Months Ended
	Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments	Note 8. Commitments Unfunded commitments As of December 31, 2023 and December 31, 2022, the Company had commitments under loan and financing agreements to fund up to $ 22.7 million to 29 portfolio companies and $ 33.0 million and 30 portfolio companies, respectively. These commitments are primarily composed of senior secured term loans, revolvers, and in the SDLP, and an analysis of their fair value is included in the Consolidated Schedule of Investments. The Company's commitment to fund commitments are generally subject to the borrowers meeting certain criteria such as compliance with covenants and certain operational metrics. The terms of the borrowings and financings subject to commitment are comparable to the terms of other loan and equity securities in our portfolio. A summary of the composition of the unfunded commitments as of December 31, 2023 and December 31, 2022 are shown in the table below (dollars in thousands): As of December 31, 2023 As of December 31, 2022 Accupac, LLC 564 564 ADPD Holdings, LLC 5 5 ADPD Holdings, LLC — 2 ADPD Holdings, LLC 12 13 ADPD Holdings, LLC 13 13 Advanced Web Technologies Holding Company — 76 Adviser Investments, LLC 9 9 Adviser Investments, LLC 37 53 Arrowhead Holdco Company — 19 Boulder Scientific Company, LLC 625 1,043 BRG Acquisition Co., LLC 600 600 Cadent, LLC — 181 Castleworks Home Services Company 7 277 Center for Autism and Related Disorders, LLC — 2,235 Concord III, L.L.C., 210 — Energy Labs Holding Corp. — 943 Express Wash Acquisition Company, LLC 115 115 Eye Health America, LLC 360 456 Eye Health America, LLC 1,092 1,146 Fingerpaint Marketing, Inc. 14 — HLSG Intermediate, LLC 1,655 — JTM Foods LLC 3 — KL Bronco Acquisition, Inc. — 27 KL Bronco Acquisition, Inc. 250 536 KL Bronco Acquisition, Inc. 1,786 1,786 Krayden Holdings, Inc. 386 — Krayden Holdings, Inc. 386 — Krayden Holdings, Inc. 405 — Leiters, Inc. 244 — M&D Midco, Inc. 11 12 M&D Midco, Inc. 10 23 MDI Buyer, Inc. 7 7 MWD Management, LLC 266 — MWD Management, LLC — 233 North Haven Stallone Buyer, LLC 333 — North Haven Stallone Buyer, LLC — 10 OIS Management Services, LLC 577 577 OIS Management Services, LLC — 1,923 Oliver Packaging, LLC 176 585 Online Labels Group, LLC 10 — Online Labels Group, LLC 9 — Online Labels Group, LLC 9 — Pediatric Home Respiratory Services, LLC — 1,063 POY Holdings, LLC 1,211 — RFI Buyer, Inc. 12 12 RFI Buyer, Inc. — 14 Senior Direct Lending Program, LLC 8,557 10,438 SGA Dental Partners Opco, LLC — 4,629 SGA Dental Partners Opco, LLC 1,394 — Techmer BB Bidco, LLC — 7 Techmer BB Bidco, LLC 32 36 Turbo Buyer, Inc. 760 760 United Musculoskeletal Partners Acquisition Holdings, LLC 562 1,630 USN Opco, LLC — 593 USSC Acquisition Corp. — 331 Total Unfunded Commitments $ 22,714 $ 32,982 The Company believes its assets will provide adequate coverage to satisfy these unfunded commitments. As of December 31, 2023, the Company had cash of $ 20.0 million, available borrowings under the JPM Facility of $ 66.1 million, subject to borrowing base limitations, available borrowings under the CIBC Facility of $ 67.2 million, subject to borrowing base limitations, and undrawn capital commitments of $ 73.5 million .

Directors Fees

Directors Fees	12 Months Ended
	Dec. 31, 2023
Debt Disclosure [Abstract]
Directors Fees	Note 9. Directors Fees The Company’s business and affairs is managed under the direction of the Board. The Board consists of four (4) members, three (3) of whom are not “interested persons” (as defined in Section 2(a)(19) of the 1940 Act) of the Company, the Adviser or any of the Company’s respective affiliates (the “Independent Directors”). On March 8, 2022, at its organizational meeting, the Board appointed the Independent Directors. The Independent Directors receive an annual fee of $ 80,000 . The Independent Directors will also receive an additional fee of $ 2,500 plus reimbursement of reasonable out-of-pocket expenses incurred in connection with attending each regular meeting of the Board. In addition, the Independent Directors will receive an additional fee of $ 1,500 plus reimbursement of reasonable out-of-pocket expenses incurred in connection with attending each special Board meeting. The Independent Directors also will receive a fee of $ 1,000 plus reimbursement of reasonable out-of-pocket expenses incurred in connection with attending each committee meeting. The lead Independent Director will receive an additional annual fee of $ 7,500 . The chair of the Board's audit committee will receive an additional annual fee of $ 15,000 in lieu of fees for attending audit committee meetings. The chair of the Board's nominating and corporate governance committee will receive an additional annual fee of $ 7,500 in lieu of fees for attending nominating and corporate governance committee meetings. For the year ended December 31, 2023, the Company accrued $ 0.3 million for directors’ fees and expenses. For the year ended December 31, 2022 , the Company accrued $ 0.3 million. As of December 31, 2023, the Company had $ 0.1 million in "Directors' fees and expenses payable" in the accompanying Consolidated Statements of Assets and Liabilities. As of December 31, 2022, the Company had $ 0.1 million in "Directors' fees and expenses payable" in the accompanying Consolidated Statements of Assets and Liabilities .

Share Data And Distributions

Share Data And Distributions	12 Months Ended
	Dec. 31, 2023
Equity [Abstract]
Share Data and Distributions	Note 10. Share Data and Distributions Earnings per share The following table sets fo r the computation of basic and diluted earnings per share, for the year ended December 31, 2023 and 2022 (dollars in thousands, except per share data): Year Ended December 31, 2023 2022 Net increase (decrease) in net assets resulting from operations $ 42,242 $ 9,242 Weighted average shares outstanding (1) 41,499,392 39,848,927 Earnings per share (basic and diluted) (1) $ 1.02 $ 0.23 (1) Per share data for the year ended December 31, 2022 was derived by using the weighted average shares outstanding from the June 2, 2022 (commencement of investment operations) through December 31, 2022 and does not include the 100 shares issued in connection with the Company's seed audit on March 29, 2022 that were subsequently redeemed on June 2, 2022 in connection with the Merger. Capital Activity The Company is authorized to issue 500,000,000 shares of common stock at a par value of $ 0.01 per share. The Company intends to offer and sell its shares of common stock to “accredited investors” (as defined in Rule 501(a) of Regulation D promulgated under the 1933 Act in a private placement in reliance on Regulation D and Regulation S, as applicable. In connection with the Fundraising Period, the Company held the Initial Closing on June 2, 2022 and entered into subscription agreements in which investors have made capital commitments to purchase shares of common stock (the “Subscription Agreements”), providing private placement of the Company’s shares of common stock. Under the terms of the Subscription Agreements, investors are required to fund drawdowns to purchase the Company's shares of common stock up to the amount of their respective capital commitment each time the Company delivers a drawdown notice. On March 29, 2022, in connection with its seed audit, the Company issued 100 shares of common stock for $ 10.00 to Varagon, which were subsequently redeemed on June 2, 2022 , in connection with the Merger. As of December 31, 2023, the Company had received capital commitments totaling $ 488.2 million ($ 73.5 million remains undrawn). On June 2, 2022, the Company held the Initial Closing and entered into Subscription Agreements with a number of investors providing for the private placement of its shares of common stock. On June 2, 2022, the Company delivered its first capital drawdown noti ce to investors relating to the issuance of 36,130,510 shares of common stock for an aggregate offering price of $ 361.3 million, of which $ 5.1 million was from Varagon and current officers and directors of the Company. The following table summarizes the total shares issued and proceeds received related to capital drawdowns delivered pursuant to the Subscription Agreements from inception through December 31, 2023 (dollars in thousands, except per share data): Issuance Date Shares Issued Amount Issuance Price per Share June 2, 2022 36,130,510 $ 361,305 $ 10.00 July 12, 2022 2,994,012 $ 30,000 $ 10.02 September 7, 2022 2,362,205 $ 24,000 $ 10.16 Distributions and Distribution Reinvestments Distributions to common shareholders are recorded on the ex-dividend date. The Company elected, and intends to qualify annually, to be treated as a RIC for U.S. federal income tax purposes under the Code. The Company will be required to distribute dividends each tax year as a RIC to its shareholders of an amount generally at least equal to 90 % of its investment company taxable income, determined without regard to any deduction for dividends paid, in order to be eligible for tax benefits allowed to a RIC under Subchapter M of the Code. The Company anticipates paying out as a distribution all or substantially all of those amounts. The amount to be paid out as a dividend is determined by the Board and is based on management’s estimate of the Company’s annual taxable income. Net realized capital gains, if any, are generally distributed, although the Company may decide to retain such net realized capital gains for investment. The Company has adopted an “opt out” distribution reinvestment plan (“DRIP”) for shareholders. As a result, if the Board authorizes, and the Company declares, a dividend or other distribution, each shareholder that has not “opted out” of the DRIP will have their dividends or distributions automatically reinvested in additional shares of our common stock rather than receiving cash distributions. Shareholders who receive distributions in the form of shares of common stock will be subject to the same U.S. federal, state and local tax consequences as if they received cash distributions. The following table reflects the distributions per share that the Company has declared, including shares issued under the DRIP, on its common stock from inception through December 31, 2023 (dollars in thousands, except per share data): Distribution Date Declared Record Date Payment Dates Amount per Share Cash Distribution DRIP Shares Issued DRIP Shares Value Quarterly December 12, 2022 December 15, 2022 December 21, 2022 $ 0.2635 $ 10,892 3,915 $ 40 Quarterly December 19, 2022 December 23, 2022 January 27, 2023 0.2405 9,941 3,665 37 Quarterly March 23, 2023 March 27, 2023 March 31, 2023 0.2222 9,185 3,619 35 Quarterly May 10, 2023 July 1, 2023 July 15, 2023 0.2246 9,284 3,780 37 Quarterly August 8, 2023 October 2, 2023 October 16, 2023 0.2271 9,387 3,825 38 Quarterly November 7, 2023 December 27, 2023 January 17, 2024 0.2397 9,908 4,089 41 Special December 18, 2023 December 27, 2023 January 17, 2024 0.1205 4,981 2,056 20 Total $ 63,578 24,949 $ 248

Income Tax Information and Dist

Income Tax Information and Distributions to Shareholders	12 Months Ended
	Dec. 31, 2023
Income Tax Disclosure [Abstract]
Income Tax Information and Distributions to Shareholders	Note 11. Income Tax Information and Distributions to Shareholders The Company has elected, and intends to qualify annually, to be treated as a RIC under Subchapter M of the Code. As a RIC, the Company generally will not pay U.S. federal income taxes at corporate tax rates on any ordinary income or capital gains that it timely distributes to its shareholders as dividends. To qualify as a RIC, the Company must meet certain minimum distribution, source-of-income, and asset diversification requirements. The minimum distribution requirements applicable to RICs require the Company to distribute at least 90 % of its investment company taxable income, as defined by the Code, each year. The Company is subject to a nondeductible 4 % U.S. federal excise tax on its undistributed income, unless it timely distributes (or is deemed to have timely distributed) an amount equal to the sum of (1) 98% of ordinary income for each calendar year, (2) 98.2% of the amount by which capital gains exceeds capital losses (adjusted for certain ordinary losses) for a one-year period ending on October 31 of the calendar year, and (3) any income and gains recognized, but not distributed, from the previous years. While the Company intends to distribute any income and capital gains to avoid imposition of this 4% U.S. federal excise tax, it may not be successful in avoiding entirely the imposition of this tax. In that case, the Company will be liable for the tax only on the amount by which it does not meet the foregoing distribution requirement. For the year ended December 31, 2023, the Company distributed at least 98 % of its ordinary income and 98.2 % of its capital gains, and as such, did no t record an excise tax. For the year ended December 31, 2022, the Company did not distribute at least 98 % of its ordinary income and 98.2 % of its capital gains. Accordingly, with respect to the year ended December 31, 2022, an excise tax of $ 0.1 million was recorded. For the fiscal year ended December 31, 2023, the Company did not record a U.S. federal income tax expense/(benefit). The Company evaluates tax positions taken in the course of preparing the Company’s tax returns to determine whether the tax positions are “more-likely-than-not” to be sustained by the applicable tax authority in accordance with ASC Topic 740, Income Taxes (“ASC 740”). Tax benefits of positions not deemed to meet the more-likely-than-not threshold, or uncertain tax positions, would be recorded as tax expense in the current year. It is the Company’s policy to recognize accrued interest and penalties related to uncertain tax benefits in income tax expense. The Company had no material uncertain tax positions as of and through December 31, 2023. The Company's current tax year and 2022 federal and state tax returns remain subject to examination by the Internal Revenue Service and state departments of revenue. Federal Income Taxes The Company is subject to the U.S. federal income tax rules and filing requirements. The Company is expected to have minimal or no income subject to tax and therefore no provision has been included for taxes due. The Company has elected, and intends to qualify annually, to be treated as a RIC under Subchapter M of the Code. As a result, the Company generally does not expect to be subject to U.S. federal income taxes. The Company has not recorded a liability for any uncertain tax positions pursuant to the provisions of ASC 740 as of December 31, 2023. In the normal course of business, the Company is subject to examination by federal and certain state and local tax regulators. The Company adopted a tax year-end of December 31. For income tax purposes, distributions paid to shareholders are reported as ordinary income, return of capital, long-term capital gains, or a combination thereof. The Company's taxable income for each period is an estimate and will not be finally determined until the Company files its tax return for each year. Therefore, the final taxable income earned in each period and carried forward for distribution in the following period may be different than this estimate. The following table sets forth the tax cost basis and the estimated aggregate gross unrealized appreciation and depreciation from investments for federal income tax purposes as of December 31, 2023 and December 31, 2022 (dollars in thousands): December 31, 2023 December 31, 2022 Tax cost of investments $ 686,423 $ 679,589 Unrealized appreciation 1,389 216 Unrealized depreciation ( 1,775 ) ( 13,659 ) Net unrealized appreciation (depreciation) from investments $ ( 386 ) $ ( 13,443 ) For U.S. federal income tax purposes, distributions paid to shareholders are reported as ordinary income, return of capital, long term capital gains or a combination thereof. The tax character of distributions paid for the years ended December 31, 2023 and December 31, 2022 was as follows (dollars in thousands): Year Ended December 31, 2023 Year Ended December 31, 2022 Ordinary Income $ 42,916 $ 20,910 Long-term Capital Gain $ — $ — Return of capital $ — $ — At December 31, 2023, and December 31, 2022, the components of distributable earnings on a tax basis detailed below differ from the amounts reflected in the Company’s Statements of Assets and Liabilities by temporary and other book/tax differences, primarily relating to the tax treatment of organizational costs and the tax treatment of partnership investments, as follows (dollars in thousands): Year Ended December 31, 2023 Year Ended December 31, 2022 Undistributed Ordinary Income $ — $ 1,998 Undistributed Capital Gains — — Capital Loss Carry Forwards ( 289 ) — Late Year Losses — — Other Accumulated Losses ( 11,575 ) ( 161 ) Unrealized appreciation/(depreciation) ( 386 ) ( 13,443 ) Components of distributable earnings/(accumulated deficits) at year end $ ( 12,250 ) $ ( 11,606 ) For tax purposes, net realized capital losses may be carried over to offset future capital gains, if any. Funds are permitted to carry forward capital losses for an indefinite period, and such losses will retain their character as either short-term or long-term capital losses. For the year ended December 31, 2023 the Company has a capital loss carryforward of $( 0.3 ) million. During the current fiscal year, permanent differences primarily due to non-deductible excise tax resulted in a net increase of $ 29,489 in distributable earnings and a net decrease of $ 29,489 in additional paid-in capital. These reclassifications had no effect on net assets. Tax information for the fiscal year ended December 31, 2023 is an estimate and will not be finally determined until the Company files its 2023 tax return. Taxable Subsidiaries The Company uses the liability method to account for its taxable subsidiary's, VCCEH, income taxes. Using this method, the Company recognizes deferred tax assets and liabilities for the estimated future tax effects attributable to temporary differences between financial reporting and tax bases of assets and liabilities. In addition, the Company recognizes deferred tax benefits associated with net operating loss carry forwards that it may use to offset future tax obligations. The Company measures deferred tax assets and liabilities using the enacted tax rates expected to apply to taxable income in the years in which it expects to recover or settle those temporary differences. For the year ended December 31, 2023 and 2022 , the Company determined that no deferred tax asset or liability was necessary. VCCEH has elected to be taxed as a corporation for U.S. federal income tax purposes. As a result, VCCEH is obligated to pay federal, state and local income tax on its taxable income. Deferred income taxes reflect the net effect of temporary differences between the carrying amount of assets and liabilities for financial reporting and tax purposes. Components of the Company's deferred tax assets and liabilities as of December 31, 2023 are as follows: Year Ended December 31, 2023 Deferred tax assets: Net operating loss carryforward $ 9,894 Net unrealized loss on investments 81,323 Valuation allowance ( 91,218 ) Total deferred tax assets — Deferred tax liabilities: Total deferred tax liabilities — Net deferred tax assets and liabilities $ — The Company's income tax provision consists of the following as of December 31, 2023: Year Ended December 31, 2023 Current tax (expense)/benefit Federal $ — State and Local — Total current tax (expense)/benefit — Deferred tax (expense)/benefit Federal 78,974 State and Local 12,244 Valuation allowance ( 91,218 ) Total deferred tax (expense)/benefit $ — Total income tax (expense)/benefit — Total income tax (expense) benefit for the Company differs from the amount computed by applying the federal statutory income tax rate of 21 % to net increase (decrease) in net assets from operations for the period January 1, 2023 through December 31, 2023, as follows: Year Ended December 31, 2023 Income tax benefit at federal statutory tax rate $ 10,409,380 Income attributable to the RIC and not subject to corporate tax ( 10,330,464 ) State and local income tax benefit (net of federal detriment) 12,235 Prior year net operating loss carryforward 3,190 Book vs. tax basis in partnership investments ( 3,123 ) Permanent differences — Valuation allowance ( 91,218 ) Total income tax (expense)/benefits $ — At December 31, 2023, the Company determined a valuation allowance was required. The Company’s assessment considered, among other matters, the nature, frequency and severity of current and cumulative losses, the duration of statutory carryforward periods and the associated risk that operating loss and capital loss carryforwards are limited or are likely to expire unused, and unrealized gains and losses on investments. Through the consideration of these factors, the Company has determined that it is more likely than not that the Company’s net deferred tax asset would not be realized. As a result, the Company recorded a full valuation allowance with respect to its deferred tax asset for the quarter ended December 31, 2023. From time to time, the Company may modify its estimates or assumptions regarding its deferred tax liability and/or asset balances and any applicable valuation allowance as new information becomes available. Modifications to the Company’s estimates or assumptions regarding its deferred tax liability and/or asset balances and any applicable valuation allowance, changes in generally accepted accounting principles or related guidance or interpretations thereof, limitations imposed on or expirations of the Company’s net operating losses and capital loss carryovers (if any) and changes in applicable tax law could result in increases or decreases in the Company’s NAV per share, which could be material A net operating loss carryforward is available to offset future taxable income. As of December 31, 2023, VCCEH had a net operating loss carryforward for federal income tax purposes of $ 40,791 . This net operating loss may be carried forward indefinitely. For tax purposes, net realize capital losses generated by VCCEH may be carried over to offset future capital gains, if any. These capital losses can be carried forward for 5 years. As of December 31, 2023, the Company did no t have any capital loss carry forwards.

Financial Highlights

Financial Highlights	12 Months Ended
	Dec. 31, 2023
Investment Company, Financial Highlights [Abstract]
Financial Highlights	Note 12. Financial Highlights The following is a schedule of financial highlights for the year ended December 31, 2023 and 2022 (dollars in thousands, except per share data): For the year ended December 31, 2023 For the period from June 2, 2022 (commencement of investment operations) through December 31, 2022 Per Share Data: (1) (2) Net asset value, beginning of period (3) $ 9.73 $ — Net investment income (loss) 1.03 0.55 Net unrealized appreciation (depreciation) — ( 0.32 ) Net realized gains (losses) ( 0.01 ) — Net increase (decrease) in net assets resulting from operations 1.02 0.23 Distributions of net investment income to shareholders (4) ( 1.04 ) ( 0.50 ) Issuance of common stock — 10.00 Net asset value per share, end of period $ 9.71 $ 9.73 Number of shares outstanding, end of period 41,505,531 41,490,642 Total return based on net asset value (5)(6) 10.81 % 2.18 % Net assets attributable to shareholders, end of period $ 403,150 $ 403,677 Ratio to average net assets attributable to shareholders: Average net assets $ 405,570 $ 395,488 Total expenses (7) 9.84 % 6.83 % Total expenses (other than incentive fee) (7) 8.35 % 6.50 % Net investment income (7) 10.51 % 9.73 % Interest expense and credit facility fees (7) 5.88 % 4.05 % Ratios/Supplemental Data: Asset coverage, end of period (8) 238.22 % 244.95 % Weighted average shares outstanding (9)(10) 41,499,392 39,848,927 Total capital commitments, end of period $ 488,208 $ 488,208 Ratio of total contributed capital to total committed capital, end of period 84.95 % 84.95 % Average debt outstanding (11) $ 277,548 $ 272,563 Average debt outstanding per share $ 6.69 $ 6.84 Portfolio turnover (6)(12) 9.85 % 10.20 % Year of formation 2019 2019 (1) The per share data for 2023 was derived by using the weighted average shares outstanding. The per share data for 2022 was derived by using the weighted average shares outstanding from June 2, 2022 (commencement of investment operations) through December 31, 2022. (2) Per share data for the year ended December 31, 2022 based upon the weighted average shares outstanding from March 29, 2022 (first issuance of common stock) through December 31, 2022 were as follows: Net investment income of $ 0.71 per share, net unrealized loss of $ 0.30 per share, net increase in net assets resulting from operations of $ 0.41 per share, distributions of net investment income of $ 0.68 per share, and net asset value per share at the end of the period of $ 9.73 per share. (3) Net asset value at the beginning of the period from June 2, 2022 (commencement of investment operations) through December 31, 2022 is adjusted to reverse the initial share issuance of 100 shares of common stock in connection with the Company's seed audit, as well as $ 81,049 of accrued expenses. Net asset value after the Company's seed audit was $( 810.39 ) per share. (4) Distributions declared per common share was calculated as the sum of distributions on common stock declared during the year divided by the number of shares of common stock outstanding at each respective quarter-end date. (5) Total return is based on the change in net asset value during the year divided by the beginning net asset value for the year, taking into account distributions declared, if any, reinvested in accordance with the Company’s DRIP. (6) Not annualized. (7) Annualized for the period from June 2, 2022 (commencement of investment operations) through December 31, 2022, except in the case of non-recurring expenses (i.e. organizational expenses). (8) Asset coverage per unit is the ratio of the carrying value of our total consolidated assets, less all liabilities and indebtedness not represented by senior securities, to the aggregate amount of senior securities representing indebtedness. Asset coverage per unit is expressed in terms of dollar amounts per $ 1,000 of indebtedness. Asset coverage ratio per unit does not include unfunded commitments. The inclusion of unfunded commitments in the calculation of the asset coverage ratio per unit would not cause the Company to be below the required amount of regulatory coverage. (9) Calculated for the period from June 2, 2022 (the commencement of investment operations) through December 31, 2022. (10) Weighted average common shares outstanding for the year ended December 31, 2022 was 30,531,755 , calculated from March 29, 2022 (first issuance of shares of common stock) through December 31, 2022. (11) Based on daily weighted average balance of debt outstanding during the period. (12) Portfolio turnover calculation does not include the non-cash acquisition of the SDLP.

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2023
Subsequent Events [Abstract]
Subsequent Events	Note 13. Subsequent Events Management has evaluated subsequent events through the date of issuance of the consolidated financial statements included herein. There have been no subsequent events that occurred during such period that would require disclosure in this Annual Report on Form 10-K or would be required to be recognized in the consolidated financial statements as of and for the year ended December 31, 2023 except as disclosed below: On February 2, 2024, in connection with each of the 2026 Notes and the 2028 Notes, the Company entered into an interest rate swap agreement for a total notional amount of $ 25,000,000 and $ 25,000,000 that matures on December 21, 2026 and December 21, 2028 , respectively. Under the interest rate swap agreement for the 2026 Notes and the 2028 Notes, the Company received a fixed interest rate of 8.10 % and 8.20 % and pay a floating interest rate of SOFR + 4.226 % and SOFR + 4.595 %, respectively. On March 20, 2024, the Board determined to extend the Fundraising Period from 24 months to 42 months after the Initial Closing. As a result of the foregoing, the Company extended the period during which it may hold subsequent closings from June 2, 2024 to December 2, 2025. On March 20, 2024 , the Board declared a dividend of $ 0.2371 per share and a special dividend of $ 0.0333 per share, both payable on April 10, 2024 to shareholders of record as of the close of business on March 29, 2024 .

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2023
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) and pursuant to Regulation S-X and include the accounts of the Company and its consolidated subsidiaries. As an investment company, the Company applies the accounting and reporting guidance in Accounting Standards Codification (“ASC”) Topic 946, Financial Services – Investment Companies (“ASC 946”) issued by the Financial Accounting Standards Board (“FASB”). The consolidated financial statements reflect all adjustments and reclassifications that, in the opinion of management, are necessary for the fair presentation of the results of operations and financial condition as of and for the period presented. All significant intercompany balances and transactions have been eliminated.
Cash	Cash Cash consists of deposits held at a custodian bank and, at times, may exceed the insured limits under applicable law. As of December 31, 2023, the Company held approximately $ 20.0 million in cash. As of December 31, 2022, the Company held approximately $ 20.4 million in ca sh.
Organizational and Offering Expenses	Organizational and Offering Expenses Organizational and offering expenses consist of all costs and expenses, whether incurred before, on or after the date of the private placement memorandum relating to the Company’s private offering of shares of common stock (the “Offering”), pertaining to the organization and establishment of the Company (including any subsidiaries of the Company and the transactions contemplated by the Merger and the acquisition of the Initial Portfolio), including, without limitation, any related third-party legal, tax and accounting advisory fees and expenses, capital raising expenses, including printing expenses and other similar costs, fees and expenses, and regulatory, compliance, and administrative filings, and other organizational and offering expenses, but excluding the fees of any placement agent engaged on behalf of the Company. The Adviser elected to incur the organizational and offering expenses associated with the Company (See "Note 7. Related Party Transactions”) for the period from July 31, 2019 through March 29, 2022. Such organizational and offering expenses are not reimbursable by the Company. For the period from July 31, 2019 through December 31, 2019, the Adviser incurred $ 46,384 of organizational and offering expenses. For the year ended December 31, 2020, the Adviser incurred $ 11,805 of organization costs. For the year ended December 31, 2021, the Adviser incurred $ 0.1 million of organizational and offering expenses. For the period of January 1, 2022 through March 29, 2022, the Adviser incurred $ 0.4 million of organizational and offering expenses. For the year ended December 31, 2023, the Company incurred and expensed $ 0.4 million of organizational expenses. For the year ended December 31, 2022 , the Company incurred and expensed $ 0.2 million of organizational expenses.
Use of Estimates in the Preparation of Financial Statements	Use of Estimates in the Preparation of Financial Statements The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Actual results could differ from those estimates.
Deferred Financing Costs	Deferred Financing Costs Deferred financing costs, incurred in connection with any revolving credit facility are presented as an asset on the Company’s Consolidated Statement of Assets and Liabilities and are deferred and amortized over the life of the respective credit facility (See "Note 6. Borrowings”).
Indemnifications	Indemnifications In the normal course of its business, the Company may enter into contracts that contain a variety of representations and warranties, which provide general indemnifications. The Company’s maximum exposure under these arrangements is unknown, as this would involve future claims that may be made against the Company that have not yet occurred. However, management believes the risk of loss to be remote.
Revenue Recognition	Revenue Recognition Investment transactions are accounted for on a trade-date basis. Realized gains or losses on investments are measured by the difference between the net proceeds from the disposition and the amortized cost basis of investment, without regard to unrealized gains or losses previously recognized. The Company reports current period changes in fair value of investments that are measured at fair value as a component of the net change in unrealized appreciation (depreciation) on investments in the Consolidated Statement of Operations. Investment Income Interest income, including amortization of premium and accretion of discount, is recorded on the accrual basis to the extent that such amounts are expected to be collected. The Company records amortized or accreted discounts or premiums as interest income using the effective interest method and is adjusted only for material amendments or prepayments. Dividend income, which represents dividends from equity investments and distributions from subsidiaries, if any, is recognized on an accrual basis to the extent that the Company expects to collect such amount. Interest income from investments in the Subordinated Certificates (as defined below) of SDLP is recorded based on an estimate of an effective yield to expected maturity utilizing assumed cash flows in accordance with ASC Topic 325-40, Beneficial Interests in Securitized Financial Assets . The Company monitors the expected cash flows from these investments, including the expected residual payments, and the effective yield is determined and updated periodically. Any difference between the cash distribution received and the amount calculated pursuant to the effective interest method is recorded as an adjustment to the cost basis of such investments. PIK Interest The Company may, from time to time, hold loans in its portfolio that contain a payment-in-kind ("PIK") interest provision. PIK interest, computed at the contractual rate specified in each loan agreement, is periodically added to the principal balance of the loan, rather than being paid to the Company in cash, and is recorded as interest income. Thus, the actual collection of PIK interest may be deferred until the time of debt principal repayment. PIK interest, which is a non-cash source of income at the time of recognition, is included in the Company’s taxable income, and therefore affects the amount the Company would be required to distribute to its shareholders to maintain its tax treatment as a RIC for U.S. federal income tax purposes, even though the Company would have not yet collected the cash. For the year ended December 31, 2023 , the Company earned PIK interest of $ 0.5 million. For the year ended December 31, 2022 , the Company earned PIK interest of $ 0.1 million. Fee Income Origination fees received are recorded as deferred income and recognized as investment income over the term of the loan. Upon prepayment of a loan, any unamortized origination fees are recorded as investment income. The Company receives certain fees from portfolio companies, which are non-recurring in nature. Such fees include loan prepayment penalties, structuring fees, covenant waiver fees and loan amendment fees, and are recorded as investment income when earned. Some of the fees earned by the Company may be PIK fee income. For the year ended December 31, 2023 , the Company earned $ 7,524 of PIK fee income. For the year ended December 31, 2022 , the Company earned $ 0.2 million of PIK fee income. Non-accrual loans A loan can be left on accrual status during the period the Company is pursuing repayment of the loan. Management reviews all loans that become 90 days or more past due on principal and interest, or when there is reasonable doubt that principal or interest will be collected, for possible placement on non-accrual status. When a loan is placed on non-accrual status, unpaid interest credited to income is reversed. Additionally, any original issue discount and market discount are no longer accreted to interest income as of the date the loan is placed on non-accrual status. Interest payments received on non-accrual loans are recognized as income or applied to principal depending upon management’s judgment. Non-accrual loans are restored to accrual status when past due principal and interest is paid, and, in management’s judgment, payments are likely to remain current. As of December 31, 2023 and December 31, 2022 , there were no loans on non-accrual.
Investment Income	Investment Classification The Company classifies its investments in accordance with the requirements of the 1940 Act. Under the 1940 Act, the C ompany would be deemed to "control" a portfolio company if the Company owned more than 25% of its outstanding voting securities and/or had the power to exercise control over the management or policies of such portfolio company. The Company refers to such investments in portfolio companies that it "controls" as "Control Investments." Under the 1940 Act, the Company would be deemed to be an "Affiliated Person" of a portfolio company if it owned between 5 % and 25 % of the portfolio company's outstanding voting securities or the Company was under common control with such portfolio company. The Company refers to such investments in Affiliated Persons as "Affiliated Investments." Investments which are neither Control Investments nor Affiliated Investments are referred to as "Non-Controlled/Non-Affiliated investments."
Fair Value Measurements	Fair Value Measurements The Company applies fair value accounting to all of its investments in accordance with the 1940 Act and ASC Topic 820, Fair Value Measurements (“ASC 820”), which defines fair value, sets a framework for measuring fair value, and requires certain disclosures about fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (i.e. exit price). Investments are reflected on the Consolidated Statement of Assets and Liabilities at fair value, with the changes in unrealized gains and losses resulting from changes in fair value, if any, reflected on the accompanying Consolidated Statement of Operations as a change in unrealized gain (loss) on investments. In accordance with ASC 820, the Company discloses the fair value of its investments in a hierarchy that prioritizes the inputs applied to valuation techniques used to measure the fair value. The hierarchy gives the highest priority to valuations based upon unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to valuations based upon unobservable inputs that are significant to the valuation (Level 3 measurements). Investments with readily available market quotations or for which fair value can be measured from quoted prices in active markets will typically have a higher degree of input observability and a lesser degree of judgment applied in determining the fair value. The guidance establishes three levels of the fair value hierarchy as follows: Level 1 – Valuations based on quoted prices in active markets for identical assets and liabilities that the Company can access as of the measurement date. Valuation utilizing Level 1 inputs do not require any degree of judgment. The type of investments generally included in Level 1 are publicly-traded securities. Level 2 – Valuations based on (i) quoted prices for similar instruments in active markets; (ii) quoted prices for which identical or similar instruments in markets that are not active that are reflective of recent market transactions; or (iii) models in which all significant inputs are observable, either directly or indirectly. The types of investments generally included in Level 2 are restricted securities listed in active markets, corporate bonds, and certain loans. Level 3 – Valuations based on indicative quotes that do not reflect recent market transactions and models or other valuation techniques in which the inputs are unobservable and significant to the fair value measurement, which includes situations where there is little, if any, market activity for the asset or liability. The inputs used in determination of fair value require significant judgment and estimation. The types of investments generally included in Level 3 are privately held debt and equity securities. The Company has established policies and procedures to ensure that valuation methodologies for investments that are categorized within all levels of the fair value hierarchy are fair and consistent. Valuations of the investments are reviewed and approved quarterly by the Adviser’s Valuation Committee, which is responsible for establishing the valuation policies and procedures and evaluating the overall fairness and consistent application of those policies. The valuation process may include a review or analysis by an independent, third-party valuation firm. The Adviser then recommends the valuations of the Company’s investments to the Board, which is responsible for determining the fair value of the Company's investments on a quarterly basis. The Company is subject to the valuation policies and procedures of the Adviser. Any changes to the valuation methodology are reviewed by management and the Board to confirm that the changes are appropriate. As markets change, new products develop and the pricing for products becomes more or less transparent, the Company will continue to refine its valuation methodologies. Currently, the Company uses interest rate swaps to manage our interest rate risk. The valuation of these instruments is determined using widely accepted valuation techniques, including discounted cash flow analysis on the expected cash flows of each derivative. This analysis reflects the contractual terms of the derivatives, including the period to maturity, and uses observable market-based inputs, including interest rate curves and implied volatilities. To comply with the provisions of ASC 820, the Company incorporates credit valuation adjustments to appropriately reflect both its own nonperformance risk and the respective counterparty’s nonperformance risk in the fair value measurements. In adjusting the fair value of the Company's derivative contracts for the effect of nonperformance risk, the Company has considered the impact of netting and any applicable credit enhancements, such as collateral postings, thresholds, mutual puts and guarantees. Rule 2a-5 under the 1940 Act (the "Rule 2a-5") establishes a regulatory framework for determining fair value in good faith for purposes of the 1940 Act. Rule 2a-5 permits boards, subject to board oversight and certain other conditions, to designate certain parties to perform the fair value determinations. Rule 2a-5 also defines when market quotations are “readily available” for purposes of the 1940 Act and the threshold for determining whether a fund must determine the fair value of a security. Rule 31a-4 under the 1940 Act (“Rule 31a-4”), provides the recordkeeping requirements associated with fair value determinations. While the Board has not designated the Adviser as the valuation designee, the Company has established policies and procedures in compliance with the applicable requirements of Rule 2a-5 and Rule 31a-4.
Derivative Instruments	Derivative Instruments For its current derivative instruments, the Company does not utilize hedge accounting and values such derivatives at fair value with the unrealized appreciation (depreciation) recorded in "net change in unrealized appreciation (depreciation) on derivatives" in the Company's consolidated statements of operations. See Note 5. "Derivative Instruments" for more information.
Recent Accounting Pronouncements	Recent Accounting Pronouncements The Company considers the applicability and impact of all accounting standard updates (“ASU”) issued by FASB. ASUs not listed below were assessed and either determined to be not applicable or expected to have minimal impact on its consolidated financial statements. In March 2020, the FASB issued ASU 2020-04, “Reference Rate Reform (Topic 848)—Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” This update provides temporary optional expedients and exceptions to the U.S. GAAP guidance on contract modifications and hedge accounting to ease the financial reporting burdens of the expected market transition from LIBOR and other interbank offered rates to alternative reference rates, such as SOFR. Entities can elect not to apply certain modification accounting requirements to contracts affected by what the guidance calls reference rate reform, if certain criteria are met. This guidance became effective upon issuance for all entities and generally was applied through December 31, 2022. As of December 31, 2023, the Company has amended its agreements with LIBOR as a reference rate to reference the forward-looking term rate published by CME Group Benchmark Administration Limited based on the secured overnight financing rate CME Term SOFR. Contract modifications are required to be evaluated in determining whether the modifications result in the establishment of new contracts or the continuation of existing contracts. The Company does not believe the adoption of ASU 2020-04 and ASU 2021-01 will have a material impact on its consolidated financial statements and disclosures when applied. In December 2022, the FASB issued ASU 2022-06, Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848 (“ASU 2022-06”). The amendments in ASU 2022-06 extend the period of time preparers can utilize the reference rate reform relief guidance. ASU 2022-06 became effective for all entities upon issuance. To ensure the relief in Topic 848 covers the period of time during which a significant number of modifications may take place, the ASU defers the sunset date of Topic 848 from December 31, 2022 to December 31, 2024, after which entities will no longer be permitted to apply the relief in Topic 848. The Company continues to evaluate the impact that the amendments in this update will have on the Company's consolidated financial statements and disclosures when applied.
Segments	Segments The Company invests in various industries. The Company separately evaluates the performance of each of its investment relationships. However, because each of these investment relationships has similar business and economic characteristics, they have been aggregated into a single investment segment. All applicable segment disclosures are included in or can be derived from the Company’s consolidated financial statements (See "Note 3. Investments").
Company Investment Risk, Concentration of Credit Risk, and Liquidity Risk	Company Investment Risk, Concentration of Credit Risk, and Liquidity Risk The Company has broad discretion in making investments. Investments generally consist of debt instruments that may be affected by business, financial market or legal uncertainties. Prices of investments may be volatile, and a variety of factors that are inherently difficult to predict, such as economic conditions in the United States, may significantly affect the results of the Company’s activities and the value of its investments. In addition, the value of the Company’s portfolio may fluctuate as the general level of interest rates fluctuate. The value of the Company’s investments in loans may be detrimentally affected to the extent, among other things, that a borrower defaults on its obligations, there is insufficient collateral and/or there are extensive legal and other costs incurred in collecting on a defaulted loan, observable secondary or primary market yields for similar instruments issued by comparable companies increase materially or risk premiums required in the market between smaller companies, such as the Company's borrowers, and those for which market yields are observable increase materially. The Company’s assets may, at any time, include securities and other financial instruments or obligations that are illiquid or thinly traded, making purchase or sale of such securities and financial instruments at desired prices or in desired quantities difficult. Furthermore, the sale of any such investments may be possible only at substantial discounts, and it may be extremely difficult to value any such investments accurately.

Investments (Tables)

Investments (Tables)	12 Months Ended
	Dec. 31, 2023
Schedule of Investments [Abstract]
Summary Of Amortized Cost And Fair Value Of Company Portfolio Investments	The following table shows the amortized cost and the fair value of the Company’s portfolio investments as of December 31, 2023 (dollars in thousands): As of December 31, 2023 Amortized Cost Percentage Fair Value Percentage Senior Secured First Lien Loans $ 506,153 72.5 % $ 497,911 72.6 % Equity 3,989 0.6 3,641 0.5 Subordinated Certificates of the SDLP 188,471 26.9 184,485 26.9 Total Investments $ 698,613 100.0 % $ 686,037 100.0 % The following table shows the amortized cost and the fair value of the Company’s portfolio investments as of December 31, 2022 (dollars in thousands): As of December 31, 2022 Amortized Cost Percentage Fair Value Percentage Senior Secured First Lien Loans $ 492,750 72.6 % $ 483,831 72.6 % Equity 3,938 0.6 3,938 0.6 Subordinated Certificates of the SDLP 182,007 26.8 178,367 26.8 Total Investments $ 678,695 100.0 % $ 666,136 100.0 % The following table shows the composition of the Company’s portfolio investments by industry grouping at amortized cost and the fair value as of December 31, 2023 (dollars in thousands): As of December 31, 2023 Amortized Cost Percentage Fair Value Percentage Investment Funds and Vehicles (1) $ 188,471 26.9 % $ 184,485 26.9 % Health Care Providers & Services 113,201 16.2 112,463 16.4 Auto Components 39,394 5.6 37,685 5.5 Diversified Consumer Services 37,219 5.3 36,881 5.4 Aerospace & Defense 28,706 4.1 28,341 4.1 Distributors 26,990 3.9 25,892 3.8 Commercial Services & Supplies 26,923 3.9 25,799 3.8 Health Care Technology 26,816 3.8 26,788 3.9 Personal Products 21,256 3.0 20,133 2.9 Insurance 20,752 3.0 20,597 3.0 Software 20,415 2.9 20,389 3.0 Containers & Packaging 19,008 2.7 18,100 2.6 Food Products 17,389 2.5 16,899 2.5 Health Care Equipment & Supplies 17,053 2.5 16,965 2.5 Road & Rail 16,629 2.4 16,389 2.4 Electronic Equipment, Instruments & Components 13,579 2.0 13,510 2.0 Professional Services 11,547 1.7 11,543 1.7 Household Products 9,353 1.3 9,177 1.3 Trading Companies & Distributors 9,310 1.3 9,407 1.4 IT Services 8,531 1.2 8,502 1.2 Energy Equipment & Services 8,320 1.2 8,392 1.2 Chemicals 8,129 1.2 7,887 1.1 Hotels, Restaurants & Leisure 4,804 0.7 4,938 0.7 Food & Staples Retailing 2,862 0.4 2,869 0.4 Construction & Engineering 662 0.1 676 0.1 Transportation Infrastructure 469 0.1 480 0.1 Pharmaceuticals 466 0.1 483 0.1 Diversified Telecommunication Services (2) 307 0.0 315 0.0 Capital Markets (2) 52 0.0 52 0.0 Total Investments $ 698,613 100.0 % $ 686,037 100.0 % (1) The following industry is solely comprised of the Subordinated Certificates of the SDLP. The portfolio companies in SDLP represent a diverse set of industry classifications, which are similar to those in which the Company invests directly. See “Senior Direct Lending Program” below. (2) Represents a percentage that is less than 0.1%. The following table shows the composition of the Company’s portfolio investments by industry grouping at amortized cost and the fair value as of December 31, 2022 (dollars in thousands): As of December 31, 2022 Amortized Cost Percentage Fair Value Percentage Investment Funds and Vehicles (1) $ 182,007 26.8 % $ 178,367 26.8 % Health Care Providers & Services 103,707 15.2 102,362 15.4 Auto Components 43,234 6.4 42,129 6.3 Diversified Consumer Services 30,804 4.6 30,400 4.6 Aerospace & Defense 27,894 4.1 27,316 4.1 Health Care Technology 24,088 3.5 23,792 3.6 Commercial Services & Supplies 23,920 3.5 23,433 3.5 Distributors 21,834 3.2 20,742 3.1 Insurance 20,913 3.1 20,672 3.1 Personal Products 20,810 3.1 20,298 3.0 Electronic Equipment, Instruments & Components 19,659 2.9 19,414 2.9 Trading Companies & Distributors 18,312 2.7 18,188 2.7 Health Care Equipment & Supplies 17,171 2.5 17,003 2.6 Software 16,939 2.5 16,654 2.5 Road & Rail 16,702 2.5 16,541 2.5 Containers & Packaging 15,316 2.3 15,119 2.3 Food Products 13,978 2.1 13,208 2.0 Professional Services 11,600 1.7 11,448 1.7 Household Products 9,686 1.4 9,462 1.4 IT Services 8,599 1.3 8,393 1.3 Energy Equipment & Services 7,655 1.1 7,477 1.1 Media 7,164 1.1 7,076 1.1 Chemicals 7,088 1.0 6,992 1.0 Hotels, Restaurants & Leisure 4,838 0.7 4,938 0.7 Food & Staples Retailing 4,144 0.6 4,077 0.6 Personal Products 500 0.1 500 0.1 Life Sciences Tools & Services (2) 97 0.0 99 0.0 Capital Markets (2) 36 0.0 36 0.0 Total Investments $ 678,695 100.0 % $ 666,136 100.0 % (1) The following industry is solely comprised of the Subordinated Certificates of the SDLP. The portfolio companies in SDLP represent a diverse set of industry classifications, which are similar to those in which the Company invests directly. See “Senior Direct Lending Program” below. (2) Represents a percentage that is less than 0.1%.
Summary Of Investment Income	During t he year ended December 31, 2023, the Company had an investment in one portfolio company designated as a controlled investment under the 1940 Act. Transactions with the controlled investment were as follows (dollars in thousands) (1) : Controlled Investment Type of Investment Fair Value at December 31, 2022 Purchases of Investments Payment-in-kind and other adjustments to cost Principal repayments Unrealized appreciation/ Realized Gain/(Loss) Fair Value at December 31, 2023 Income Earned Senior Direct Lending Program Subordinated Certificates of the SDLP $ 178,367 $ 25,562 $ ( 1,230 ) $ ( 17,868 ) $ ( 346 ) $ — $ 184,485 $ 25,933 During the year ended December 31, 2022, the Company had an investment in one portfolio company designated as a controlled investment under the 1940 Act. Transactions with the controlled investment were as follows (dollars in thousands): Controlled Investment Type of Investment Fair Value at December 31, 2021 Purchases of Investments Payment-in-kind and other adjustments to cost Principal repayments Unrealized appreciation/ Realized Gain/(Loss) Fair Value at December 31, 2022 Income Earned Senior Direct Lending Program Subordinated Certificates of the SDLP $ — $ 182,516 $ — $ ( 509 ) $ ( 3,640 ) $ — $ 178,367 $ 12,877 (1) The December 31, 2022 presentation has been revised to conform to the December 31, 2023 presentation.
Summary Of Schedule Investments SDLP Listing	As of December 31, 2023 and December 31, 2022, loans in one portfolio company were on non-accrual status. Below is a summary of the SDLP’s portfolio as of December 31, 2023 and December 31, 2022 (dollars in millions): As of December 31, 2023 As of December 31, 2022 Total first lien senior secured loans (1) $ 5,431 $ 5,174 Largest loan to a single borrower (1) $ 370 $ 377 Total of five largest loans to borrower (1) $ 1,650 $ 1,631 Number of borrowers in the SDLP 22 22 Commitments to fund delayed draw loans (2) $ 260 $ 294 (1) At principal amount. (2) As discussed above, these commitments have been approved by the SDLP Investment Committee Below is a listing of SDLP’s individual investments as of December 31, 2023 (dollars in thousands): Company Industry Type of Investment Reference Rate and Spread (1) Interest Rate Maturity Par Amortized Cost Fair Value Footnotes Senior Secured First Lien Loans Aerospace & Defense Precinmac (US) Holdings Inc. Aerospace & Defense Term Loan SOFR + 6.00 % (M) 11.46 % 8/31/2027 $ 11,478 $ 11,478 $ 11,363 (2) Precinmac (US) Holdings Inc. Aerospace & Defense Delayed Draw Term Loan SOFR + 6.00 % (M) 11.46 % 8/31/2027 45,911 45,911 45,452 (2) Precinmac (US) Holdings Inc. Aerospace & Defense Term Loan SOFR + 6.00 % (Q) 11.54 % 8/31/2027 157,588 157,588 156,012 (2) Precinmac (US) Holdings Inc. Aerospace & Defense Term Loan SOFR + 6.00 % (M) 11.46 % 8/31/2027 41,110 41,110 40,699 (2) Qnnect, LLC and Connector TopCo, LP Aerospace & Defense Delayed Draw Term Loan SOFR + 7.00 % (Q) 12.38 % 11/2/2029 3,179 3,179 3,179 (2) Qnnect, LLC and Connector TopCo, LP Aerospace & Defense Term Loan SOFR + 7.00 % (Q) 12.38 % 11/2/2029 275,175 275,175 275,175 (2) 534,441 531,880 Auto Components Arrowhead Holdco Company Auto Components Term Loan SOFR + 4.50 % (Q) 10.04 % 8/31/2028 169,531 169,531 152,578 (2) Arrowhead Holdco Company Auto Components Delayed Draw Term Loan SOFR + 4.50 % (Q) 10.05 % 8/31/2028 34,859 34,859 31,373 (2) Arrowhead Holdco Company Auto Components Term Loan SOFR + 4.50 % (Q) 10.05 % 8/31/2028 24,859 24,859 22,374 (2) Arrowhead Holdco Company Auto Components Delayed Draw Term Loan SOFR + 4.50 % (Q) 10.05 % 8/31/2028 2,270 2,270 2,043 (2) Arrowhead Holdco Company Auto Components Delayed Draw Term Loan SOFR + 4.50 % (Q) 10.05 % 8/31/2028 40,033 40,033 36,030 (2) North Haven Falcon Buyer, LLC Auto Components Delayed Draw Term Loan SOFR + 8.00 % (Q) 13.50 % 5/19/2027 32,199 32,199 26,081 (2) North Haven Falcon Buyer, LLC Auto Components Term Loan SOFR + 8.00 % (Q) 13.52 % 5/19/2027 192,273 192,272 155,741 (2) 496,023 426,220 Commercial Services & Supplies ISQ Hawkeye HoldCo, Inc. Commercial Services & Supplies Term Loan SOFR + 6.00 % (M) 11.38 % 8/17/2029 228,385 228,385 228,385 (2) ISQ Hawkeye HoldCo, Inc. Commercial Services & Supplies Delayed Draw Term Loan SOFR + 6.00 % (M) 11.38 % 8/17/2029 67,198 67,198 67,198 (2) Pritchard Industries, LLC Commercial Services & Supplies Delayed Draw Term Loan SOFR + 5.50 % (S) 10.93 % 10/13/2027 47,311 47,311 46,365 (2) Pritchard Industries, LLC Commercial Services & Supplies Term Loan SOFR + 5.50 % (Q) 10.93 % 10/13/2027 197,885 197,885 193,927 (2) Valcourt Holdings II, LLC Commercial Services & Supplies Term Loan SOFR + 5.75 % (S) 11.27 % 11/21/2029 262,536 262,536 257,286 (2) Valcourt Holdings II, LLC Commercial Services & Supplies Delayed Draw Term Loan SOFR + 5.75 % (S) 11.27 % 11/21/2029 — — — (2) 803,315 793,161 Diversified Consumer Services Excelligence Learning Corporation Diversified Consumer Services Term Loan SOFR + 6.00 % (Q) 11.46 % 1/18/2024 145,432 145,429 145,432 (2) 145,429 145,432 Food & Staples Retailing FS Squared Holding Corp. Food & Staples Retailing Delayed Draw Term Loan SOFR + 5.75 % (M) 11.21 % 3/28/2025 83,991 83,991 83,991 (2) FS Squared Holding Corp. Food & Staples Retailing Delayed Draw Term Loan SOFR + 5.25 % (M) 10.71 % 3/28/2025 64,989 64,989 64,989 (2) FS Squared Holding Corp. Food & Staples Retailing Term Loan SOFR + 5.25 % (M) 10.71 % 3/28/2025 170,089 170,089 170,089 (2) FS Squared Holding Corp. Food & Staples Retailing Delayed Draw Term Loan SOFR + 5.25 % (M) 10.71 % 3/28/2025 4,252 4,252 4,252 (2) 323,321 323,321 Food Products Manna Pro Products, LLC Food Products Term Loan SOFR + 6.00 % (M) 11.46 % 12/10/2026 13,970 13,970 13,132 (2) Manna Pro Products, LLC Food Products Delayed Draw Term Loan SOFR + 6.00 % (M) 11.46 % 12/10/2026 29,294 29,294 27,536 (2) Manna Pro Products, LLC Food Products Term Loan SOFR + 6.00 % (M) 11.46 % 12/10/2026 47,131 47,131 44,303 (2) Manna Pro Products, LLC Food Products Term Loan SOFR + 6.00 % (M) 11.46 % 12/10/2026 177,136 177,136 166,508 (2) 267,531 251,479 Health Care Providers and Services Center for Autism and Related Disorders, LLC Health Care Providers and Services Term Loan SOFR + 6.50 % (Q) 12.00 % 11/21/2024 4,820 — — (2)(3) Center for Autism and Related Disorders, LLC Health Care Providers and Services Term Loan SOFR + 6.50 % (Q) 12.00 % 11/21/2024 19,452 — — (2)(3) Center for Autism and Related Disorders, LLC Health Care Providers and Services Term Loan SOFR + 6.50 % (Q) 12.00 % 11/21/2024 132,765 — — (2)(3) Center for Autism and Related Disorders, LLC Health Care Providers and Services Delayed Draw Term Loan SOFR + 6.50 % (Q) 12.00 % 11/21/2024 7,307 — — (2)(3) — — Hotels, Restaurants & Leisure Triwizard Holdings, Inc. Hotels, Restaurants & Leisure Term Loan SOFR + 6.25 % (Q) 11.72 % 6/29/2029 169,150 169,150 169,150 (2) Triwizard Holdings, Inc. Hotels, Restaurants & Leisure Delayed Draw Term Loan SOFR + 6.25 % (Q) 11.72 % 6/29/2029 — — — (2) Concert Golf Partners Holdco LLC Hotels, Restaurants, & Leisure Term Loan SOFR + 5.50 % (Q) 11.25 % 4/2/2029 233,445 233,445 233,445 (2) Concert Golf Partners Holdco LLC Hotels, Restaurants, & Leisure Delayed Draw Term Loan SOFR + 5.50 % (Q) 11.25 % 4/2/2029 40,012 40,012 40,012 (2) HGC Holdings, LLC Hotels, Restaurants, & Leisure Delayed Draw Term Loan SOFR + 5.50 % (Q) 11.03 % 6/8/2026 24,670 24,670 24,670 (2) HGC Holdings, LLC Hotels, Restaurants, & Leisure Term Loan SOFR + 5.50 % (Q) 11.04 % 6/8/2026 103,425 103,425 103,425 (2) HGC Holdings, LLC Hotels, Restaurants, & Leisure Delayed Draw Term Loan SOFR + 5.50 % (Q) 11.08 % 6/8/2026 50,000 50,000 50,000 (2) HGC Holdings, LLC Hotels, Restaurants, & Leisure Delayed Draw Term Loan SOFR + 6.25 % (Q) 11.62 % 6/8/2026 53,865 53,865 53,865 (2) 674,567 674,567 Household Products Walnut Parent, Inc. Household Products Term Loan SOFR + 5.50 % (Q) 11.00 % 11/9/2027 303,188 303,188 300,156 (2) Walnut Parent, Inc. Household Products Term Loan SOFR + 5.50 % (Q) 11.00 % 11/9/2027 40,367 40,367 39,963 (2) Walnut Parent, Inc. Household Products Term Loan SOFR + 5.50 % (Q) 11.00 % 11/9/2027 26,670 26,670 26,403 (2) 370,225 366,522 Insurance Benecon Midco II, LLC Insurance Term Loan SOFR + 5.25 % (M) 10.71 % 12/4/2026 170,188 170,188 170,188 (2) THG Acquisition, LLC Insurance Delayed Draw Term Loan SOFR + 5.75 % (M) 11.21 % 12/2/2026 24,463 24,463 24,463 (2) THG Acquisition, LLC Insurance Term Loan SOFR + 5.75 % (M) 11.21 % 12/2/2026 14,550 14,550 14,550 (2) THG Acquisition, LLC Insurance Term Loan SOFR + 5.75 % (M) 11.21 % 12/2/2026 206,190 206,190 206,190 (2) THG Acquisition, LLC Insurance Delayed Draw Term Loan SOFR + 5.75 % (M) 11.21 % 12/2/2026 58,320 58,320 58,320 (2) THG Acquisition, LLC Insurance Delayed Draw Term Loan SOFR + 5.75 % (M) 11.21 % 12/2/2026 22,025 22,025 21,805 (2) 495,736 495,516 Machinery Harvey Tool Company, LLC Machinery Delayed Draw Term Loan SOFR + 5.50 % (Q) 11.03 % 10/26/2027 34,940 34,940 34,591 (2) Harvey Tool Company, LLC Machinery Term Loan SOFR + 5.50 % (Q) 11.00 % 10/26/2027 221,631 221,631 219,415 (2) NCWS Intermediate, Inc. Machinery Delayed Draw Term Loan SOFR + 6.00 % (Q) 11.53 % 12/29/2026 61,696 61,696 61,696 (2) NCWS Intermediate, Inc. Machinery Term Loan SOFR + 6.00 % (Q) 11.53 % 12/29/2026 205,398 205,398 205,398 (2) NCWS Intermediate, Inc. Machinery Delayed Draw Term Loan SOFR + 6.50 % (Q) 12.03 % 12/29/2026 12,600 12,600 12,600 (2) 536,265 533,700 Software Emergency Communications Network, LLC Software Term Loan SOFR + 8.75 % (Q) 14.13 % 6/30/2024 252,313 252,295 219,512 (2) Pegasus Global Enterprise Holdings, LLC Software Term Loan SOFR + 5.25 % (Q) 10.75 % 5/29/2025 259,306 259,306 259,306 (2) Pegasus Global Enterprise Holdings, LLC Software Delayed Draw Term Loan SOFR + 5.25 % (Q) 10.75 % 5/29/2025 75,601 75,601 75,601 (2) 587,202 554,419 Trading Companies & Distributors Penn Detroit Diesel Allison, LLC Trading Companies & Distributors Term Loan SOFR + 6.25 % (M) 11.71 % 12/14/2027 32,913 32,913 32,913 (2) 32,913 32,913 Total Investments, December 31, 2023 $ 5,266,968 $ 5,129,130 (1) Variable rate loans to the portfolio companies bear interest at a rate that may be determined by reference to SOFR, or an alternate base rate (commonly based on the Federal Funds Rate or the Prime Rate), at the borrower’s option, w hich reset semi-annually (S), quarterly (Q), or monthly (M). For each such loan, the interest rate provided was the rate in effect as of December 31, 2023 . (2) Loan includes interest rate floor feature. (3) The investment was on non-accrual status as of December 31, 2023 . Below is a listing of SDLP’s individual investments as of December 31, 2022 (dollars in thousands): Company Type of Investment Reference Rate and Spread (1) Interest Rate Maturity Par Amortized Cost Fair Value Footnotes Senior Secured First Lien Loans Aerospace & Defense Precinmac (US) Holdings Inc. Term Loan SOFR + 6.00 % (M) 10.42 % 8/31/2027 $ 11,595 $ 11,595 $ 11,363 (2) Precinmac (US) Holdings Inc. Delayed Draw Term Loan SOFR + 6.00 % (M) 10.42 % 8/31/2027 46,379 46,379 45,451 (2) Precinmac (US) Holdings Inc. Term Loan SOFR + 6.00 % (M) 10.42 % 8/31/2027 159,200 159,200 156,016 (2) Precinmac (US) Holdings Inc. Term Loan SOFR + 6.00 % (M) 10.42 % 8/31/2027 41,530 41,530 40,700 (2) Qnnect, LLC and Connector TopCo, LP Term Loan SOFR + 7.00 % (S) 11.11 % 11/2/2029 277,255 277,255 268,937 (2) 535,959 522,467 Auto Components Arrowhead Holdco Company Term Loan SOFR + 4.50 % (Q) 9.05 % 8/31/2028 171,265 171,265 162,702 (2) Arrowhead Holdco Company Delayed Draw Term Loan SOFR + 4.50 % (Q) 8.61 % 8/31/2028 35,215 35,215 33,454 (2) Arrowhead Holdco Company Term Loan LIBOR + 4.50 % (Q) 8.61 % 8/31/2028 25,113 25,113 23,857 (2) Arrowhead Holdco Company Delayed Draw Term Loan LIBOR + 4.50 % (Q) 8.61 % 8/31/2028 2,293 2,293 2,179 (2) Arrowhead Holdco Company Delayed Draw Term Loan LIBOR + 4.50 % (Q) 8.61 % 8/31/2028 40,442 40,442 38,420 (2) North Haven Falcon Buyer, LLC Delayed Draw Term Loan LIBOR + 6.50 % (Q) 11.65 % 5/19/2027 31,155 31,155 28,974 (2) North Haven Falcon Buyer, LLC Term Loan LIBOR + 6.50 % (Q) 11.18 % 5/19/2027 186,042 186,042 173,019 (2) 491,525 462,605 Commercial Services & Supplies ISQ Hawkeye HoldCo, Inc. Term Loan SOFR + 6.25 % (M) 10.63 % 8/17/2029 230,698 230,698 226,084 (2) ISQ Hawkeye HoldCo, Inc. Delayed Draw Term Loan SOFR + 6.25 % (M) 10.63 % 8/17/2029 55,816 55,816 54,700 (2) Pritchard Industries, LLC Delayed Draw Term Loan SOFR + 5.50 % (S) 10.54 % 10/13/2027 42,384 42,384 41,113 (2) Pritchard Industries, LLC Term Loan SOFR + 5.50 % (S) 10.54 % 10/13/2027 199,904 199,904 193,907 (2) 528,802 515,804 Diversified Consumer Services Excelligence Learning Corporation Term Loan LIBOR + 6.00 % (Q) 9.67 % 1/18/2024 146,348 146,289 146,348 (2) 146,289 146,348 Food & Staples Retailing FS Squared Holding Corp. Delayed Draw Term Loan SOFR + 5.75 % (Q) 9.99 % 3/28/2025 66,164 66,164 66,164 (2) FS Squared Holding Corp. Delayed Draw Term Loan SOFR + 5.25 % (Q) 9.49 % 3/28/2025 65,659 65,659 65,659 (2) FS Squared Holding Corp. Term Loan SOFR + 5.25 % (Q) 9.49 % 3/28/2025 171,875 171,875 171,875 (2) FS Squared Holding Corp. Delayed Draw Term Loan SOFR + 5.25 % (Q) 9.49 % 3/28/2025 4,297 4,297 4,297 (2) 307,995 307,995 Food Products Manna Pro Products, LLC Term Loan LIBOR + 6.00 % (M) 10.29 % 12/10/2026 14,114 14,114 13,126 (2) Manna Pro Products, LLC Delayed Draw Term Loan LIBOR + 6.00 % (M) 10.38 % 12/10/2026 29,641 29,641 27,566 (2) Manna Pro Products, LLC Term Loan LIBOR + 6.00 % (M) 10.07 % 12/10/2026 47,565 47,565 44,236 (2) Manna Pro Products, LLC Term Loan LIBOR + 6.00 % (M) 10.07 % 12/10/2026 178,962 178,962 166,435 (2) 270,282 251,363 Health Care Providers and Services Center for Autism and Related Disorders, LLC Term Loan LIBOR + 6.50 % (Q) 11.34 % 11/21/2024 4,551 4,340 1,911 (2)(3) Center for Autism and Related Disorders, LLC Term Loan LIBOR + 6.50 % (Q) 11.34 % 11/21/2024 18,369 17,518 7,715 (2)(3) Center for Autism and Related Disorders, LLC Term Loan SOFR + 6.50 % (Q) 11.34 % ( 4.00 % PIK) 11/21/2024 125,369 119,560 52,655 (2)(3) Center for Autism and Related Disorders, LLC Delayed Draw Term Loan LIBOR + 6.50 % (Q) 10.17 % 11/21/2024 6,900 6,580 2,898 (2)(3) 147,998 65,179 Hotels, Restaurants, & Leisure Concert Golf Partners Holdco LLC Term Loan SOFR + 5.50 % (Q) 10.28 % 4/2/2029 235,815 235,815 235,815 (2) Concert Golf Partners Holdco LLC Delayed Draw Term Loan SOFR + 5.50 % (Q) 6.25 % 4/2/2029 19,507 19,507 19,507 (2) HGC Holdings, LLC Delayed Draw Term Loan SOFR + 5.00 % (S) 9.87 % 6/8/2026 24,920 24,920 24,920 (2) HGC Holdings, LLC Term Loan SOFR + 5.00 % (Q) 9.55 % 6/8/2026 104,475 104,475 104,475 (2) HGC Holdings, LLC Delayed Draw Term Loan SOFR + 5.25 % (Q) 8.89 % 6/8/2026 12,000 12,000 12,000 (2) Towne Holdings, Inc. Term Loan SOFR + 8.75 % (Q) 13.79 % 8/31/2023 146,866 146,866 143,929 (2) 543,583 540,646 Household Products Walnut Parent, Inc. Term Loan LIBOR + 5.50 % (Q) 10.24 % 11/9/2027 308,000 308,000 298,760 (2) Walnut Parent, Inc. Term Loan LIBOR + 5.50 % (Q) 10.24 % 11/9/2027 41,834 41,834 40,579 (2) Walnut Parent, Inc. Term Loan LIBOR + 5.50 % (Q) 10.24 % 11/9/2027 27,171 27,171 26,355 (2) 377,005 365,694 Insurance Benecon Midco II, LLC Term Loan LIBOR + 5.25 % (Q) 9.98 % 12/4/2026 171,938 171,938 171,938 (2) THG Acquisition, LLC Delayed Draw Term Loan LIBOR + 5.75 % (M) 10.13 % 12/2/2026 24,713 24,713 24,466 (2) THG Acquisition, LLC Term Loan LIBOR + 5.75 % (M) 10.13 % 12/2/2026 14,700 14,700 14,553 (2) THG Acquisition, LLC Term Loan LIBOR + 5.75 % (M) 10.13 % 12/2/2026 208,338 208,338 206,254 (2) THG Acquisition, LLC Delayed Draw Term Loan LIBOR + 5.75 % (M) 10.13 % 12/2/2026 58,922 58,922 58,333 (2) THG Acquisition, LLC Delayed Draw Term Loan LIBOR + 5.75 % (M) 10.13 % 12/2/2026 14,521 14,521 14,231 (2) 493,132 489,775 Machinery Harvey Tool Company, LLC Delayed Draw Term Loan LIBOR + 5.50 % (Q) 10.69 % 10/26/2027 9,720 9,720 9,623 (2) Harvey Tool Company, LLC Term Loan LIBOR + 5.50 % (Q) 10.23 % 10/26/2027 223,893 223,893 221,654 (2) NCWS Intermediate, Inc. Delayed Draw Term Loan LIBOR + 6.00 % (M) 10.38 % 12/29/2026 62,329 62,329 61,082 (2) NCWS Intermediate, Inc. Term Loan LIBOR + 6.00 % (M) 10.38 % 12/29/2026 207,515 207,515 203,365 (2) 503,457 495,724 Software Emergency Communications Network, LLC Term Loan SOFR + 7.75 % (Q) 11.84 % 6/30/2024 238,820 238,766 214,938 (2) n2y Holdings, LLC Term Loan LIBOR + 5.75 % (M) 10.14 % 11/13/2026 66,150 66,150 65,489 (2) n2y Holdings, LLC Term Loan LIBOR + 5.75 % (M) 10.14 % 11/13/2026 127,313 127,313 126,039 (2) Pegasus Global Enterprise Holdings, LLC Term Loan LIBOR + 5.25 % (Q) 9.98 % 5/29/2025 262,021 262,021 262,021 (2) Pegasus Global Enterprise Holdings, LLC Delayed Draw Term Loan LIBOR + 5.25 % (Q) 6.25 % 5/29/2025 76,382 76,382 76,382 (2) 770,632 744,869 Trading Companies & Distributors Penn Detroit Diesel Allison, LLC Term Loan SOFR + 7.00 % (M) 11.42 % 12/14/2027 49,614 49,614 49,614 (2) 49,614 49,614 Total Investments, December 31, 2022 $ 5,166,273 $ 4,958,083 (1) Variable rate loans to the portfolio companies bear interest at a rate that may be determined by reference to LIBOR, SOFR, or an alternate base rate (commonly based on the Federal Funds Rate or the Prime Rate), at the borrower’s option, w hich reset semi-annually (S), quarterly (Q), or monthly (M). For each such loan, the interest rate provided was the rate in effect as of December 31, 2022 . (2) Loan includes interest rate floor feature. (3) The investment was on non-accrual status as of December 31, 2022 .

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	12 Months Ended
	Dec. 31, 2023
Fair Value Disclosures [Abstract]
Schedule of Fair Value Measurements of Investments	The following table presents the fair value measurements of the Company's investments, by major class according to the fair value hierarchy, as o f December 31, 2023 (dollars in thousands): As of December 31, 2023 Investments Level 1 Level 2 Level 3 Total Senior Secured First Lien Loans $ — $ 89 $ 497,822 $ 497,911 Equity — — 3,641 3,641 Subordinated Certificates of the SDLP — — 184,485 184,485 Total $ — $ 89 $ 685,948 $ 686,037 Total investments at fair value $ 686,037 Derivative contracts payable, at fair value — 91 — 91 Total Derivative contracts payable, at fair value $ — $ 91 $ — $ 91 The following table presents the fair value measurements of the Company's investments, by major class according to the fair value hierarchy, as of December 31, 2022 (dollars in thousands): As of December 31, 2022 Investments Level 1 Level 2 Level 3 Total Senior Secured First Lien Loans $ — $ 91 $ 483,740 $ 483,831 Equity — — 2,633 2,633 Subordinated Certificates of the SDLP — — 178,367 178,367 Total $ — $ 91 $ 664,740 $ 664,831 Investments measured at NAV (1) 1,305 Total $ 666,136 (1) Certain investments that are measured at fair value using the NAV practical expedient have not been categorized in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amount presented in the Consolidated Statements of Assets and Liabilities.
Schedule of Changes in Level 3 Investment Securities	The following table provides a reconciliation of the begin ning and ending balances for investments that use Level 3 inputs for the year ended December 31, 2023 (dollars in thousands): Senior Secured First Lien Loans Equity Subordinated Certificates of the SDLP Total Balance as of December 31, 2022 $ 483,740 $ 2,633 $ 178,367 $ 664,740 Purchases 64,281 51 25,562 89,894 Payment-in-kind and other adjustments to cost 656 — ( 1,230 ) ( 574 ) Principal repayments ( 53,083 ) — ( 17,868 ) ( 70,951 ) Net realized gains/(losses) ( 289 ) — — ( 289 ) Net amortization of premium/discount 1,838 — — 1,838 Net change unrealized gains/(losses) 679 ( 348 ) ( 346 ) ( 15 ) Transfers into Level 3 — 1,305 — 1,305 Balance as of December 31, 2023 $ 497,822 $ 3,641 $ 184,485 $ 685,948 Net change unrealized appreciation/(depreciation) for $ ( 8,237 ) $ ( 348 ) $ ( 3,987 ) $ ( 12,572 ) The following table provides a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the year ended December 31, 2022 (dollars in thousands): Senior Secured First Lien Loans Equity Subordinated Certificates of the SDLP Total Balance as of December 31, 2021 $ — $ — $ — $ — Purchases 543,253 3,633 182,516 729,402 Payment-in-kind and other adjustments to cost 265 — — 265 Principal repayments ( 52,263 ) — ( 509 ) ( 52,772 ) Net amortization of premium/discount 1,401 — — 1,401 Net change unrealized gains/(losses) ( 8,916 ) — ( 3,640 ) ( 12,556 ) Transfer out of Level 3 — ( 1,000 ) — ( 1,000 ) Balance as of December 31, 2022 $ 483,740 $ 2,633 $ 178,367 $ 664,740 Net change unrealized appreciation/(depreciation) for $ ( 8,916 ) $ — $ ( 3,640 ) $ ( 12,556 )
Schedule of Quantitative Information About Level 3 Fair Value Measurement of Investments	The following table presents the quantitative information about Level 3 fair value measurements of the Company's investments, as of December 31, 2023 (dollars in thousands): As of December 31, 2023 Fair Value Valuation Techniques Significant Unobservable Inputs Range of Significant Unobservable Inputs Weighted Average (1) Senior Secured First Lien Term Loans $ 476,551 Income Approach (DCF) Discount Rate 8.4 % - 16.5 % 10.5 % Senior Secured First Lien Term Loans 21,271 Recent Transaction Transactions Prices 97.0 % - 98.9 % 97.7 % Equity 1,735 Income Approach (DCF) Long Term Growth Rate, Discount Rate 7.5 % - 10.5 % 8.8 % Market Approach EBIDTA Multiple 10.5 x - 17.6 x 13.5 x Equity 1,101 Market Approach EBIDTA Multiple 11.0 x - 20.0 x 14.4 x Equity 805 Recent Transaction Transactions Price 100.0 % - 100.0 % 100.0 % Subordinated Certificates of the SDLP 184,485 Income Approach (DCF) Discount Rate 8.5 % - 9.5 % 9.5 % Total $ 685,948 (1) Unobservable inputs were weighted by the relative fair value of the investments. The following table presents the quantitative information about Level 3 fair value measurements of the Company's investments, as of December 31, 2022 (dollars in thousands): As of December 31, 2022 Fair Value Valuation Techniques Significant Unobservable Inputs Range of Significant Unobservable Inputs Weighted Average (1) Senior Secured First Lien Term Loans $ 459,838 Income Approach (DCF) Discount Rate 8.0 % - 13.3 % 9.8 % Senior Secured First Lien Term Loans 21,628 Recent Transaction Transaction Prices 96.2 % - 99.0 % 97.3 % Senior Secured First Lien Term Loans 2,274 Market Approach EBITDA Multiple 7.9 x - 14.0 x 11.8 x Equity 2,633 Income Approach (DCF), EBITDA Multiple, 6.3 % - 10.3 % 8.3 % Subordinated Certificates of the SDLP 178,367 Income Approach (DCF) Discount Rate 10.0 % - 11.0 % 10.7 % Total $ 664,740 (1) Unobservable inputs were weighted by the relative fair value of the investments.

Derivative Instruments (Table)

Derivative Instruments (Table)	12 Months Ended
	Dec. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Company's Derivative Instruments	Certain information related to the Company's derivative instruments as of December 31, 2023 are presented in the following location in the Consolidated Statement of Assets and Liabilities: December 31, 2023 Derivative Instrument Notional Amount Maturity Date Gross Amount of Recognized Assets Gross Amount of Recognized Liabilities Consolidated Statements of Assets and Liabilities Location Interest rate swap $ 25,000 12/21/2026 $ — $ 20 Derivative contracts payable, at fair value Interest rate swap 25,000 12/21/2028 — $ 71 Derivative contracts payable, at fair value Total $ 50,000 $ — $ 91
Schedule of Net Unrealized Gain (Loss) on Derivative Instruments	Net unrealized appreciation (depreciation) on derivative instruments recognized by the Company for the year ended December 31, 2023 is presented in the following location in the Consolidated Statements of Operations and Consolidated Statements of Cash Flows: Derivative Instrument Consolidated Statements of Operations and Consolidated Statements of Cash Flows Locations For the Year Ended December 31, 2023 Interest rate swaps Net change in unrealized appreciation (depreciation) on derivatives ( 91 ) Total ( 91 )

Borrowings (Tables)

Borrowings (Tables)	12 Months Ended
	Dec. 31, 2023
Debt Instrument [Line Items]
Schedule of Outstanding Debt	The Company’s outstanding debt as of December 31, 2023 and December 31, 2022 was as follows (dollars in thousands): As of December 31, 2023 As of December 31, 2022 Aggregate Principal Amount Available Principal Amount Outstanding Carrying Value Fair Value Aggregate Principal Amount Available Principal Amount Outstanding Carrying Value Fair Value JPM Facility $ 300,000 $ 233,900 $ 233,900 $ 233,900 $ 500,000 $ 270,500 $ 270,500 $ 270,500 CIBC Facility 75,000 7,770 7,770 7,770 — — — — Fronting Agreement (1) — — — — 15,000 8,000 8,000 8,000 2026 Notes 25,000 25,000 25,000 25,000 — — — — 2028 Notes 25,000 25,000 25,000 25,000 — — — — Total borrowings outstanding, net of deferred financing costs $ 425,000 $ 291,670 $ 291,670 $ 291,670 $ 515,000 $ 278,500 $ 278,500 $ 278,500 (1) See Note 7. Related Party Transactions for details on the Fronting Amount.
J P M Facility
Debt Instrument [Line Items]
Summary of Interest Expense, Non-usage Fees And Amortization of Financing Costs	The following table summarizes the interest expense, non-usage fees and amortization of financing costs incurred on the JPM Facility for the year ended December 31, 2023 and 2022, respectively (dollars in thousands): Year Ended December 31, 2023 2022 JPM Facility interest $ 19,427 $ 8,191 JPM Facility unused fees 374 675 Amortization of debt issuance costs 1,918 471 Total interest and financing expenses related to the JPM Facility $ 21,719 $ 9,337 Weighted average outstanding debt balance of the JPM Facility $ 254,857 $ 272,019 Weighted average interest rate of the JPM Facility (annualized) 7.6 % 5.2 %
C I B C Facility
Debt Instrument [Line Items]
Summary of Interest Expense, Non-usage Fees And Amortization of Financing Costs	The following table summarizes the interest expense, non-usage fees and amortization of financing costs incurred on the CIBC Facility for the year ended December 31, 2023 and 2022, respectively (dollars in thousands): Year Ended December 31, 2023 2022 CIBC Facility interest $ 1,647 $ — CIBC Facility unused fees 181 — Amortization of debt issuance costs 199 — Total interest and financing expenses related to the CIBC Facility $ 2,027 $ — Weighted average outstanding debt balance of the CIBC Facility $ 21,184 $ — Weighted average interest rate of the CIBC Facility (annualized) 7.8 % — %
Unsecured Notes
Debt Instrument [Line Items]
Summary of Interest Expense, Non-usage Fees And Amortization of Financing Costs	The following table summarizes the interest expenses and amortization of financing costs incurred on the Notes for the year ended December 31, 2023 and 2022 (dollars in thousands): For the Year Ended December 31, 2023 2022 2026 Notes interest $ 56 $ — 2028 Notes interest 57 $ — Amortization of debt issuance costs 4 $ — Total $ 117 $ — Weighted average stated interest rate 8.2 % $ — Weighted average outstanding balance 1,507 $ —

Commitments (Tables)

Commitments (Tables)	12 Months Ended
	Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Schedule of Unfunded Commitments	A summary of the composition of the unfunded commitments as of December 31, 2023 and December 31, 2022 are shown in the table below (dollars in thousands): As of December 31, 2023 As of December 31, 2022 Accupac, LLC 564 564 ADPD Holdings, LLC 5 5 ADPD Holdings, LLC — 2 ADPD Holdings, LLC 12 13 ADPD Holdings, LLC 13 13 Advanced Web Technologies Holding Company — 76 Adviser Investments, LLC 9 9 Adviser Investments, LLC 37 53 Arrowhead Holdco Company — 19 Boulder Scientific Company, LLC 625 1,043 BRG Acquisition Co., LLC 600 600 Cadent, LLC — 181 Castleworks Home Services Company 7 277 Center for Autism and Related Disorders, LLC — 2,235 Concord III, L.L.C., 210 — Energy Labs Holding Corp. — 943 Express Wash Acquisition Company, LLC 115 115 Eye Health America, LLC 360 456 Eye Health America, LLC 1,092 1,146 Fingerpaint Marketing, Inc. 14 — HLSG Intermediate, LLC 1,655 — JTM Foods LLC 3 — KL Bronco Acquisition, Inc. — 27 KL Bronco Acquisition, Inc. 250 536 KL Bronco Acquisition, Inc. 1,786 1,786 Krayden Holdings, Inc. 386 — Krayden Holdings, Inc. 386 — Krayden Holdings, Inc. 405 — Leiters, Inc. 244 — M&D Midco, Inc. 11 12 M&D Midco, Inc. 10 23 MDI Buyer, Inc. 7 7 MWD Management, LLC 266 — MWD Management, LLC — 233 North Haven Stallone Buyer, LLC 333 — North Haven Stallone Buyer, LLC — 10 OIS Management Services, LLC 577 577 OIS Management Services, LLC — 1,923 Oliver Packaging, LLC 176 585 Online Labels Group, LLC 10 — Online Labels Group, LLC 9 — Online Labels Group, LLC 9 — Pediatric Home Respiratory Services, LLC — 1,063 POY Holdings, LLC 1,211 — RFI Buyer, Inc. 12 12 RFI Buyer, Inc. — 14 Senior Direct Lending Program, LLC 8,557 10,438 SGA Dental Partners Opco, LLC — 4,629 SGA Dental Partners Opco, LLC 1,394 — Techmer BB Bidco, LLC — 7 Techmer BB Bidco, LLC 32 36 Turbo Buyer, Inc. 760 760 United Musculoskeletal Partners Acquisition Holdings, LLC 562 1,630 USN Opco, LLC — 593 USSC Acquisition Corp. — 331 Total Unfunded Commitments $ 22,714 $ 32,982

Share Data And Distributions (T

Share Data And Distributions (Tables)	12 Months Ended
	Dec. 31, 2023
Equity [Abstract]
Summary of Computation of Basic and Diluted Earnings Per Share	The following table sets fo r the computation of basic and diluted earnings per share, for the year ended December 31, 2023 and 2022 (dollars in thousands, except per share data): Year Ended December 31, 2023 2022 Net increase (decrease) in net assets resulting from operations $ 42,242 $ 9,242 Weighted average shares outstanding (1) 41,499,392 39,848,927 Earnings per share (basic and diluted) (1) $ 1.02 $ 0.23 (1) Per share data for the year ended December 31, 2022 was derived by using the weighted average shares outstanding from the June 2, 2022 (commencement of investment operations) through December 31, 2022 and does not include the 100 shares issued in connection with the Company's seed audit on March 29, 2022 that were subsequently redeemed on June 2, 2022 in connection with the Merger.
Summary of Total Shares Issued and Proceeds Received to Capital Drawdowns	The following table summarizes the total shares issued and proceeds received related to capital drawdowns delivered pursuant to the Subscription Agreements from inception through December 31, 2023 (dollars in thousands, except per share data): Issuance Date Shares Issued Amount Issuance Price per Share June 2, 2022 36,130,510 $ 361,305 $ 10.00 July 12, 2022 2,994,012 $ 30,000 $ 10.02 September 7, 2022 2,362,205 $ 24,000 $ 10.16
Summary of Shares Issued Under DRIP	The following table reflects the distributions per share that the Company has declared, including shares issued under the DRIP, on its common stock from inception through December 31, 2023 (dollars in thousands, except per share data): Distribution Date Declared Record Date Payment Dates Amount per Share Cash Distribution DRIP Shares Issued DRIP Shares Value Quarterly December 12, 2022 December 15, 2022 December 21, 2022 $ 0.2635 $ 10,892 3,915 $ 40 Quarterly December 19, 2022 December 23, 2022 January 27, 2023 0.2405 9,941 3,665 37 Quarterly March 23, 2023 March 27, 2023 March 31, 2023 0.2222 9,185 3,619 35 Quarterly May 10, 2023 July 1, 2023 July 15, 2023 0.2246 9,284 3,780 37 Quarterly August 8, 2023 October 2, 2023 October 16, 2023 0.2271 9,387 3,825 38 Quarterly November 7, 2023 December 27, 2023 January 17, 2024 0.2397 9,908 4,089 41 Special December 18, 2023 December 27, 2023 January 17, 2024 0.1205 4,981 2,056 20 Total $ 63,578 24,949 $ 248

Income Tax Information and Di_2

Income Tax Information and Distributions to Shareholders (Tables)	12 Months Ended
	Dec. 31, 2023
Income Tax Disclosure [Abstract]
Summary of Tax Cost of Investments, Gross and Net Unrealized Appreciation and Depreciation	The following table sets forth the tax cost basis and the estimated aggregate gross unrealized appreciation and depreciation from investments for federal income tax purposes as of December 31, 2023 and December 31, 2022 (dollars in thousands): December 31, 2023 December 31, 2022 Tax cost of investments $ 686,423 $ 679,589 Unrealized appreciation 1,389 216 Unrealized depreciation ( 1,775 ) ( 13,659 ) Net unrealized appreciation (depreciation) from investments $ ( 386 ) $ ( 13,443 )
Summary of Tax Character of Distributions Paid	The tax character of distributions paid for the years ended December 31, 2023 and December 31, 2022 was as follows (dollars in thousands): Year Ended December 31, 2023 Year Ended December 31, 2022 Ordinary Income $ 42,916 $ 20,910 Long-term Capital Gain $ — $ — Return of capital $ — $ —
Schedule Of Components Of Distributable Earnings On Tax Basis	At December 31, 2023, and December 31, 2022, the components of distributable earnings on a tax basis detailed below differ from the amounts reflected in the Company’s Statements of Assets and Liabilities by temporary and other book/tax differences, primarily relating to the tax treatment of organizational costs and the tax treatment of partnership investments, as follows (dollars in thousands): Year Ended December 31, 2023 Year Ended December 31, 2022 Undistributed Ordinary Income $ — $ 1,998 Undistributed Capital Gains — — Capital Loss Carry Forwards ( 289 ) — Late Year Losses — — Other Accumulated Losses ( 11,575 ) ( 161 ) Unrealized appreciation/(depreciation) ( 386 ) ( 13,443 ) Components of distributable earnings/(accumulated deficits) at year end $ ( 12,250 ) $ ( 11,606 )
Schedule of Deferred Tax Assets and Liabilities	Components of the Company's deferred tax assets and liabilities as of December 31, 2023 are as follows: Year Ended December 31, 2023 Deferred tax assets: Net operating loss carryforward $ 9,894 Net unrealized loss on investments 81,323 Valuation allowance ( 91,218 ) Total deferred tax assets — Deferred tax liabilities: Total deferred tax liabilities — Net deferred tax assets and liabilities $ —
Schedule of Components of Income Tax Expense (Benefit)	The Company's income tax provision consists of the following as of December 31, 2023: Year Ended December 31, 2023 Current tax (expense)/benefit Federal $ — State and Local — Total current tax (expense)/benefit — Deferred tax (expense)/benefit Federal 78,974 State and Local 12,244 Valuation allowance ( 91,218 ) Total deferred tax (expense)/benefit $ — Total income tax (expense)/benefit —
Schedule of Effective Income Tax Rate Reconciliation	Total income tax (expense) benefit for the Company differs from the amount computed by applying the federal statutory income tax rate of 21 % to net increase (decrease) in net assets from operations for the period January 1, 2023 through December 31, 2023, as follows: Year Ended December 31, 2023 Income tax benefit at federal statutory tax rate $ 10,409,380 Income attributable to the RIC and not subject to corporate tax ( 10,330,464 ) State and local income tax benefit (net of federal detriment) 12,235 Prior year net operating loss carryforward 3,190 Book vs. tax basis in partnership investments ( 3,123 ) Permanent differences — Valuation allowance ( 91,218 ) Total income tax (expense)/benefits $ —

Financial Highlights (Tables)

Financial Highlights (Tables)	12 Months Ended
	Dec. 31, 2023
Investment Company, Financial Highlights [Abstract]
Schedule of Financial Highlights	The following is a schedule of financial highlights for the year ended December 31, 2023 and 2022 (dollars in thousands, except per share data): For the year ended December 31, 2023 For the period from June 2, 2022 (commencement of investment operations) through December 31, 2022 Per Share Data: (1) (2) Net asset value, beginning of period (3) $ 9.73 $ — Net investment income (loss) 1.03 0.55 Net unrealized appreciation (depreciation) — ( 0.32 ) Net realized gains (losses) ( 0.01 ) — Net increase (decrease) in net assets resulting from operations 1.02 0.23 Distributions of net investment income to shareholders (4) ( 1.04 ) ( 0.50 ) Issuance of common stock — 10.00 Net asset value per share, end of period $ 9.71 $ 9.73 Number of shares outstanding, end of period 41,505,531 41,490,642 Total return based on net asset value (5)(6) 10.81 % 2.18 % Net assets attributable to shareholders, end of period $ 403,150 $ 403,677 Ratio to average net assets attributable to shareholders: Average net assets $ 405,570 $ 395,488 Total expenses (7) 9.84 % 6.83 % Total expenses (other than incentive fee) (7) 8.35 % 6.50 % Net investment income (7) 10.51 % 9.73 % Interest expense and credit facility fees (7) 5.88 % 4.05 % Ratios/Supplemental Data: Asset coverage, end of period (8) 238.22 % 244.95 % Weighted average shares outstanding (9)(10) 41,499,392 39,848,927 Total capital commitments, end of period $ 488,208 $ 488,208 Ratio of total contributed capital to total committed capital, end of period 84.95 % 84.95 % Average debt outstanding (11) $ 277,548 $ 272,563 Average debt outstanding per share $ 6.69 $ 6.84 Portfolio turnover (6)(12) 9.85 % 10.20 % Year of formation 2019 2019 (1) The per share data for 2023 was derived by using the weighted average shares outstanding. The per share data for 2022 was derived by using the weighted average shares outstanding from June 2, 2022 (commencement of investment operations) through December 31, 2022. (2) Per share data for the year ended December 31, 2022 based upon the weighted average shares outstanding from March 29, 2022 (first issuance of common stock) through December 31, 2022 were as follows: Net investment income of $ 0.71 per share, net unrealized loss of $ 0.30 per share, net increase in net assets resulting from operations of $ 0.41 per share, distributions of net investment income of $ 0.68 per share, and net asset value per share at the end of the period of $ 9.73 per share. (3) Net asset value at the beginning of the period from June 2, 2022 (commencement of investment operations) through December 31, 2022 is adjusted to reverse the initial share issuance of 100 shares of common stock in connection with the Company's seed audit, as well as $ 81,049 of accrued expenses. Net asset value after the Company's seed audit was $( 810.39 ) per share. (4) Distributions declared per common share was calculated as the sum of distributions on common stock declared during the year divided by the number of shares of common stock outstanding at each respective quarter-end date. (5) Total return is based on the change in net asset value during the year divided by the beginning net asset value for the year, taking into account distributions declared, if any, reinvested in accordance with the Company’s DRIP. (6) Not annualized. (7) Annualized for the period from June 2, 2022 (commencement of investment operations) through December 31, 2022, except in the case of non-recurring expenses (i.e. organizational expenses). (8) Asset coverage per unit is the ratio of the carrying value of our total consolidated assets, less all liabilities and indebtedness not represented by senior securities, to the aggregate amount of senior securities representing indebtedness. Asset coverage per unit is expressed in terms of dollar amounts per $ 1,000 of indebtedness. Asset coverage ratio per unit does not include unfunded commitments. The inclusion of unfunded commitments in the calculation of the asset coverage ratio per unit would not cause the Company to be below the required amount of regulatory coverage. (9) Calculated for the period from June 2, 2022 (the commencement of investment operations) through December 31, 2022. (10) Weighted average common shares outstanding for the year ended December 31, 2022 was 30,531,755 , calculated from March 29, 2022 (first issuance of shares of common stock) through December 31, 2022. (11) Based on daily weighted average balance of debt outstanding during the period. (12) Portfolio turnover calculation does not include the non-cash acquisition of the SDLP.

Organization - Additional Infor

Organization - Additional Information (Details) - USD ($) $ / shares in Units, $ in Millions	Jun. 02, 2022	Mar. 29, 2022	Dec. 31, 2023	Dec. 31, 2022
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Number of shares issued in Seed audit		100
Common stock, per share values		$ 10
Common Stock, Par or Stated Value Per Share		$ 10	$ 0.01	$ 0.01
Varagon Fund ILP
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Merger agreement date	Jun. 02, 2022
Company received cash	$ 40.9
Investment at fair value	145.2
Purchase of non cash investment	142.1
Accumulated earnings	3.1
Investor converted capital commitments	191.3
Actual funded amount of Investor converted capital commitments	$ 185.5
Common shares issued for merger conversion	18,600,000
Common Stock, Par or Stated Value Per Share	$ 10
Company received capital commitments	$ 296.9
Business combination funded capital commitments	175.2
Company shares issue	$ 17.5
Common stock new investors	$ 10
Company purchase of portfolio loan	$ 449.4

Significant Accounting Polici_3

Significant Accounting Policies - Additional Information (Details) - USD ($)	3 Months Ended	5 Months Ended	12 Months Ended
	Mar. 28, 2022	Dec. 31, 2019	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Significant Accounting Policies [Line Items]
Cash			$ 19,976,000	$ 20,416,000
Organizational and offering expenses	$ 400,000	$ 46,384	400,000	200,000	$ 100,000	$ 11,805
Investment increases due to payment-in-kind income			500,000	100,000
Non accrual loans amortized cost			0	0
PIK fee income			$ 7,524	$ 200,000
Minimum | Affiliated Investments
Significant Accounting Policies [Line Items]
Ownership percentage			5%
Maximum | Affiliated Investments
Significant Accounting Policies [Line Items]
Ownership percentage			25%

Investments - Summary of Amorti

Investments - Summary of Amortized Cost and Fair Value of Portfolio Investments (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Schedule of Investments [Line Items]
Amortized Cost	$ 698,613	$ 678,695
Amortized Cost Percentage	100%	100%
Fair Value	$ 686,037	$ 666,136
Fair Value Percentage	100%	100%
Senior Secured First Lien Loans
Schedule of Investments [Line Items]
Amortized Cost	$ 506,153	$ 492,750
Amortized Cost Percentage	72.50%	72.60%
Fair Value	$ 497,911	$ 483,831
Fair Value Percentage	72.60%	72.60%
Equity
Schedule of Investments [Line Items]
Amortized Cost	$ 3,989	$ 3,938
Amortized Cost Percentage	0.60%	0.60%
Fair Value	$ 3,641	$ 3,938
Fair Value Percentage	0.50%	0.60%
Subordinated Certificates Of SDLP
Schedule of Investments [Line Items]
Amortized Cost	$ 188,471	$ 182,007
Amortized Cost Percentage	26.90%	26.80%
Fair Value	$ 184,485	$ 178,367
Fair Value Percentage	26.90%	26.80%

Investments - Summary of Portfo

Investments - Summary of Portfolio Investments By Industry Grouping At Amortized Cost And The Fair Value (Details) - USD ($)		12 Months Ended
		Dec. 31, 2023		Dec. 31, 2022
Schedule of Investments [Line Items]
Amortized Cost		$ 698,613,000		$ 678,695,000
Amortized Cost Percentage		100%		100%
Fair Value		$ 686,037,000		$ 666,136,000
Fair Value Percentage		100%		100%
Net realized gains/(losses) on investments		$ (289,000)		$ 0
Senior Direct Lending Program
Schedule of Investments [Line Items]
Amortized Cost		5,266,968,000		5,166,273,000
Fair Value		5,129,130,000		4,958,083,000
Senior Direct Lending Program | Subordinated Certificates Of SDLP
Schedule of Investments [Line Items]
Fair Value	[1]	184,485,000		178,367,000
Purchases of Investments		25,562,000	[1]	182,516,000
Payment-in-kind and other adjustments to cost	[1]	(1,230)
Principal repayments		(17,868,000)	[1]	(509,000)
Unrealized appreciation/ (depreciation)		(346,000)	[1]	(3,640,000)
Interest income		25,933,000	[1]	12,877,000
Investment Funds And Vehicles
Schedule of Investments [Line Items]
Amortized Cost		$ 188,471,000	[2]	$ 182,007,000	[3]
Amortized Cost Percentage		26.90%	[2]	26.80%	[3]
Fair Value		$ 184,485,000	[2]	$ 178,367,000	[3]
Fair Value Percentage		26.90%	[2]	26.80%	[3]
Health Care Providers & Services
Schedule of Investments [Line Items]
Amortized Cost		$ 113,201,000		$ 103,707,000
Amortized Cost Percentage		16.20%		15.20%
Fair Value		$ 112,463,000		$ 102,362,000
Fair Value Percentage		16.40%		15.40%
Auto Components
Schedule of Investments [Line Items]
Amortized Cost		$ 39,394,000		$ 43,234,000
Amortized Cost Percentage		5.60%		6.40%
Fair Value		$ 37,685,000		$ 42,129,000
Fair Value Percentage		5.50%		6.30%
Diversified Consumer Services
Schedule of Investments [Line Items]
Amortized Cost		$ 37,219,000		$ 30,804,000
Amortized Cost Percentage		5.30%		4.60%
Fair Value		$ 36,881,000		$ 30,400,000
Fair Value Percentage		5.40%		4.60%
Aerospace & Defense
Schedule of Investments [Line Items]
Amortized Cost		$ 28,706,000		$ 27,894,000
Amortized Cost Percentage		4.10%		4.10%
Fair Value		$ 28,341,000		$ 27,316,000
Fair Value Percentage		4.10%		4.10%
Distributors
Schedule of Investments [Line Items]
Amortized Cost		$ 26,990,000		$ 21,834,000
Amortized Cost Percentage		3.90%		3.20%
Fair Value		$ 25,892,000		$ 20,742,000
Fair Value Percentage		3.80%		3.10%
Commercial Services & Supplies
Schedule of Investments [Line Items]
Amortized Cost		$ 26,923,000		$ 23,920,000
Amortized Cost Percentage		3.90%		3.50%
Fair Value		$ 25,799,000		$ 23,433,000
Fair Value Percentage		3.80%		3.50%
Health Care Technology
Schedule of Investments [Line Items]
Amortized Cost		$ 26,816,000		$ 24,088,000
Amortized Cost Percentage		3.80%		3.50%
Fair Value		$ 26,788		$ 23,792,000
Fair Value Percentage		3.90%		3.60%
Personal Products
Schedule of Investments [Line Items]
Amortized Cost		$ 21,256,000		$ 20,810,000
Amortized Cost Percentage		3%		3.10%
Fair Value		$ 20,133,000		$ 20,298,000
Fair Value Percentage		2.90%		3%
Insurance
Schedule of Investments [Line Items]
Amortized Cost		$ 20,752,000		$ 20,913,000
Amortized Cost Percentage		3%		3.10%
Fair Value		$ 20,597,000		$ 20,672,000
Fair Value Percentage		3%		3.10%
Software
Schedule of Investments [Line Items]
Amortized Cost		$ 20,415,000		$ 16,939,000
Amortized Cost Percentage		2.90%		2.50%
Fair Value		$ 20,389,000		$ 16,654,000
Fair Value Percentage		3%		2.50%
Containers & Packaging
Schedule of Investments [Line Items]
Amortized Cost		$ 19,008,000		$ 15,316,000
Amortized Cost Percentage		2.70%		2.30%
Fair Value		$ 18,100,000		$ 15,119,000
Fair Value Percentage		2.60%		2.30%
Food Products
Schedule of Investments [Line Items]
Amortized Cost		$ 17,389,000		$ 13,978,000
Amortized Cost Percentage		2.50%		2.10%
Fair Value		$ 16,899,000		$ 13,208,000
Fair Value Percentage		2.50%		2%
Health Care Equipment & Supplies
Schedule of Investments [Line Items]
Amortized Cost		$ 17,053,000		$ 17,171,000
Amortized Cost Percentage		2.50%		2.50%
Fair Value		$ 16,965,000		$ 17,003,000
Fair Value Percentage		2.50%		2.60%
Road & Rail
Schedule of Investments [Line Items]
Amortized Cost		$ 16,629,000		$ 16,702,000
Amortized Cost Percentage		2.40%		2.50%
Fair Value		$ 16,389,000		$ 16,541,000
Fair Value Percentage		2.40%		2.50%
Electronic Equipment, Instruments & Components
Schedule of Investments [Line Items]
Amortized Cost		$ 13,579,000		$ 19,659,000
Amortized Cost Percentage		2%		2.90%
Fair Value		$ 13,510,000		$ 19,414,000
Fair Value Percentage		2%		2.90%
Professional Services
Schedule of Investments [Line Items]
Amortized Cost		$ 11,547,000		$ 11,600,000
Amortized Cost Percentage		1.70%		1.70%
Fair Value		$ 11,543,000		$ 11,448,000
Fair Value Percentage		1.70%		1.70%
Household Products
Schedule of Investments [Line Items]
Amortized Cost		$ 9,353,000		$ 9,686,000
Amortized Cost Percentage		1.30%		1.40%
Fair Value		$ 9,177,000		$ 9,462,000
Fair Value Percentage		1.30%		1.40%
Trading Companies & Distributors
Schedule of Investments [Line Items]
Amortized Cost		$ 9,310,000		$ 18,312,000
Amortized Cost Percentage		1.30%		2.70%
Fair Value		$ 9,407,000		$ 18,188,000
Fair Value Percentage		1.40%		2.70%
IT Services
Schedule of Investments [Line Items]
Amortized Cost		$ 8,531,000		$ 8,599,000
Amortized Cost Percentage		1.20%		1.30%
Fair Value		$ 8,502,000		$ 8,393,000
Fair Value Percentage		1.20%		1.30%
Energy Equipment & Services
Schedule of Investments [Line Items]
Amortized Cost		$ 8,320,000		$ 7,655,000
Amortized Cost Percentage		1.20%		1.10%
Fair Value		$ 8,392,000		$ 7,477,000
Fair Value Percentage		1.20%		1.10%
Chemicals
Schedule of Investments [Line Items]
Amortized Cost		$ 8,129,000		$ 7,088,000
Amortized Cost Percentage		1.20%		1%
Fair Value		$ 7,887,000		$ 6,992,000
Fair Value Percentage		1.10%		1%
Hotels, Restaurants & Leisure
Schedule of Investments [Line Items]
Amortized Cost		$ 4,804,000		$ 4,838,000
Amortized Cost Percentage		0.70%		0.70%
Fair Value		$ 4,938,000		$ 4,938,000
Fair Value Percentage		0.70%		0.70%
Food & Staples Retailing
Schedule of Investments [Line Items]
Amortized Cost		$ 2,862,000		$ 4,144,000
Amortized Cost Percentage		0.40%		0.60%
Fair Value		$ 2,869,000		$ 4,077,000
Fair Value Percentage		0.40%		0.60%
Construction & Engineering
Schedule of Investments [Line Items]
Amortized Cost		$ 662,000
Amortized Cost Percentage		0.10%
Fair Value		$ 676,000
Fair Value Percentage		0.10%
Transportation Infrastructure
Schedule of Investments [Line Items]
Amortized Cost		$ 469,000
Amortized Cost Percentage		0.10%
Fair Value		$ 480,000
Fair Value Percentage		0.10%
Pharmaceuticals
Schedule of Investments [Line Items]
Amortized Cost		$ 466,000
Amortized Cost Percentage		0.10%
Fair Value		$ 483,000
Fair Value Percentage		0.10%
Diversified Telecommunication Services
Schedule of Investments [Line Items]
Amortized Cost	[4]	$ 307,000
Amortized Cost Percentage	[4]	0%
Fair Value	[4]	$ 315,000
Fair Value Percentage	[4]	0%
Capital Markets
Schedule of Investments [Line Items]
Amortized Cost		$ 52,000	[4]	$ 36,000	[5]
Amortized Cost Percentage		0%	[4]	0%	[5]
Fair Value		$ 52,000	[4]	$ 36,000	[5]
Fair Value Percentage		0%	[4]	0%	[5]
Media
Schedule of Investments [Line Items]
Amortized Cost				$ 7,164,000
Amortized Cost Percentage				1.10%
Fair Value				$ 7,076,000
Fair Value Percentage				1.10%
Personal Products One
Schedule of Investments [Line Items]
Amortized Cost				$ 500,000
Amortized Cost Percentage				0.10%
Fair Value				$ 500,000
Fair Value Percentage				0.10%
Life Sciences Tools & Services
Schedule of Investments [Line Items]
Amortized Cost	[5]			$ 97,000
Amortized Cost Percentage	[5]			0%
Fair Value	[5]			$ 99,000
Fair Value Percentage	[5]			0%
[1] (1) The December 31, 2022 presentation has been revised to conform to the December 31, 2023 presentation. (1) The following industry is solely comprised of the Subordinated Certificates of the SDLP. The portfolio companies in SDLP represent a diverse set of industry classifications, which are similar to those in which the Company invests directly. See “Senior Direct Lending Program” below. (1) The following industry is solely comprised of the Subordinated Certificates of the SDLP. The portfolio companies in SDLP represent a diverse set of industry classifications, which are similar to those in which the Company invests directly. See “Senior Direct Lending Program” below. (2) Represents a percentage that is less than 0.1%. (2) Represents a percentage that is less than 0.1%.

Investments - Additional Inform

Investments - Additional Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Schedule of Investments [Line Items]
Investments in loans at fair value	$ 698,613	$ 678,695
Fair Value	$ 686,037	$ 666,136
Amortized Cost Percentage	100%	100%
Fair Value Percentage	100%	100%
SOFR
Schedule of Investments [Line Items]
Interest rate	8%
Senior Direct Lending Program
Schedule of Investments [Line Items]
Funded commitments	$ 189,700	$ 182,000
Unfunded commitments	16,600	24,300
Investments in loans at fair value	5,266,968	5,166,273
Fair Value	5,129,130	4,958,083
Investment Yield In Subordinated Certificates
Schedule of Investments [Line Items]
Investments in loans at fair value	188,500	182,000
Fair Value	184,500	178,400
Interest income	25,900	12,900
Interest receivable	$ 6,800	$ 6,400
Amortized Cost Percentage	14.30%	13.50%
Fair Value Percentage	14.60%	13.80%
Minimum | Rule 3-09
Schedule of Investments [Line Items]
Amortized Cost Percentage		50%
Fair Value Percentage		20%
Percentage of Net Assets ^		20%
Fair value of subsidiary, percentage		5%
Minimum | Rule 4-08
Schedule of Investments [Line Items]
Amortized Cost Percentage		25%
Fair Value Percentage		10%
Percentage of Net Assets ^		10%
Fair value of subsidiary, percentage		5%
Minimum | Senior Direct Lending Program
Schedule of Investments [Line Items]
Amortized Cost Percentage		20%
Total income, percentage		20%
Maximum | Rule 3-09
Schedule of Investments [Line Items]
Percentage of Net Assets ^		80%
Maximum | Rule 4-08
Schedule of Investments [Line Items]
Percentage of Net Assets ^		80%
Ares Capital Corporation | Senior Direct Lending Program
Schedule of Investments [Line Items]
Fair Value	$ 1,700,000	$ 1,700,000
Ares Capital Corporation | Minimum
Schedule of Investments [Line Items]
Investment owned, percent of outstanding	12.50%
Ares Capital Corporation | Maximum
Schedule of Investments [Line Items]
Investment owned, percent of outstanding		87.50%
Varagon SDLP, LLC | Senior Direct Lending Program
Schedule of Investments [Line Items]
Fair Value	$ 206,300	$ 206,300

Investments - Summary of Senior

Investments - Summary of Senior Direct Lending Program's Portfolio (Details) $ in Millions		Dec. 31, 2023 USD ($) Borrower	Dec. 31, 2022 USD ($) Borrower
Schedule of Investments [Abstract]
Total first lien senior secured loans	[1]	$ 5,431	$ 5,174
Largest loan to a single borrower(1)	[1]	370	377
Total of five largest loans to borrower(1)	[1]	$ 1,650	$ 1,631
Number of borrowers in the SDLP | Borrower		22	22
Commitments to fund delayed draw loans (2)	[2]	$ 260	$ 294
[1] (1) At principal amount. (2) As discussed above, these commitments have been approved by the SDLP Investment Committee

Investments - Summary of Listin

Investments - Summary of Listing of Senior Direct Lending Program's Individual Investments (Details) - USD ($)		Dec. 31, 2023		Dec. 31, 2022
Amortized Cost		$ 698,613,000		$ 678,695,000
Fair Value		686,037,000		666,136,000
Senior Secured First Lien Loans
Amortized Cost		506,153,000		492,750,000
Fair Value		497,911,000		483,831,000
Senior Secured First Lien Loans | Auto Components
Amortized Cost		496,023,000		491,525,000
Fair Value		426,220,000		462,605,000
Senior Secured First Lien Loans | Insurance
Amortized Cost		495,736,000		493,132,000
Fair Value		495,516,000		489,775,000
Senior Secured First Lien Loans | Health Care Providers & Services
Amortized Cost		0		147,998,000
Fair Value				65,179,000
Senior Secured First Lien Loans | Hotels, Restaurants & Leisure
Amortized Cost		674,567,000		543,583,000
Fair Value		674,567,000		540,646,000
Senior Secured First Lien Loans | Software
Amortized Cost		587,202,000		770,632,000
Fair Value		554,419,000		744,869,000
Senior Secured First Lien Loans | Diversified Consumer Services
Amortized Cost		145,429,000		146,289,000
Fair Value		145,432,000		146,348,000
Senior Secured First Lien Loans | Food & Staples Retailing
Amortized Cost		323,321,000		307,995,000
Fair Value		323,321,000		307,995,000
Senior Secured First Lien Loans | Machinery
Amortized Cost		536,265,000		503,457,000
Fair Value		533,700,000		495,724,000
Senior Secured First Lien Loans | Commercial Services & Supplies
Amortized Cost		803,315,000		528,802,000
Fair Value		793,161,000		515,804,000
Senior Secured First Lien Loans | Food Products
Amortized Cost		267,531,000		270,282,000
Fair Value		251,479,000		251,363,000
Senior Secured First Lien Loans | Trading Companies & Distributors
Amortized Cost		32,913,000		49,614,000
Fair Value		32,913,000		49,614,000
Senior Secured First Lien Loans | Aerospace & Defense
Amortized Cost		534,441,000		535,959,000
Fair Value		531,880,000		522,467,000
Senior Secured First Lien Loans | Household Products
Amortized Cost		370,225,000		377,005,000
Fair Value		$ 366,522,000		$ 365,694,000
Senior Secured First Lien Loans | Arrowhead Holdco Company | Auto Components | Term Loan | SOFR
Reference Rate and Spread		4.50%	[1],[2]	4.50%	[3],[4]
Interest Rate		10.04%	[2]	9.05%	[4]
Maturity		Aug. 31, 2028	[2]	Aug. 31, 2028	[4]
Par Amount / Shares		$ 169,531,000	[2]	$ 171,265,000	[4]
Amortized Cost		169,531,000	[2]	171,265,000	[4]
Fair Value		$ 152,578,000	[2]	$ 162,702,000	[4]
Senior Secured First Lien Loans | Arrowhead Holdco Company | Auto Components | Term Loan | LIBOR
Reference Rate and Spread	[3],[4]			4.50%
Interest Rate	[4]			8.61%
Maturity	[4]			Aug. 31, 2028
Par Amount / Shares	[4]			$ 25,113,000
Amortized Cost	[4]			25,113,000
Fair Value	[4]			$ 23,857,000
Senior Secured First Lien Loans | Arrowhead Holdco Company | Auto Components | Delayed Draw Term Loan | SOFR
Reference Rate and Spread		4.50%	[1],[2]	4.50%	[3],[4]
Interest Rate		10.05%	[2]	8.61%	[4]
Maturity		Aug. 31, 2028	[2]	Aug. 31, 2028	[4]
Par Amount / Shares		$ 34,859,000	[2]	$ 35,215,000	[4]
Amortized Cost		34,859,000	[2]	35,215,000	[4]
Fair Value		$ 31,373,000	[2]	$ 33,454,000	[4]
Senior Secured First Lien Loans | Arrowhead Holdco Company | Auto Components | Delayed Draw Term Loan | LIBOR
Reference Rate and Spread	[3],[4]			4.50%
Interest Rate	[4]			8.61%
Maturity	[4]			Aug. 31, 2028
Par Amount / Shares	[4]			$ 2,293,000
Amortized Cost	[4]			2,293,000
Fair Value	[4]			$ 2,179,000
Senior Secured First Lien Loans | Arrowhead Holdco Company | Auto Components | Term Loan 1 | SOFR
Reference Rate and Spread	[1],[2]	4.50%
Interest Rate	[2]	10.05%
Maturity	[2]	Aug. 31, 2028
Par Amount / Shares	[2]	$ 24,859,000
Amortized Cost	[2]	24,859,000
Fair Value	[2]	$ 22,374,000
Senior Secured First Lien Loans | Arrowhead Holdco Company | Auto Components | Delayed Draw Term Loan 1 | SOFR
Reference Rate and Spread	[1],[2]	4.50%
Interest Rate	[2]	10.05%
Maturity	[2]	Aug. 31, 2028
Par Amount / Shares	[2]	$ 2,270,000
Amortized Cost	[2]	2,270,000
Fair Value	[2]	$ 2,043,000
Senior Secured First Lien Loans | Arrowhead Holdco Company | Auto Components | Delayed Draw Term Loan 1 | LIBOR
Reference Rate and Spread	[3],[4]			4.50%
Interest Rate	[4]			8.61%
Maturity	[4]			Aug. 31, 2028
Par Amount / Shares	[4]			$ 40,442,000
Amortized Cost	[4]			40,442,000
Fair Value	[4]			$ 38,420,000
Senior Secured First Lien Loans | Arrowhead Holdco Company | Auto Components | Delayed Draw Term Loan 2 | SOFR
Reference Rate and Spread	[1],[2]	4.50%
Interest Rate	[2]	10.05%
Maturity	[2]	Aug. 31, 2028
Par Amount / Shares	[2]	$ 40,033,000
Amortized Cost	[2]	40,033,000
Fair Value	[2]	$ 36,030,000
Senior Secured First Lien Loans | Benecon Midco II, LLC | Insurance | Term Loan | SOFR
Reference Rate and Spread	[1],[2]	5.25%
Interest Rate	[2]	10.71%
Maturity	[2]	Dec. 04, 2026
Par Amount / Shares	[2]	$ 170,188,000
Amortized Cost	[2]	170,188,000
Fair Value	[2]	$ 170,188,000
Senior Secured First Lien Loans | Benecon Midco II, LLC | Insurance | Term Loan | LIBOR
Reference Rate and Spread	[3],[4]			5.25%
Interest Rate	[4]			9.98%
Maturity	[4]			Dec. 04, 2026
Par Amount / Shares	[4]			$ 171,938,000
Amortized Cost	[4]			171,938,000
Fair Value	[4]			$ 171,938,000
Senior Secured First Lien Loans | Center For Autism and Related Disorders, LLC | Health Care Providers & Services | Term Loan | SOFR
Reference Rate and Spread		6.50%	[1],[2],[5]	6.50%	[3],[4],[6]
Interest Rate		12%	[2],[5]	11.34%	[4],[6]
Interest Rate * PIK	[4],[6]			4%
Maturity		Nov. 21, 2024	[2],[5]	Nov. 21, 2024	[4],[6]
Par Amount / Shares		$ 4,820,000	[2],[5]	$ 125,369,000	[4],[6]
Amortized Cost		$ 0	[2],[5]	119,560,000	[4],[6]
Fair Value	[4],[6]			$ 52,655,000
Senior Secured First Lien Loans | Center For Autism and Related Disorders, LLC | Health Care Providers & Services | Term Loan | LIBOR
Reference Rate and Spread	[3],[4],[6]			6.50%
Interest Rate	[4],[6]			11.34%
Maturity	[4],[6]			Nov. 21, 2024
Par Amount / Shares	[4],[6]			$ 4,551,000
Amortized Cost	[4],[6]			4,340,000
Fair Value	[4],[6]			$ 1,911,000
Senior Secured First Lien Loans | Center For Autism and Related Disorders, LLC | Health Care Providers & Services | Delayed Draw Term Loan | SOFR
Reference Rate and Spread	[1],[2],[5]	6.50%
Interest Rate	[2],[5]	12%
Maturity	[2],[5]	Nov. 21, 2024
Par Amount / Shares	[2],[5]	$ 7,307,000
Amortized Cost	[2],[5]	$ 0
Senior Secured First Lien Loans | Center For Autism and Related Disorders, LLC | Health Care Providers & Services | Delayed Draw Term Loan | LIBOR
Reference Rate and Spread	[3],[4],[6]			6.50%
Interest Rate	[4],[6]			10.17%
Maturity	[4],[6]			Nov. 21, 2024
Par Amount / Shares	[4],[6]			$ 6,900,000
Amortized Cost	[4],[6]			6,580,000
Fair Value	[4],[6]			$ 2,898,000
Senior Secured First Lien Loans | Center For Autism and Related Disorders, LLC | Health Care Providers & Services | Term Loan 1 | SOFR
Reference Rate and Spread	[1],[2],[5]	6.50%
Interest Rate	[2],[5]	12%
Maturity	[2],[5]	Nov. 21, 2024
Par Amount / Shares	[2],[5]	$ 19,452,000
Amortized Cost	[2],[5]	$ 0
Senior Secured First Lien Loans | Center For Autism and Related Disorders, LLC | Health Care Providers & Services | Term Loan 1 | LIBOR
Reference Rate and Spread	[3],[4],[6]			6.50%
Interest Rate	[4],[6]			11.34%
Maturity	[4],[6]			Nov. 21, 2024
Par Amount / Shares	[4],[6]			$ 18,369,000
Amortized Cost	[4],[6]			17,518,000
Fair Value	[4],[6]			$ 7,715,000
Senior Secured First Lien Loans | Center For Autism and Related Disorders, LLC | Health Care Providers & Services | Term Loan 2 | SOFR
Reference Rate and Spread	[1],[2],[5]	6.50%
Interest Rate	[2],[5]	12%
Maturity	[2],[5]	Nov. 21, 2024
Par Amount / Shares	[2],[5]	$ 132,765,000
Amortized Cost	[2],[5]	$ 0
Senior Secured First Lien Loans | Concert Golf Partners Holdco LLC | Hotels, Restaurants & Leisure | Term Loan | SOFR
Reference Rate and Spread		5.50%	[1],[2]	5.50%	[3],[4]
Interest Rate		11.25%	[2]	10.28%	[4]
Maturity		Apr. 02, 2029	[2]	Apr. 02, 2029	[4]
Par Amount / Shares		$ 233,445,000	[2]	$ 235,815,000	[4]
Amortized Cost		233,445,000	[2]	235,815,000	[4]
Fair Value		$ 233,445,000	[2]	$ 235,815,000	[4]
Senior Secured First Lien Loans | Concert Golf Partners Holdco LLC | Hotels, Restaurants & Leisure | Delayed Draw Term Loan | SOFR
Reference Rate and Spread		5.50%	[1],[2]	5.50%	[3],[4]
Interest Rate		11.25%	[2]	6.25%	[4]
Maturity		Apr. 02, 2029	[2]	Apr. 02, 2029	[4]
Par Amount / Shares		$ 40,012,000	[2]	$ 19,507,000	[4]
Amortized Cost		40,012,000	[2]	19,507,000	[4]
Fair Value		$ 40,012,000	[2]	$ 19,507,000	[4]
Senior Secured First Lien Loans | Emergency Communications Network, LLC | Software | Term Loan | SOFR
Reference Rate and Spread		8.75%	[1],[2]	7.75%	[3],[4]
Interest Rate		14.13%	[2]	11.84%	[4]
Maturity		Jun. 30, 2024	[2]	Jun. 30, 2024	[4]
Par Amount / Shares		$ 252,313,000	[2]	$ 238,820,000	[4]
Amortized Cost		252,295,000	[2]	238,766,000	[4]
Fair Value		$ 219,512,000	[2]	$ 214,938,000	[4]
Senior Secured First Lien Loans | Excelligence Learning Corporation | Diversified Consumer Services | Term Loan | SOFR
Reference Rate and Spread	[1],[2]	6%
Interest Rate	[2]	11.46%
Maturity	[2]	Jan. 18, 2024
Par Amount / Shares	[2]	$ 145,432,000
Amortized Cost	[2]	145,429,000
Fair Value	[2]	$ 145,432,000
Senior Secured First Lien Loans | Excelligence Learning Corporation | Diversified Consumer Services | Term Loan | LIBOR
Reference Rate and Spread	[3],[4]			6%
Interest Rate	[4]			9.67%
Maturity	[4]			Jan. 18, 2024
Par Amount / Shares	[4]			$ 146,348,000
Amortized Cost	[4]			146,289,000
Fair Value	[4]			$ 146,348,000
Senior Secured First Lien Loans | FS Squared Holding Corp. | Food & Staples Retailing | Term Loan | SOFR
Reference Rate and Spread	[2]	5.25%	[1]	5.25%
Interest Rate	[2]	10.71%		9.49%
Maturity	[2]	Mar. 28, 2025		Mar. 28, 2025
Par Amount / Shares	[2]	$ 170,089,000		$ 171,875,000
Amortized Cost	[2]	170,089,000		171,875,000
Fair Value	[2]	$ 170,089,000		$ 171,875,000
Senior Secured First Lien Loans | FS Squared Holding Corp. | Food & Staples Retailing | Delayed Draw Term Loan | SOFR
Reference Rate and Spread		5.75%	[1],[2]	5.75%	[3],[4]
Interest Rate		11.21%	[2]	9.99%	[4]
Maturity		Mar. 28, 2025	[2]	Mar. 28, 2025	[4]
Par Amount / Shares		$ 83,991,000	[2]	$ 66,164,000	[4]
Amortized Cost		83,991,000	[2]	66,164,000	[4]
Fair Value		$ 83,991,000	[2]	$ 66,164,000	[4]
Senior Secured First Lien Loans | FS Squared Holding Corp. | Food & Staples Retailing | Delayed Draw Term Loan 1 | SOFR
Reference Rate and Spread		5.25%	[1],[2]	5.25%	[3],[4]
Interest Rate		10.71%	[2]	9.49%	[4]
Maturity		Mar. 28, 2025	[2]	Mar. 28, 2025	[4]
Par Amount / Shares		$ 64,989,000	[2]	$ 65,659,000	[4]
Amortized Cost		64,989,000	[2]	65,659,000	[4]
Fair Value		$ 64,989,000	[2]	$ 65,659,000	[4]
Senior Secured First Lien Loans | FS Squared Holding Corp. | Food & Staples Retailing | Delayed Draw Term Loan 2 | SOFR
Reference Rate and Spread		5.25%	[1],[2]	5.25%	[3],[4]
Interest Rate		10.71%	[2]	9.49%	[4]
Maturity		Mar. 28, 2025	[2]	Mar. 28, 2025	[4]
Par Amount / Shares		$ 4,252,000	[2]	$ 4,297,000	[4]
Amortized Cost		4,252,000	[2]	4,297,000	[4]
Fair Value		$ 4,252,000	[2]	$ 4,297,000	[4]
Senior Secured First Lien Loans | Harvey Tool Company, LLC | Machinery | Term Loan | SOFR
Reference Rate and Spread	[1],[2]	5.50%
Interest Rate	[2]	11%
Maturity	[2]	Oct. 26, 2027
Par Amount / Shares	[2]	$ 221,631,000
Amortized Cost	[2]	221,631,000
Fair Value	[2]	$ 219,415,000
Senior Secured First Lien Loans | Harvey Tool Company, LLC | Machinery | Term Loan | LIBOR
Reference Rate and Spread	[3],[4]			5.50%
Interest Rate	[4]			10.69%
Maturity	[4]			Oct. 26, 2027
Par Amount / Shares	[4]			$ 9,720,000
Amortized Cost	[4]			9,720,000
Fair Value	[4]			$ 9,623,000
Senior Secured First Lien Loans | Harvey Tool Company, LLC | Machinery | Delayed Draw Term Loan | SOFR
Reference Rate and Spread	[1],[2]	5.50%
Interest Rate	[2]	11.03%
Maturity	[2]	Oct. 26, 2027
Par Amount / Shares	[2]	$ 34,940,000
Amortized Cost	[2]	34,940,000
Fair Value	[2]	$ 34,591,000
Senior Secured First Lien Loans | Harvey Tool Company, LLC | Machinery | Term Loan 1 | LIBOR
Reference Rate and Spread	[3],[4]			5.50%
Interest Rate	[4]			10.23%
Maturity	[4]			Oct. 26, 2027
Par Amount / Shares	[4]			$ 223,893,000
Amortized Cost	[4]			223,893,000
Fair Value	[4]			$ 221,654,000
Senior Secured First Lien Loans | H G C Holdings L L C | Hotels, Restaurants & Leisure | Term Loan | SOFR
Reference Rate and Spread		5.50%	[1],[2]	5%	[3],[4]
Interest Rate		11.04%	[2]	9.55%	[4]
Maturity		Jun. 08, 2026	[2]	Jun. 08, 2026	[4]
Par Amount / Shares		$ 103,425,000	[2]	$ 104,475,000	[4]
Amortized Cost		103,425,000	[2]	104,475,000	[4]
Fair Value		$ 103,425,000	[2]	$ 104,475,000	[4]
Senior Secured First Lien Loans | H G C Holdings L L C | Hotels, Restaurants & Leisure | Delayed Draw Term Loan | SOFR
Reference Rate and Spread		5.50%	[1],[2]	5%	[3],[4]
Interest Rate		11.03%	[2]	9.87%	[4]
Maturity		Jun. 08, 2026	[2]	Jun. 08, 2026	[4]
Par Amount / Shares		$ 24,670,000	[2]	$ 24,920,000	[4]
Amortized Cost		24,670,000	[2]	24,920,000	[4]
Fair Value		$ 24,670,000	[2]	$ 24,920,000	[4]
Senior Secured First Lien Loans | H G C Holdings L L C | Hotels, Restaurants & Leisure | Delayed Draw Term Loan 1 | SOFR
Reference Rate and Spread		5.50%	[1],[2]	5.25%	[3],[4]
Interest Rate		11.08%	[2]	8.89%	[4]
Maturity		Jun. 08, 2026	[2]	Jun. 08, 2026	[4]
Par Amount / Shares		$ 50,000,000	[2]	$ 12,000,000	[4]
Amortized Cost		50,000,000	[2]	12,000,000	[4]
Fair Value		$ 50,000,000	[2]	$ 12,000,000	[4]
Senior Secured First Lien Loans | H G C Holdings L L C | Hotels, Restaurants & Leisure | Delayed Draw Term Loan 2 | SOFR
Reference Rate and Spread	[1],[2]	6.25%
Interest Rate	[2]	11.62%
Maturity	[2]	Jun. 08, 2026
Par Amount / Shares	[2]	$ 53,865,000
Amortized Cost	[2]	53,865,000
Fair Value	[2]	$ 53,865,000
Senior Secured First Lien Loans | ISQ Hawkeye HoldCo, Inc. | Commercial Services & Supplies | Term Loan | SOFR
Reference Rate and Spread		6%	[1],[2]	6.25%	[3],[4]
Interest Rate		11.38%	[2]	10.63%	[4]
Maturity		Aug. 17, 2029	[2]	Aug. 17, 2029	[4]
Par Amount / Shares		$ 228,385,000	[2]	$ 230,698,000	[4]
Amortized Cost		228,385,000	[2]	230,698,000	[4]
Fair Value		$ 228,385,000	[2]	$ 226,084,000	[4]
Senior Secured First Lien Loans | ISQ Hawkeye HoldCo, Inc. | Commercial Services & Supplies | Delayed Draw Term Loan | SOFR
Reference Rate and Spread		6%	[1],[2]	6.25%	[3],[4]
Interest Rate		11.38%	[2]	10.63%	[4]
Maturity		Aug. 17, 2029	[2]	Aug. 17, 2029	[4]
Par Amount / Shares		$ 67,198,000	[2]	$ 55,816,000	[4]
Amortized Cost		67,198,000	[2]	55,816,000	[4]
Fair Value		$ 67,198,000	[2]	$ 54,700,000	[4]
Senior Secured First Lien Loans | Manna Pro Products L L C | Food Products | Term Loan | SOFR
Reference Rate and Spread	[1],[2]	6%
Interest Rate	[2]	11.46%
Maturity	[2]	Dec. 10, 2026
Par Amount / Shares	[2]	$ 13,970,000
Amortized Cost	[2]	13,970,000
Fair Value	[2]	$ 13,132,000
Senior Secured First Lien Loans | Manna Pro Products L L C | Food Products | Term Loan | LIBOR
Reference Rate and Spread	[3],[4]			6%
Interest Rate	[4]			10.29%
Maturity	[4]			Dec. 10, 2026
Par Amount / Shares	[4]			$ 14,114,000
Amortized Cost	[4]			14,114,000
Fair Value	[4]			$ 13,126,000
Senior Secured First Lien Loans | Manna Pro Products L L C | Food Products | Delayed Draw Term Loan | SOFR
Reference Rate and Spread	[1],[2]	6%
Interest Rate	[2]	11.46%
Maturity	[2]	Dec. 10, 2026
Par Amount / Shares	[2]	$ 29,294,000
Amortized Cost	[2]	29,294,000
Fair Value	[2]	$ 27,536,000
Senior Secured First Lien Loans | Manna Pro Products L L C | Food Products | Delayed Draw Term Loan | LIBOR
Reference Rate and Spread	[3],[4]			6%
Interest Rate	[4]			10.38%
Maturity	[4]			Dec. 10, 2026
Par Amount / Shares	[4]			$ 29,641,000
Amortized Cost	[4]			29,641,000
Fair Value	[4]			$ 27,566,000
Senior Secured First Lien Loans | Manna Pro Products L L C | Food Products | Term Loan 1 | SOFR
Reference Rate and Spread	[1],[2]	6%
Interest Rate	[2]	11.46%
Maturity	[2]	Dec. 10, 2026
Par Amount / Shares	[2]	$ 47,131,000
Amortized Cost	[2]	47,131,000
Fair Value	[2]	$ 44,303,000
Senior Secured First Lien Loans | Manna Pro Products L L C | Food Products | Term Loan 1 | LIBOR
Reference Rate and Spread	[3],[4]			6%
Interest Rate	[4]			10.07%
Maturity	[4]			Dec. 10, 2026
Par Amount / Shares	[4]			$ 47,565,000
Amortized Cost	[4]			47,565,000
Fair Value	[4]			$ 44,236,000
Senior Secured First Lien Loans | Manna Pro Products L L C | Food Products | Term Loan 2 | SOFR
Reference Rate and Spread	[1],[2]	6%
Interest Rate	[2]	11.46%
Maturity	[2]	Dec. 10, 2026
Par Amount / Shares	[2]	$ 177,136,000
Amortized Cost	[2]	177,136,000
Fair Value	[2]	$ 166,508,000
Senior Secured First Lien Loans | Manna Pro Products L L C | Food Products | Term Loan 2 | LIBOR
Reference Rate and Spread	[3],[4]			6%
Interest Rate	[4]			10.07%
Maturity	[4]			Dec. 10, 2026
Par Amount / Shares	[4]			$ 178,962,000
Amortized Cost	[4]			178,962,000
Fair Value	[4]			$ 166,435,000
Senior Secured First Lien Loans | n2y Holdings, LLC | Software | Term Loan | LIBOR
Reference Rate and Spread	[3],[4]			5.75%
Interest Rate	[4]			10.14%
Maturity	[4]			Nov. 13, 2026
Par Amount / Shares	[4]			$ 66,150,000
Amortized Cost	[4]			66,150,000
Fair Value	[4]			$ 65,489,000
Senior Secured First Lien Loans | n2y Holdings, LLC | Software | Term Loan 1 | LIBOR
Reference Rate and Spread	[3],[4]			5.75%
Interest Rate	[4]			10.14%
Maturity	[4]			Nov. 13, 2026
Par Amount / Shares	[4]			$ 127,313,000
Amortized Cost	[4]			127,313,000
Fair Value	[4]			$ 126,039,000
Senior Secured First Lien Loans | N C W S Intermediate Inc | Machinery | Term Loan | SOFR
Reference Rate and Spread	[1],[2]	6%
Interest Rate	[2]	11.53%
Maturity	[2]	Dec. 29, 2026
Par Amount / Shares	[2]	$ 205,398,000
Amortized Cost	[2]	205,398,000
Fair Value	[2]	$ 205,398,000
Senior Secured First Lien Loans | N C W S Intermediate Inc | Machinery | Term Loan | LIBOR
Reference Rate and Spread	[3],[4]			6%
Interest Rate	[4]			10.38%
Maturity	[4]			Dec. 29, 2026
Par Amount / Shares	[4]			$ 207,515,000
Amortized Cost	[4]			207,515,000
Fair Value	[4]			$ 203,365,000
Senior Secured First Lien Loans | N C W S Intermediate Inc | Machinery | Delayed Draw Term Loan | SOFR
Reference Rate and Spread	[1],[2]	6%
Interest Rate	[2]	11.53%
Maturity	[2]	Dec. 29, 2026
Par Amount / Shares	[2]	$ 61,696,000
Amortized Cost	[2]	61,696,000
Fair Value	[2]	$ 61,696,000
Senior Secured First Lien Loans | N C W S Intermediate Inc | Machinery | Delayed Draw Term Loan | LIBOR
Reference Rate and Spread	[3],[4]			6%
Interest Rate	[4]			10.38%
Maturity	[4]			Dec. 29, 2026
Par Amount / Shares	[4]			$ 62,329,000
Amortized Cost	[4]			62,329,000
Fair Value	[4]			$ 61,082,000
Senior Secured First Lien Loans | N C W S Intermediate Inc | Machinery | Delayed Draw Term Loan 1 | SOFR
Reference Rate and Spread	[1],[2]	6.50%
Interest Rate	[2]	12.03%
Maturity	[2]	Dec. 29, 2026
Par Amount / Shares	[2]	$ 12,600,000
Amortized Cost	[2]	12,600,000
Fair Value	[2]	$ 12,600,000
Senior Secured First Lien Loans | North Haven Falcon Buyer, LLC | Auto Components | Term Loan | SOFR
Reference Rate and Spread	[1],[2]	8%
Interest Rate	[2]	13.52%
Maturity	[2]	May 19, 2027
Par Amount / Shares	[2]	$ 192,273,000
Amortized Cost	[2]	192,272,000
Fair Value	[2]	$ 155,741,000
Senior Secured First Lien Loans | North Haven Falcon Buyer, LLC | Auto Components | Term Loan | LIBOR
Reference Rate and Spread	[3],[4]			6.50%
Interest Rate	[4]			11.18%
Maturity	[4]			May 19, 2027
Par Amount / Shares	[4]			$ 186,042,000
Amortized Cost	[4]			186,042,000
Fair Value	[4]			$ 173,019,000
Senior Secured First Lien Loans | North Haven Falcon Buyer, LLC | Auto Components | Delayed Draw Term Loan | SOFR
Reference Rate and Spread	[1],[2]	8%
Interest Rate	[2]	13.50%
Maturity	[2]	May 19, 2027
Par Amount / Shares	[2]	$ 32,199,000
Amortized Cost	[2]	32,199,000
Fair Value	[2]	$ 26,081,000
Senior Secured First Lien Loans | North Haven Falcon Buyer, LLC | Auto Components | Delayed Draw Term Loan | LIBOR
Reference Rate and Spread	[3],[4]			6.50%
Interest Rate	[4]			11.65%
Maturity	[4]			May 19, 2027
Par Amount / Shares	[4]			$ 31,155,000
Amortized Cost	[4]			31,155,000
Fair Value	[4]			$ 28,974,000
Senior Secured First Lien Loans | Pegasus Global Enterprise Holdings, LLC | Software | Term Loan | SOFR
Reference Rate and Spread	[1],[2]	5.25%
Interest Rate	[2]	10.75%
Maturity	[2]	May 29, 2025
Par Amount / Shares	[2]	$ 259,306,000
Amortized Cost	[2]	259,306,000
Fair Value	[2]	$ 259,306,000
Senior Secured First Lien Loans | Pegasus Global Enterprise Holdings, LLC | Software | Term Loan | LIBOR
Reference Rate and Spread	[3],[4]			5.25%
Interest Rate	[4]			9.98%
Maturity	[4]			May 29, 2025
Par Amount / Shares	[4]			$ 262,021,000
Amortized Cost	[4]			262,021,000
Fair Value	[4]			$ 262,021,000
Senior Secured First Lien Loans | Pegasus Global Enterprise Holdings, LLC | Software | Delayed Draw Term Loan | SOFR
Reference Rate and Spread	[1],[2]	5.25%
Interest Rate	[2]	10.75%
Maturity	[2]	May 29, 2025
Par Amount / Shares	[2]	$ 75,601,000
Amortized Cost	[2]	75,601,000
Fair Value	[2]	$ 75,601,000
Senior Secured First Lien Loans | Pegasus Global Enterprise Holdings, LLC | Software | Delayed Draw Term Loan | LIBOR
Reference Rate and Spread	[3],[4]			5.25%
Interest Rate	[4]			6.25%
Maturity	[4]			May 29, 2025
Par Amount / Shares	[4]			$ 76,382,000
Amortized Cost	[4]			76,382,000
Fair Value	[4]			$ 76,382,000
Senior Secured First Lien Loans | Penn Detroit Diesel Allison, LLC | Trading Companies & Distributors | Term Loan | SOFR
Reference Rate and Spread		6.25%	[1],[2]	7%	[3],[4]
Interest Rate		11.71%	[2]	11.42%	[4]
Maturity		Dec. 14, 2027	[2]	Dec. 14, 2027	[4]
Par Amount / Shares		$ 32,913,000	[2]	$ 49,614,000	[4]
Amortized Cost		32,913,000	[2]	49,614,000	[4]
Fair Value		$ 32,913,000	[2]	$ 49,614,000	[4]
Senior Secured First Lien Loans | Precinmac (US) Holdings Inc. | Aerospace & Defense | Term Loan | SOFR
Reference Rate and Spread		6%	[1],[2]	6%	[3],[4]
Interest Rate		11.46%	[2]	10.42%	[4]
Maturity		Aug. 31, 2027	[2]	Aug. 31, 2027	[4]
Par Amount / Shares		$ 11,478,000	[2]	$ 11,595,000	[4]
Amortized Cost		11,478,000	[2]	11,595,000	[4]
Fair Value		$ 11,363,000	[2]	$ 11,363,000	[4]
Senior Secured First Lien Loans | Precinmac (US) Holdings Inc. | Aerospace & Defense | Delayed Draw Term Loan | SOFR
Reference Rate and Spread		6%	[1],[2]	6%	[3],[4]
Interest Rate		11.46%	[2]	10.42%	[4]
Maturity		Aug. 31, 2027	[2]	Aug. 31, 2027	[4]
Par Amount / Shares		$ 45,911,000	[2]	$ 46,379,000	[4]
Amortized Cost		45,911,000	[2]	46,379,000	[4]
Fair Value		$ 45,452,000	[2]	$ 45,451,000	[4]
Senior Secured First Lien Loans | Precinmac (US) Holdings Inc. | Aerospace & Defense | Term Loan 1 | SOFR
Reference Rate and Spread		6%	[1],[2]	6%	[3],[4]
Interest Rate		11.54%	[2]	10.42%	[4]
Maturity		Aug. 31, 2027	[2]	Aug. 31, 2027	[4]
Par Amount / Shares		$ 157,588,000	[2]	$ 159,200,000	[4]
Amortized Cost		157,588,000	[2]	159,200,000	[4]
Fair Value		$ 156,012,000	[2]	$ 156,016,000	[4]
Senior Secured First Lien Loans | Precinmac (US) Holdings Inc. | Aerospace & Defense | Term Loan 2 | SOFR
Reference Rate and Spread		6%	[1],[2]	6%	[3],[4]
Interest Rate		11.46%	[2]	10.42%	[4]
Maturity		Aug. 31, 2027	[2]	Aug. 31, 2027	[4]
Par Amount / Shares		$ 41,110,000	[2]	$ 41,530,000	[4]
Amortized Cost		41,110,000	[2]	41,530,000	[4]
Fair Value		$ 40,699,000	[2]	$ 40,700,000	[4]
Senior Secured First Lien Loans | Pritchard Industries, LLC | Commercial Services & Supplies | Term Loan | SOFR
Reference Rate and Spread		5.50%	[1],[2]	5.50%	[3],[4]
Interest Rate		10.93%	[2]	10.54%	[4]
Maturity		Oct. 13, 2027	[2]	Oct. 13, 2027	[4]
Par Amount / Shares		$ 197,885,000	[2]	$ 199,904,000	[4]
Amortized Cost		197,885,000	[2]	199,904,000	[4]
Fair Value		$ 193,927,000	[2]	$ 193,907,000	[4]
Senior Secured First Lien Loans | Pritchard Industries, LLC | Commercial Services & Supplies | Delayed Draw Term Loan | SOFR
Reference Rate and Spread		5.50%	[1],[2]	5.50%	[3],[4]
Interest Rate		10.93%	[2]	10.54%	[4]
Maturity		Oct. 13, 2027	[2]	Oct. 13, 2027	[4]
Par Amount / Shares		$ 47,311,000	[2]	$ 42,384,000	[4]
Amortized Cost		47,311,000	[2]	42,384,000	[4]
Fair Value		$ 46,365,000	[2]	$ 41,113,000	[4]
Senior Secured First Lien Loans | Qnnect L L C And Connector Top Co L P | Aerospace & Defense | Term Loan | SOFR
Reference Rate and Spread		7%	[1],[2]	7%	[3],[4]
Interest Rate		12.38%	[2]	11.11%	[4]
Maturity		Nov. 02, 2029	[2]	Nov. 02, 2029	[4]
Par Amount / Shares		$ 275,175,000	[2]	$ 277,255,000	[4]
Amortized Cost		275,175,000	[2]	277,255,000	[4]
Fair Value		$ 275,175,000	[2]	$ 268,937,000	[4]
Senior Secured First Lien Loans | Qnnect L L C And Connector Top Co L P | Aerospace & Defense | Delayed Draw Term Loan | SOFR
Reference Rate and Spread	[1],[2]	7%
Interest Rate	[2]	12.38%
Maturity	[2]	Nov. 02, 2029
Par Amount / Shares	[2]	$ 3,179,000
Amortized Cost	[2]	3,179,000
Fair Value	[2]	$ 3,179,000
Senior Secured First Lien Loans | THG Acquisition, LLC | Insurance | Term Loan | SOFR
Reference Rate and Spread	[1],[2]	5.75%
Interest Rate	[2]	11.21%
Maturity	[2]	Dec. 02, 2026
Par Amount / Shares	[2]	$ 14,550,000
Amortized Cost	[2]	14,550,000
Fair Value	[2]	$ 14,550,000
Senior Secured First Lien Loans | THG Acquisition, LLC | Insurance | Term Loan | LIBOR
Reference Rate and Spread	[3],[4]			5.75%
Interest Rate	[4]			10.13%
Maturity	[4]			Dec. 02, 2026
Par Amount / Shares	[4]			$ 14,700,000
Amortized Cost	[4]			14,700,000
Fair Value	[4]			$ 14,553,000
Senior Secured First Lien Loans | THG Acquisition, LLC | Insurance | Delayed Draw Term Loan | SOFR
Reference Rate and Spread	[1],[2]	5.75%
Interest Rate	[2]	11.21%
Maturity	[2]	Dec. 02, 2026
Par Amount / Shares	[2]	$ 24,463,000
Amortized Cost	[2]	24,463,000
Fair Value	[2]	$ 24,463,000
Senior Secured First Lien Loans | THG Acquisition, LLC | Insurance | Delayed Draw Term Loan | LIBOR
Reference Rate and Spread	[3],[4]			5.75%
Interest Rate	[4]			10.13%
Maturity	[4]			Dec. 02, 2026
Par Amount / Shares	[4]			$ 24,713,000
Amortized Cost	[4]			24,713,000
Fair Value	[4]			$ 24,466,000
Senior Secured First Lien Loans | THG Acquisition, LLC | Insurance | Term Loan 1 | SOFR
Reference Rate and Spread	[1],[2]	5.75%
Interest Rate	[2]	11.21%
Maturity	[2]	Dec. 02, 2026
Par Amount / Shares	[2]	$ 206,190,000
Amortized Cost	[2]	206,190,000
Fair Value	[2]	$ 206,190,000
Senior Secured First Lien Loans | THG Acquisition, LLC | Insurance | Term Loan 1 | LIBOR
Reference Rate and Spread	[3],[4]			5.75%
Interest Rate	[4]			10.13%
Maturity	[4]			Dec. 02, 2026
Par Amount / Shares	[4]			$ 208,338,000
Amortized Cost	[4]			208,338,000
Fair Value	[4]			$ 206,254,000
Senior Secured First Lien Loans | THG Acquisition, LLC | Insurance | Delayed Draw Term Loan 1 | SOFR
Reference Rate and Spread	[1],[2]	5.75%
Interest Rate	[2]	11.21%
Maturity	[2]	Dec. 02, 2026
Par Amount / Shares	[2]	$ 58,320,000
Amortized Cost	[2]	58,320,000
Fair Value	[2]	$ 58,320,000
Senior Secured First Lien Loans | THG Acquisition, LLC | Insurance | Delayed Draw Term Loan 1 | LIBOR
Reference Rate and Spread	[3],[4]			5.75%
Interest Rate	[4]			10.13%
Maturity	[4]			Dec. 02, 2026
Par Amount / Shares	[4]			$ 58,922,000
Amortized Cost	[4]			58,922,000
Fair Value	[4]			$ 58,333,000
Senior Secured First Lien Loans | THG Acquisition, LLC | Insurance | Delayed Draw Term Loan 2 | SOFR
Reference Rate and Spread	[1],[2]	5.75%
Interest Rate	[2]	11.21%
Maturity	[2]	Dec. 02, 2026
Par Amount / Shares	[2]	$ 22,025,000
Amortized Cost	[2]	22,025,000
Fair Value	[2]	$ 21,805,000
Senior Secured First Lien Loans | THG Acquisition, LLC | Insurance | Delayed Draw Term Loan 2 | LIBOR
Reference Rate and Spread	[3],[4]			5.75%
Interest Rate	[4]			10.13%
Maturity	[4]			Dec. 02, 2026
Par Amount / Shares	[4]			$ 14,521,000
Amortized Cost	[4]			14,521,000
Fair Value	[4]			$ 14,231,000
Senior Secured First Lien Loans | Valcourt Holdings II, LLC | Commercial Services & Supplies | Term Loan | SOFR
Reference Rate and Spread	[1],[2]	5.75%
Interest Rate	[2]	11.27%
Maturity	[2]	Nov. 21, 2029
Par Amount / Shares	[2]	$ 262,536,000
Amortized Cost	[2]	262,536,000
Fair Value	[2]	$ 257,286,000
Senior Secured First Lien Loans | Valcourt Holdings II, LLC | Commercial Services & Supplies | Delayed Draw Term Loan | SOFR
Reference Rate and Spread	[1],[2]	5.75%
Interest Rate	[2]	11.27%
Maturity	[2]	Nov. 21, 2029
Par Amount / Shares	[2]	$ 0
Amortized Cost	[2]	0
Fair Value	[2]	$ 0
Senior Secured First Lien Loans | Triwizard Holdings, Inc. | Hotels, Restaurants & Leisure | Term Loan | SOFR
Reference Rate and Spread	[1],[2]	6.25%
Interest Rate	[2]	11.72%
Maturity	[2]	Jun. 29, 2029
Par Amount / Shares	[2]	$ 169,150,000
Amortized Cost	[2]	169,150,000
Fair Value	[2]	$ 169,150,000
Senior Secured First Lien Loans | Triwizard Holdings, Inc. | Hotels, Restaurants & Leisure | Delayed Draw Term Loan | SOFR
Reference Rate and Spread	[2]	6.25%
Interest Rate	[2]	11.72%
Maturity	[2]	Jun. 29, 2029
Par Amount / Shares	[2]	$ 0
Amortized Cost	[2]	$ 0
Senior Secured First Lien Loans | Towne Holdings, Inc. | Hotels, Restaurants & Leisure | Term Loan 1 | SOFR
Reference Rate and Spread	[3],[4]			8.75%
Interest Rate	[4]			13.79%
Maturity	[4]			Aug. 31, 2023
Par Amount / Shares	[4]			$ 146,866,000
Amortized Cost	[4]			146,866,000
Fair Value	[4]			$ 143,929,000
Senior Secured First Lien Loans | Walnut Parent, Inc. | Household Products | Term Loan | SOFR
Reference Rate and Spread	[1],[2]	5.50%
Interest Rate	[2]	11%
Maturity	[2]	Nov. 09, 2027
Par Amount / Shares	[2]	$ 303,188,000
Amortized Cost	[2]	303,188,000
Fair Value	[2]	$ 300,156,000
Senior Secured First Lien Loans | Walnut Parent, Inc. | Household Products | Term Loan | LIBOR
Reference Rate and Spread	[3],[4]			5.50%
Interest Rate	[4]			10.24%
Maturity	[4]			Nov. 09, 2027
Par Amount / Shares	[4]			$ 308,000,000
Amortized Cost	[4]			308,000,000
Fair Value	[4]			$ 298,760,000
Senior Secured First Lien Loans | Walnut Parent, Inc. | Household Products | Term Loan 1 | SOFR
Reference Rate and Spread	[1],[2]	5.50%
Interest Rate	[2]	11%
Maturity	[2]	Nov. 09, 2027
Par Amount / Shares	[2]	$ 40,367,000
Amortized Cost	[2]	40,367,000
Fair Value	[2]	$ 39,963,000
Senior Secured First Lien Loans | Walnut Parent, Inc. | Household Products | Term Loan 1 | LIBOR
Reference Rate and Spread	[3],[4]			5.50%
Interest Rate	[4]			10.24%
Maturity	[4]			Nov. 09, 2027
Par Amount / Shares	[4]			$ 41,834,000
Amortized Cost	[4]			41,834,000
Fair Value	[4]			$ 40,579,000
Senior Secured First Lien Loans | Walnut Parent, Inc. | Household Products | Term Loan 2 | SOFR
Reference Rate and Spread	[1],[2]	5.50%
Interest Rate	[2]	11%
Maturity	[2]	Nov. 09, 2027
Par Amount / Shares	[2]	$ 26,670,000
Amortized Cost	[2]	26,670,000
Fair Value	[2]	26,403,000
Senior Secured First Lien Loans | Walnut Parent, Inc. | Household Products | Term Loan 2 | LIBOR
Reference Rate and Spread	[3],[4]			5.50%
Interest Rate	[4]			10.24%
Maturity	[4]			Nov. 09, 2027
Par Amount / Shares	[4]			$ 27,171,000
Amortized Cost	[4]			27,171,000
Fair Value	[4]			26,355,000
Senior Direct Lending Program
Amortized Cost		5,266,968,000		5,166,273,000
Fair Value		$ 5,129,130,000		$ 4,958,083,000
[1] (1) Variable rate loans to the portfolio companies bear interest at a rate that may be determined by reference to SOFR, or an alternate base rate (commonly based on the Federal Funds Rate or the Prime Rate), at the borrower’s option, w hich reset semi-annually (S), quarterly (Q), or monthly (M). For each such loan, the interest rate provided was the rate in effect as of December 31, 2023 . (2) Loan includes interest rate floor feature. (1) Variable rate loans to the portfolio companies bear interest at a rate that may be determined by reference to LIBOR, SOFR, or an alternate base rate (commonly based on the Federal Funds Rate or the Prime Rate), at the borrower’s option, w hich reset semi-annually (S), quarterly (Q), or monthly (M). For each such loan, the interest rate provided was the rate in effect as of December 31, 2022 . (2) Loan includes interest rate floor feature. (3) The investment was on non-accrual status as of December 31, 2023 . (3) The investment was on non-accrual status as of December 31, 2022 .

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of Fair Value Measurements of Investments (Details) - USD ($) $ in Thousands		Dec. 31, 2023	Dec. 31, 2022
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Derivative contracts payable, at fair value		$ 91	$ 0
Fair Value, Recurring
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Investments at fair value		686,037	664,831
Investments measured at NAV	[1]		1,305
Total investments measured at fair value		686,037	666,136
Derivative contracts payable, at fair value		91
Total Derivative contracts payable, at fair value		91
Fair Value, Recurring | Level 2
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Investments at fair value		89	91
Derivative contracts payable, at fair value		91
Total Derivative contracts payable, at fair value		91
Fair Value, Recurring | Level 3
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Investments at fair value		685,948	664,740
Fair Value, Recurring | Senior Secured First Lien Loans
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Investments at fair value		497,911	483,831
Fair Value, Recurring | Senior Secured First Lien Loans | Level 2
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Investments at fair value		89	91
Fair Value, Recurring | Senior Secured First Lien Loans | Level 3
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Investments at fair value		497,822	483,740
Fair Value, Recurring | Equity
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Investments at fair value		3,641	2,633
Fair Value, Recurring | Equity | Level 3
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Investments at fair value		3,641	2,633
Fair Value, Recurring | Subordinated Certificates Of SDLP
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Investments at fair value		184,485	178,367
Fair Value, Recurring | Subordinated Certificates Of SDLP | Level 3
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Investments at fair value		$ 184,485	$ 178,367
[1] (1) Certain investments that are measured at fair value using the NAV practical expedient have not been categorized in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amount presented in the Consolidated Statements of Assets and Liabilities.

Fair Value Measurements - Sch_2

Fair Value Measurements - Schedule of Changes in Level 3 Investment Securities (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Net realized gains/(losses) on investments	$ (289)	$ 0
Fair Value, Asset, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]		Investment Income, Operating, after Expense and Tax
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Investment Income, Operating, after Expense and Tax
Level 3
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Balance, Beginning of Period	$ 664,740	$ 0
Purchases	89,894	729,402
Payment-in-kind and other adjustments to cost	(574)	265
Principal repayments	(70,951)	(52,772)
Net realized gains/(losses) on investments	(289)
Net amortization of premium/discount	1,838	1,401
Net change unrealized gains/(losses)	(15)	(12,556)
Transfers into Level 3	1,305
Transfer out of Level 3		(1,000)
Balance, End of Period	685,948	664,740
Net change unrealized appreciation/(depreciation) for investments still held	(12,572)	(12,556)
Level 3 | Senior Secured First Lien Loans
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Balance, Beginning of Period	483,740	0
Purchases	64,281	543,253
Payment-in-kind and other adjustments to cost	656	265
Principal repayments	(53,083)	(52,263)
Net realized gains/(losses) on investments	(289)
Net amortization of premium/discount	1,838	1,401
Net change unrealized gains/(losses)	679	(8,916)
Balance, End of Period	497,822	483,740
Net change unrealized appreciation/(depreciation) for investments still held	(8,237)	(8,916)
Level 3 | Equity
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Balance, Beginning of Period	2,633	0
Purchases	51	3,633
Net change unrealized gains/(losses)	(348)
Transfers into Level 3	1,305
Transfer out of Level 3		(1,000)
Balance, End of Period	3,641	2,633
Net change unrealized appreciation/(depreciation) for investments still held	(348)	0
Level 3 | Subordinated Certificates Of SDLP
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Balance, Beginning of Period	178,367	0
Purchases	25,562	182,516
Payment-in-kind and other adjustments to cost	(1,230)
Principal repayments	(17,868)	(509)
Net change unrealized gains/(losses)	(346)	(3,640)
Balance, End of Period	184,485	178,367
Net change unrealized appreciation/(depreciation) for investments still held	$ (3,987)	$ (3,640)

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2023 USD ($)
Level 3
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Transfers into Level 3	$ 1,305

Fair Value Measurements - Sch_3

Fair Value Measurements - Schedule of Quantitative Information About Level 3 Fair Value Measurements of Investments (Details) - Level 3 $ in Thousands		Dec. 31, 2023 USD ($)		Dec. 31, 2022 USD ($)
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Senior Secured First Lien Term Loans		$ 685,948		$ 664,740
Market approach (Recovery) | EBITDA Multiple | Minimum
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Senior Secured First Lien Term Loans		0.0105
Market approach (Recovery) | EBITDA Multiple | Maximum
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Senior Secured First Lien Term Loans		0.0176
Market approach (Recovery) | EBITDA Multiple | Weighted Average
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Senior Secured First Lien Term Loans	[1]	0.00135
Senior Secured First Lien Loans | Income approach (DCF) | Discount Rate
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Senior Secured First Lien Term Loans		$ 476,551		$ 459,838
Senior Secured First Lien Term Loans | Income approach (DCF) | Discount Rate | Minimum
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Senior Secured First Lien Term Loans		0.0084		0.008
Senior Secured First Lien Term Loans | Income approach (DCF) | Discount Rate | Maximum
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Senior Secured First Lien Term Loans		0.0165		0.0133
Senior Secured First Lien Term Loans | Income approach (DCF) | Discount Rate | Weighted Average
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Senior Secured First Lien Term Loans		0.00105	[1]	0.00098	[2]
Senior Secured First Lien Term Loans | Recent Transaction | Transaction Prices
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Senior Secured First Lien Term Loans		$ 21,271		$ 21,628
Senior Secured First Lien Term Loans | Recent Transaction | Transaction Prices | Minimum
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Senior Secured First Lien Term Loans		0.097		0.0962
Senior Secured First Lien Term Loans | Recent Transaction | Transaction Prices | Maximum
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Senior Secured First Lien Term Loans		0.0989		0.099
Senior Secured First Lien Term Loans | Recent Transaction | Transaction Prices | Weighted Average
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Senior Secured First Lien Term Loans		0.00977	[1]	0.00973	[2]
Senior Secured First Lien Term Loans | Market approach (Recovery) | EBITDA Multiple
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Senior Secured First Lien Term Loans				$ 2,274
Senior Secured First Lien Term Loans | Market approach (Recovery) | EBITDA Multiple | Minimum
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Senior Secured First Lien Term Loans				0.0079
Senior Secured First Lien Term Loans | Market approach (Recovery) | EBITDA Multiple | Maximum
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Senior Secured First Lien Term Loans				0.014
Senior Secured First Lien Term Loans | Market approach (Recovery) | EBITDA Multiple | Weighted Average
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Senior Secured First Lien Term Loans	[2]			0.00118
Subordinated Certificates Of SDLP | Income approach (DCF) | Discount Rate
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Senior Secured First Lien Term Loans		$ 184,485		$ 178,367
Subordinated Certificates Of SDLP | Income approach (DCF) | Discount Rate | Minimum
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Senior Secured First Lien Term Loans		0.0085		0.010
Subordinated Certificates Of SDLP | Income approach (DCF) | Discount Rate | Maximum
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Senior Secured First Lien Term Loans		0.0095		0.011
Subordinated Certificates Of SDLP | Income approach (DCF) | Discount Rate | Weighted Average
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Senior Secured First Lien Term Loans	[2]	0.0095		0.00107
Equity | Income approach (DCF) | Discount Rate
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Senior Secured First Lien Term Loans		$ 1,735
Equity | Income approach (DCF) | Discount Rate | Minimum
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Senior Secured First Lien Term Loans		0.0075
Equity | Income approach (DCF) | Discount Rate | Maximum
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Senior Secured First Lien Term Loans		0.0105
Equity | Income approach (DCF) | Discount Rate | Weighted Average
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Senior Secured First Lien Term Loans	[1]	0.00088
Equity | Recent Transaction | Transaction Prices
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Senior Secured First Lien Term Loans		$ 805
Senior Secured First Lien Term Loans		0.100
Equity | Recent Transaction | Transaction Prices | Weighted Average
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Senior Secured First Lien Term Loans	[1]	0.0100
Equity | Market approach (Recovery) | Discount Rate
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Senior Secured First Lien Term Loans		$ 1,101
Equity | Market approach (Recovery) | EBITDA Multiple | Minimum
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Senior Secured First Lien Term Loans		0.011
Equity | Market approach (Recovery) | EBITDA Multiple | Maximum
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Senior Secured First Lien Term Loans		0.020
Equity | Market approach (Recovery) | EBITDA Multiple | Weighted Average
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Senior Secured First Lien Term Loans	[1]	0.00144
Equity | Income approach (DCF) market approach | E B I T D A Multiple Long Term Growth Rate Discount Rate Market Comps
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Senior Secured First Lien Term Loans				$ 2,633
Equity | Income Approach And Market Valuation Technique Approach | Measurement Input, Long-Term Revenue Growth Rate | Minimum
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Senior Secured First Lien Term Loans				0.0063
Equity | Income Approach And Market Valuation Technique Approach | Measurement Input, Long-Term Revenue Growth Rate | Maximum
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Senior Secured First Lien Term Loans				0.0103
Equity | Income Approach And Market Valuation Technique Approach | Measurement Input, Long-Term Revenue Growth Rate | Weighted Average
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Senior Secured First Lien Term Loans	[2]			0.00083
[1] (1) Unobservable inputs were weighted by the relative fair value of the investments. (1) Unobservable inputs were weighted by the relative fair value of the investments.

Derivative Instruments - Summar

Derivative Instruments - Summary of Company's Derivative Instruments Related to Assets and Liabilities (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2023 USD ($)
Derivative [Line Items]
Notional Amount	$ 50,000
Gross Amount of Recognized Assets	0
Gross Amount of Recognized Liabilities	$ 91
Interest Rate Swap Due On 12/21/2026
Derivative [Line Items]
Maturity Date	Dec. 21, 2026
Notional Amount	$ 25,000
Gross Amount of Recognized Assets	0
Gross Amount of Recognized Liabilities	$ 20
Interest Rate Swap Due On 12/21/2028
Derivative [Line Items]
Maturity Date	Dec. 21, 2028
Notional Amount	$ 25,000
Gross Amount of Recognized Assets	0
Gross Amount of Recognized Liabilities	$ 71

Derivative Instruments - Summ_2

Derivative Instruments - Summary of Net Unrealized Gain (loss) on Derivative Instruments (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Derivative [Line Items]
Net change in unrealized appreciation (depreciation) on derivatives	$ (91)	$ 0
Interest Rate Swap
Derivative [Line Items]
Net change in unrealized appreciation (depreciation) on derivatives	$ (91)

Derivative Instruments - Additi

Derivative Instruments - Additional Information (Details) $ in Thousands	Dec. 31, 2023 USD ($)
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Termination fair value of derivatives	$ (95)

Borrowings - Additional Informa

Borrowings - Additional Information (Details) - USD ($)						12 Months Ended
	Nov. 20, 2023	Mar. 03, 2023	Jan. 31, 2023	Jan. 26, 2023	Jun. 02, 2022	Dec. 31, 2023	Dec. 21, 2023	Dec. 31, 2022
Debt Instrument [Line Items]
Initial shareholder authorized decreasing in asset coverage ratio						150%
Asset coverage ratio						238.22%
Debt instrument termination date					Jun. 02, 2027
Borrowing base limitations						$ 67,200,000
Aggregate Principal Amount Available						425,000,000		$ 515,000,000
J P M Facility
Debt Instrument [Line Items]
Debt financing cost				$ 1,400,000
Aggregate Principal Amount Available						$ 300,000,000		$ 500,000,000
Percentage of minimum funding amount	85%
Decreased percentage of minimum funding amount	75%
Percentage of collateral principal amount	0%
Increased percentage of collateral principal amount	10%
C I B C Facility
Debt Instrument [Line Items]
Initial principal amount			$ 75,000,000
Borrowing base limitations			$ 150,000,000
Description of debt instrument rate						The Company pays a fee of 0.375% per annum on the average daily committed but unused amounts under the CIBC Facility during the first nine months of the CIBC Facility (January 31, 2023 up to but not including October 31, 2023), and thereafter, 0.375% if the average daily used amount of the commitment exceeds 25% of the total commitment or otherwise, 0.50%.
Aggregate Principal Amount Available						$ 75,000,000
2026 Notes
Debt Instrument [Line Items]
Aggregate Principal Amount Available						25,000,000
2026 Notes | Tranche A
Debt Instrument [Line Items]
Aggregate Principal Amount Available							$ 25,000,000
Interest rate							8.10%
2028 Notes
Debt Instrument [Line Items]
Aggregate Principal Amount Available						$ 25,000,000
2028 Notes | Tranche B
Debt Instrument [Line Items]
Aggregate Principal Amount Available							$ 25,000,000
Interest rate							8.20%
Prime Rate | C I B C Facility
Debt Instrument [Line Items]
Debt instrument, interest rate, effective percentage			1%
SOFR
Debt Instrument [Line Items]
Debt instrument, interest rate, effective percentage					2.375%
Interest rate						8%
SOFR | C I B C Facility
Debt Instrument [Line Items]
Debt instrument, interest rate, effective percentage			2.50%
Debt instrument interest rate effective percentage after availability period			2.75%
LIBOR
Debt Instrument [Line Items]
Debt instrument, interest rate, effective percentage					2.494%
Base Rate
Debt Instrument [Line Items]
Debt instrument, interest rate, effective percentage					2.475%
Base Rate | C I B C Facility
Debt Instrument [Line Items]
Debt instrument, interest rate, effective percentage			1.50%
Debt instrument interest rate effective percentage after availability period			1.75%
Maximum
Debt Instrument [Line Items]
Asset coverage ratio						150%
Borrowings under investment agreements					$ 300,000,000
Other borrowings					$ 600,000,000
Company fee percentage		0.75%
Maximum | J P M Facility
Debt Instrument [Line Items]
Reduced borrowings related to leverage and borrowing based restrictions				500,000,000
Line of credit commitment increase reduced to lender consent				800,000,000
Minimum
Debt Instrument [Line Items]
Liabilities other than indebtedness total						200%
Asset coverage ratio						150%
Company fee percentage					0.50%
Minimum | J P M Facility
Debt Instrument [Line Items]
Reduced borrowings related to leverage and borrowing based restrictions				300,000,000
Line of credit commitment increase reduced to lender consent				$ 600,000,000

Borrowings - Schedule of Outsta

Borrowings - Schedule of Outstanding Debt (Details) - USD ($) $ in Thousands		Dec. 31, 2023	Dec. 31, 2022
Debt Instrument [Line Items]
Aggregate Principal Amount Available		$ 425,000	$ 515,000
Principal Amount Outstanding		291,670	278,500
Carrying Value		291,670	278,500
Fair Value		291,670	278,500
J P M Facility
Debt Instrument [Line Items]
Aggregate Principal Amount Available		300,000	500,000
Principal Amount Outstanding		233,900	270,500
Carrying Value		233,900	270,500
Fair Value		233,900	270,500
C I B C Facility
Debt Instrument [Line Items]
Aggregate Principal Amount Available		75,000
Principal Amount Outstanding		7,770
Carrying Value		7,770
Fair Value		7,770
Fronting Letter Agreement
Debt Instrument [Line Items]
Aggregate Principal Amount Available	[1]		15,000
Principal Amount Outstanding	[1]		8,000
Carrying Value	[1]		8,000
Fair Value	[1]		$ 8,000
2026 Notes
Debt Instrument [Line Items]
Aggregate Principal Amount Available		25,000
Principal Amount Outstanding		25,000
Carrying Value		25,000
Fair Value		25,000
2028 Notes
Debt Instrument [Line Items]
Aggregate Principal Amount Available		25,000
Principal Amount Outstanding		25,000
Carrying Value		25,000
Fair Value		$ 25,000
[1] (1) See Note 7. Related Party Transactions for details on the Fronting Amount.

Borrowings - Summary Of Interes

Borrowings - Summary Of Interest Expense, Non Usage Fees And Amortization Of Financing Costs (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Debt Instrument [Line Items]
Facility interest	$ 21,187	$ 8,191
Facility unused fees	2,676	1,146
Amortization of debt issuance costs	2,120	471
J P M Facility
Debt Instrument [Line Items]
Facility interest	19,427	8,191
Facility unused fees	374	675
Amortization of debt issuance costs	1,918	471
Total interest and financing expenses	21,719	9,337
Weighted average outstanding debt balance	$ 254,857	$ 272,019
Weighted average interest rate (annualized)	7.60%	5.20%
C I B C Facility
Debt Instrument [Line Items]
Facility interest	$ 1,647
Facility unused fees	181
Amortization of debt issuance costs	199
Total interest and financing expenses	2,027
Weighted average outstanding debt balance	$ 21,184
Weighted average interest rate (annualized)	7.80%
2026 Notes
Debt Instrument [Line Items]
Facility interest	$ 56
2028 Notes
Debt Instrument [Line Items]
Facility interest	57
Unsecured Notes
Debt Instrument [Line Items]
Amortization of debt issuance costs	4
Total interest and financing expenses	$ 117
Weighted average stated interest rate	8.20%
Weighted average outstanding balance	$ 1,507

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Details) - USD ($)		12 Months Ended
	Dec. 15, 2022	Dec. 31, 2023	Dec. 31, 2022	Jan. 17, 2023	Dec. 28, 2022
Related Party Transaction [Line Items]
Base management fees (Note 7)		$ 5,081,000	$ 2,818,000
Base management fees payable (Note 7)		1,286,000	1,264,000
Organizational expenses		378,000	187,000
Administrator expenses payable		287,000	295,000
Fronting amount payable (Note 7)		$ 0	8,000,000
Varagon
Related Party Transaction [Line Items]
Remaining amount repaid				$ 8,000,000
Investment Advisory Agreement
Related Party Transaction [Line Items]
Management fee at an annual rate of adjusted gross assets		0.75%
Management fee payable at an annual rate of adjusted gross assets		1%
Base management fees (Note 7)		$ 5,100,000	2,800,000
Income incentive fees		6,000,000	1,300,000
Income incentive fees payable (Note 7)		2,200,000	500,000
Capital gains incentive fee		$ 0	0
Investment Advisory Agreement | Advisor
Related Party Transaction [Line Items]
Agreement entered date		Jun. 02, 2022
Investment Advisory Agreement | Prior to Public Listing
Related Party Transaction [Line Items]
Incentive fee hurdle rate per quarter		1.75%
Incentive fee hurdle rate annualized		7%
Catch up amount based on percentage of pre incentive fee net investment income		12.50%
Remaining pre-incentive fee net investment income		12.50%
Percentage of cumulative net return		12.50%
Capital gains incentive fee based on percentage of realized capital gains prior to public listing		12.50%
Investment Advisory Agreement | Prior to Public Listing | Maximum
Related Party Transaction [Line Items]
Percentage of pre incentive fee net investment income		100%
Investment Advisory Agreement | Following a Public Listing
Related Party Transaction [Line Items]
Incentive fee hurdle rate per quarter		1.75%
Incentive fee hurdle rate annualized		7%
Catch up amount based on percentage of pre incentive fee net investment income		20%
Remaining pre-incentive fee net investment income		20%
Percentage of cumulative net return		20%
Capital gains incentive fee based on percentage of realized capital gains prior to public listing		20%
Investment Advisory Agreement | Following a Public Listing | Maximum
Related Party Transaction [Line Items]
Percentage of pre incentive fee net investment income		100%
Administration Agreement
Related Party Transaction [Line Items]
Organizational expenses		$ 1,200,000	700,000
Administrator expenses payable		$ 300,000	300,000
Expense Reimbursement Agreement
Related Party Transaction [Line Items]
Agreement entered date		Jun. 02, 2022
Fronting Letter Agreement
Related Party Transaction [Line Items]
Agreement entered date		Dec. 15, 2022
Number of days to reimburse each fronted amount		90 days
Advanced fronted amount			10,000,000
Fronted amount repaid					$ 2,000,000
Fronting amount payable (Note 7)			$ 8,000,000
Fronting Letter Agreement | Maximum
Related Party Transaction [Line Items]
Advance aggregate amount of fronted amount	$ 15,000,000
Placement Agent Agreements | Rondout Partners LLC
Related Party Transaction [Line Items]
Agreement entered date		May 23, 2022
Agreement termination date		Jul. 18, 2023
Placement Agent Agreements | Man Investments Inc
Related Party Transaction [Line Items]
Agreement entered date		Sep. 06, 2023

Commitments- Additional Informa

Commitments- Additional Information (Details) $ in Thousands	Dec. 31, 2023 USD ($) Borrower	Dec. 31, 2022 USD ($) Borrower
Unrecorded Unconditional Purchase Obligation [Line Items]
Commitments fund through portfolio companies	$ 22,714	$ 32,982
Number of portfolio companies | Borrower	29	30
Cash	$ 19,976	$ 20,416
Available borrowings	488,200
Borrowing base limitations	67,200
Undrawn capital commitments	73,500
J P M Facility
Unrecorded Unconditional Purchase Obligation [Line Items]
Cash	20,000
Available borrowings	$ 66,100

Commitments - Schedule of Unfun

Commitments - Schedule of Unfunded Commitments (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	$ 22,714	$ 32,982
Accupac, LLC
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	564	564
ADPD Holdings, LLC.
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	5	5
ADPD Holdings, LLC.
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	0	2
ADPD Holdings, LLC.
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	12	13
ADPD Holdings, LLC.
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	13	13
Advanced Web Technologies Holding Company
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	0	76
Adviser Investments, LLC
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	9	9
Adviser Investments, LLC
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	37	53
Arrowhead Holdco Company
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	0	19
Boulder Scientific Company, LLC
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	625	1,043
BRG Acquisition Co., LLC
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	600	600
Cadent, LLC
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	0	181
Castleworks Home Services Company
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	7	277
Center For Autism and Related Disorders, LLC
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	0	2,235
Concord III, L.L.C.
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	210	0
Energy Labs Holdings Corp.
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	0	943
Express Wash Acquisition Company, LLC
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	115	115
Eye Health America, LLC
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	360	456
Eye Health America, LLC
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	1,092	1,146
Fingerpaint Marketing, Inc.
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	14	0
HLSG Intermediate, LLC
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	1,655	0
JTM Foods LLC
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	3	0
KL Bronco Acquisition, Inc.
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	0	27
KL Bronco Acquisition, Inc.
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	250	536
KL Bronco Acquisition, Inc.
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	1,786	1,786
Krayden Holdings, Inc
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	386	0
Krayden Holdings, Inc
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	386	0
Krayden Holdings, Inc
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	405	0
Leiters, Inc
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	244	0
M&D Midco, Inc.
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	11	12
M&D Midco, Inc.
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	10	23
MDI Buyer, Inc.
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	7	7
MWD Management, LLC
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	266	0
MWD Management, LLC
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	0	233
North Haven Stallone Buyer, LLC
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	333	0
North Haven Stallone Buyer, LLC
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	0	10
OIS Management Services, LLC
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	577	577
OIS Management Services, LLC
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	0	1,923
Oliver Packaging, LLC
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	176	585
Online Labels Group, LLC
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	10	0
Online Labels Group, LLC
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	9	0
Online Labels Group, LLC
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	9	0
Pediatric Home Respiratory Services, LLC
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	0	1,063
POY Holdings, LLC
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	1,211	0
RFI Buyer, Inc.
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	12	12
RFI Buyer, Inc.
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	0	14
Senior Direct Lending Program, LLC
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	8,557	10,438
SGA Dental Partners Opco, LLC
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	0	4,629
SGA Dental Partners Opco, LLC
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	1,394	0
Techmer BB Bidco, LLC
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	0	7
Techmer BB Bidco, LLC
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	32	36
Turbo Buyer, Inc.
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	760	760
United Musculoskeletal Partners Acquisition Holdings, LLC
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	562	1,630
USN Opco, LLC
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	0	593
USSC Acquisition Corp.
Unrecorded Unconditional Purchase Obligation [Line Items]
Total Unfunded Commitments	$ 0	$ 331

Directors Fees - Additional Inf

Directors Fees - Additional Information (Details) - USD ($)		12 Months Ended
	Mar. 08, 2022	Dec. 31, 2023	Dec. 31, 2022
Deferred Compensation Arrangement With Individual Share Based Payments [Line Items]
Directors' fees and expenses		$ 339,000	$ 349,000
Directors' fees and expenses payable		$ 82,000	$ 84,000
Independent Director [Member]
Deferred Compensation Arrangement With Individual Share Based Payments [Line Items]
Annual Fees	$ 80,000
Reimbursement expense	1,000
Additional annual fee	1,500
Board Of Directors Chairman [Member]
Deferred Compensation Arrangement With Individual Share Based Payments [Line Items]
Reimbursement expense	2,500
Lead independent director [Member]
Deferred Compensation Arrangement With Individual Share Based Payments [Line Items]
Additional annual fee	7,500
Chair Person of Board's Audit Committee [Member]
Deferred Compensation Arrangement With Individual Share Based Payments [Line Items]
Additional annual fee	15,000
Board's Nominating And Corporate Governance Committee [Member]
Deferred Compensation Arrangement With Individual Share Based Payments [Line Items]
Additional annual fee	$ 7,500

Share Data And Distributions -

Share Data And Distributions - Summary of Computation of Basic and Diluted Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands		7 Months Ended		9 Months Ended	12 Months Ended
		Dec. 31, 2022	[1],[2]	Dec. 31, 2022	Dec. 31, 2023		Dec. 31, 2022
Equity [Abstract]
Net Income (Loss)					$ 42,242		$ 9,242
Weighted average shares outstanding, Basic		39,848,927		30,531,755	41,499,392	[1],[2],[3]	39,848,927	[3]
Earnings per share basic	[3],[4]				$ 1.02		$ 0.23
Earnings per share diluted	[3],[4]				$ 1.02		$ 0.23
[1] (10) Weighted average common shares outstanding for the year ended December 31, 2022 was 30,531,755 , calculated from March 29, 2022 (first issuance of shares of common stock) through December 31, 2022. (9) Calculated for the period from June 2, 2022 (the commencement of investment operations) through December 31, 2022. (1) Per share data for the year ended December 31, 2022 was derived by using the weighted average shares outstanding from the June 2, 2022 (commencement of investment operations) through December 31, 2022 and does not include the 100 shares issued in connection with the Company's seed audit on March 29, 2022 that were subsequently redeemed on June 2, 2022 in connection with the Merger. Per share data was derived by using the weighted average shares outstanding from the June 2, 2022 (commencement of investment operations) through December 31, 2022 and does not include the 100 shares issued in connection with the Company's seed audit on March 29, 2022 that were subsequently redeemed on June 2, 2022 in connection with the merger of Varagon Fund I, L.P. with and into the Company, with the Company as the surviving entity in the merger.

Share Data And Distributions _2

Share Data And Distributions - Summary of Computation of Basic and Diluted Earnings Per Share (Paranthetical) (Details)	Mar. 29, 2022 shares
Equity [Abstract]
Redeemable shares issued	100

Share Data And Distributions _3

Share Data And Distributions - Additional Information (Details) $ / shares in Units, $ in Thousands		12 Months Ended
	Mar. 29, 2022 $ / shares shares	Dec. 31, 2023 USD ($) $ / shares shares	Dec. 31, 2022 USD ($) $ / shares shares	Jun. 02, 2022 shares
Deferred Compensation Arrangement With Individual Excluding Share Based Payments And Postretirement Benefits [Line Items]
Common stock issued | shares	100	41,505,531	41,490,642	100
Common stock, shares authorized | shares		500,000,000	500,000,000
Common Stock, Par or Stated Value Per Share | $ / shares	$ 10	$ 0.01	$ 0.01
Redemption date	Jun. 02, 2022
Available borrowings		$ 488,200
Undrawn capital commitments		73,500
Common Stock Value		$ 415	$ 415
Percentage of dividends distributed		0.90
June 2, 2022
Deferred Compensation Arrangement With Individual Excluding Share Based Payments And Postretirement Benefits [Line Items]
Common stock issued | shares		36,130,510
Common Stock, Par or Stated Value Per Share | $ / shares		$ 10
Common Stock Value		$ 361,305
Adviser And Affiliates Executives And Employees Of Adviser And Officers And Directors | June 2, 2022
Deferred Compensation Arrangement With Individual Excluding Share Based Payments And Postretirement Benefits [Line Items]
Common Stock Value		$ 5,100

Share Data And Distributions _4

Share Data And Distributions - Summary of Total Shares Issued and Proceeds Received to Capital Drawdowns (Details) - USD ($) $ / shares in Units, $ in Thousands	Dec. 31, 2023	Dec. 31, 2022	Jun. 02, 2022	Mar. 29, 2022
Class Of Stock [Line Items]
Common stock, Shares issued	41,505,531	41,490,642	100	100
Common Stock Value	$ 415	$ 415
Common Stock, Par or Stated Value Per Share	$ 0.01	$ 0.01		$ 10
June 2, 2022
Class Of Stock [Line Items]
Common stock, Shares issued	36,130,510
Common Stock Value	$ 361,305
Common Stock, Par or Stated Value Per Share	$ 10
July 12, 2022
Class Of Stock [Line Items]
Common stock, Shares issued	2,994,012
Common Stock Value	$ 30,000
Common Stock, Par or Stated Value Per Share	$ 10.02
September 7, 2022
Class Of Stock [Line Items]
Common stock, Shares issued	2,362,205
Common Stock Value	$ 24,000
Common Stock, Par or Stated Value Per Share	$ 10.16

Share Data And Distributions _5

Share Data And Distributions - Summary Of Shares Issued Under DRIP (Details)	12 Months Ended
	Dec. 31, 2023 USD ($) $ / shares shares
Class Of Stock [Line Items]
Cash Distribution	$ 63,578
DRIP Shares Issued | shares	24,949
DRIP Shares Value	$ 248
Quarterly One
Class Of Stock [Line Items]
Date Declared	Dec. 12, 2022
Record Date	Dec. 15, 2022
Payment Dates	Dec. 21, 2022
Amount per Share | $ / shares	$ 0.2635
Cash Distribution	$ 10,892
DRIP Shares Issued | shares	3,915
DRIP Shares Value	$ 40
Quarterly Two
Class Of Stock [Line Items]
Date Declared	Dec. 19, 2022
Record Date	Dec. 23, 2022
Payment Dates	Jan. 27, 2023
Amount per Share | $ / shares	$ 0.2405
Cash Distribution	$ 9,941
DRIP Shares Issued | shares	3,665
DRIP Shares Value	$ 37
Quarterly Three
Class Of Stock [Line Items]
Date Declared	Mar. 23, 2023
Record Date	Mar. 27, 2023
Payment Dates	Mar. 31, 2023
Amount per Share | $ / shares	$ 0.2222
Cash Distribution	$ 9,185
DRIP Shares Issued | shares	3,619
DRIP Shares Value	$ 35
Quarterly Four
Class Of Stock [Line Items]
Date Declared	May 10, 2023
Record Date	Jul. 01, 2023
Payment Dates	Jul. 15, 2023
Amount per Share | $ / shares	$ 0.2246
Cash Distribution	$ 9,284
DRIP Shares Issued | shares	3,780
DRIP Shares Value	$ 37
Quarterly Five
Class Of Stock [Line Items]
Date Declared	Aug. 08, 2023
Record Date	Oct. 02, 2023
Payment Dates	Oct. 16, 2023
Amount per Share | $ / shares	$ 0.2271
Cash Distribution	$ 9,387
DRIP Shares Issued | shares	3,825
DRIP Shares Value	$ 38
Quarterly Six
Class Of Stock [Line Items]
Date Declared	Nov. 07, 2023
Record Date	Dec. 27, 2023
Payment Dates	Jan. 17, 2024
Amount per Share | $ / shares	$ 0.2397
Cash Distribution	$ 9,908
DRIP Shares Issued | shares	4,089
DRIP Shares Value	$ 41
Special
Class Of Stock [Line Items]
Date Declared	Dec. 18, 2023
Record Date	Dec. 27, 2023
Payment Dates	Jan. 17, 2024
Amount per Share | $ / shares	$ 0.1205
Cash Distribution	$ 4,981
DRIP Shares Issued | shares	2,056
DRIP Shares Value	$ 20

Income Tax Information and Di_3

Income Tax Information and Distributions to Shareholders - Additional Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Income tax [Line item]
Minimum percentage of investment company taxable income distribute to stockholders in each taxable year to qualify as RIC	90%
Nondeductible U.S. federal excise tax percentage	4%
Distributed percentage of ordinary income	98%
Distributed percentage of capital gains	98.20%
Undistributed percentage of ordinary income		98%
Undistributed percentage of capital gains		98.20%
Excise tax	$ 0	$ 100
Capital Loss Carryforwards	(300)
Net operating loss carryforward for federal income tax	40,791
Capital loss carry forwards	0
Deferred Tax Assets and Liabilities	$ 0	$ 0
Federal Statutory income tax rate	21%
Additional Paid-in Capital [Member]
Income tax [Line item]
Investment Company, Tax Reclassification	$ (29,489)
Retained Earnings [Member]
Income tax [Line item]
Investment Company, Tax Reclassification	$ 29,489

Income Tax Information and Di_4

Income Tax Information and Distributions to Shareholders - Summary of Tax Cost of Investments, Gross and Net Unrealized Appreciation and Depreciation (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Tax cost of investments	$ 686,423	$ 679,589
Unrealized appreciation	1,389	216
Unrealized depreciation	(1,775)	(13,659)
Net unrealized appreciation (depreciation) from investments	$ (386)	$ (13,443)

Income Tax Information and Di_5

Income Tax Information and Distributions to Shareholders - Summary of Tax Character of Distributions Paid (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Ordinary Income	$ 42,916	$ 20,910
Long-term Capital Gain	0	0
Return of capital	$ 0	$ 0

Income Tax Information and Di_6

Income Tax Information and Distributions to Shareholders - Schedule Of Components Of Distributable Earnings On Tax Basis (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Undistributed Ordinary Income	$ 0	$ 1,998
Undistributed capital gains	0	0
Capital Loss Carry Forwards	(289)	0
Late Year Losses	0	0
Other Accumulated Losses	(11,575)	(161)
Unrealized appreciation/(depreciation)	(386)	(13,443)
Components of distributable earnings/(accumulated deficits) at year end	$ (12,250)	$ (11,606)

Income Tax Information and Di_7

Income Tax Information and Distributions to Shareholders - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Deferred tax assets:
Net operating loss carryforward	$ 9,894
Net unrealized loss on investments	81,323
Valuation allowance	(91,218)
Total deferred tax assets	0
Deferred tax liabilities:
Total deferred tax liabilities	0
Net deferred tax assets and liabilities	$ 0	$ 0

Income Tax Information and Di_8

Income Tax Information and Distributions to Shareholders - Schedule of Components of Income Tax Expense (Benefit) (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2023 USD ($)
Current tax (expense)/benefit
Federal	$ 0
State and Local	0
Total current tax (expense)/benefit	0
Deferred tax (expense)/benefit
Federal	78,974
State and Local	12,244
Valuation allowance	(91,218)
Total deferred tax (expense)/benefit	0
Total income tax (expense)/benefit	$ 0

Income Tax Information and Di_9

Income Tax Information and Distributions to Shareholders - Schedule of Effective Income Tax Rate Reconciliation (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2023 USD ($)
Income Tax Disclosure [Abstract]
Income tax benefit at federal statutory tax rate	$ 10,409,380
Income attributable to the RIC and not subject to corporate tax	(10,330,464)
State and local income tax benefit (net of federal detriment)	12,235
Prior year net operating loss carryforward	3,190
Book vs. tax basis in partnership investments	(3,123)
Permanent differences	0
Valuation allowance	(91,218)
Total income tax (expense)/benefit	$ 0

Financial Highlights - Schedule

Financial Highlights - Schedule of Financial Highlights (Details) - USD ($) $ / shares in Units, $ in Thousands		7 Months Ended		9 Months Ended		12 Months Ended
		Dec. 31, 2022		Dec. 31, 2022		Dec. 31, 2023		Dec. 31, 2022
Per Share Data: (1)(2)
Net asset value, beginning of period (3)	[1],[2],[3]					$ 9.73
Net investment income (loss)		$ 0.55	[1],[2]			1.03	[1],[2]	$ 0.71
Net unrealized appreciation (depreciation)	[1],[2]	(0.32)				0
Net realized gains (losses)	[1],[2]					(0.01)
Net increase (decrease) in net assets resulting from operations		0.23	[1],[2]			1.02	[1],[2]	0.41
Distributions of net investment income to shareholders (4)	[1],[2],[4]	(0.5)				(1.04)
Issuance of common stock	[1],[2]	10
Net asset value per share, end of period	[1],[2]	$ 9.73	[3]	$ 9.73	[3]	$ 9.71		$ 9.73	[3]
Ending balance, shares	[1],[2]	41,490,642		41,490,642		41,505,531		41,490,642
Total return based on net asset value (5)(6)	[1],[2],[5],[6]	2.18%				10.81%
Net assets attributable to shareholders, end of period	[1],[2]	$ 403,677		$ 403,677		$ 403,150		$ 403,677
Ratio to average net assets attributable to shareholders:
Average net assets		$ 395,488				$ 405,570
Total expenses (7)	[7]	6.83%				9.84%
Total expenses (other than incentive fee) (7)	[7]	6.50%				8.35%
Net investment income (7)	[7]	9.73%				10.51%
Interest expense and credit facility fees (7)	[7]	4.05%				5.88%
Ratios/Supplemental Data:
Asset coverage, end of period (8)	[8]	244.95%				238.22%
Weighted average shares outstanding, Basic		39,848,927	[9],[10]	30,531,755		41,499,392	[9],[10],[11]	39,848,927	[11]
Weighted average shares outstanding, Diluted		39,848,927	[9],[10]	30,531,755		41,499,392	[9],[10]	39,848,927
Total capital commitments, end of period		$ 488,208				$ 488,208
Ratio of total contributed capital to total committed capital, end of period	[12]	84.95%				84.95%
Average debt outstanding (11)	[12]	$ 272,563				$ 277,548
Average debt outstanding per share		$ 6.84				$ 6.69
Portfolio turnover (6)(12)	[6],[13]	10.20%				9.85%
Year of formation		2019				2019
[1] (1) The per share data for 2023 was derived by using the weighted average shares outstanding. The per share data for 2022 was derived by using the weighted average shares outstanding from June 2, 2022 (commencement of investment operations) through December 31, 2022. (2) Per share data for the year ended December 31, 2022 based upon the weighted average shares outstanding from March 29, 2022 (first issuance of common stock) through December 31, 2022 were as follows: Net investment income of $ 0.71 per share, net unrealized loss of $ 0.30 per share, net increase in net assets resulting from operations of $ 0.41 per share, distributions of net investment income of $ 0.68 per share, and net asset value per share at the end of the period of $ 9.73 per share. (3) Net asset value at the beginning of the period from June 2, 2022 (commencement of investment operations) through December 31, 2022 is adjusted to reverse the initial share issuance of 100 shares of common stock in connection with the Company's seed audit, as well as $ 81,049 of accrued expenses. Net asset value after the Company's seed audit was $( 810.39 ) per share. (4) Distributions declared per common share was calculated as the sum of distributions on common stock declared during the year divided by the number of shares of common stock outstanding at each respective quarter-end date. (5) Total return is based on the change in net asset value during the year divided by the beginning net asset value for the year, taking into account distributions declared, if any, reinvested in accordance with the Company’s DRIP. (6) Not annualized. (7) Annualized for the period from June 2, 2022 (commencement of investment operations) through December 31, 2022, except in the case of non-recurring expenses (i.e. organizational expenses). (8) Asset coverage per unit is the ratio of the carrying value of our total consolidated assets, less all liabilities and indebtedness not represented by senior securities, to the aggregate amount of senior securities representing indebtedness. Asset coverage per unit is expressed in terms of dollar amounts per $ 1,000 of indebtedness. Asset coverage ratio per unit does not include unfunded commitments. The inclusion of unfunded commitments in the calculation of the asset coverage ratio per unit would not cause the Company to be below the required amount of regulatory coverage. (10) Weighted average common shares outstanding for the year ended December 31, 2022 was 30,531,755 , calculated from March 29, 2022 (first issuance of shares of common stock) through December 31, 2022. (9) Calculated for the period from June 2, 2022 (the commencement of investment operations) through December 31, 2022. (1) Per share data for the year ended December 31, 2022 was derived by using the weighted average shares outstanding from the June 2, 2022 (commencement of investment operations) through December 31, 2022 and does not include the 100 shares issued in connection with the Company's seed audit on March 29, 2022 that were subsequently redeemed on June 2, 2022 in connection with the Merger. (11) Based on daily weighted average balance of debt outstanding during the period. (12) Portfolio turnover calculation does not include the non-cash acquisition of the SDLP.

Financial Highlights - Schedu_2

Financial Highlights - Schedule of Financial Highlights (Parenthetical) (Details) - USD ($)	7 Months Ended		9 Months Ended		12 Months Ended
	Dec. 31, 2022		Dec. 31, 2022		Dec. 31, 2023		Dec. 31, 2022		Jun. 02, 2022	Mar. 29, 2022
Retained Earnings (Accumulated Deficit) [Abstract]
Net investment income (loss)	$ 0.55	[1],[2]			$ 1.03	[1],[2]	$ 0.71
Net unrealized loss							$ 0.3
Net increase (decrease) in net assets resulting from operations	0.23	[1],[2]			1.02	[1],[2]	$ 0.41
Distributions of net investment income							0.68
Net asset value per share	$ (9.73)	[1],[2],[3]	$ (9.73)	[1],[2],[3]	$ (9.71)	[1],[2]	$ (9.73)	[1],[2],[3]	$ (810.39)
Common stock, Shares issued	41,490,642		41,490,642		41,505,531		41,490,642		100	100
Accrued expenses									$ 81,049,000
Asset coverage to indebtedness	$ 1,000,000		$ 1,000,000				$ 1,000,000
Weighted average shares outstanding, Basic	39,848,927	[4],[5]	30,531,755		41,499,392	[4],[5],[6]	39,848,927	[6]
Weighted average shares outstanding, Diluted	39,848,927	[4],[5]	30,531,755		41,499,392	[4],[5]	39,848,927
[1] (1) The per share data for 2023 was derived by using the weighted average shares outstanding. The per share data for 2022 was derived by using the weighted average shares outstanding from June 2, 2022 (commencement of investment operations) through December 31, 2022. (2) Per share data for the year ended December 31, 2022 based upon the weighted average shares outstanding from March 29, 2022 (first issuance of common stock) through December 31, 2022 were as follows: Net investment income of $ 0.71 per share, net unrealized loss of $ 0.30 per share, net increase in net assets resulting from operations of $ 0.41 per share, distributions of net investment income of $ 0.68 per share, and net asset value per share at the end of the period of $ 9.73 per share. (3) Net asset value at the beginning of the period from June 2, 2022 (commencement of investment operations) through December 31, 2022 is adjusted to reverse the initial share issuance of 100 shares of common stock in connection with the Company's seed audit, as well as $ 81,049 of accrued expenses. Net asset value after the Company's seed audit was $( 810.39 ) per share. (10) Weighted average common shares outstanding for the year ended December 31, 2022 was 30,531,755 , calculated from March 29, 2022 (first issuance of shares of common stock) through December 31, 2022. (9) Calculated for the period from June 2, 2022 (the commencement of investment operations) through December 31, 2022. (1) Per share data for the year ended December 31, 2022 was derived by using the weighted average shares outstanding from the June 2, 2022 (commencement of investment operations) through December 31, 2022 and does not include the 100 shares issued in connection with the Company's seed audit on March 29, 2022 that were subsequently redeemed on June 2, 2022 in connection with the Merger.

Subsequent Events - Additional

Subsequent Events - Additional Information (Details) - USD ($)	Mar. 20, 2024	Feb. 02, 2024	Dec. 31, 2023
Subsequent Event [Line Items]
Notional Amount			$ 50,000,000
Subsequent Event
Subsequent Event [Line Items]
Dividends Payable Declared Date	Mar. 20, 2024
Dividends Payable Date to be Paid	Apr. 10, 2024
Dividends Payable Date of Record	Mar. 29, 2024
Dividend Declared Per Share	$ 0.2371
Special Dividends Payable Amount Per Share	$ 0.0333
Two Thousand Twenty Six Notes Interest Rate Swap [Member] | Subsequent Event
Subsequent Event [Line Items]
Notional Amount		$ 25,000,000
Fixed interest rate under swap agreements		8.10%
Maturity Date		Dec. 21, 2026
Two Thousand Twenty Six Notes Interest Rate Swap [Member] | SOFR | Subsequent Event
Subsequent Event [Line Items]
Interest rate spread above SOFR		4.226%
Two Thousand Twenty Eight Notes Interest Rate Swap [Member] | Subsequent Event
Subsequent Event [Line Items]
Notional Amount		$ 25,000,000
Fixed interest rate under swap agreements		8.20%
Maturity Date		Dec. 21, 2028
Two Thousand Twenty Eight Notes Interest Rate Swap [Member] | SOFR | Subsequent Event
Subsequent Event [Line Items]
Interest rate spread above SOFR		4.595%